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So, come up to the lab and see what’s on the slab. 
I see you shiver with anticipation. 
But maybe the rain isn’t really to blame, 
So I’ll remove the cause… but not the symptom! 












DNA topoisomerase VI (topo VI) is a type IIB DNA topoisomerase, found predominantly in 
archaea but with eukaryotic presence in various plant and algal species, and possibly 
plasmodia.  In Arabidopsis thaliana, topo VI is an indispensable nuclear protein, essential for 
endoreduplication, despite the presence of other type IIA topoisomerases, capable of 
performing the same reactions. Whilst topo VI has been proposed to be a DNA decatenase 
since its discovery, robust evidence and a mechanism for its preferential decatenation activity 
was lacking. In this research, the activity of topo VI from the mesophilic archaeon 
Methanosarcina mazei (MmT6) was characterised using ensemble biochemistry, single-
molecule magnetic tweezers and next-generation DNA sequencing (NGS). This demonstrated 
that MmT6 activity was significantly enhanced in the presence of catenated or braided DNA 
substrates, as opposed to supercoiled, through a strong preference for DNA crossings with 
angles close to 90°. In addition, MmT6 behaved as a true crossing sensor with dramatic 
increases in ATPase activity, DNA binding and the rate of strand-passage, with increasing DNA 
writhe. Taken together, these results strongly suggest that MmT6 has evolved an intrinsic 
preference for the unknotting and decatenation of interlinked chromosomes, simultaneously 
disfavouring the relaxation of supercoils, by sensing DNA crossings directly with geometries 
close to 90°. This provided an explanation for why topo VI homologues persist in higher 
eukaryotes during situations in which the genome undergoes rapid duplication, potentially as a 
dedicated DNA decatenase that cannot be substituted by other topoisomerases. It was also 
shown, using an NGS-based technique, that MmT6 cleaved DNA with the sequence preference 
5ʹ-[G/C][G/C]^[A/C/T], generating 2-base overhangs. The in vitro plasmid-based NGS 
technique developed to attain this result was extended to begin exploring the in vitro DNA 
cleavage preferences of other type IIA topoisomerases, namely E. coli DNA topoisomerase IV 
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1.1 The Importance of DNA Topology  
The DNA duplex is one of life’s most fundamental molecules and therefore, maintaining its 
integrity is paramount. Not long after its structure was first elucidated in 1953 by James Watson, 
Francis Crick and Rosalind Franklin [1], potential topological issues associated with such a 
molecular structure recognised [2]. The consequences of topological perturbations in DNA are 
exemplified during replication in which the strands of the duplex are separated. This separation 
leads to the formation of positive supercoils ahead of the replication fork and precatenanes 
behind [3]. If the positive supercoils were not relaxed, binding of the replication machinery and 
progression of the replication fork would be impeded. Furthermore, during replication, the two 
daughter duplexes of closed-circular DNA remain interlinked as catenanes, and large linear 
chromosomes can become knotted and linked. During transcription, DNA strand separation 
also promotes positive supercoiling ahead and negative supercoiling behind the transcriptional 
complex. These structures must be resolved if the cell cycle is to proceed, allowing the cell to 
partition its genetic material and divide unhindered, as well as transcribe and synthesise 
polypeptides. During plasmid replication, negative supercoiling of the origin is required for 
initiation as local melting is necessary for protein binding [4]. And, in addition, the genome of 
E. coli is compacted, which is maintained in part by enzyme-dependent negative supercoiling 
[5]. The proteins responsible for performing these vital roles in DNA topology manipulation are 
called the DNA topoisomerases (topos) and they are crucial to the life of the cell. This 
indispensability, along with their prevalence across all organisms, makes DNA topoisomerases 
key anti-microbial and anti-cancer targets. 
 
Chapter 1: Introduction 
 
 2 
1.2 Describing DNA Topology 
DNA topology, explored thoroughly by Bates and Maxwell [6], describes the structural 
consequences that occur as a result of the DNA double helix and includes supercoils, knots 
and catenanes. Due to the right-handed helical nature of B-form DNA, when the two strands 
are separated during transcription, positive supercoils are generated ahead of the fork and 
negative supercoils behind. In order to discuss DNA topology in this manner, a few terms 
warrant defining. The linking number (Lk) is a term which describes the number of times one 
strand of the duplex fully wraps around the helical axis, and for relaxed DNA there are 10.5 
base pairs (bp) per each of these helical turns (Figure 1A). The following equation can be used 
to calculate the Lk for constrained, relaxed DNA, where N is the total number of bp in the 





Equation 1.1: Calculating the linking number (Lk) for DNA. 
As an example, pBR322, a 4361 bp E. coli plasmid commonly used in topology assays, has a 
linking number of ~ +415. This value is positive as B-form DNA is a right-handed molecule. In 
other words, the two strands within the duplex do not simply lie parallel to each other, but rather, 
they wrap around each other in the right-handed direction. It is also an approximate value owing 
to the fact that a linking number is an integer, however the precise value obtained from using 
equation 1 is 415.3 as the DNA duplex is being treated as a linear segment. In reality, the 
plasmid is circular and the extra twisting needed to bring the two ends into register with each 
other will be distributed throughout the plasmid and count towards changing the topology away 
from the relaxed state. Therefore, the term more commonly employed when describing a fully 
relaxed plasmid is given the specific denotation, Lk°, which has a subtle difference to Lk in that 
it need not be an integer as it is not a true linking number, but rather a reference point for 
evaluating changes in topology. Furthermore, when discussing changes in topology, the 
change in Lk (∆Lk) is used rather than the new total Lk. For instance, if four full righthanded 
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turns were added to relaxed pBR322, the plasmid would be described as ∆Lk = +4 rather than 
Lk = +419. Increasing the linking number by 4 in a small plasmid increases the torsional strain 
more significantly than it would in a large plasmid, so another useful topology term is the 
specific linking difference or superhelical density (σ), as it allows the ∆Lk to be scaled with 





Equation 1.2: Calculating the specific linking difference (σ). 
By describing the extent of supercoiling in this manner, the topology of different sized plasmids 
can be compared.  
 
Figure 1.1: Pictorial representation of DNA topology. A: Representation of the B-form DNA 
duplex. The black vertical dashed line represents the helical axis and bracketed regions highlight 
each full helical twist, which is 10.5 bp (in relaxed DNA) and equals a linking number (Lk) of +1. 
B: Representation of twist and writhe in both positively- (overwound) and negatively- 
(underwound) supercoiled circular DNA.  
 
Twist and writhe are important terms used to describe the physical manifestation of 
increasing or decreasing the Lk for a DNA duplex. If you imagine a strand of DNA constrained 
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at one end and rotate it 360º in a right-handed direction you will increase the Lk of the DNA 
segment by +1, generating positive twist in the DNA, meaning that one strand wraps fully 
around the other in less than 10.5 bp. This is analogous to what happens ahead of the 
replication fork. If you kept rotating the free end of the DNA in this direction, eventually twist 
would be converted to writhe and the helix would begin wrapping around itself, creating positive 
(left-handed) crossings. If you add twist into the helix in a left-handed direction, negative twist 
is introduced, decreasing the Lk and eventually converting to negative (right-handed) writhe 
(Figure 1B). This is analogous to what occurs behind the transcriptional fork and, in vivo, 
metabolically active DNA is generally negatively supercoiled as underwound DNA is easier to 
access [7]. Being the physical manifestation of the Lk, the twist and writhe within constrained 
DNA must add up to the Lk [8, 9]. 
𝐿𝑘 = 𝑇𝑤 +𝑊𝑟 
Equation 1.3: The relationship between twist (Tw), writhe (Wr) and linking number (Lk). 
As must the change in twist and writhe within that molecule, add up to the change in Lk. 
∆𝐿𝑘 = ∆𝑇𝑤 + ∆𝑊𝑟 
Equation 1.4: The relationship among the change in twist (∆Tw), writhe (∆Wr) and linking number 
(∆Lk). 
Alongside supercoiling, DNA duplexes can also become catenated or knotted. 
Catenanes are particularly prevalent within biological systems, being a natural product of 
circular DNA replication. A catenane is formed when two plasmids remain interlinked and this 
situation requires resolution before the cell can divide. Within the cell the DNA topoisomerases 
are responsible for mediating changes in twist and writhe by transiently cleaving one or both 
strands of the duplex and allowing either rotation of the DNA about its axis or passage of one 
or both strands through a transient break in one or both strands, thereby modifying the topology 
of DNA. They possess the ability to relax supercoils (or generate them, specifically in the case 
of DNA gyrase and reverse gyrase), unknot and decatenate DNA, all of which are vital functions 
and make topoisomerases fundamental to the physiology of the cell.  
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Figure 1.2: Topological activities of DNA topoisomerases: relaxation of positive and negative 
supercoils, decatenation, and unknotting. Colour is representative of the topo type: red is type 
IA, orange is type IB, yellow is type IC, green is type IIA and blue is type IIB. Yellow stars represent 
ATP-dependency, green stars represent nucleotide-dependency (e.g. reverse gyrase can relax 
negative supercoils using CTP, GTP and UTP)  and the blue circles indicate that single-stranded 
or nicked DNA is required for activity.  
 
1.3  DNA Topoisomerases 
DNA topoisomerases (topos) are ubiquitous across all domains of life and indispensable to 
cellular survival due to their role in DNA topology maintenance. They are classified as type I or 
type II depending on whether they catalyse the formation/re-ligation of single- or double-
stranded DNA breaks, respectively [10, 11]. In general all topoisomerases perform a similar 
task (i.e. interconverting the topological states of DNA), however, the precise ways in which 
this is achieved differs between enzyme groups and imparts certain activity preferences, for 
example: preferential decatenation rather than relaxation (Figure 1.2). These intriguing 
enzymes have been of keen scientific interest since the first was discovered in 1971 [12]. As 
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topos transiently disrupt the integrity of the duplex in order to maintain it, they must function in 
a highly coordinated and precise manner so as to avoid generating permanent DNA breaks. 
This mechanism makes topoisomerases vulnerable to poisoning, which is currently being 
exploited in the use of antimicrobial and anticancer therapeutics.  
 A key feature linking all topos, is the formation of a covalent DNA-protein intermediate 
in which a phosotyrosyl linkage is formed via a nucleophilic attack of the phosphate group in 
the DNA by the active site tyrosine of the topoisomerase. This can be the 5ʹ-phosphate, in the 
case of the type IA and type II topos, or the 3ʹ-phosphate, in the case of type IB and IC topos 
(Figure 1.3) [13]. Explored below are the numerous ways in which the topoisomerase family 
employ this DNA cleavage mechanism in the preservation of genome integrity.  
 
Figure 1.3: The reaction that takes place between the DNA backbone and the active-site tyrosine 
of the topoisomerase. The -OH group attacks the phosphate group, replacing either the 3’ oxygen 
(in the case of type IB) or the 5’ oxygen (in the case of type IA or type II), forming a covalent yet 
reversible bond. Image design based on [14]. 
 
1.3.1 Type I DNA topoisomerases 
Type I topoisomerases are further categorised into A, B and C subgroups, depending on protein 
structure and mechanism. Whilst all type I topos function via the transient cleavage of a single 
DNA strand, and modify the DNA linking number in steps of one, the way in which this is utilised 
to modify DNA topology varies among the subcategories.  
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1.3.1.1 Type IA DNA topoisomerases 
The type IA DNA topoisomerases (type IA topos), were the first to be discovered and 
characterised biochemically [12]. They function via the transient formation of a single-stranded 
DNA nick, forming a covalent 5ʹ-phosphotyrosine linkage. Type IA topo activity is generally 
Mg2+-dependent and ATP-independent, performing thermodynamically favourable reactions 
(aside from reverse gyrase, see 1.3.1.1.3).  
 
1.3.1.1.1 DNA topoisomerase I 
The first topo to be discovered was a type IA, originally called ω and now known as prokaryotic 
DNA topoisomerase I (topo IA) [12]. Isolated from E. coli, topo IA was shown to reduce the 
superhelical density of a negatively supercoiled plasmid in the absence of a nucleotide cofactor. 
It is hypothesised that the main cellular function of topo IA is in the prevention of hyper-negative 
supercoil accumulation during transcription, rather than global control of negative supercoiling 
[15]. It is likely that the activity of topo IA impacts the global supercoiling within the cell, 
however, this is seen as secondary to its primary function during transcription. Hyper-negative 
supercoiling has been demonstrated to result in stable R-loop formation (a DNA:RNA hybrid) 
and if unresolved, R-loops can go on to disrupt genome integrity and inhibit DNA metabolism 
[16]. Topo IA has been shown to prevent the excessive accumulation of R-loops. These nucleic 
acid structures are an ideal substrate for topo I due to the presence of single stranded-DNA 
[17], a feature required for optimal topo IA binding [18]. Furthermore, topo IA has been shown 
to directly interact with the βʹ domain of RNA polymerase via its C-terminal domain [19]. 
Together, these data strongly indicate that the main role of topo IA is topology maintenance, 
specifically during transcription, counteracting the activity of DNA gyrase (section 1.3.2.1.1) 
and preventing the formation of hyper-negative supercoils. Interestingly, when using positively 
supercoiled DNA containing a single-stranded loop, topo IA exhibited relaxation activity [20]. 
This implies that the topo IA preference for relaxing negatively supercoiled DNA arises mainly 
from the presence of single-stranded DNA (ssDNA) regions which are far more prevalent in 
negatively supercoiled DNA.  
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Topo IA is a monomeric 97-kDa protein with a toroidal conformation (Figure 1.4A and 
B). It has a positively charged central cavity large enough to accommodate a single DNA duplex 
(2.8 nm in diameter). The first topo I structure was solved using a truncated 67-kDa fragment, 
missing a portion of the C-terminal domain (CTD) and unable to relax negatively supercoiled 
DNA (however the ability to cleave ss-DNA remained intact) (Figure 1.4A) [21, 22]. Even though 
this structure led to invaluable insights on the mechanism of topo I, a full-length structure 
complexed with ss-DNA has also been solved [23] (Figure 1.4B). The presence of both the ss-
DNA and the topo IA CTD, has facilitated even deeper insight into the mechanism of topo IA. 
This monomeric protein has 9 distinct domains, highlighted in Figure 1.4E. The 67-kDa 
structure (Figure 1.4A) contained domains 1 to 4, with domains 5 to 9 being included in the full-
length  structure (Figure 1.4B). Domains 1, 3 and 4 are believed to be the site in which the 
ssDNA substrate is bound and cleaved; the active site tyrosine (Y319) being present in domain 
3. Domain 2 is a hinge region, and whilst the architecture of domains 1, 3 and 4 are in good 
agreement between the two structures, domain 2 shows the largest conformational change, 
indicating that the presence of the CTD and ssDNA substrate has a more profound effect on 
domain 2 architecture. Moreover, a flexible loop of charged residues in domain 2, disordered 
in the 67-kDa structure, is now visible in the full-length structure and hypothesised to play a 
role in strand passage as it is highly conserved amongst type IA topos. Domains 5 to 7 are 4-
cys zinc ribbon domains and each coordinates a Zn2+ using 4 cysteines, a methionine and a 
hydrophobic residue (residue identity varies amongst domains). The ssDNA in this structure is 
bound to the CTD, with the 3’OH group interacting predominantly with domain 5. Domain 6 is 
the primary domain of the CTD which is in contact with the NTD, mostly with domains 2 and 4. 
Domains 8 and 9 are zinc ribbon-like domains and do not coordinate Zn2+ as the methionine 
has been substituted for a phenylalanine in domain 8, and a tyrosine in domain 9. Whilst these 
two  domains  play a role  in activity,  if they  are  removed  the  protein  retains  partial  relaxation     
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Figure 1.4: Protein structures and gene domain organisation of type IA DNA topoisomerases. A: 
67-kDa structure of G-segment bound E. coli DNA topoisomerase I (topo IA). PDB: 3PX7 (Zhang 
et al., 2011, unpublished). B: Full-length (97-kDa) structure of T-segment bound E. coli topo IA. 
PDB: 4RUL [23]. C: Topo IA double chain model, demonstrating predicted DNA binding position 
for the G-segment (cleaved by the catalytic tyrosine in D3) [23]. D: Structure of E. coli DNA 
topoisomerase III (topo III). PDB: 2O54 [24]. E: Gene domain schematics for E. coli topo I and III. 
Black vertical bars indicate key residues. D stands for domains, which are colour coded 
throughout as follows; D1 is red, D2 is blue, D3 is green, D4 is yellow, D5 is purple, D6 is teal, D7 
is pink, D8 is orange, and D9 is grey. DNA is in black. 




activity [25]. However the activity is far more distributive, in comparison to the processive full-
length topo IA, indicating that domains 8 and 9 are likely to be important for ssDNA binding. In 
light of this new structural information, a model for topo IA binding was proposed in which the 
gate strand (G-strand) is bound and cleaved by domains 1, 3 and 4, with the transport strand 
(T-strand) being bound by domains 5 to 9 (Figure 1.4C). It is then proposed that the way in 
which this enzyme alters topology of DNA is by the passing of the T-strand through the cleaved 
G-strand, in a process termed ‘strand-passage’. The term strand-passage is applied to the 
reactions executed by all type IA and type II topoisomerases, the difference being that type IA 
topos pass a single strand or duplex (topo III, described below) through a break in another 
single strand, whilst type II topos form double-stranded breaks (DSBs) through which another 
duplex is passed. 
 
1.3.1.1.2 DNA topoisomerase III 
DNA topoisomerase III (topo III) is another integral member of the type IA subfamily and is 
highly conserved across not only prokaryotic lineages but also archaeal and eukaryotic. Whilst 
the focus here is mainly on prokaryotic topo III, it’s worth noting that in eukaryotes such as 
Drosophila and mammals, two isoforms, topo IIIα and IIIβ, are found and appear to play distinct 
roles in cellular development [26]. As seen in Figure 1.4D, the full-length crystal structure of E. 
coli topo III closely resembles that of the 67-kDa structure of topo I (Figure 1.4A), with 4 distinct 
domains (Figure 1.4E), and also functions in an ATP-independent manner. Topo III lacks the 
zinc-binding domains of topo I, but has added sequence that appears to imbue the enzyme 
with highly efficient decatenation activity, allowing topo III to pass a duplex through a single-
stranded break, providing the other strand contains a pre-existing nick. These regions are 
known as the decatenation loop and loop 241-255. Whilst the function of loop 241-255 remains 
unclear, the decatenation loop has been established to play an important role during 
decatenation [27]. If the loop is replaced with a homologous sequence from topo I, the 
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decatenation activity is almost completely abolished, thought to be a consequence of reduced 
protein interaction with the duplex strand.   
 
1.3.1.1.3 Reverse gyrase 
Reverse gyrase is a distinctive type IA topoisomerase, as unlike topo I and III, it utilises ATP to 
both relax negative supercoiling and input positive supercoils. It was first discovered in 
Sulfolobus [28] and has since been identified in many species of thermophilic and 
hyperthermophillic archaea and eubacteria, indicating that reverse gyrase is important for 
adaptation to high temperature environments [29]. This curious enzyme has two distinct regions 
with the NTD exhibiting sequence similarity with helicases from superfamilies I and II, whereas 
the CTD bears remarkable similarity to prokaryotic topo I (Figure 1.5A) [30]. In 2002, reverse 
gyrase from Archaeoglobus fulgidus became the first full length supercoiling enzyme to be 
crystallised, with and without the non-hydrolysable ATP analogue, ADPNP (Figure 1.5B) [31]. 
This structure revealed a ‘padlock’ shaped enzyme with two folds (H1 and H2) at the NTD that 
resembled the E. coli RecA protein’s ATP-binding region. At the CTD, four domains (TOPO, 
TOPRIM, Zn1 and Zn2) are arranged in a toroidal structure and are highly homologous to 
domains 1-4 of prokaryotic topo IA. The helicase and topo domains of reverse gyrase interact 
via the latch domain, which has structural similarity to the E. coli transcription terminator, rho. 
The helicase domain of reverse gyrase has been shown to alternate between high and low 
DNA-affinity states in an ATP-dependent manner [32], which, in the presence of ATP, can 
transiently destabilise the DNA duplex [33]. The topo I-like domain has been shown to exhibit 
nucleotide-independent DNA relaxation when the helicase domain is deleted, a common 
feature amongst type IA topos [34]. It appears that the unique combination of these two protein 
regions, imparts reverse gyrase with the ability to positively supercoil DNA. Interestingly, in the 
absence of the latch domain, reverse gyrase is unable to supercoil due to abolishing the 
enzymes ability to unwind the DNA, thus functionally linking the destabilisation of the duplex to 
the strand passage reaction, whereby the protein increases the DNA linking number [33]. Also, 
reverse gyrase is able to relax negative writhe when ATP is replaced by CTP, GTP or UTP, but 
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as it is unable to hydrolyse these nucleotides, only ATP hydrolysis can support positive 
supercoiling [35]. 
 
Figure 1.5: Archaeglobus fulgidus Reverse gyrase gene domain organisation and protein 
structure. A: Gene domain organisation of A. fulgidus reverse gyrase. B: Structure of A. fulgidus 
reverse gyrase. PDB: 4DDU [31]. Throughout domains are labelled as follows: Zn1 is grey, H1 is 
red, insert is yellow, H2 is green, latch is orange, TOPRIM is teal, Zn2 is purple, and TOPO is blue. 
 
1.3.1.2 Type IB DNA topoisomerases 
The type IB topos, e.g. eukaryotic DNA topoisomerase I (topo IB), were first discovered in 1972 
and found to be able to relax both positive and negative supercoils in closed circular DNA via 
a transient single-stranded cleavage event between the protein and the 3ʹ phosphate of the 
DNA backbone [36]. Human topo IB was crystallised using an N-terminally truncated 70-kDa 
protein in complex with a 22-bp DNA duplex [37] (Figure 1.6), which led to a greater 
understanding of how this enzyme binds DNA and the proposal that it functions via the 
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controlled rotation mechanism, first described using Vaccinia topo I [38]. This mechanism is 
quite different to the strand-passage reaction employed by type IA and begins with topo IB 
creating a single-strand nick in the DNA. This then permits the rotation of DNA, the speed of 
which is controlled by friction within the enzyme cavity, before the re-ligation of the strand. The 
core domain, formed from the three subdomains (Figure 1.6) and the C-terminal domain (CTD) 
are strictly required for relaxation activity, and when expressed and purified individually, the 
reconstitution of these two domains is the minimal requirement for activity [39]. Both the N-
terminal domain (NTD) (not crystallised in Figure 1.6) and the linker are poorly conserved 
among the type IB topos and less important for relaxation in vitro [40]. However, the NTD 
harbours 6 nuclear localisation signals (NLS) and is therefore necessary for activity in vivo [41]. 
Using single-molecule methods, it was shown that, on average, human topo IB removed 19 
DNA turns per cleavage/re-ligation cycle [42]. The in vivo role of topo IB is believed to be in the 
removal of torsional strain during replication, transcription and chromosome condensation [40].  
 
 
Figure 1.6: DNA-bound structure of human DNA topoisomerase IB. The core subdomain I is 
yellow, II is blue, III is red, C-terminal domain is green, linker is orange and DNA is black. PDB: 
1A36 [37]. 
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1.3.1.3 Type IC DNA topoisomerases 
DNA topoisomerase V (topo V) was first isolated from the hyperthermophillic methanogen, 
Methanopyrus kandleri and described as the prokaryotic version of topo IB [43]. This was based 
on the findings that topo V activity was both ATP- and Mg2+-independent, that it could efficiently 
relax both negative and positive supercoils, and that the covalent protein:DNA complex was 
formed with the 3’ phosphate of the DNA backbone. In addition to these data, 
  
Figure 1.7: DNA topoisomerase V (topo V) gene domain organisation and protein structure. A: 
Gene domain organisation of Methanopyrus kandleri topo V. B: Structure of M. kandleri topo V. 
PDB: 5HM5 [31, 44]. Throughout domains are labelled as follows: TOPO is grey, (HhH)2 domains 
are each coloured individually (colour scheme of gene domains matching that of structure).  
 
a single molecule approach found that topo V relaxed DNA using controlled rotation, at a rate 
of 12 turns per cleavage/re-ligation cycle, on average [45]. For these reasons, topo V was 
initially regarded as type IB, however it has since been proposed that it constitute a new type 
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IC class due to structural and biochemical differences [44, 46]. The first topo V structure was a 
61-kDa N-terminal fragment, from M. kandleri, and it revealed how divergent this protein was 
in relation to all other topoisomerases [46] (Figure 1.7). Not only did it lack any sequence 
similarities, the folds adopted by topo V are unique amongst topoisomerases and the active 
site itself is quite different, indicating an alternative cleavage/re-ligation mechanism. In addition 
to this, topo V also has DNA repair activity as an AP(apurinic or apyrimidinic)-lyase, involved 
in the repair of abasic DNA damage [47, 48]. This DNA repair activity functions independently 
of the topoisomerase activity as mutation of the active site tyrosine did not change topo V’s 
ability to perform DNA repair [47]. With the resolution of the 97-kDa structure in 2016, topo V 
has proved to be a very curious enzyme with a total of four active sites contained within a single 
polypeptide; one topoisomerase site and three AP lyase sites [44] (Figure 1.7). The protein has 
a globular N-terminal region housing the topoisomerase active site, followed by 12 helix-
hairpin-helix, motif 2 ((HhH)2) domains. The first AP-lyase active site was determined to be 
between the fifth and sixth (HhH)2 domains [48], the second in the vicinity of the tenth  (HhH)2 
domain and the third at the extreme CTD within the twelfth (HhH)2 domain [44]. Even though 
all topos are considered to be indirectly involved with DNA repair and maintenance, only topo 
V possesses the direct ability to repair abasic DNA damage. Whilst fascinating, this unique 
enzyme appears to only be present in a single species of archaeal halophilic 
hyperthermophiles, M. kandleri, living within hydrothermal vents of the deep ocean, and has 
therefore been postulated to have a viral origin [49].  
 
1.3.2 Type II DNA topoisomerases  
The type II topoisomerases (type II topos) are divided into A and B subgroups based on 
structural and evolutionary grounds [11]. All type II topos function via transient double-stranded 
DNA breaks (DSBs) and employ a strand-passage mechanism, through which DNA topology 
can be manipulated. They share key functional domains (explored below) and employ a 
divalent cation-dependent mechanism (preferably Mg2+) in order to change Lk by two, generally 
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in pursuit of DNA relaxation and decatenation.  
 
1.3.2.1 Type IIA topoisomerases 
Type IIA topos are well-studied and include the prokaryotic enzymes, DNA gyrase (gyrase) and 
topoisomerase IV (topo IV), and eukaryotic topoisomerase II (topo II). All three enzymes have 
been shown to decatenate, unknot and relax positively and negatively supercoiled DNA. For 
topo IV and topo II, these activities are Mg2+- and ATP-dependent, with the exception being the 
ATP-independent relaxation of negatively-supercoiled DNA by gyrase. In addition, gyrase can 
also introduce negative supercoils in the presence of ATP. Topo IV and gyrase are 
heterotetramers with an A2B2 subunit arrangement, whilst topo II is a homodimer, with the 
monomer seemingly arising from the fusion of the two gyrase subunits [50]. In general, strand 
passage for the type IIA topos begins with the binding of one DNA duplex, termed the gate 
segment (G-segment), to the enzyme at the DNA gate, which is then transiently cleaved 
forming a DSB with 5ʹ 4-base overhangs. Another duplex, termed the transport segment (T-
segment), is captured by the ATP-operated clamp (N-gate) and passed through the break in 
the G-segment before it is resealed. The T-segment exits through the C-gate, resulting in a 
ΔLk of 2, and the ATP-operated clamp reopens allowing the enzyme to perform another 
consecutive round of strand-passage or disengage from the DNA (Figure 1.8). This reaction is 
also known as the two-gate model, owing to the alternate opening and closure of the N-gate 
and the DNA-gate [51]. The specifics of this reaction, such as the effect of DNA topology on 
enzyme activity, varies amongst the type IIA topos, with each type both intrinsically (e.g. 
structure) and extrinsically (e.g. protein-protein interactions and temporal/spatial regulation) 
adapted to preferentially perform different DNA topology manipulations. Together with type I 
topos, the type IIA topos are fundamental to cellular viability through the maintenance of DNA 
integrity. A key aspect that makes type IIA topos both fascinating and clinically-relevant, is this 
role in DNA-integrity protection, which is achieved through disruption of the DNA duplex. The 
formation and resealing of the DSB must be highly coordinated and rapid, so that type II topos 
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do not form extensive genotoxic damage. Under normal circumstances this activity is highly 
efficient, but also forms a juncture of vulnerability which can be exploited by drugs targeting 
either the activity of type II topos or stabilising the DSBs, preventing re-ligation.  
 
Figure 1.8: Generalised strand-passage mechanism for the type IIA DNA topoisomerases. (1) The 
G-segment is bound to the DNA-gate of the topo, and the T-segment is captured. (2) ATP binding 
drives dimerization of the N-gate and cleavage of the G-segment, through which the T-segment 
is passed. (3) The DNA-gate closes, G-segment re-ligated and the T-segment released through 
the C-gate. (4) ADP and phosphate dissociate and the N-gate reopens. (5) The enzyme may 
disengage with the G-segment, or, (1) remain bound and perform a consecutive strand-passage 
event.  
 
Structurally, there are a number of key protein domains shared amongst the type IIA 
topos (as well as some also found in type IIB and type I topos) [13] (Figure 1.9). In the type IIA 
topos, all the following domains are present in pairs within the holoenzyme. Firstly, there are 
two domains fundamental to the Mg2+-dependent double-stranded DNA cleavage activity, the 
WHD (winged-helix domain), also known as the 5Y-CAP domain, and the TOPRIM 
(topoisomerase/primase) domain, which are located in the prokaryotic A subunit (named GyrA 
in gyrase and ParC in topo IV). The WHD contains a helix-turn-helix fold, commonly found in 
other DNA-binding proteins, such as the E. coli catabolite activator protein (CAP) [52]. 
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However, even though this domain is often associated with highly sequence-specific DNA-
binding activity in alternative proteins, in topos it has seemingly evolved to supress DNA 
sequence preference, allowing topos to bind and act on DNA duplexes of any sequence [53]. 
This appears to be due to the two ‘recognition’ helices being much closer together in topos, 
preventing them from binding a major groove each and hence occupying a single major groove 
together, thus reducing the extent of the intermolecular interactions with the DNA and 
supressing sequence preference. Interestingly, with the advent of next-generation sequencing 
(NGS) techniques, mild sequence preferences are evident within different topo families, to 
differing degrees and in response to variable DNA sequences, indicating that the WHDs have 
partially retained the ability to bind and cleave particular DNA sequences more efficiently, 
however their activity on alternative sequences is not restricted by this [54]. This makes logical 
sense as DNA metabolism, particularly DNA replication, affects the entire genome and causes 
topological perturbations independent of DNA sequence, which topos must resolve. In addition 
to the DNA binding activity of the WHD, it also houses the catalytic tyrosine residue, involved 
in the attack on the scissile phosphate of the DNA backbone and forming the reversible 
covalent bond [55], and an isoleucine, which intercalates into the DNA and produces a ~150° 
bend in the G-segment [56], which is considered important for promoting DNA cleavage 
efficiency [57].  
The second region important for DNA cleavage activity is the TOPRIM domain, formed 
from an α/β/α Rossmann-like fold [53]. This protein conformation is commonly found in proteins 
that act on DNA, including DnaG type primases, OLD family nucleases, RecR proteins and 
topos [58]. For type II and IA topos, this domain is fundamental to the transesterification 
reaction between the scissile phosphate and the catalytic tyrosine, as it contains a DxD motif 
which chelates Mg2+, and a glutamate residue thought to act as a general acid/base during the 
reaction [58, 59]. Together, the DxD Mg2+ chelating motif of the TOPRIM domain and the active 
site tyrosine of the WHD, form a bipartite active site capable of forming transient breaks in the 
duplex [13]. In addition to its role in cleavage catalysis, the TOPRIM domain also houses 
conserved regions, namely the EGDS and PLRGK motifs, which form numerous interactions 
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with the G-segment and assist with DNA binding [53, 60].  
 
 
Figure 1.9: Type IIA DNA topoisomerase gene domain organisation of E. coli DNA gyrase, E. coli 
DNA topoisomerase IV (topo IV) and Saccharomyces cerevisiae DNA topoisomerase II (topo II). 
The domains are colour coded throughout, as follows: GHKL is red, transducer is orange, 
TOPRIM is teal, TOPRIM insertion is yellow, WHD is blue, tower is purple, coiled coil is green, 
CTD is pink (grey in the case of topo II), and the GyrA box is magenta. Vertical black bars 
represent key catalytic residues.  
 
A third domain, only present in type IIA topos and thought to be important in DNA 
binding, is the tower. It contains a β-sheet that interacts with the G-segment as it leaves the 
WHD, anchoring the outer portion of the bent duplex, stabilising it and therefore promoting both 
DNA binding and cleavage efficiency [56]. It has been speculated, that as this domain is absent 
in type IA and IIB topos, it is likely they are unable to induce DNA bending [53]. However, for 
type IIB enzymes, there is mounting evidence in opposition to this, demonstrating that DNA 
bending is either induced or recognised to facilitate binding, albeit via a distinct mechanism [61, 
62].  
The fourth noteworthy domain is the GHKL (DNA Gyrase, Hsp90, bacterial CheA-family 
histidine kinases and MutL) ATPase domain. The ATP binding region of this domain is formed 
from an 8-stranded antiparallel β-sheet surrounded by several α-helices, and the binding of 
ATP stimulates B-subunit dimerisation, stabilising the N-gate in a closed conformation [13]. The 
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bound ATP is contacted by a lysine residue, which resides outside of the GHKL domain, in the 
transducer domain, and likely stabilises the ATP-hydrolysis transition state by forming a 
hydrogen bond to the γ-phosphate [63-65]. This interaction has been shown to facilitate 
significant rotation (11-18°) between the GHKL and transducer domains [64, 66, 67] and is 
thought to permit transduction of free-energy from ATP hydrolysis to the DNA-gate. The precise 
role(s) of ATP in type II topo activity is still unclear, however, along with evidence that it 
promotes DNA cleavage through transducer domain movement (although this clearly isn’t 
necessary for gyrase-dependent DNA relaxation), it is hypothesised that ATP 
binding/hydrolysis modulate B-subunit dimerization, forming a stable interface which protects 
against the formation of genotoxic DSBs [68]. Gyrase may be able to circumvent this necessity 
due to its extensive DNA wrapping ability (see 1.3.2.1.1).  
Even though there are a number of significant similarities within the structure and 
function of type IIA topos, there are also key differences that speak to their evolution into distinct 
enzyme types with varying preferential activities in vivo, explored in depth below.  
 
1.3.2.1.1 DNA gyrase 
DNA gyrase is a unique type IIA topoisomerase, found predominantly in bacteria [69], however 
it is also present in plants [70], apicomplexans [71] and archaea [72, 73]. In 1972, it was shown 
using sedimentation analysis, that the DNA within E. coli was negatively supercoiled [74], with 
gyrase, the enzyme responsible for this DNA topology, purified in 1976 [69]. Gyrase can relax 
supercoils (positive and negative), decatenate and unknot DNA, in an Mg2+-dependent manner 
[11]. A unique feature of gyrase is that it can also input negative supercoils into closed-circular 
DNA molecules in the presence of ATP [69], and that the relaxation activity is ATP-independent 
[75] (unknotting and decatenation are ATP-dependent [76-78]). E. coli gyrase, the most 
extensively characterised, is a 374-kDa heterotetrameric enzyme formed from two A-subunits 
(GyrA) and 2 B-subunits (GyrB), 97-kDa and 90-kDa, respectively [75]. As gyrase is essential 
to bacterial viability, and absent in humans, it has had significant and ongoing clinical success 
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as a target for antibacterial agents [79, 80]. 
 Structurally, DNA gyrase is formed of the same core protein domains as other type IIA 
topos (explored in 1.3.2.1, Figure 1.9), however, its unique ability to negatively supercoil DNA 
arises from its ability to wrap DNA via the CTDs of the GyrA subunit. This 35-kDa GyrA CTD is 
formed of six β-strands which form a β-pinwheel fold with two-thirds of the outer surface being 
basic, which indicates a role in DNA binding/bending [81-84] (Figure 10C). Also within the CTD 
is a structural motif, situated within a loop between β-strands 1 and 6, called the GyrA-box, 
which has been determined to be crucial to the supercoiling activity of gyrase [85, 86]. The 
GyrA-box is seven amino acids long (QRRGGKG), and if deleted or substituted with alanines, 
gyrase is rendered unable to negatively supercoil (whilst the decatenation and relaxation 
activities remain unaffected) [85]. Hence the presence of the GyrA-box in gyrase, and its 
absence in all other type IIA topos, suggests it is the major determinant of gyrase supercoiling 
activity. The way in which gyrase is thought to impart negative supercoiling begins with G-
segment binding to the DNA-gate (formed from the WHD of GyrA and the TOPRIM domain of 
GyrB) which is then chirally wrapped around one of the GyrA CTDs, before being presented 
over the G-segment, at ~60°, as the T-segment, which forms a left-handed (positive) crossing. 
The passing of the T-segment in this orientation, through the G-segment, results in the 
conversion of the left-handed crossing to a right-handed (negative) crossing, thus adding 
negative writhe to the DNA molecule [87]. The length of DNA bound and wrapped by gyrase, 
and therefore protected from degradation, is between ∼120-150 bp, as measured by nucleolytic 
digestion [88-90]. 
 Attaining a full-length crystal structure of gyrase has continued to prove unsuccessful, 
however there are many examples of truncated, fused and domain structures, which have 
added greatly to our understanding of gyrase activity. The first crystal structure was of the GyrB 
N-terminal domains (NTDs) in complex with ADPNP, which revealed a dimer with an extensive 
interface between the two subunits, and forming a positively-charged 20 Å-wide cavity, large 
enough to accommodate a duplex [91] (Figure 10A). Follow-up mutagenesis studies showed 
that at least one of the arginines within the positively-charged central cavity is important for 
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DNA supercoiling and DNA-dependent ATPase stimulation [92].  The GyrB CTD has also been 
crystallised, from E. coli and Mycobacterium tuberculosis, either in isolation [93, 94] or as part 
of a GyrB-A fusion [95], revealing another dimeric structure with the TOPRIM domains forming 
the dimer interface and the transducer domains extending upwards [93]. The E. coli GyrB CTD 
structure, crystallised using a fusion of amino acids 388-804 of GyrB, directly to amino acids 1-
525 of GyrA, allowed elucidation of a large 170 amino acid TOPRIM insertion, present in a 
number of bacterial phyla, including proteobacteria, acidobacteria, chlamydia and aquificales, 
but absent in others such as actinobacteria (e.g. M. tuberculosis) and firmicutes [95] (Figure 
1.10B). The domain adopts a novel fold formed from a unique combination of β-sheets and α-
helices, that protrudes from the TOPRIM domain, lying alongside the coiled-coil domain of the 
GyrA subunit. Its deletion leads to dramatic reduction in DNA binding, supercoiling and ATPase 
activity [95, 96].  
 
Figure 1.10: Structures of E. coli DNA gyrase. A. Homodimer of E. coli GyrB bound to ADPNP. 
PDB: 1EI1 [97]. B: GyrBA fusion of E. coli DNA binding/cleavage core. PDB: 3NUH [95]. C: E. coli 
gyrase GyrA CTD. Each β-strand is coloured differently to demonstrate the pinwheel structure. 
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PDB: 1ZI0 [83]. A-C are crystal structures. D: Cryo-EM structure of full length E. coli DNA gyrase 
bound to DNA and gepotidacin. PDB: 6KRW [98]. In figures A, B and D, domains are coloured as 
follows: GHKL is red, transducer is orange, TOPRIM is teal, TOPRIM insertion is yellow, WHD is 
blue, tower is purple, coiled coil is green, CTD is pink, and the GyrA box is magenta. 
 
As technologies have advanced, cryogenic electron microscopy (cryo-EM) has become 
an excellent structural technique for use on large multimeric proteins that have been resistant 
to crystallisation. In 2019, the first full length structure of E. coli DNA gyrase in complex with 
DNA and the antibiotic gepotidacin, was solved using cryo-EM, with resolution of the DNA-
binding domains reaching as high as 3.0 Å [98] (Figure 1.10D). This unprecedented structure 
gives an in-depth view of the overall architecture of DNA gyrase, revealing the spatial 
organisation of the domains, the position of the GyrA-box, and insight into DNA-cleavage site 
conformational changes, particularly in regard to the position of the TOPRIM insertion domain. 
This work has paved the way for future structural characterisation studies on not only gyrase, 
but other type IIA topos. 
 Gyrase is a vital cellular component, integral to bacterial DNA metabolism. Early on, it 
was found to be the target of nalidixic acid and oxolinic acid [99], as well as novobiocin and 
coumermycin [100], all of which are compounds previously used to inhibit DNA replication in E. 
coli [101, 102]. However, although it is clear that gyrase is fundamental to cellular viability, 
exactly which roles it plays in vivo has been more difficult to elucidate. A lot is known about the 
in vitro activity of gyrase, but whether this translates directly to its in vivo behaviour is not a 
straightforward question to answer. It is believed that the fundamental role of gyrase in vivo is 
the introduction of negative supercoiling. Indeed, if gyrase is inhibited, the genome becomes 
relaxed, indicating that gyrase plays a role in the homeostatic maintenance of the genome in a 
negatively supercoiled state [103-106]. Negative supercoiling has been shown to be important 
for the initiation of DNA replication and transcription as underwinding the DNA encourages 
melting of the origin and gene promoters [107, 108]. Using microarray analysis, inhibition of 
DNA gyrase (and topo IV) caused a variable effect on gene transcription [109]. The expression 
of certain genes were more sensitive to the reduced level of negative supercoiling, for instance, 
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nalidixic acid inhibition reduced the expression of catabolite sensitive genes, such as the 
lactose and galactose operons [110]. However, for some genes, a reduction in the level of 
negative supercoiling caused an increase in expression [109]. The expression of the genes 
encoding GyrA and GyrB are themselves sensitive to the superhelical density, with expression 
stimulated when the DNA is relaxed [106].  
 In addition to its role in maintaining a negatively supercoiled genome, gyrase is also 
considered vital during the elongation phase of replication and transcription, a role of which the 
effects are intertwined with homeostatic negative supercoiling. The twin supercoiled domain 
model, first described in 1987 [111], describes how DNA strand separation during transcription 
leads to positive supercoiling ahead of the fork and negative supercoiling behind (this is similar 
for replication, however precatenanes form behind). If the positive supercoiling is not relaxed, 
the built-up torsional strain will impede the progression of the protein machinery, and prevent 
DNA replication or transcription. Numerous lines of evidence support the role of gyrase in 
positive supercoil relaxation, including gyrase loss-of-function mutations resulting in a dramatic 
decline of both replication and transcription, as measured by the level of incorporated tritium 
(3H)-labelled nucleotides [112]. Using NGS, the binding of both gyrase and topo IA were 
enriched in areas of high transcriptional activity, directly correlated to the binding of RNA 
polymerase, and also at the origin of replication, implicating gyrase and topo IA in these 
processes in vivo [113]. An in vitro DNA replication system also demonstrated a role for gyrase 
in the removal of positive supercoils ahead of the fork, whilst topo IV was found to favour 
removal of the precatenanes formed behind [114].   
 
1.3.2.1.2 DNA topoisomerase IV 
DNA topoisomerase IV (topo IV) was discovered in 1990 as a gyrase homologue, which was 
fundamental to chromosome segregation and cellular partitioning in E. coli [115]. It is composed 
of two ParC (homologous to GyrA) and two ParE (homologous to GyrB) subunits, with 
considerable structural similarity to gyrase, and was shown to relax positive and negative 
Chapter 1: Introduction 
 25 
supercoils and decatenate, in an ATP/Mg2+-dependent manner [116]. Whilst topo IV shares 
numerous functional domains with gyrase (Figure 9), including the WHD, TOPRIM, GHKL, 
tower, coiled-coil and transducer domains, it is unable to supercoil DNA. As discussed 
previously, negative supercoiling by gyrase arises from its ability to wrap DNA (~130 bp) and 
present a T-segment with a positive chirality over the G-segment, prior to strand-passage [11, 
87]. The topo IV ParC CTD, whilst similar to the GyrA CTD, has a more degenerate structure, 
with five β-strands rather than six, and the absence of the GyrA-box. Structurally, this 
suggested that topo IV lacks the ability to supercoil DNA, which was later confirmed 
biochemically [116]. However, as the outer surface of the ParC CTD is positively charged, this 
suggests a role in DNA binding and it is thought to mediate topo IV substrate specificity [117]. 
Indeed, when the activity of topo IV missing the ParC CTD is compared to wild-type, a clear 
reduction in rate is seen for the relaxation of negative supercoils (~10-fold), positive supercoils 
(~100-fold) and decatenation (~100-fold) [117]. Topo IV is known to preferentially act on 
positive supercoils (as opposed to negative) with a ~20-fold increase in rate [118], corroborated 
by single-molecule assays with the relaxation rate ~25-fold faster on positive supercoils [119]. 
Using a single-molecule magnetic tweezers DNA braid assay, the DNA crossing angle 
preference for topo IV was shown to be 85.5°, and while this crossing angle appears more 
frequently in positive writhe than negative (~3-fold) [119], it is not enough to explain the stark 
difference in relaxation rates [120]. It was then demonstrated that the CTD of ParC permits the 
highly processive relaxation of positive supercoils, whilst negative supercoil relaxation is 
perfectly distributive [120], hence providing an explanation for the preferential relaxation of 
positive writhe as a combination of both a crossing angle preference below 90° and DNA-
binding activity of the ParC CTDs, the latter playing a larger role. The presence of the CTDs 
also dramatically increases the decatenation activity of topo IV, and together with preferential 
positive supercoil relaxation, suggests that the CTDs recognise DNA geometries more common 
in positive supercoils and catenanes than in negative supercoils, and may potentially be able 
to manipulate DNA geometry in order to achieve the preferential DNA crossing angles [117]. If 
the GyrA CTD is removed, the enzyme becomes unable to supercoil and has enhanced 
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decatenation activity, much like topo IV [121].  
 As DNA topo IV was identified in E. coli with partition defects, it was hypothesised early 
on that the main in vivo role for topo IV was decatenation and chromosome segregation [115]. 
This idea has been built upon since with numerous lines of evidence suggesting this is indeed 
the major role for topo IV within the cell. Using an in vitro replication system, topo IV was highly 
efficient at unlinking replicated daughter chromosomes, whilst gyrase failed to do so under all 
conditions tested [122]. So, even though gyrase does have limited ability to decatenate in vivo 
[123], it is only around 1% of the efficiency capable by topo IV [124]. Using NGS, topo IV 
binding/cleavage was also found to be specifically enriched at the dif site, where E. coli 
chromosomes are unlinked [125]. However, as mentioned previously, topo IV is also highly 
efficient at relaxing positive supercoils in vitro [117, 118], which has led to consideration that 
topo IV plays a role during replication and transcription, relaxing positive supercoils ahead of 
the protein machinery. It has been found that topo IV over-expression from a plasmid [126] or 
ParC/ParE gene locus duplications [127], can rescue cells with topo IA mutations. More 
recently, expression of ParC and ParE was shown to be amplified in Bacillus subtilis harbouring 
topo IA suppression mutations, with topo IV able to functionally replace all type IA topos in B. 
subtilis [128]. In addition, it was shown topo IV can, to an extent, support replication and 
transcription fork progression in vivo using cells encoding temperature-sensitive mutants of 
DNA gyrase [129]. Evidence such as this would indeed support the idea of topo IV providing 
functional redundancy, particularly for topo IA, and less so, gyrase, in certain organisms. 
However, it seems that the preferential decatenation activity of topo IV in vivo,  arises from a 
combination of protein-protein recruitment via the E. coil SMC (structural maintenance of 
chromosome) complex, known as MukBEF [130-133], and temporal regulation [134]. These 
regulatory factors, alongside topo IVs intrinsic efficiency during decatenation, makes topo IV 
the major decatenation enzyme within bacteria.  
 
1.3.2.1.3 DNA topoisomerase II 
DNA topoisomerase II (topo II), structurally akin to its prokaryotic counterparts (albeit with the 
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A and B subunits fused into a single polypeptide chain), is the major type IIA topoisomerase 
found in eukaryotes and is vital to cellular vitality and survival. It is present in both lower 
eukaryotes, such as Saccharomyces cerevisiae (yeast) [135, 136] and Drosophila 
melanogaster [137], as well higher eukaryotes, such as Xenopus laevis [138] and humans [139, 
140]. In higher eukaryotes, topo II arises as two isoforms, named topo IIα and topo IIβ, which 
have distinct cellular functions [141], but either can complement the loss of topo II in yeast [142, 
143]. Although all topo II enzymes have the critical functional domains described in 1.3.3.1 
(Figure 1.9), the structural variations, as well as variable regulation, has led to functionally non-
redundant proteins, e.g. if you knock out topo IIα, topo IIβ cannot support DNA metabolism 
alone [144].  
 Yeast topo II, one of the more thoroughly characterised, is a homodimeric enzyme 
capable of relaxing positive and negative supercoils, decatenation and unknotting, using ATP 
and Mg2+ [145]. By employing yeast harbouring temperature sensitive mutations in topo II, it 
was found that absence of topo II was only lethal when the cells initiated mitosis, and this effect 
could be mitigated using compounds that block cell cycle progression [146]. This implied that 
the fundamental role of topo II in yeast is chromosome segregation and unknotting. Yeast topo 
II  has also been demonstrated to play a key role in the transcription of long genes (>3kb), with 
its absence causing a stall in fork progression which cannot be rescued by topo I alone [147]. 
Topo II was found to be insensitive to commonly used type IIA prokaryotic inhibitors such as 
oxolinic acid, nalidixic acid and novobiocin [145], hence these compounds and their derivatives 
have had clinical success as antibiotics. Yeast topo II has also proved to be a useful screening 
tools in the quest to find human topo II inhibitors for use as chemotherapeutics and to explore 
drug resistance mutations [148-150]. 
Structurally, crystallised yeast topo II has led to significant advancements in the 
understanding of type IIA topos. One such example was the crystallisation of yeast topo II 
amino acids 408-1177, in complex with a 30 bp G-segment [56] (Figure 1.11A). It revealed how 
topo II bends the G-segment, producing a ~150° angle, the duplex ends extending towards the 
GHKL domain. It also revealed that the DNA bound to the DNA-gate is A-form, rather than B, 
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further demonstrating how topo II markedly deforms the G-segment upon binding. In 2012, 
another yeast topo II structure was presented in which a fully functional and minimally truncated 
topo II (amino acids 1-1177) was crystallised in complex with a 30 bp G-segment and ADPNP 
[151] (Figure 1.11B). It revealed that the GHKL domains sit atop the G-segment binding 
interface, with a 45° offset. For the first time the K-loop was revealed, which is a typically 
disordered (in previous structures) stretch of amino acids containing six consecutive lysine 
residues, housed within the transducer domain. It was shown to interact with the G-segment, 
upon which its structure became ordered enough to resolve. This then led to the mutagenesis 
of various lysines to either alanine or glutamate, to establish its role in topo II activity. It was 
found that the KKKK to AAAA mutation resulted in 75% reduction in relaxation activity and the 
KKKK to AEEA mutation resulted in a 90% reduction [151], the latter reduction likely due to the 
reversal of the electrostatic charge of the K-loop in the most highly conserved lysine positions. 
The analogous investigation for human topo IIα was carried out (however only three conserved 
lysines are present in human topo II), with both alanine and glutamate substitutions causing 
dramatic loss of activity, the latter again having a more severe effect. Decatenation activity was 
also dramatically reduced whilst cleavage levels remained similar to wild-type, therefore 
implicating the K-loop in strand passage, post G-segment cleavage, by preventing DNA-
stimulated ATPase activity, further consolidated using ATPase assays [151].  
 
Figure 1.11: Structures of S. cerevisiae DNA topoisomerase II. A: DNA topo II (AA408-1177) bound 
to G-segment DNA. PDB: 2RGR [56]. B: DNA topo II (AA1-1177) bound to G-segment DNA and 
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ADPNP. PDB: 4GFH [151]. Domains are coloured as follows: GHKL is red, transducer is orange, 
TOPRIM is teal, WHD is blue, tower is purple, coiled coil is green, and DNA is black. The second 
Top2 subunit is grey.  
 
A previously mentioned, higher eukaryotes encode two isoforms of topo II, namely topo 
IIα (180-kDa) and topo IIβ (170-kDa), and whilst they share similar in vitro biochemical activities 
to both each other and yeast topo II, topo IIα and β perform distinct cellular roles and are 
controlled by separate regulatory mechanisms [152]. Topo IIα is critical during cellular 
proliferation [153], with expression low during G1, rising through S-phase and greatest during 
G2/M-phase [154]. Using NGS, it was shown in human cells that topo IIα activity is higher in 
regions of compact genome, with activity correlating to gene length and transcription rate [155]. 
In vitro, topo IIα is more active in the relaxation of positive supercoils, than negative [156], 
which is dependent on the presence of the CTDs [157]. Using a single-molecule magnetic 
tweezers approach, wild-type topo IIα relaxed positive writhe twice as fast as negative but was 
roughly equal in processivity [158]. However, if the CTDs were removed, this chiral 
discrimination was reversed with ~1.4-fold increase in negative writhe relaxation over positive, 
whilst processivity again remained constant, indicating the CTDs control the sign of the chiral 
preference, not the processivity. This is in contrast to topo IV, as in the absence of the ParC 
CTDs, topo IV’s chiral preference is removed through abolishing the enzymes processive 
nature during positive writhe relaxation [117]. This demonstrates the major evolutionary 
divergence between topo IIα and topo IV, with chiral discrimination mechanisms arising 
separately [158], which, interestingly, is absent for yeast topo II as it demonstrates no chiral 
preference in the relaxation of positive and negative writhe, with a preferred DNA crossing 
angle of 90° [120]. 
Topo IIβ expression patterns differ in comparison to topo IIα, with topo IIβ staying 
relatively constant throughout the cell cycle [154], but with variable levels of expression during 
fetal development and in different cell types [153]. Topo IIβ knockouts are lethal owing to 
disruption of neuronal differentiation [26]. Conditional knockouts implicated topo IIβ activity in 
retinal development [159] and ovulation [160], and the use of poisons showed it played a role 
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in spermatogenesis [161] and lymphocyte activation [162]. This has led to a picture of topo IIβ 
as an important factor in tissue-specific development and cellular differentiation, a concept 
elaborated upon using ChIP-seq [163]. It was found that topo IIβ interacts with the 
transcriptional regulator CTCF and the cohesion complex and acts on DNA located at the 
borders of chromosomal domains as well as conserved transcription factor binding sites. Topo 
IIβ activity cannot functionally replace topo IIα, unless topo IIβ CTDs are replaced with those 
from α, indicating the CTDs play a significant role in preferential in vivo activity [164]. Topo IIβ 
further diverges from topo IIα, with in vitro relaxation activity being highly distributive, 
differentially sensitive to inhibitory compounds, and more thermostable [140].  
 
1.3.2.2 Type IIB DNA topoisomerases 
The type IIB topoisomerases, despite also employing ATP/Mg2+-dependent double-stranded 
DNA cleavage, are separated from type IIA based on structural and evolutionary grounds. The 
two enzymes within this class are DNA topoisomerase VI (topo VI) and DNA topoisomerase 
VIII (topo VIII). Arguably, they have the simplest protein architecture possible for a type II topo, 
with only two protein interfaces (rather than the three found in type IIA), meaning that only one 
interface is intact at any one time to prevent the formation of stable DSB. Therefore, whilst type 
IIB topos are also hypothesised to follow the general strand-passage reaction (explored in 
Figure 1.8 and 1.3.2.1.1), it is believed that activity must be much more highly coordinated in 
order to prevent the excessive formation of DSB. Topo VI, being the main focus of this research, 
is explored in depth in a subsequent section (see Section 1.4). 
 
1.3.2.2.1 DNA topoisomerase VIII 
The most recent topoisomerase family discovered, in 2014, was the second member of the 
type IIB topoisomerases, named DNA topoisomerase VIII (topo VIII) [165]. Identified through 
database screening using the B subunit of Sulfolobus shibatae topo VI, topo VIII was classified 
as a highly divergent type IIB, in which the Bergerat fold (GHKL ATP-binding domain) and 
TOPRIM domain were contained within a single polypeptide chain, along with the H2TH and 
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transducer domains, which are characteristic of type IIB topos. Currently, 77 topo VIII enzymes 
have been identified in nine bacterial phyla, four in archaea, all within the euryarchaeota 
phylum, and one still unclassified [166]. Along with the dramatic sequence divergence from 
topo VI, being a homodimer, and being more common in bacteria than archaea, topo VIII is 
further distinct from topo VI due to its encoding being dependent on plasmids and integrated 
elements [166]. Of the topo VIII enzymes currently characterised biochemically, two exhibited 
Mg2+-dependent relaxation of positive and negative supercoils (Microscilla marina and 
Paenibacillus polymyxa), however the M. marina topo VIII performed these reactions 
independent of ATP, a behaviour not typical of type IIB topos [165]. Topo VIII from Ammonifex 
degensii, in the presence of SDS and proteinase K, only demonstrated cleavage activity, 
however this was also ATP-independent. In all cases the activity wasn’t strong, and moreover, 
many of the topo VIII enzymes found seem to be in a state of inactivation. So whether topo VIII 
plays a considerable role, if any, in the organisms in which it arises, is still unclear. In those 
cases where the topo VIII is encoded within a plasmid, other topos including topo VI and topo 
IA have also been detected, indicating that these enzymes may be important in the DNA 
metabolism of the plasmid itself [166].  
 
1.4 DNA Topoisomerase VI 
1.4.1 Overview 
The principal enzyme, and until recently, the only enzyme, of the class type IIB is DNA 
topoisomerase VI (topo VI), the subject of this project. Topo VI was initially identified in the 
archaeal hyperthermophile, Sulfolobus shibatae, and reported as the first member of the type 
IIB topoisomerase family [167]. It has since been found throughout the archaea, a few bacterial 
species, and intriguingly, in eukaryotes such as plants and algae [168, 169]. Topo VI has an 
A2B2 heterotetrameric subunit arrangement with minimal homology to the type IIA 
topoisomerases, mainly found in the DNA-binding, magnesium-chelating and ATPase domains 
[64, 170]. The A subunit (Top6A) is homologous to the eukaryotic meiotic recombination factor, 
Spo11, which is a key protein involved in meiosis [171, 172]. Until recently, no B-subunit 
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(Top6B) homologue had been identified, until the focus was shifted from the gene sequence to 
the protein structure. Structural homologues of Top6B have been identified via bioinformatic 
analysis in various eukaryotes, including mouse and A. thaliana, and have been shown to 
interact with Spo11β [173, 174]. The link between topo VI and these eukaryotic meiosis proteins 
will be explored in further detail below. The domain organisation of topo VI differs from type IIA 
in that the WHD domain and TOPRIM domains are contained within the same polypeptide, 
Top6A. Furthermore, topo VI is thought to represent the simplest form a type II enzyme can 
have, with only two protein interfaces (instead of the three found in IIA), which open and close 
alternatively. This makes topo VI of keen interest in the dissection of the strand-passage 
reaction, particularly the role of ATP in the opening/closing of the N-gate [64]. 
Whilst topo VI is distinct from the type IIA topos, it also bears remarkable similarity in 
key domains which are responsible for topology manipulation, such as ATP, Mg2+ and DNA-
binding regions. This, along with the structural simplicity of the enzyme, makes topo VI a 
marvellous candidate for in depth characterisation, which may provide not only insights into the 
workings of type IIB, but also IIA and eukaryotic meiotic factors.     
 
1.4.2 Plant topoisomerase VI 
Genomic analysis of Arabidopsis thaliana revealed three distantly related homologs of the 
Top6A/Spo11 subunit (AtSPO11-1, -2 and -3) and one of the Topo6B (AtTOP6B) subunit [175, 
176]. These genes have since been bioinformatically identified within various plant species, 
including Oryza sativa (rice), Medicago truncatula and Lycopersicon esculentum (tomato). In 
A. thaliana, the AtSPO11-1 protein is vital for efficient meiotic recombination and the production 
of viable gametes, indicating its role is homologous to that of Spo11 from Saccharomyces 
cerevisiae [177]. AtTOP6B and AtSPO11-3 have high levels of expression and the proteins 
have also been demonstrated to interact. AtTOP6B has also been shown to interact with 
AtSPO11-2 (although AtSPO11-2 is not highly transcribed) but not AtSPO11-1 [175]. A. 
thaliana mutants, homozygous for null mutations in either AtTOP6B or AtSPO11-3, display 
identical phenotypes, with severely growth stunted plants failing to live much past 4-5 weeks 
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[178]. Furthermore, double mutants displayed a phenotype identical to that of either single 
mutant, demonstrating the proteins likely function in the same process, or even the same 
protein complex. This study suggested that the topo VI homologues play a key role in DNA 
replication/metabolism and cell growth. A process called endoreduplication, in which the 
genome is replicated multiple times in the absence of cellular division, is critical for plant growth 
to enlarge cells of the hypocotyl and leaves [179]. Endoreduplication is deficient in the 
AtSPO11-3/AtTOP6B mutants and can explain the dwarf aspect of the phenotype. Sugimoto-
Shirasu et al. [169], found that mutations in either AtSPO11-3 or AtTOP6B did indeed halt 
endoreduplication, however the phenotype was not quite as severe as Hartung et al. had found 
[178]. The plants also produced fertile seeds, indicating that the topo VI homologues do not 
play such a central role in DNA metabolism (at least in the particular ecotype analysed) as 
previous work had suggested, and their primary role is likely during endoreduplication. 
However, A. thaliana possesses both topoisomerase II and DNA gyrase homologues, both of 
which are type IIA topoisomerases capable of the same reactions as topo VI, namely DNA 
decatenation, unknotting and relaxation. So why A. thaliana requires topo VI (AtSPO11-3 and 
AtTOP6B) exclusively during endoreduplication isn’t clear. One possibility is that it functions to 
resolve endoreduplication specific DNA intermediates, however no such DNA species have yet 
been found. Topo VI may also be under distinct regulation and so expressed specifically during 
endoreduplication [180].   
An important difference between archaeal and plant topo VI, is the identification of two 
other proteins that seemingly interact with plant topo VI to form the functional complex, which 
haven’t been found in archaea, called BIN4 (brassinosteroid-insensitive4) and RHL1 
(roothairless-1) [181, 182]. Mutants in either of these proteins results in plants with severely 
restricted growth due to the inability to complete the endoreduplication cycle. The BIN4 protein 
binds DNA and in the absence of a functional version, DNA damage response pathways are 
activated and endocycles are prematurely arrested leading to the prevention of cell expansion 
[182]. The RHL1 protein, likewise has DNA binding activity and when mutated, successive 
rounds of genome replication during endoredulplication is prevented after the first 2 endocycles 
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[181]. RHL1 shows sequence similarities to the topo IIα C-terminal domain, and whilst the 
function of this domain isn’t fully understood, both it and RHL1 contain putative phosphorylation 
sites and the PEST sequence (thought to be involved in rapid protein degradation [183]. And, 
in addition, it is the C-terminal domain of topo IIα, which varies most from the IIβ isoform, 
indicating a potential role in differential regulation [184]. So, whilst it is plausible that RHL1 may 
be directly involved in the topo VI chemical reaction, its main function may possibly be 
regulation of the complex’s activity [181].  
Plant topo VI has also been shown to modulate the expression of numerous genes, 
such as those regulated by plant steroid hormones, brassinosteriods, implicating topo VI in 
plant growth and development via an alternative route to endoreduplication defects [185]. 
Another study implicated plant topo VI in cellular growth and development, through a role in 
chromatin organisation and transcriptional silencing [186]. Mutants in the mid gene, encoding 
the MIDGET (MID) protein, exhibited identical phenotypes as mutants in rhl1, rhl2 and top6B, 
with MID demonstrating a physical interaction with RHL1, and that the absence of MID results 
in DNA damage check-point activation. Furthermore, A. thaliana Top6B mutants have been 
shown to have defects in epidermal development, producing dysfunctional root hairs and 
trichomes; and carbon partitioning, with cell walls becoming inundated with pectins and other 
proteins, and the matrix accumulating callose and starch [187]. The rice Top6A and B subunits 
were overexpressed in A. thaliana, with the resultant phenotype involving reduced abscisic acid 
(ABA) sensitivity, high salt tolerance and dehydration resistance [188]. A single base 
substitution in A. thaliana topo6A, caused defects in the reactive oxygen-species response, 
thought to be due to the failure of top6A binding in the activation of critical genes [189].  
Together, these data indicate that topo VI likely plays a role in mediating the plant’s response 
to endogenous and exogenous cues, integrating them through chromatin remodelling and 
transcriptional control, and is therefore an important determinant of cellular development.  
 
1.4.3 Plasmodial topoisomerase VI 
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For plasmodia, the literature is presently in disagreement as to the presence of a functional 
topo VI within the genome. A review on Plasmodium genomics from 2003, claimed that 
plasmodia encoded both a Top6A and Top6B subunit based on homology to domains and 
subunit arrangement also found in archaeal topo VI proteins [190]. For instance, Top6A was 
identified due to the presence of both a WHD domain, harbouring the catalytic tyrosine residue, 
followed by a TOPRIM domain. It is true that Top6A has this architecture, but it is also present 
in Spo11. A subsequent paper from a different group, interested in the presence of Spo11 in 
the genomes of eukaryotes, stated that whilst plasmodia (apicomplexans) contained a Top6B 
homologue, it did not encode Top6A, only Spo11 [191]. The paper only speculated that Top6A 
may have been lost over time and as the Top6B is highly divergent from archaeal Top6B, with 
only N-terminal homology in the GHKL domain, that perhaps it functions independently of 
Top6A. The situation is further confounded when in 2016, a group claimed that topo VI from 
Plasmodium falciparum can complement the function of topo II in Saccharomyces cerevisiae 
when expressed transiently and that it is sensitive to the ATPase inhibitor radicicol [192].  
If topo VI is present in plasmodia, it is hypothesised that it may play a potential role in 
schizogeny, asexual reproduction via numerous genome replications followed by cytokinesis, 
and could have promise as a novel antimalarial drug target. However, clearly substantially more 
research is required.  
 
1.4.4 Archaeal topoisomerase VI 
Most of the work previously carried out on archaeal topo VI comes from characterisation of the 
enzyme from the hyperthermophillic archaeon, S. shibatae. Other archaeal species analysed 
include the hyperthrmophillic Methanococcus jannaschii and the mesophilic Methanosarcina 
mazei. The S. shibatae topo VI (SsT6) is an A2B2 hetrotetramer with an A subunit of 47 kDa 
(Top6A) and a B subunit of 60 kDa (Top6B). It was shown to relax both positive and negative 
supercoils in the presence of ATP and Mg2+, have no supercoiling activity, and to be more 
efficient in decatenation than in relaxation [167]. Double stranded DNA cleavage by SsT6 was 
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found in the presence of both nucleotide (ATP or ADPNP) and divalent cation (Mg2+ or Ca2+), 
but in the absence of either nucleotide or cation, no cleavage was detected [193]. The optimal 
conditions to experimentally stabilise the cleavage complex of SsT6 in the absence of 
compounds was shown to be in the presence of 10 mM CaCl2 and 1 mM ADPNP [194], with 
the enzyme becoming covalently bound to DNA at the 5ʹ phosphate, as for type IIA topos [193, 
194]. SsT6 has also been shown to generate a 2-base stagger during DNA cleavage, rather 
than the 4-base found in type IIA topos, and whilst no specific cleavage site sequence has yet 
been described, a potential preference for A and T nucleotides has been reported [194].  
 
Figure 1.12: Protein structures and gene domain organisation of DNA topoisomerase VI (topo VI). 
A: Methanosarcina mazei topo VI. PDB: 2Q2E [195]. B: Sulfolobus shibateae topo VI. PDB: 2ZBK 
Chapter 1: Introduction 
 37 
[196]. C: Gene domain organisation of M. mazei topo VI. Domains are coloured throughout as 
follows: GHKL is red, H2TH is pink, Transducer is orange, Top6B CTD is green, WHD is blue and 
TOPRIM is teal. The other Top6B and Top6A subunits and light and dark grey, respectively. 
Vertical black bars in C represent key catalytic residues.  
 
Structural work on archaeal topo VI has been carried out on the S. shibatae, M. 
jannacshii and M. mazei enzymes, revealing the domain architecture and quaternary structure 
of Top6A and Top6B, as well as the heterotetramer in a closed (Figure 1.12A) and open (Figure 
1.12B) conformation. A truncated version of M. jannaschii Top6A, containing the DNA binding 
core, was crystallised and resolved at 2.0-Å resolution, shedding light on the DNA-cleavage 
mechanism of topo VI and revealed structural motifs shared between type IIA and IIB topos 
[170]. Namely the N-terminal winged-helix domain (WHD) that harbours the catalytic tyrosine 
residue and the C-terminal TOPRIM domain, previously referred to as the Rossman-like fold, 
which chelates divalent cations, specifically Mg2+. In topo VI, this is achieved via conserved 
acidic residues Asp249, Asp251, and Glu197 (M. jannaschii numbering). Both oxygens of 
Asp251 are hydrogen-bonded to two water molecules, along with another two observed water 
molecules that complete the octahedral coordination geometry necessary for Mg2+ binding. 
Analysis of the structure of the Top6A homodimer revealed the formation of a positively 
electrostatic groove, 18 Å in diameter, seemingly capable of accommodating a DNA duplex. 
Furthermore, the catalytic tyrosine and the TOPRIM domain face the interior of the groove, 
plausibly in position to interact with a captured G-segment.  
The Top6B subunit, responsible for the binding and hydrolysis of ATP was crystallised 
from S. shibatae, as both an un-liganded monomer and a nucleotide-bound dimer with three 
key domains described [64]. The N-terminal ATP-binding fold of Top6B was found to be a 
member of the GHKL family of ATPases (Gyrase, Hsp90, Histidine Kinase, MutL), a shared 
feature with the type IIA topos. Despite <15 sequence identity between the GHKL domains of 
Top6B and the B subunit (GyrB) of E. coli gyrase (type IIA), the overall structure of the GHKL 
core 112 residues was found to be very similar with a Cα r.m.s.d of only 1.17 Å. The second 
Top6B domain is called the helix-two-turns-helix (H2TH) motif and contains 4 α-helices. It is 
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found in all the type IIB enzymes, archaeal and eukaryotic, and is not present in any type I or 
type IIA topos. It is thought to play a role in G-segment bending and recognition, and coupling 
G-segment cleavage to strand-passage [62]. The third domain is known as the transducer 
domain, and remarkably again, shows high structural similarity with the equivalent domain of 
E. coli GyrB, giving a Cα r.m.s.d of only 1.54-Å despite <11% sequence identity. It has been 
proposed that for both topo VI and gyrase, this domain is key in transducing energy from the 
ATPase domain to the DNA binding/cleavage domain. This structural data demonstrated the 
increasing likelihood that type IIA and IIB topos are directly related in terms of evolution and 
despite being so structurally distinct, key mechanistic motifs have been highly conserved 
between the two families. It is known that the GHKL domains of type IIA topos and MutL 
proteins dimerise in response to ATP binding, and in the case of type IIA topos this dimerisation 
of the N-gate is key to the strand passage reaction, allowing the DNA gate to open without the 
BA dimers dissociating and producing genotoxic DNA breaks [197]. This dimerisation also 
occurs when nucleotide is bound to the Top6B subunit, and was demonstrated 
crystallographically using ADPNP [64]. This began to indicate that, although the structure and 
sequence of topo VI was quite distinct from type IIA topos, its mechanism likely follows a similar 
path to the strand-passage mechanism of type IIA topos. For a visual representation of topo VI 
gene domain organisation, see Figure 1.12C. 
The enzyme this research project centres around is topo VI from the mesophilic                                                                          
archaeon M. mazei (MmT6). Multiple reasons make MmT6 an attractive candidate for topo VI 
characterisation, including the ability to express it in E. coli and an optimum activity temperature 
of ∼37°C. The optimum temperature for activity of S. shibatae topo VI is ∼80°C, making assays 
troublesome to perform. Its suitability was further consolidated through the full-length 
crystallisation of the MmT6 heteroteramer to 4-Å resolution (Figure 12A) [195]. This was done 
in the absence of nucleotide, with an AB dimer occupying each asymmetric unit of the crystal 
and the heterotetramer recapitulated through a crystallographic two-fold rotation axis. The 
heterotetramer appears to form a rough square with overall dimensions of ∼170 Å x 130 Å x 
70 Å and an internal, electrostatically positive cavity of adequate size to accommodate 2 DNA 
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duplexes. The Top6A/Top6B dimer interface is formed from the tight association of a helical 
hair pin that extends from the Top6B transducer domain, with two α-helices found in the N-
terminal region of Top6A.  
The Top6A subunits form a dimer, creating a 20-Å wide, positively-charged channel, in 
which the active site tyrosine of the WHD domain and the Mg2+-binding centre of the TOPRIM 
domain of each Top6A are in position to interact with a G-segment. It is likely that this Top6A 
dimer, in association with the Top6B dimer, cleaves the G-segment to produce a DSB in which 
the 5ʹ end of each strand is covalently bound to the tyrosine (Y105) of each Top6A. This 
structural data is in agreement with that obtained from the crystallisation of the truncated DNA 
binding core of Top6A, explored above [170]. In the MmT6 structure, the less well conserved, 
N-terminal 70 amino acids of Top6A can now be seen, including an α-helix (amino acids 17-
37) that, along with the first α-helix of the WHD (amino acids 71-94), forms the binding interface 
with Top6B. These two α-helices are linked by a region of disordered amino acids (44-67), 
conserved amongst topo VI homologues as well as Spo11, which contains two arginine 
residues (Arg44 and Arg67) and one asparagine residue (Asn48), and appears to jut out over 
the DNA-binding groove and may interact with the G-segment (Figure 1.13B).  
As previously discussed, the Top6B subunit of topo VI has an N-terminal GHKL domain 
responsible for the binding and hydrolysis of ATP. This is followed by the H2TH domain, and 
the transducer domain. The transducer moves relative to the GHKL domain upon ATP 
binding/hydrolysis and transmits this movement to the DNA binding core of Top6A. The 
movement of the transducer domain is mediated by a conserved lysine residue (Lys435 in 
MmT6 and Lys427 in SsT6) that reaches into the GHKL domain and interacts with the γ-
phosphate of the bound nucleotide via a hydrogen bond (Figure 1.13A). Once the nucleotide 
is hydrolysed and the phosphate released, the lysine residue turns away from the active site, 
returning the transducer domain back to its relaxed state [67]. Following the transducer domain 
is a C-terminal domain (CTD), which is absent in the SsT6 Top6B [64]. It adopts an 
immunoglobulin-type fold, placing it in a functionally diverse protein family, with key roles in the 
binding of macromolecules, typically in the form of carbohydrates and proteins. The complete 
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deletion of the MmT6 CTD modestly reduces activity in vitro but does not change the enzyme’s 
preference for different DNA substrates. Interestingly, the few archaeal species in which the 
Top6B CTD is present, are those which also possess DNA gyrase. It has been hypothesised, 
therefore, that the CTD may be involved in regulating topo VI spatially, localising it to certain 
cellular compartments [195].  
 
Figure 1.13: Close ups of DNA topoisomerase VI structures. A: S. shibatae topo VI close up of 
the GHKL (red) domain bound to ADP and phosphate. The ‘switch lysine’ present in the 
transducer domain, Lys427 (435 in M. mazei) can be seen reaching into the ATP-binding pocket. 
PDB: 2ZBK [196]. B: Close up of the interface between Top6A and Top6B, from M. mazei. Two α-
helices from the transducer domain of Top6B, interact with two α-helices from the WHD of Top6A, 
forming a highly-stable non-covalent interface. The blue dotted line represents the conserved 
and disordered amino acids 44-67, believed to form a loop that extends over and interacts with 
the bound G-segment. PDB: 2Q2E [195]. 
 
Along with solving the structure of the MmT6 holoenzyme, the work done by Corbett et 
al., 2007 [195] also delved further into the ATP-mediated conformational changes of the SsT6 
enzyme using small-angle X-ray scattering (SAXS) analyses, complementing and adding to 
previous crystallographic analyses of the Top6B subunit in the apo-state and bound to AMP-
PNP, ADP·AlF4
-
, ADP·Pi, and ADP [64, 67]. This work gave great insight into the ATP-
mediated DNA cleavage reaction of topo VI, making it possible to model the strand passage 
mechanism by which the enzyme likely functions. The 2-gate model of strand passage, used 
to describe the working of all type II topos, involves the formation of two protein interfaces that 
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alternately open and close in the presence of ATP/Mg2+ to allow the capture and passage of a 
T-segment through a cleaved G-segment before its re-ligation [198]. The MmT6 holoenzyme 
structure substantiates the 2-gate model, by demonstrating the existence of two protein 
interfaces that can alternately open and close to allow the capture of two DNA segments. In 
the absence of ATP, the Top6A subunits are dimerised, whilst the Top6B subunits remain open, 
allowing the capture of the G- and T-segments. Upon ATP binding the Top6B subunits 
dimerise, forming a strong protein interface. Due to the Lys345 residue mentioned above, ATP 
binding is coupled to transducer domain movement, which transmits this conformational 
change to the WHD of Top6A. This is thought to cause the catalytic tyrosine of the WHD to 
become correctly positioned in the vicinity of the Mg2+ binding centre of the TOPRIM domain, 
forming the bipartite active site capable of G-segment cleavage. The subsequent hydrolysis of 
an ATP to ADP + Pi then to ADP (Pi release), explored using the SsT6 B subunit structures, 
showed an 11° outward rotation of the transducer domain [67]. If the Top6B/Top6A dimer 
interface is present, this transducer domain movement should theoretically be able to separate 
the Top6A subunits, allowing the passage of the T-segment. Hydrolysis and release of the 
second ATP, should then reset the enzyme, allowing it to undergo another strand passage 
cycle. A simplified schematic of the topo VI mechanism can be seen in Figure 1.14.  
Recently, a study was published detailing extensive biochemical characterisation of the 
DNA sensing regions of the M. mazei Top6B subunit [62]. In this study, site-directed 
mutagenesis revealed three conserved, positively charged regions within Top6B that are of 
importance in sensing DNA bends and crossings by MmT6 and tightly coupling strand scission 
by the Top6A subunit to ATPase activity in the Top6B subunit. The three motifs explored were 
the H2TH domain, the KGRR(186-189) loop, and the WKxY loop, with key residues of each motif 
substituted to either alanine or glutamate residues. Using a combination of biochemical and 
biophysical techniques, their active role in sensing the T-segment and coupling this to ATPase 
activity was revealed. Compared to wild-type topo VI, mutations in the KGRR and WKxY loops 
abolished strand-passage, whilst it was significantly impaired by mutations in the H2TH 
domain. The ATPase activity in the presence of supercoiled DNA was increased for KGRR 
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mutants, indicating futile cycling (ATP hydrolysis in the absence of strand-passage); roughly 
equal to wildtype for H2TH mutants; and completely abolished for WKxY mutants. Binding to 
supercoiled DNA is also moderately affected for H2TH and KGRR mutants, with no binding 
detected for the WkxY mutant. This research led to the conclusions that the WkxY loop was 
integral to strong G-segment binding; the KGRR loop (of the GHKL domain) is involved in 
sensing the T-segment and coupling its presence to ATPase activity; and the H2TH promotes 
G-segment bending in the presence of ATP, and aids in coupling ATP hydrolysis to DNA 
cleavage and strand-passage [62].  
 
Figure 1.14: Simplified DNA topoisomerase VI reaction mechanism. (1) The heterotetramer binds 
a G-segment (green) to the Top6A subunits (light and dark blue), and captures a T-segment (red), 
within the enzymes central cavity. (2) An ATP molecule binds to each Top6B subunit (light and 
dark purple) causing Top6B dimerisation. (3) ATP is hydrolysed and an inorganic phosphate (Pi) 
is released which leads to conformational changes causing G-segment cleavage and duplex 
opening, so as to allow the T-segment to pass through and exit the enzyme. (4) The G-segment 
is re-ligated and the dissociation of ADP and Pi triggers the opening of the Top6B subunits so 
that then enzyme can perform a consecutive round of strand passage or disengage from the DNA 
[62, 195].  
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1.4.5 Spo11  
Spo11, a 45-kDa protein, was first identified in Saccharomyces cerevisiae using assays 
designed to characterise the genomes of yeast deficient in sporulation and therefore meiosis 
[199, 200]. Spo11 initiates meiotic recombination in prophase I via the formation of double-
stranded DNA breaks (DSBs), becoming covalently bound to the 5ʹ phosphate via an invariant 
tyrosine residue, not only found in all topo VI enzymes but also throughout the topoisomerase 
family [172]. Mutation of this tyrosine residue to a phenylalanine in Spo11, removes its ability 
to form DSBs [171]. Once Spo11 generates a DSB it is endonucleolytically removed from the 
DNA, likely via the Mre11-Rad50-Xrs2 complex, yielding a Spo11-oligonucleotide complex 
[201]. The resultant double-strand break is processed before undergoing recombination (or, 
less frequently, repair), thus making Spo11 an important component in the generation of 
genetic diversity [202]. Spo11 orthologs appear in numerous eukaryotic organisms as a 
meiosis-specific factor, including fungi, invertebrates, mammals and plants [203, 204].  
When the topo6A gene was sequenced, the homology to Spo11 was recognised early 
on, and the tyrosine responsible for the topo-like activity of the Spo11 protein was determined 
[171]. Spo11 also generates a 2-base stagger upon cleavage [205], as does topo VI [194], thus 
strengthening the evolutionary relationship between them. However, Spo11 has been 
notoriously difficult to express and purify for in vitro analysis, hence making characterisation of 
Top6A particularly important for Spo11 research, which has already led to key insights on the 
potential catalysis mechanism of Spo11-induced DSBs. For instance, it was found that when 
Top6A was expressed alone it was extremely insoluble [193] and only when expressed in the 
presence of Top6B, or purified from the parental organism [167], could considerable amounts 
of active protein be collected [195]. This indicated that Top6B plays a key role in the stabilisation 
of Top6A and led to the notion that there may be Top6B homologs also present, which stabilise 
Spo11 and may also play a role in meiosis. Bioinformatics did not reveal any homologs based 
on DNA sequence alone, however when the focus was shifted to structural homology, 
candidates were identified [173, 174]. In two papers, published back to back, Top6B-like 
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homologs were explored in A. thaliana [174], S. cerevisiae (Rec102), Shizosaccharomyces 
pombe (Rec6), Drosophila melanogaster (MEI-P22) and mouse [173]. A. thaliana encodes 3 
Spo11 homologs (AtSpo11-1, AtSpo11-2 and AtSpo11-3), with AtSpo11-3 being the Top6A 
subunit homolog, necessary for endoreduplication (see 1.4.2). AtSpo11-1 and AtSpo11-2 are 
believed to play key, non-redundant roles in DSB-formation during meiosis, with mutations in 
either producing similar phenotypes and leading to the postulation that they function as a 
heterodimer [177, 206, 207]. In 2016, it was demonstrated that a structural homolog of archaeal 
Top6B (AtTop6B-like) was present in A. thaliana, with its absence causing plant sterility through 
defects in female gamete development [174]. Using a yeast triple-hybrid assay, AtTop6B-like 
was important for the formation of the AtSpo11-1/AtSpo11-2 heterodimer. Structurally, 
AtTop6B shared key conserved domains in the GHKL and transducer domains. In mice, 
another structural homolog was identified (MmTop6B-like), which was shown to interact with 
Spo11-β, but not Spo11-α, via a 38-amino acid insertion at the NTD of Spo11-β, which is absent 
in Spo11-α [173]. In tissues, MmTop6B-like had similar expression profiles to Spo11-β, 
expressed only in the testes or ovaries during meiosis. Homozygous truncation mutations in 
MmTop6B-like rendered adult mice deficient in spermatogenesis, with MmTop6B-like being 
demonstrated to be directly involved with DSB formation during meiosis. Later in 2016, another 
paper emerged detailing similar findings for a rice top6B-like protein also necessary during 
meiotic recombination [208, 209]. Very recently, in 2020, a further study was published in which 
the Saccharomyces cerevisiae Spo11 complex was purified from insect cells, after decades of 
trial and error, achieved only through the identification and dual expression of Top6B-like 
homologues, Rec102 and Rec104, as well as a third protein, Ski8 [210]. This has allowed in 
vitro biochemical characterisation of Spo11 to finally begin. The work done on Top6B-like 
homologs is yet another example of how the characterisation of archaeal topo VI has facilitated 
breakthroughs in the study of meiosis. 
 
1.4.6 DNA topoisomerase VI inhibition 
When it comes to inhibition of type II topos, two key mechanisms have been described. One 
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class of inhibitors are known as cleavage-complex stabilisers, as they bind between the double 
stranded break and prevent its re-ligation. This leads to stalling of replication machinery and 
the accumulation of lethal DSBs. This mode of action is used by the prokaryotic type IIA inhibitor 
class, the quinolones [99, 211], and the eukaryotic anti-cancer drug, etoposide, which targets 
topo II [212]. The other potent class of topoisomerase drugs are the aminocoumarins. These 
molecules competitively bind to the ATP domain, preventing the binding of ATP, therefore 
hindering the ATP-dependent function of the enzyme [213]. The aminocoumarins, whilst very 
potent in vitro, are not used clinically due to their high levels of toxicity [214]. For topo VI, a few 
inhibitors have been identified including the Hsp90 inhibitor radicicol, which is an ATPase 
inhibitor [215]. A screen was also performed using topo II inhibitors, and whilst the mechanism 
of action isn’t clear, some topo II drugs did inhibit SsT6. In 2013, a novel microtitre based assay 
used for the high-throughput screening of drugs against type II topos, was described [216]. 
Here novel inhibitors against MmT6 were identified. These included m-amsacrine, suramin, 
hexylresorcinol, 9-aminoacridine, purpurin and quinacrine. M-amsacrine, 9-aminoacridine and 
quinacrine were shown to prevent DNA cleavage by MmT6, suramin and purpurin blocked DNA 
binding and hexylresorcinol’s mode of action remains unknown. This study also looked at the 
effects of growing plants in the presence of hexylresorcinol. Plants exhibited symptoms akin to 
those of the topo VI knockouts, including endoreduplication defects, but it cannot be said with 
absolute certainty that this is due to the inhibition of plant topo VI as hexylresorcinol may have 
a number of cellular targets. However, the evidence of hexylresorcinol’s in vitro inhibition of 
MmT6 provides indirect evidence that inhibition of plant topo VI may well be the main cause of 
the phenotype. This demonstrated the potential that MmT6 research has in advancing 
knowledge of plant, and potentially plasmodial, biology, which are organisms that are important 
in agriculture and human disease.  
 
1.5 Single-Molecule Methods 
1.5.1 Overview 
In the past, exploring the function and mechanism of topoisomerases was dominated by 
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ensemble or “bulk” experiments that have led to a great body of data and understanding on the 
enzymes’ activity. However, the averaging effect that comes from working with many topo 
molecules in solution has the tendency to obscure the finer mechanistic details. As 
technologies and scientific understanding increases, the ways in which one can explore at the 
molecular level are expanding. One key set of techniques being used progressively more for 
the characterisation of topos, are single-molecule assays. As the name suggest, these assays 
involve using exceedingly low concentrations of protein to attain data on the activity of a single 
enzyme reacting with a single substrate. Mapping conformational changes in the B. subtilus 
DNA gyrase in solution has been achieved through single-molecule fluorescence (förster) 
resonance energy transfer (smFRET) [217]. FRET analysis has shown that the GyrB subunits 
dimerise in the presence of ATP and reopen post ATP hydrolysis. Also using FRET it was 
shown that the DNA gate is predominately in the closed conformation during the reaction, 
providing evidence that DNA gate opening is a rare and brief stage due to the danger of DSBs 
[218]. Fluorescence has also been used in vivo, studying the localisation of DNA gyrase, topo 
IV and topo I in Bacillus subtilis [219]. Using fluorescently-labelled subunits, it was shown that 
the topo IV subunits are uniformly distributed in the nucleoid, however DNA gyrase and DNA 
topoisomerase I dynamically associated with DNA replication forks. This indicated an important 
role for gyrase and topo I in topology maintenance during replication.  
In terms of single-molecule in vitro techniques that have shown to be well-suited to the 
study of topos, there are two which allow the precise manipulation of DNA topology, with the 
resolution to detect single strand-passage events. These are the magnetic tweezers technique 
and the optical trap. During the course of this research the magnetic tweezers technique has 
been employed in the characterisation of MmT6, and therefore described in depth below (see 
1.5.2 and Chapter 4). Briefly, the optical trap, in this context, involves tethering a DNA duplex 
to a micron-sized bead which can be manipulated with nano-scale precision using highly 
focussed light [220]. This set up can vary, for instance, one extreme end of the DNA duplex 
can be tethered to a slide and the other to a bead which can be rotationally manipulated using 
light polarisation. Another set up, used in topo research, involves tethering the duplex at both 
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extreme ends to micron sized beads, one of which is held still in the optical trap whilst the other 
is rotated by an attached micro-pipette. This assay was implemented in characterisation of topo 
IV, demonstrating its chiral preference for positive supercoils [119].  
 
1.5.2 Magnetic tweezers 
By researching in the lab of Dr. Keir Neuman, the opportunity to explore MmT6 activity using 
single molecule assays, namely the magnetic tweezers technique, was facilitated. This method 
provides an elegant way in which the activity of a single topoisomerase on a single DNA duplex 
can be tracked in real time and with high accuracy. For in depth reviews see cited articles [221-
223]. The set-up is relatively simple and consists of a sample cell containing DNA that is 
tethered to the slide at one extreme end, and to a paramagnetic micron-sized bead at the other, 
all via noncovalent interactions. Two permanent magnets fixed 1 mm from each other are 
placed above the sample cell and produce a magnetic field gradient that exerts an upward force 
on the tethered magnetic bead. The sample cell is placed on top of an inverted oil immersion 
microscope, which relays the image of the slide to a camera. The magnetic beads produce 
diffraction rings and the appearance of these rings can be used to measure the distance of the 
bead from the surface of the sample cell. This allows the extension of the DNA to be tracked, 
with the measurement of extremely small changes in extension (1-20 nm, depending on 
magnetic force) being possible. As well as being able to apply a relatively constant force over 
an extensive range (potentially reaching in excess of 200 pN) to the DNA, this set up can also 
manipulate the DNA topology. By rotating the magnets above the sample cell, the DNA tethered 
bead will also rotate causing the introduction of twist and writhe into the DNA. As DNA becomes 
more twisted, the energy stored will eventually be converted to writhe, forming a plectoneme. 
The production of this plectoneme is accompanied by a decrease in the DNA extension and 
therefore can be measured (see Chapter 4). Topos, such as MmT6, can relax plectonemes 
and as they do so, the DNA extension increases and this can be accurately measured. So, the 
magnetic tweezers form a powerful tool that can be used to study the activity of topos at the 
single molecule level with the ability to capture single strand passage events. 
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The magnetic tweezers technique has been used to show that topo IV is more active in 
relaxing positive supercoils over negative supercoils, due in part to a preferential DNA 
crossover angle of 85.5° [120]. Acute crossover angles are more often found in DNA that is 
positively supercoiled, whilst the angle is obtuse for negatively supercoiled DNA. TopoIV has 
also shown to be highly processive when relaxing positive supercoils, as a result of its CTDs, 
while being perfectly distributive on negatively supercoiled DNA. This work also demonstrated 
that for yeast topo II, the angle preference was 90°, hence providing an explanation for its non-
preferential activity in the presence of positive and negative writhe [120]. Also, human topo IIα, 
as described in section 1.3.2.1.3, was demonstrated to be equally processive on positive and 
negative writhe, however the rate increase in the presence of positive is dictated by the CTDs, 
with the removal of the CTDs changing the chiral sign preference rather than the processivity 
[158]. A more comprehensive swivel mechanism for topo IB was established, showing that the 
enzyme nicks a single strand allowing the DNA to rotate in a controlled manner arising from 
friction generated within the enzyme cavity, with a chance of re-ligation with each full rotation 
[42]. More recently, the magnetic tweezers were used to measure the gate-opening dynamics 
of the type IA topos, E. coli topo I and III [224]. Gate opening is an event so transient that it had 
been impossible to measure using other biochemical or crystallographic techniques. The 
magnetic tweezers approach applies a constant force to assay these enzymes at the single-
molecule level, allowing the elucidation of this previously uncaptured event. Single-molecule 
data, such as those mentioned, complements that obtained from ensemble experiments, 
together providing a deeper understanding into topo mechanism and function. This project has 
aimed to achieve this for M. mazei topo VI, elucidating previously unseen activities with 
implications for the mechanism and in vivo roles of this little-known enzyme.  
 
1.6 Next-Generation Sequencing Techniques 
The use of next-generation sequencing techniques in the field of topos has been gaining 
momentum over the last 10 years, as a way of studying topo-dependent genome cleavage 
patterns in vivo [54]. For a comprehensive literature review on the topic, see Chapter 5, Section 
Chapter 1: Introduction 
 49 
5.1, in which the current published data utilising NGS techniques will be discussed and used 
to inform on the generation of the novel technique utilised in the data collection for that chapter.   
 
1.7 Project Aims 
Despite its surprisingly ubiquitous nature in all domains of life, less is known functionally about 
topo VI and its homologues in comparison to type IIA. This project has sought to integrate the 
use of ensemble assays with the single-molecule technique, the magnetic tweezers, to perform 
an in-depth analysis of the activity of wild-type M. mazei topo VI. This is with the purpose to 
gain a deeper understanding of the mechanism, particularly how DNA topology modulates 
activity, and inform speculations into topo VI’s role in vivo. As M. mazei topo VI expression and 
purification is accessible, and a full-length crystal structure is already obtained [195], the 
research reported here further develops M. mazei topo VI as a model topo VI enzyme, highly 
amenable to various forms of in vitro analysis. Further knowledge gained may be translated 
into finding inhibitors of the eukaryotic topo VI enzymes, which may have potential as herbicidal 









Materials and Methods 
 
2.1 Ensemble Assay Methods 
This section details the materials and methods used in the acquisition of data presented and 
discussed in Chapter 3.  
 
Table 2.1: Names and constituents of frequently used buffers and solutions for data collected 
using ensemble techniques.  
 
Buffers/solutions Details 
MmT6 dilution buffer 
(DB)  
20 mM HEPES pH 7.5, 10% (v/v) glycerol, 100 mM potassium 
glutamate and 2 mM β-mercaptoethanol. Buffer stored at -20°C.  
MmT6 minimal 
buffer (MB) 
20 mM bis-tris propane pH 7, 100 mM potassium glutamate and 1 
mM DTT. Buffer stored as 5x concentrate at -20°C. 
MmT6 relaxation 
buffer (RB) 
20 mM bis-tris propane pH 7, 100 mM potassium glutamate, 10 mM 




20 mM bis-tris propane pH 7, 100 mM potassium glutamate, 10 mM 
MgCl2 and 1 mM DTT. Buffer stored as 5x concentrate at -20°C. 
STEB (2x) 100 mM Tris･HCL pH 8.0, 40% (v/v) sucrose, 100 mM EDTA, 0.5 
mg/ml Bromophenol Blue 
SAB (5x) 125 mM Tris (pH 6.8), 4% (w/v) SDS, 20% (v/v) glycerol, 10% (v/v) 
β-mercaptoethanol and 0.002% (v/v) bromophenol blue. 
TAE 40 mM Tris-Acetate pH 8.0, 1 mM EDTA 
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Purification buffer A 20 mM HEPES pH 7.5, 10% (v/v) glycerol, 800 mM NaCl, 20 mM 
Imidazole, 2 mM β-mercaptoethanol and EDTA free protease 
inhibitors.        
Purification buffer B 20 mM HEPES pH 7.5, 10% (v/v) glycerol, 150 mM NaCl, 20 mM 
Imidazole, 2 mM β-mercaptoethanol, and EDTA free protease 
inhibitors.                            
Purification buffer 
B1 
20 mM HEPES pH 7.5, 10% (v/v) glycerol, 150 mM NaCl, 500 mM 
Imidazole, 2 mM β-mercaptoethanol, and EDTA free protease 
inhibitors.                            
Purification buffer 
B2 
20 mM HEPES pH 7.5, 10% (v/v) glycerol, 800 mM NaCl, 20 mM 
Imidazole, 2 mM β-mercaptoethanol. 
Purification buffer C  20 mM HEPES pH 7.5, 10% (v/v) glycerol, 300 mM NaCl, 2 mM β-
mercaptoethanol and EDTA free protease inhibitors.                                  
Auto induction 
media (AIM) 
10 g/L tryptone, 5 g/L yeast extract, 3.3 g/L ammonium sulphate, 6.8 
g/L potassium dihydrogen phosphate, 0.5 g/L glucose, 2 g/L lactose, 
and 0.15 g/L magnesium sulphate 
 
2.1.1 M. mazei DNA topoisomerase VI expression and purification 
Both subunits of MmT6 (Top6A and Top6B) were expressed from a polycistronic duel-
expression vector (Corbett et al., 2007), transformed into Rosetta 2 + pLysS Escherichia coli 
expression cells. They were grown for 24 hr at 37 °C in autoinduction growth media (AIM) 
(Formedium) in the presence of kanamycin (50 mg/ml) and Chloramphenicol (35 mg/ml). The 
culture was then centrifuged using the Sorvall RC6+ centrifuge in the FS9 rotor for 8 min, at 
8000 rpm and 4°C. Supernatant was discarded and the pellet resuspended in buffer A (refer to 
Table 2.1 for all buffers mentioned, unless otherwise stated). 
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Cells were lysed under high pressure using the Avestin high-pressure homogeniser. 
Samples were then spun at 18,500 rpm for 1 hr at 4°C with the Sorvall RC 6+ centrifuge and 
SS34 rotor. The lysate was then passed over a HisTrap™ FF Ni2+ column (5 ml/min, GE Life 
Sciences) and washed with purification buffer B. The protein was stepped of in purification 
buffer B1 and then loaded on to a HiTrap™ SP Sepharose HP column (5 ml/min, GE Life 
Sciences) followed in tandem by a HiTrap™ Q Sepharose HP column (5 ml/min, GE Life 
Sciences). The SP Sepharose column was removed before the protein was stepped off from 
the Q Sepharose with purification buffer B2. Protein concentration was assessed using solution 
absorbance at 280 nm, determined using the Lamba 25 spectrophotometer, the molecular 
weight and the theoretical extinction coefficient for MmT6 (for the heterotetramer: 220 kDa and 
187,260 M-1cm-1, respectively). Samples were also analysed after each column procedure via 
the addition of 5x SAB and boiling for 5 min, before being loaded onto a RunBlueTM 12% (w/v) 
precast SDS acrylamide gel from Expedeon, at 180V for ∼40 min. The His-tag was cleaved 
using tobacco etch virus protease (TEV) (New England BioLabs) at a 1:50 concentration ratio 
(TEV:MmT6). The cleaved protein was then passed over a HisTrap™ FF Ni2+ column (5 ml/min, 
GE Life Sciences) and washed with purification buffer B, with the cleaved protein collected in 
the flow-through. The un-cleaved protein, his-tag and TEV were then stepped off in buffer B1. 
Fractions of MmT6 were pooled and concentrated using Amicon Ultra 15 mL centrifugal filter 
units (10 kDa cut-off, MilliporeSigma) before being passed down a Superose 6 10/300 (GE Life 
Sciences) column in buffer C, at 0.2-0.5 mLmin-1. MmT6-containg fractions were subsequently 
concentrated as before and protein concentration determined using the method described 
above. All proteins stored at -80°C. 
 
2.1.2 SEC-MALS and iSCAT 
Size Exclusions Chromatography coupled to Multi-Angle Light Scattering (SEC-MALS) and 
Inferometric Scattering Technology (iSCAT) were techniques used to explore the holoenzyme 
structure of MmT6. Both were conducted with the help of the NHLBI Biophysical platform 
(Bethesda, USA). Provision of MmT6 in dilution buffer was all that was required, with each 
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technique being carried out by the platform. For SEC-MALS, two samples of MmT6 were 
provided 0.45 μM and 2.27 μM, and for iSCAT, one sample of 20 nM MmT6. The data from 
both assays was personally plotted and analysed using Igor Pro 7 (Wavemetrics).  
 
2.1.3 DNA relaxation assays 
Generally, the final MmT6 concentrations used ranged from 0.4 to 114 nM (20-40 nM being 
optimal) and were assayed in the presence of 2 nM pBR322* (see Chapter 3 for more details 
on pBR322*), either negatively supercoiled or positively supercoiled (Inspiralis), relaxation 
buffer, dilution buffer, with a 30 μl final volume. Samples were incubated at 21 or 37°C for 30 
min before the reaction was stopped with the addition of 20 μL 2 x STEB and 30 μL chloroform: 
isoamyl alcohol (24:1 v/v). Samples were vortexed thoroughly, centrifuged at 13000 rpm using 
an Eppendorf table-top centrifuge for 3 min before being loaded onto a 1% (w/v) agarose gel. 
Generally, gels were run for 10-15 hrs at 2 Vcm-1, before being stained with 0.5 μg/mL ethidium 
bromide (EtBr) and imaged under UV illumination using the Syngene Gel Doc system. DNA 
topology (negatively supercoiled, positively supercoiled, relaxed and linear), divalent metal ion 
identity and concentration (MgCl2, MnCl2, ZnCl2, CaCl2, CoCl2 and NiCl2 titrated at 0.5-100 mM), 
pH (6-9), temperature (20-90°C), use of potassium glutamate versus acetate, and incubation 
time were varied depending on the particular assay being performed. For details on specific 
relaxation assay conditions, see Figure legends associated with data presented in Chapters 3-
5.  
 
2.1.4 DNA decatenation assays 
These assays are highly similar to DNA relaxation assays, aside from the DNA substrate 
utilised. Generally, the final MmT6 concentrations used ranged from 0.1 to 40 nM (0.5-5 nM 
being optimal depending on the catenated substrate in use) and were assayed in the presence 
of 250 ng of kinetoplast DNA (kDNA) or 2 nM of singly-catenated plasmids (Inspiralis), 
relaxation buffer, dilution buffer, with a 30 μL final volume. Samples were incubated at 21 or 
37°C for 30 min before the reaction was stopped with the addition of 20 μL 2x STEB and 30 μL 
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chloroform: isoamyl alcohol (24:1). Samples were vortexed thoroughly, centrifuged at 13000 
rpm using an Eppendorf table-top centrifuge for 3 min before being loaded onto a 1% (w/v) 
agarose gel. Generally, gels were run for 10-15 hrs at 2 Vcm-1, before being stained with 0.5 
μg/mL ethidium bromide (EtBr) and imaged under UV illumination using the Syngene Gel Doc 
system.  
 
2.1.5 DNA cleavage assays 
Generally, the final MmT6 concentrations ranged from 5 nM up to 160 nM (∼160 nM being 
optimal) and were assayed in the presence of 3-4 nM pBR322* (Inspiralis), minimal buffer, 
dilution buffer, 1 mM ADPNP, 10 mM MgCl2 and the final volume made up to 30 μl. Samples 
were incubated at 37°C for 30 min before the addition of 3 μL proteinase K (New England 
BioLabs) and 3 μl 2% (w/v) sodium dodecyl sulphate (SDS). Samples were incubated for 1 hr 
at 37°C before the reaction was stopped with the addition of 20 μL 2 x STEB and 30 μL 
chloroform: isoamyl alcohol (24:1). Samples were vortexed thoroughly, centrifuged at 13000 
rpm using an Eppendorf table-top centrifuge for 5 min before being loaded onto a 1% (w/v) 
agarose gel.  Generally, gels were run for 8-12 hrs at 2 Vcm-1, before being stained with 0.5 
μg/mL ethidium bromide (EtBr) and imaged under UV illumination using the Syngene Gel Doc 
system. DNA topology (negatively supercoiled, positively supercoiled, relaxed and linear), 
divalent metal ion concentration (MgCl2, MnCl2, ZnCl2, CaCl2, CoCl2 and NiCl2 titrated at 0.5-
100 mM), pH (6-9), temperature (30-50°C), use of potassium glutamate versus acetate, and 
incubation time were varied depending on the particular assay being performed. For details on 
specific DNA cleavage assay conditions, see figure legends associated with data presented in 
Chapters 3-5. 
 For samples in which ethylenediaminetetraacetic acid (EDTA) was used to stimulate 
DNA cleavage reversal (Chapter 3, Section 3.2.5.6), the addition of EDTA occurred between 
MmT6 incubation and proteinase K/SDS treatment, and unless otherwise stated, was 
incubated at room temperature for 5 min. The concentration of EDTA was titrated 8-100 mM, 
and the incubation time varied 1-30 min.  
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2.1.6 DNA binding assays 
To asses MmT6 DNA binding in the absence of cleavage, three separate assays were 
employed, all of which involved the use of a nitrocellulose membrane capture technique.  
 The first assay began with incubating 16 nM MmT6 with 10 nM pBR322*, which 
contained negatively-supercoiled, relaxed and linear pBR322* (Inspiralis) within the same 
sample, in MmT6 in binding buffer (BB, see Table 2.1) in 500 µL total volume, for 30 min at 
37°C. The 0.45 μm nitrocellulose Centrex MF filters (Whatman) were prewashed with 500 µL 
of BB by centrifuging at 2000 rpm for 5 min using the Allegra X-I4R centrifuge (Beckman 
Coulter). The prewash flow-through was discarded and the binding assay applied to the column 
and centrifuged in the same manner as just described. The eluent (unbound DNA) was 
collected, before another 500 µL of BB was added to wash the filter. Once centrifuged, the 
wash was collected and the protein-bound DNA was then displaced from the filter using 500 
µL 0.2% (w/v) SDS solution and centrifugation. The unbound DNA and MmT6-bound DNA 
fractions were applied to 30-kDa spin columns, prewashed with 10 mM Tris･HCl pH 7.5, and 
spun for 10 min at 14,000 rcf using an Eppendorf table top centrifuge. The eluent was discarded 
and the sample washed with 500 µL of 10 mM Tris･HCl pH 7.5, centrifuged again for 10 min 
at 14,000 rcf. This was repeated twice to fully exchange the buffers before the spin filter was 
inverted in a new collection tube and concentrated samples were eluted by centrifuging at 1000 
rcf for 2 min. The DNA concentration of the samples was analysed using the Nanodrop. Using 
a 1% (w/v) native agarose gel, 100 ng of DNA from both the unbound and MmT6-bound DNA 
samples was run for 12 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged 
under UV illumination. Data used in construction of the graph (Chapter 3, Figure 3.22) was 
extracted from the gels using ImageJ and analysed in Excel. 
 The second assay used to explore MmT6 binding, followed a very similar protocol to 
the first, with 16 nM MmT6 being incubated with different topologies of 10 nM pBR322* 
separately, namely negatively supercoiled, positively supercoiled, relaxed and linear (obtained 
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from Inspiralis), but without the requirement for gel electrophoresis. MmT6-bound DNA was 
analysed as a percentage of the total DNA added, using Microsoft Excel. 
 The third assay, first described in Litwin et al. [225], was used to attain a measure of 
relative MmT6 binding affinity for pBR322* topoisomers of varying superhelical density. To 
begin, extended distributions of negatively- and positively-supercoiled topoisomers were 
generated by incubating 11 nM negatively-supercoiled pBR322* with 100 nM Archeoglobus 
fugidus (gifted by Yeonee Seol, NHLBI, NIH, Bethesda, USA) in 50 mM Tris･HCl (pH 8.0), 10 
mM NaCl, 10 mM MgCl2, and 1 mM ATP, (30 μL reaction volume) at 95°C for 10 and 20 s, 
respectively. The reaction was stopped via the addition of 125 mM EDTA, 3 μL 2% (w/v) SDS 
and 2 μL proteinase K (New England BioLabs), and incubated for 1 hr at 37°C. The pBR322* 
was then purified using the Qiagen PCR clean up kit and ran on a 1% (w/v) agarose gel for 13 
hr at ~2 Vcm-1, with and without 1.5 μg/mL chloroquine, to validate the topology. Agarose gels 
were stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. The gel 
containing chloroquine (Chapter 3, Figure 3.23C) was soaked in 1x TAE for ~1 hr, prior to 
ethidium bromide staining.  
 Once the pBR322* topoisomer distributions were attained,  MmT6  (8 nM) was 
incubated with 5 nM pBR322*, either positively or negatively supercoiled, in BB for 30 min at 
37°C. The MmT6-bound DNA was separated from the unbound DNA using 0.45μm 
nitrocellulose Centrex MF filters (Whatman), and cleaned using 30 kDa Amicon spin filters, 
exactly as described above. The MmT6-bound and unbound DNA samples were run on a 1% 
(w/v) agarose gel for 13 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged 
under UV illumination. The concentration of each topoisomer was measured as a function of 
band intensity, using ImageJ and Igor Pro 7 (Wavemetrics). In ImageJ, the gel image was 
corrected for the background using a rolling ball radius of 100, and the pixel intensity profile for 
each lane was extracted and imported into IgorPro7, where each peak was fitted to a Gaussian 
to attain the area. The area of each peak was used as a measure of topoisomer concentration, 
with the ratio of unbound to MmT6-bound DNA providing a measure of the relative dissociation 
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constant (Kd) for that particular topoisomer. See Chapter 3, Section 3.2.6, and [225] for further 
detail. 
 
2.1.7 ATPase assays 
2.1.7.1 PK/LDH assay 
Constituents and their final concentrations can be found in table 2.2. Typical sample volumes 
were made up to 100 μL and placed in a flat-bottom 96-well microtitre plate. E. coli DNA gyrase 
(200 nM) (gifted by Lesley Mitchenall, JIC, UK) in the presence of 21 nM relaxed pBR322* was 
used as a control. The concentration of MmT6 used was 750 nM and the concentration of 
supercoiled pBR322* varied from 21 nM to 181 nM. The solution absorbance at 340 nm was 
measured using the CLARIOstar plate reader (BMG LabTech) every minute up to 60-90 min at 
37°C. ATP/ADP were omitted from the solutions and added to the relevant samples after 10 
min. Novobiocin, 1 μM, was used to inhibit the gyrase control and was added after 50 min. The 
output data were exported to and analysed using Microsoft Excel.  
 
Table 2.2: Constituents of ATPase assay and respective final concentrations. NADH, PEP, 










Constituent Final Concentration 
Nicotinamide adenine dinucleotide (NADH) 400 μM 
Phosphoenolpyruvic acid (PEP) 800 μM 
Pyruvate Kinase/Lactate Dehydrogenase (PK) 0.9-1.5/1.35-2.1 units 
Adenosine triphosphate (ATP) 1 mM 
Adenosine diphosphate (ADP) 1 mM 
5X Minimal Buffer 1X 
Magnesium Chloride (MgCl2) 10 mM 
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2.1.7.2 Radioactive ATPase assay  
2.1.7.2.1 Purification of [γ-32]-ATP  
The following procedure was developed and modified in [226]. An ATP purification column was 
prepared using P-2 gel (Biorad). In 10 mL of P-2 wash buffer (10 mM Tris-HCl pH 8, 50 mM 
NaCl, 1 mM EDTA), 1.67 g of P-2 was added and left to hydrate overnight at room temperature. 
The supernatant was removed from the hydrated gel, which was then washed 4 times with 
degassed P-2 wash buffer. The gel was then poured into a 4 mL Econo-Column® (Biorad) and 
allowed to settle before P-2 buffer was slowly pumped through the column at 0.2 mL/min. A 
100 μL ATP solution was made using 97 μL of 100 mM ATP, 2 μL of 33 mM [γ-32]-ATP and 1 
μL of a 1% (w/v) bromophenol blue solution dissolved in DMSO. Any residual P-2 wash buffer 
was carefully removed without disturbing the column matrix and the [γ-32]-ATP solution added. 
Once the ATP solution had fully entered the column, the column was filled to the top with P-2 
buffer. The ATP solution was left to migrate down the column, and using a Geiger counter 
pointed at the base of the column, the arrival of the radioactive [γ-32]-ATP was monitored. Once 
the [γ-32]ATP was close to eluting from the column, single drops were collected as separate 
fractions until the radioactive signal intensity dropped again. Using TLC plates, 0.5 μL drops 
were spotted from each [γ-32]-ATP fraction, 1 cm from the bottom of the plate. The plate was 
then positioned upright with the ATP spots at the bottom in TLC running buffer (0.5 M lithium 
chloride in 1 M glacial acetic acid). The running buffer was allowed to move at least two thirds 
up the TLC plate before being removed and fully dried using heat. The dry TLC plates were 
then exposed to a phosphor screen for an hour before being imaged using the Typhoon FLA 
7000 plate reader. The fractions shown to contain the most [γ-32]-ATP and the least released 
phosphate were pooled and the concentration attained using absorbance at 260 nm (ATP ε = 
15400 M-1cm-1) (Figure 2.1). 




Figure 2.1: TLC plate imaged using the Typhoon FLA 7000 plate reader. Each ATP fraction was 
tested for its concentration of [γ-32]-ATP (bottom signal) and released phosphate (top signal). 
Those fractions highlighted in red were pooled and used in the MmT6 radioactive ATP hydrolysis 
assay.  
 
2.1.7.2.2 [γ-32]-ATP hydrolysis activity of MmT6 
This assay was, in effect, a relaxation time course, but replacing ATP with [γ-32]-ATP. The 
reaction constituents were as follows; 0.5 µM MmT6 (A2B2), 430 nM DNA (relaxed, linear and 
supercoiled pBR322* were explored), 450 µM [γ-32]-ATP, 10 mM MgCl2 and 1x minimal buffer 
(20 mM bis-tris propane (pH 7), 100 mM potassium glutamate and 1 mM DTT), in a 55 µL 
reaction volume total. At each time point (1, 2, 4, 6 ,8, 10, 15, 20, and 30 minutes) a 5 µL aliquot 
was taken from the reaction and quenched using 5 µl of 2% (w/v) SDS and 100 mM EDTA. A 
1 µL aliquot of each time point was then spotted onto a TLC plate and treated as above 
(2.1.7.2.1 Purification of [γ-32]-ATP). The intensity of the spots were calculated using ImageJ 
and the amount of ATP hydrolysed at each time point calculated by looking at the proportion of 
[γ-32]-Pi released compared to unhydrolysed [γ-32]-ATP (see Chapter 3 for more details).  
 
2.2 Magnetic Tweezers Methods 
This section details the materials and methods used in the acquisition of data presented and 
discussed in Chapter 4, collected using the magnetic tweezers (MT).  
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Table 2.3: Names and constituents of frequently used buffers and solutions, for data collected 




Wash buffer (WB) 
 
1x PBS, 60 µM BSA and 0.02 (v/v) Tween-20 
Bead wash buffer (BWB) 10 mM Tris-HCl pH 7.5 and 2M NaCl 
KOH-ethanol solution 10% (w/v) KOH pellets dissolved in 95% (v/v) 
Ethanol 
MmT6 MT activity buffer 20 mM Bis-Tris propane pH7, 100 mM potassium 
glutamate, 10 mM MgCl2, 1 mM DTT, 0.01% (v/v) 
tween-20, 30 µM BSA  
MmT6 MT storage buffer 20 mM HEPES pH 7, 40% (v/v) glycerol, 2 mM 
DTT, 15 µM BSA, 100 mM potassium glutamate 
 
2.2.1 5-kb coilable DNA substrate synthesis 
A 5-kb DNA segment from pET28b was amplified via PCR, using 5 ng/μL of pET28b, 0.5 μM 
of 5kbF and 5kbR primers (Table 2.4), 200 μM dNTPs, 1x Phusion buffer and 1 unit/50 μL of 
Phusion DNA polymerase (ThermoFisher). The biotin and digoxigenin DNA handles were also 
PCR-amplified using BioF/BioDigR and DigF/BioDigR respectively (Table 2.4) and 5 ng/μL 
pBlueScript plasmid as the template. Thermocycler conditions are shown in Table 2.5. All DNA 
products were run on a 1% (w/v) agarose gel to determine size followed by gel extraction using 
the Qiagen gel extraction kit. The 5-kb fragment, biotin-labelled and digoxigenin-labelled 
handles were all digested separately with BsaI-HF (New England Biolabs) using 5 μL of 
enzyme to 1 μg of DNA and incubating at 37°C for 6 hr, followed by the addition of another 3 
uL of BsaI-HF and a further incubation at 37°C for 6 hr. The BsaI-HF was deactivated by 
incubating the samples at 65°C for 20 min, which were then purified using the Roche PCR 
clean up kit. The biotin and digoxigenin handles were ligated to the 5-kb fragment by incubating 
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2 nM of each DNA constituent with 1 unit T4 DNA ligase (New England Biolabs) per 50 μL 
reaction, for 3 hr at 25°C followed by 15 hr at 16°C. A sample of the ligation reaction was then 
run on a 1% (w/v) agarose gel to check the ligation efficiency. If the sample contained various 
products (e.g. 5-kb fragment with only 1 ligated handle) then the DNA sample was gel extracted 
and cleaned using the Qiagen gel extraction kit. See Figure 2.2 for illustration of the protocol 
as well as gel-based analysis of the DNA fragments synthesised. 
 
 
Figure 2.2: Synthesising the magnetic tweezers 5-kb coilable DNA substrate. A: The stages 
involved in generating the 5-kb coilable DNA substrate. 1. The 5-kb fragment is amplified via the 
polymerase chain reaction (PCR) from the pET28-b plasmid, whilst the biotin- and digoxigenin-
labelled DNA handles are PCR amplified from pBluescript II KS. 2. All fragments are then digested 
using the restriction enzyme BsaI-HF. 3. The handles are then ligated to the 5-kb fragment and 
gel purified. B: DNA fragments used in the generation of the 5-kb coilable DNA substrate, before 
and after ligation, run on a 1% (w/v) agarose gel, alongside a 1-kb plus DNA ladder. The first band 
of the last lane (ligation product) is the desired substrate and was gel purified to separate it from 
DNA with either one or no handle.   
 
2.2.2 5-kb braiding DNA substrate synthesis 
A 5-kb DNA segment from pET28b was amplified via PCR, using 5 ng/μL of pET28b, 0.5 μM 
of 5kbBF and 5kbBR primers (Table 2.4), 200 μM dNTPs, 1x Phusion buffer and 1 unit/50 μL 
of Phusion DNA polymerase. Thermocycler conditions are shown in Table 2.5. The PCR 
product was gel extracted using the Qiagen gel extraction kit and any nicks re-ligated by 
incubating 2 nM DNA with 1 unit T4 DNA ligase (New England Biolabs) per 50 μL reaction, for 
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3 hrs at 25°C followed by 15 hr at 16°C. In the single crossing assays the DNA duplex used 
was 3-kb, rather than 5-kb, and was kindly gifted in its purified form by Yeonee Seol (NHLBI, 
NIH, Bethesda, US).  
 
2.2.3 12-kb force calibration DNA substrate synthesis 
A 12-kb DNA segment was amplified via PCR, using 5ng/μL of λ DNA as the template, 0.5 μM 
of 12kbF and 12kbR primers (Table 2.4), 200 μM dNTPs, 1x Phusion buffer and 1 unit/50 μL 
of Phusion DNA polymerase. Thermocycler conditions are shown in Table 2.5. As there were 
no contaminating PCR products, gel extraction wasn’t required. 
 
Table 2.4: Primers used in the production of the 5-kb coilable DNA substrate used in the magnetic 
tweezer assays.  
Primer name Sequence 
5-kb forward (5kbF) GCTGGGTCTCGCAACGAAACCCGACAGGACTATAAAG 
5-kb reverse (5kbR) GCTGGGTCTCGACCACTCTGATGCCG CATAGTTAAG 
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Table 2.5: Thermocycler programs for the PCR amplification of the 5 kb coilable, 
biotin/digoxigenin DNA handles, 12 kb force calibration and 5 kb braiding substrates. 










12 kb force 
calibration 
DNA 
5 kb braidable 
DNA 
Temp Time Temp Time Temp Time Temp Time 
Initial denaturation 98°C 2 min 94°C 2 min 98°C 30 s 98°C 2 min 
Denaturation 98°C 30 s 94°C 20 s 98°C 10 s 98°C 30 s 
Annealing 66°C 15 s 60°C 30 s 64°C 15 s 66°C 15 s 
Extension 72°C 2 min 
30 s 
68°C 2 min 72°C 6 min 72°C 2 min 
30 s 
Final extension 72°C 5 min 68°C 5 min 72°C 10 min 72°C 5 min 
Hold 4°C hold 4°C hold 4°C hold 4°C hold 
 
2.2.4 Cover glass cleaning 
The cover glass slides were placed vertically in a Teflon slide holder and submerged fully in a 
KOH-ethanol solution (10% (w/v)) in a 1 L glass beaker and sonicated for 30 minutes. The 
slides were then transferred to another 1 L beaker containing deionised water and sonicated 
for a further 30 min. The slides were then sonicated in deionised water twice more to fully 
remove the KOH-ethanol solution. The Teflon slide holder was removed from the beaker and 
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rinsed with deionised water, followed by 95% (v/v) ethanol. The slides were then fully dried by 
microwaving for 3 min at full power and stored in an airtight container at room temperature.  
 
2.2.5 Sample cell assembly 
The flow cell was composed of two different cover glass slides; the base was #1½ (24 mm x 
60 mm) and the top was #1 (24 mm x 60 mm). The top cover glass had 2 mm inlet holes at 
either side, made using a bead blaster with aluminium particles. The top and bottom cover 
glass slides were adhered to each other using double-sided tape with a central channel cut out 
using a CO2 laser engraver/cutter. Nylon chimneys, one larger serving as a buffer reservoir, 
and one smaller serving as an outlet channel, were placed over the 2 mm inlet holes at either 
side of the top cover glass. An airtight seal was produced using vacuum grease. Epoxy was 
then used around the base of the chimneys to securely fasten them to the slide and left to cure 
for an hour. Sample cells were then stored in an airtight container at room temperature.  See 
Figure 2.3 for an illustration of the sample cell construction and Figure 2.4 for a photograph of 
a complete sample cell. 
 
Figure 2.3: Magnetic tweezers sample cell assembly, showing the arrangement of the different 
parts, which come together to form the complete sample cell. The bottom (1.5 mm) cover glass 
is adhered to the top (1 mm) cover glass via a piece of double sided tape containing a 44x4 mm 
cut out. The nylon chimneys (large and small) are sealed over the top of the inlet holes cut into 
the top cover glass, using vacuum grease and epoxy.  
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Figure 2.4: Photograph of an assembled sample cell. 
 
2.2.6 Stuck bead generation 
The following allows for the generation of 8-10 stuck bead sample cells. In a 1.5 µL Eppendorf 
tube, 200 µL of deionised water was mixed with 2 µL of 2 µm polystyrene beads (4% (w/v)) and 
mixed by quickly vortexing. The bead solution was then sonicated for 5 min. A 200 µL aliquot 
of acetone was added to the bead solution, vortexed quickly and then 40 µL introduced 
immediately to the sample chamber. The sample cell was then incubated for 5-10 min at room 
temperature before the sample cell was washed with 200 µL of deionised water (being careful 
not to fully remove the water) followed by 300 µL of 100% (v/v) ethanol (HPLC grade). Using a 
vacuum line, the ethanol was completely removed from the sample chamber and the sample 
cells baked on a hot plate at 125°C for 15 s. The stuck beads were then checked under a 
microscope.  
 
2.2.7 DNA tether formation for supercoil relaxation assays 
A 0.2 mg/ml anti-digoxigenin solution was made in 1% (w/v) PBS. With n = number of sample 
chambers, in a 1.5 µL Eppendorf tube, 45 x n µL of 1% (w/v) PBS, 3 x n µL of anti-digoxigenin 
solution and n µL of 0.5 nM coilable DNA substrate were added and incubated for 30 min at 
room temperature. A 40 µL aliquot was introduced to the sample chamber and left to incubate 
at 4°C overnight. The sample chamber was then washed with 200 µL of wash buffer (see Table 
2.3).   
 
2.2.8 Magnetic bead attachment to DNA for supercoil relaxation assays  
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In an Eppendorf tube, 10 µL of a 1% (w/v) magnetic particle suspension (1 μm diameter, 
Dynabeads MyOne Streptavidin T1; 35601, Invitrogen) was added to 200 µL of bead wash 
buffer (BWB) and vortexed. The tube was then placed on a magnet to collect the beads whilst 
the supernatant was pipetted off. This was repeated, before another 200 µL of BWB was added 
and the mixture sonicated for 5 min at room temperature. A 40 µL aliquot of the magnetic bead 
solution was then introduced to the sample chamber containing the tethered DNA molecules 
and left to incubate at room temperature for 10 min. The unbound beads were washed out by 
gently flowing through 1 mL of wash buffer (WB).  
 
2.2.9 Slide preparation for DNA braiding 
In contrast to slide preparation for supercoiling, better results are achieved for braiding when 
the DNA is incubated with the magnetic beads and then introduced into a slide coated in anti-
digoxigenin. First, 10 µL of a 1% (w/v) magnetic particle suspension (1 μm diameter, 
Dynabeads MyOne Streptavidin T1; 35601, Invitrogen) was added to 200 µL of bead wash 
buffer (BWB) and vortexed. The tube was then placed on a magnet to collect the beads whilst 
the supernatant was pipetted off. This was then repeated, before 20 µL of wash buffer (WB) 
was added and the mixture sonicated for 5 min at room temperature. The starting concentration 
of the bead suspension was 16.7 pM, which was diluted to 8.35 pM after washing. The braided 
DNA substrate was added in 5-fold excess to the final bead concentration. The DNA and 
magnetic bead mixture were left to incubate overnight at 4°C with rotation. The slide surface 
was prepared by incubating it with 0.015 mg/ml anti-digoxigenin in 1x PBS and was left 
overnight at 4°C. The following day, the slide was washed with 200 µL of WB and 5-10 µL of 
the magnetic bead-DNA mixture was gently introduced into the sample cell and left to incubate 
at room temperature for 1 hr. The unbound beads were then washed out by gently flowing 
through 1 mL of wash buffer (WB).  
 
2.2.10 The magnetic tweezers instrument 
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The instrument, built by Andrew Dittmore and later modified by myself and Yeonee Seol 
(NHLBI, NIH, Bethesda, USA), is comprised of five main elements; the stages on which the 
sample cell is mounted, two permanent magnets fixed 1 mm apart, a red LED, an oil immersion 
objective and a camera. See Chapter 4 for both a photograph of the instrument itself and a 
schematic. The sample cell is mounted on top of two stages, one responsible for fine 
movements (minimum movement is 1 nm) and the other for coarse (minimum movement is 10 
nm) in the x and y directions. Directly above and parallel to the sample cell are two permanent 
magnets fixed 1 mm from each other. They are powered by a motor which both rotates the 
magnets and moves them in the z coordinate. The distance of the magnets from the sample 
cell determines the force on the DNA. Below the sample cell is an oil immersion objective, 
capable of visualising the stuck and tethered beads, 1-2 µm in diameter. The image is captured 
by a camera which relays it to the computer and allows the user to see the contents of the 
sample cell. Specialised programs for operating the instrument are written using Lab view 2018 
software (National Instruments). For the instrument used here, the program coding was done 
by Andrew Dittmore and Yeonee Seol (NHLBI, NIH, Bethesda, USA).  
 
2.2.11 Camera resolution determination 
To increase the field of view, a new camera was purchased and installed (acA1920-155um 
Basler ace from Basler). As this camera was more sophisticated than the previous, it was 
necessary to attain the resolution in nmpixel-1. To do this a tethered DNA molecule was 
calibrated at high force and then while the program was tracking its position, the sample cell 
was moved 2 µm in either the x or y direction. The data recorded was then opened using Igor 
Pro 7 (Wavemetrics). Depending on whether the data was for movement in the x or y direction, 
a graph was made with x or y position against time. An average of magnetic bead position 
before and after the movement was calculated and the difference between them calculated in 
pixels. Because the sample cell was moved 2 µm, the pixel number was divided by 2000 to get 
the nmpixel-1 of the new camera. In this case, the resolution of the camera was 98.66 nm pixel-
1 in x and 99.5 nm pixel-1 in y.  




2.2.12 Force extension calibration  
The force on the tethered DNA was dependent on how close the magnets were to the sample 
cell. The closer to the sample cell, the higher the force on the DNA. To obtain an accurate 
measurement of the force on the DNA, as topos show force dependence in their activity, a 
force-extension calibration was performed. This was done using 12-kb tethered DNA 
molecules.  
 Tethered 12-kb DNA molecules were calibrated at high force with a stuck bead as a 
reference. Once their position was being tracked correctly, the force was dropped rapidly from 
high (~10 pN) to extremely low (~0 pN), achieved by moving the magnets from as close to the 
sample cell as possible to 8 cm away, at which point the effective force on the DNA applied by 
the magnets is ~0. The difference in extension measured will later be used as the DNA contour 
length (z) in the calculation of the force. The force was then increased to maximum. The 
software (Lab View 2018) was then programmed to move the magnets away from the sample 
cell by 0.1 mm every 20 s, until it was 6 cm from its starting position. At each position the beads 
displacement in the x coordinate was recorded. To generate an accurate force-extension curve, 
numerous data sets are required, in this case, 5 different DNA molecules were each assayed 
thrice. Fully derived in Chapter 4, the following equation was used to calculate the magnetic 





Equation 2.1: Calculating the magnetic force on the DNA-tethered bead. 
Where Fz is the force on the DNA in z, kBT is the Boltzmann constant multiplied by room 
temperature expressed in kelvin (4.06 pN nm), z is the DNA contour length and x is the average 
displacement of the bead in the x coordinate. The assay described above provides both the 
DNA contour length (z) and the average displacement of the bead in the x coordinate (x), which 
are used to calculate the force (Fz). All data analysis was performed using Igor Pro 7 
(Wavemetrics).  
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2.2.13 MmT6 -80°C storage for use in magnetic tweezers 
Using two different strategies to probe MmT6 activity raised some questions as to how MmT6 
should be stored for use in the magnetic tweezers in a manner which minimises protein waste 
and maintains MmT6 stability. In comparison to ensemble methods that use MmT6 in the 
concentration range 1-1000 nM, the magnetic tweezers require a far lower range from 0.025 to 
2 nM. It was therefore necessary to store the protein at a much lower stock concentration in 
the -80 °C, of 300 nM, which was kept stable by the addition of 15 µM BSA and 40% (v/v) 
glycerol. When in use, the protein is diluted using the standard dilution buffer from Table 2.1. It 
is important for the magnetic tweezers assay that glycerol concentration is kept to a minimum 
to prevent non-specific interactions, or “sticking”, of the magnetic bead to the surface.  
 
2.2.14 MmT6-dependent supercoil relaxation assays 
DNA tethers were first determined to be coilable by performing a calibration in which the DNA 
extension was measured as a function of magnet rotation. Once a coilable DNA tether was 
found and calibrated in MmT6 MT activity buffer (Table 2.3), MmT6 at the desired concentration 
(0.25-2 nM) was added to the sample cell with 1 mM ATP at 21°C, under 0.4 pN. The DNA 
tether was then supercoiled via the rotation of the magnets with 16-18 rotations producing a 
plectoneme on which MmT6 acted, relaxing each supercoil and increasing the DNA extension 
in distinct steps of ∼110 nm. The data output was DNA extension change over time, and was 
stored as a delimited text file. The text file was opened and analysed in Igor Pro 7 
(Wavemetrics) using a T-test based procedure, coded by Yeonee Seol (NHLBI, NIH, Bethesda, 
USA) [227]. All MT data analysed in this work has been done using this procedure in Igor Pro 
7 (Wavemetrics), unless otherwise stated. The analysis procedure used a sliding window to 
determine time points at which the DNA extension changed and provided information on the 
size of the extension change and the rate of change, enabling determination of the average 
plectoneme relaxation rate, recorded as strand-passage events/min. This was plotted as a 
function of MmT6 concentration and fitted to the equation,  







Equation 2.2: Michaelis-Menten-like equation.  
 To determine how the level of supercoiling affected MmT6 activity, 750 nM MmT6 was 
incubated with 1 mM ATP at 21°C and under 0.4 pN, and left to relax a plectoneme of 20 
supercoils. The dwell time between each strand-passage event was extracted and plotted as 
a function of the supercoil number (also known as the ‘DNA crossing number’) during the dwell 
time in question, for both positive and negative supercoiling. For instance, the average dwell 
time when there were 2 supercoils was ~80 s, whilst the average dwell time when there were 
20 supercoils was ~10 s. These data were fitted to an inverse relationship, where the dwell 
time was found to be inversely proportional to the number of supercoils present.  
 To determine how force affected MmT6 relaxation activity, force was varied whilst 
MmT6 concentration was kept constant (750 pM). For positive supercoiling, the force regime 
was 0.2, 0.5, 1, 1.5 and 2 pN, and for negative supercoiling it was 0.2, 0.4, 0.6 and 0.8 pN. The 
DNA tethers were calibrated to determine the buckling point at which DNA writhe begins to 
form, and the DNA extension change per magnet rotation, for each of the forces assayed. This 
allows the same number of DNA supercoils to be input regardless of the force and facilitates 
data analysis. Once calibration was complete, the plectoneme was incubated with 750 pM 
MmT6, 1 mM ATP at 21°C and the average rate of relaxation (strand-passage events/min) at 
each force on both positive and negative supercoils was extracted and plot as a function of 
force.  
 
2.2.15 MmT6-dependent braid unlinking assays 
DNA tethers were first determined to be braidable by performing a calibration in which the DNA 
extension was measured as a function of magnet rotation. Once a braidable DNA tether was 
found and calibrated in MmT6 MT activity buffer (Table 2.3), MmT6 at the desired concentration 
(0.025-0.9 nM) was added to the sample cell with 1 mM ATP at 21°C, under 0.5 pN. The 
average rate of braid unlinking was extracted and plotted as a function of MmT6 concentration. 
The data was also fitted to the Michaelis-Menten-like equation (equation 2.2). As MmT6 
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displayed a moderately processive behaviour during braid unlinking, further data analysis was 
performed. A ‘burst’ is defined as MmT6-dependent unlinking activity in which two or more 
strand-passage events occur in quick succession. The processivity rate (average rate of 
unlinking per burst, measured as strand-passage events/min), processivity step size 
(measured as number of strand-passage events/burst) and the average dwell time (measured 
in seconds) between bursts, were all extracted and plotted as a function of MmT6 concentration 
(see Figure 2.5 for labelled MT trace of MmT6-dependent braid unlinking).  
 
 
Figure 2.5: Labelled MT trace of MmT6-depedent braid unlinking. The average braid unlinking 
rate was calculated as the change in DNA extension over time, measured from the lowest DNA 
extension to the highest and expressed in strand-passage events/min (events/min). For this 
example of a positive braid being unlinked by 50 pM MmT6 under 0.5 pN at 21°C, the average rate 
was 6 events/min. However the data can be analysed to a greater depth by extracting the average 
processivity rate (blue line), the average step size (yellow line) and the average dwell time (green 
line). In this example, for the portions of the trace labelled, the processivity rate was 75 
events/min, the step size was 5 events and the dwell time was 45 s. The light grey points are the 
raw data with the black representing the smoothed data, achieved using the Savitzky–Golay filter 
(smoothing window of 199 data points) in Igor Pro 7 (Wavemetrics). The red dashed line indicates 
periods of inactivity (horizontal portions) and processive bursts of multiple strand passage 
events (diagonal portions). The red line is a scale bar, highlighting how the unlinking activity is 
occurring in steps larger than a ΔLk of 2.   
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To determine how force affected MmT6 unlinking activity, force was varied whilst MmT6 
concentration was kept constant (500 pM). For positive supercoiling, the force regime was 0.5, 
1, 2, 3 and 4 pN, and for negative supercoiling it was 0.5, 1, 2 and 3 pN. The DNA braids were 
calibrated to determine the DNA extension change per magnet rotation, for each of the forces 
assayed, which facilitates data analysis. Once calibration was complete, the braid was 
incubated with 500 pM MmT6, 1 mM ATP at 21°C and the average rate of relaxation (strand-
passage events/min), the processivity rate (strand-passage events/min), the step size (strand-
passage events/burst) at each force on both positive and negative supercoils was extracted 
and plot as a function of force.  
 
2.2.16 MmT6-dependent single crossing assays 
First described in [120], the single crossing assay was employed to explore the DNA crossing 
geometry preference of MmT6 in detail. To begin the DNA extension as a function of magnet 
position must be precisely measured for the input of the first crossing. This is achieved by 
measuring the DNA extension every tenth of a magnet rotation, and fitting the resulting curve 
to a geometric function, shown below. 
𝑳 = 	-𝑳𝟎𝟐 − 𝟒𝒆𝟐𝒔𝒊𝒏𝟐(𝒏𝝅)	– 𝐫 +	9𝒓𝟐 − 𝒆𝟐, |𝒏| < 𝟎. 𝟓 
Equation 2.3: Geometric function used to determine the DNA spacing and extension, where L is 
the measured DNA extension (dependent on the force applied), L0 is the maximum DNA 
extension, e is half the separation distance between the DNA molecules, n is the number of 
magnet rotations, and r is the radius of the magnetic bead to which the tethers are bound [120]. 
 
This equation allowed the extension of the DNA and the spacing between the two DNA tethers 
to be calculated, both of which were important pieces of information for execution of DNA 
crossing-angle simulations. Once calibrated, the single crossing was incubated with 900 pM 
MmT6 and 1 mM ATP at 21°C. A high concentration of MmT6 was used as the reaction is 
complete in a single cycle, so as to ensure T-segment engagement, rather than G-segment 
binding, was rate limiting. Force was varied as single braids were used to attain multiple data 
sets. Changing the force under which the assay was conducted changed the crossing angle 
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geometry and in effect presented MmT6 with a different DNA crossing geometry on which to 
act. The assay involved the input of a single crossing in one direction, allowing MmT6 to relax 
the crossing, before the input of a single crossing with the opposite chirality and so on. This 
was done until a single data set contained 50-100 unlinking events for both positive and 
negative DNA crossings. The data were then plotted as histograms and fit to single 
exponentials to attain the characteristic (or average) relaxation times for the unlinking of 
positive (τL) and negative (τR) DNA crossings, and the ratio of these times was calculated (τL/τR).  
The assumption was that the rate-limiting step in the MmT6-dependent unlinking of the 
single crossing was sensitive to DNA crossing geometry. In order to relate the unlinking time 
ratio (τL/τR) to a value for the preferred MmT6 DNA crossing angle, simulations were performed. 
Here, two different types of simulation were used, Monte Carlo (MC) and Brownian Dynamics 
(BD). The BD simulations were conducted by Parth Desai (NHLBI, NIH, Bethesda, USA). 
These simulations use alternative methods to attain the distribution of crossing angles 
experienced by the single crossing and their execution relies on the data extracted from the 
calibration, namely the DNA spacing and extension, as well as the force under which the assay 
was conducted. Using the assumption that the ratio of unlinking times (τL/τR) is equal to the 
ratio of angle probabilities between negative (PR(α0)) and positive (PL(α0)) DNA crossings (τL/τR 
= PR(α0)/ PL(α0)), the experimental data was related to a precise value for preferred DNA 
crossing geometry. In other words, if a positive crossing was unlinked 3-fold faster than 
negative, the preferred angle was defined as the angle that was 3-fold more probable in positive 
crossings over negative. This assay was performed on 14 different DNA crossing geometries 
and the experimental data was related to the both the MC- and BD-derived crossing angle 
distributions to attain an averaged value for the MmT6 preferred DNA crossing angle. For each 
data set, this value was plotted against the average angle of the positive crossing distribution 
and the force, demonstrating the insensitivity of this value to both these parameters.  
 
2.3 Utilising Next Generation Sequencing to Explore Type II DNA 
Topoisomerase cleavage specificity in vitro Using Plasmid DNA 
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This section details the materials and methods used in the acquisition of data presented and 
discussed in Chapter 5.  
 
Table 2.6: Names and constituents of frequently used buffers and solutions, for data collected 




MmT6 minimal buffer 
 
20 mM bis-tris propane pH 7, 100 mM potassium 
glutamate and 1 mM DTT. Buffer stored as 5x 
concentrate at -20°C. 
EcT4 minimal buffer 40 mM Tris-HCl pH 7.5, 100 mM potassium 
acetate and 1 mM DTT. Buffer stored as 5x 
concentrate at -20°C.  
EcGyrase minimal buffer 35 mM Tris-HCl, 24 mM potassium chloride, 2 
mM DTT, 6.5% glycerol (w/v) and 0.1 mg/mL BSA   
 
 
2.3.1 Gel-based type II topo DNA cleavage pattern 
The first approach implemented in the analysis of type II topo cleavage specificity was an 
agarose gel-based assay, in which topo cleavage on plasmid DNA, coupled with plasmid 
linearization and agarose gel electrophoresis, allowed resolution of topo-specific DNA 
fragmentation patterns. The type II topos used were M. mazei topo VI (MmT6), E. coli topo IV 
(EcT4) (gifted by Yeonee Seol) and E. coli gyrase (EcGyrase) (Inspiralis). Buffer conditions for 
each topo can be found in Table 2.6. For MmT6, 500 nM MmT6 was incubated with MmT6 
minimal buffer, 11 nM pBR322* (linear, positively and negatively supercoiled), 2 mM ADPNP 
and 10 mM MgCl2 for 30 min and 37°C. For EcT4, 150 nM EcT4 was incubated with EcT4 
minimal buffer, 11 nM pBR322* (linear, positively and negatively supercoiled), 2 mM ADPNP 
and 10 mM CaCl2 for 30 min and 37°C. For gyrase, 64 nM gyrase was incubated with gyrase 
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minimal buffer, 11 nM pBR322* (linear, positively and negatively supercoiled, and relaxed) and 
20 mM CaCl2 for 30 min and 37°C. For MmT6 and EcT4 cleavage reactions, this was followed 
by the addition of 2 μL EcoRI and 2 μL of 10x cut smart buffer (New England BioLabs, 
#R3101S), and then a further 30 min incubation at 37°C to linearise pBR322* in samples 
containing relaxed, negatively or positively supercoiled DNA (linear pBR322*, obtained from 
Inspiralis, has already been cut with EcoRI prior to use here). A 3 μL aliquot of 2% (v/v) SDS 
and 3 μL of proteinase K (New England BioLabs, #P8107S) is then added to all samples which 
are incubated for 1 hr at 37°C. The samples were then treated using 20 μL STEB and 30 μL 
chloroform:IAA (24:1) and centrifuged at max speed for 5 min using a table-top Eppendorf 
centrifuge. The gyrase protocol differs as EcoRI is not active in EcGyrase minimal buffer. Once 
the EcGyrase cleavage reaction was complete, 3 μL of 2% (v/v) SDS and 3 μL of proteinase K 
were added and the reactions are incubated for 1 hr at 37°C. This is followed by DNA extraction 
using the QIAquick PCR purification kit to the recommended protocol (Qiagen, #28106). The 
DNA concentration was measured using the Nandrop™ and then treated with EcoRI (as 
recommended), and incubated at 37°C for 30 min. This was followed by the addition of 5 μL 
STEB. For all topo reactions, 200-400 ng of DNA was loaded onto a 1% (w/v) TAE agarose gel 
alongside 5 μL of a 1-kb plus DNA ladder (Invitrogen™, #10787018) and run for 13 hr at 20 V. 
The gels were stained using SyBr green I (ThermoFisher Scientific, #S7567) (2 μL in 200 uL 
1x TAE) for 1 hr, and destained in 1x TAE for 30 min before imaging using UV illumination.   
 To extract the sizes of the fragments produced by the different topos, the image of the 
agarose gel was analysed using the following software. To begin the image was opened in 
ImageJ, the background subtracted using a rolling ball radius of 100, and then saved as an 8-
bit jpeg file. This file was then opened in GelAnalyzer, in which each lane was presented as a 
graph of band intensity against pixel number (Figure 2.6A). Each peak was assigned an Rf 
value (migration distance), so using the 1-kb ladder, a calibration curve was plotted in Igor Pro 
7 (Wavemetrics) for Rf value against DNA fragment size in base pairs (bp) (Figure 2.6B). This 
could then be used in conjunction with Rf values extracted for each fragment arising as a result 
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of topo-dependent cleavage, to calculate their size, which was later compared to the data from 
next generation sequencing (NGS).  
 
 
Figure 2.6: Agarose gel analysis of topo-dependent DNA fragmentation patterns. A: Example of 
MmT6-dependent cleavage on linear pBR322*, with a 1-kb plus ladder to the left. The plot 
represents a pixel intensity value for the MmT6 lane plotted against the pixel number, with each 
peak representing a band on the gel (those peaks starred in order from left to right are highlighted 
in the gel image from top to bottom).   
 
2.3.2 DNA preparation for Illumina library preparation and sequencing 
Reactions were set up in which MmT6, EcT4 and EcGyrase were incubated with pBR322* and 
allowed to cleave the DNA. For MmT6, in 300 μL total, 500 nM MmT6 was incubated with 
MmT6 minimal buffer, 10 mM MgCl2, 2 mM ADPNP and 10 nM pBR322* (negatively 
supercoiled), for 30 min at 37°C. For EcT4, in 300 μL total, 240 nM EcT4 was incubated with 
EcT4 minimal buffer, 20 mM CaCl2, 2 mM ADPNP and 10 nM pBR322* (relaxed, negatively 
and positively supercoiled For EcGyrase, 64 nM EcGyrase was incubated with EcGyrase 
minimal buffer, 20 mM CaCl2 and 11 nM pBR322* (relaxed, negatively and positively 
supercoiled), for 30 min at 37°C. The DNA only control involved incubating 11 nM negatively 
supercoiled pBR322* in 1x MmT6 minimal buffer at 37°C for 30 min. For the MluCI restriction 
enzyme control, 11 nM of negatively supercoiled pBR322* was incubated with MluCI (New 
England BioLabs, #R0538) to the recommended protocol. All samples were sonicated, 10 s on 
(100 watts) followed by 20 s rest, for a total of 10 min on time (30 min in total), to sheer the 
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DNA into 100-500 bp fragments. The protein bound DNA was separated from unbound DNA 
using 0.45μm nitrocellulose Centrex MF filter (Whatman) pre-washed with the minimal buffer 
of the relevant protein. This stage was skipped for DNA-only and MluCI controls as no protein 
is covalently linked to the protein in these samples. The samples were each loaded onto the 
nitrocellulose column and centrifuged at 2000 rpm for 5 min using the Allegra X-I4R centrifuge 
from Beckman Coulter. The unbound DNA flow-through was discarded and the membrane 
washed using the addition of 300 μL of the relevant minimal buffer, and centrifuged again as 
previously described. The wash flow-through was discarded and the protein-bound DNA was 
eluted from the membrane using 200 μL of 0.8% (v/v) SDS, centrifuging the sample once more. 
The QIAquick PCR purification kit (Qiagen, #28106) was used to clean each sample, to the 
recommended protocol, and the presence of DNA (still attached to protein) was assessed using 
the NanoDrop™. The samples were then taken to the NHLBI sequencing core, in which the 
first round of Illumina sequencing adapter ligation was performed. As the protein is still attached 
to the DNA, only unbound DNA ends will be ligated to adapters with a specific bar code, 
allowing the DNA ends to be separated once sequenced. For DNA-only and MluCI controls, 
both ends of the DNA fragments are adapter ligated at this stage as no DNA end is protected 
by protein attachment. Once the first round of adapter ligation was complete, the topo-related 
samples were treated using 3 μL of 2% (w/v) SDS and 3 μL of proteinase K (New England 
BioLabs, #P8107S), and incubated for 1 hr at 37°C. The samples were cleaned again using 
the QIAquick PCR purification kit (Qiagen, #28106) to the recommended protocol, before the 
addition of 3 μL calf intestinal alkaline phosphatase (CIP) and 10x cutsmart buffer (New 
England BioLabs, #M0290), incubated for 2 hr at 37°C, before the addition of a further 3 μL of 
CIP and incubation overnight at 37°C. The Samples were then cleaned again using the 
QIAquick PCR purification kit (Qiagen, #28106) to the recommended protocol. The DNA was 
then quantified using the NanoDrop™, before the samples were taken back the NHLBI 
sequencing core for the second round of adapter ligation and sequencing using the Illumina 
MiSeq platform. Fragments were paired end sequenced to 75 bp (PE75).   
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Whist the end DNA library generation stages were outsourced to the NHLBI sequencing 
core, in general the protocol is as follows. The first stage in DNA library generation is to repair 
the DNA ends so that they are all blunt. The end repair mixture used contained T4 DNA 
polymerase, E. coli DNA Polymerase I Klenow fragment and T4 polynucleotide kinase, which 
resected 3ʹ overhangs and filled in 5ʹ overhangs. The DNA fragments are then adenylated so 
that 5ʹ and 3ʹ adapters can be ligated. Adapters are known as Y-shaped and contain unique 
sequences which allow the DNA to be barcoded. This facilitates the parallel sequencing of 
multiple pooled samples, or in this case, allows the two ends of the DNA to be distinguished. 
The DNA is then solid-phase PCR amplified to generate clusters of identical fragments and 
sequenced using fluorescent reversible terminator bases (Illumina).  
 
2.3.3 Sequencing data analysis 
Data obtained from the NHLBI sequencing core was in the file format fastq.gz, and contained 
sequence data for thousands to millions of DNA fragments. Analysis was performed using the 
NIH high performance computing system, BioWulf, and the coding pipeline created by Vijender 
Chaitankar, a member of the NHLBI bioinformatics core. In descriptive terms, the first stage 
was to unzip the sequence data files, remove primer contamination and run an alignment code 
that assigned each sequence to a position on the reference genome, which in this more unusual 
case, was the E. coli plasmid, pBR322*. This was then visualised using Integrated Genome 
Viewer (IGV), which allowed the visualisation of where these reads mapped to the designated 
reference material. The code used for data analysis is shown below (written by Vijender 
Chaitankar). 
 
sinteractive –mem=32g –cpus-per-task=8 
module load trimmomatic bwa samtools; 
java -jar $TRIMMOJAR SE -threads 8 ./SM4853-4_1_S7_L001_R1_001.fastq 
./trim/SM4853-4_1_S7_L001_R1_001.fastq 
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ILLUMINACLIP:/usr/local/apps/trimmomatic/Trimmomatic-
0.36/adapters/TruSeq3-SE.fa:2:30:10 SLIDINGWINDOW:2:15 CROP:14; 
bwa index /home/kimr3/MiSEQ/plasmid_reference/pBR322sequence.fa; 
bwa aln -t 8 -n 0 /home/kimr3/MiSEQ/plasmid_reference/pBR322sequence.fa 
./trim/SM4853-4_1_S7_L001_R1_001.fastq > ./align/SM4853-
4_1_S7_L001_R1_001.sai; 
bwa samse /home/kimr3/MiSEQ/plasmid_reference/pBR322sequence.fa 
./align/SM4853-4_1_S7_L001_R1_001.sai ./trim/SM4853-
4_1_S7_L001_R1_001.fastq | samtools view 
-q 25 -F 3844 -h - | grep "XT:A:U\|@*" | samtools sort -@ 8 -o 
./align/SM4853-4_1_S7_L001_R1_001.bam - ; 
samtools index ./align/SM4853-4_1_S7_L001_R1_001.bam; 
 
Commands of note are in bold. The code involves the use of pre-scripted modules called 
trimmomatic and BWA samtools, the former being used for trimming Illumina sequencing data, 
removing adapter sequence and low-quality reads, and the latter being used to align the filtered 
sequence to the reference genome. The command SE instructs the computer to align the data 
as single end, which generated alignment files in which only one of the paired ends is included. 
During sequencing, fragments were sequenced from one end before being flipped in situ and 
then sequenced from the other. This not only sequenced both ends of the fragment (important 
here as all DNA ends could have potentially been associated with a topo) but also linked the 
two sequences as having originated from the same fragment. In order to separate topo-cleaved 
ends from background noise, the data was aligned as a single end. The sequencing was also 
performed to a depth of 75 bp, which is a level of detail unnecessary here, so the sequence 
was cropped to 14 bp prior to alignment (see command CROP:14). Through bioinformatic 
analysis, by Vijender Chaitankar (NHLBI, NIH, Bethesda, US) it was determined that 14 bp was 
short enough that noise was reduced, whilst still allowing each sequence to be uniquely aligned 
to pBR322*. The final command of note, -q 25, allowed the optimisation of the quality of reads 
which are mapped to the reference.  
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In brief, as this is described in detail in Chapter 5, the motivation behind designing this 
assay was to reveal if there was any sequence specificity for cleavage by MmT6 specifically, 
and by extension, other type II topos, and the length of the base-stagger generated during 
cleavage. The answer to the first question should be readily attainable by looking at sequence 
density bias around the plasmid. If there was a preference for a sequence, more reads would 
cluster to a particular region. However, if there were no density bias and all regions of the 
plasmid were represented equally, then this would provide evidence for MmT6 having little to 
no sequence specificity. The second question, the size of the overhang generated, is a harder 
question to answer and relied on the presence of specificity. As the enzyme is known to cleave 
double-stranded DNA, forming two covalent 5ʹ phosphotyrosyl linkages, one to each strand of 
the duplex, this meant that during the end repair stage, these overhangs were filled in on both 
sides of the cut site. This should result in a two-fold enrichment of the sequence of the overhang 
and it is this footprint which allowed cleavage overhang size determination. Without specificity, 
potentially the whole plasmid would be enriched equally and so the stagger would be hard to 
glean from the data. Please refer to Chapter 5 for a comprehensive description of the protocol 
rational.   
As it currently stands, the way in which the preferred sequences were analysed once 
aligned involved the use of visual inspection. For certain data sets (see Chapter 5) the peaks 
were obvious and displayed a characteristic shape, allowing for easy identification. The 
sequence at each peak was extracted and in the case of MmT6 data, it was analysed using 
WebLogo online software (http://weblogo.threeplusone.com/) [228], in order to assess any 
base identity preferences around the cleavage sites. In the case of EcT4 and EcGyrase data 
analysis, an online wordcount software was used (http://www.bioinformatics.nl/cgi-
bin/emboss/wordcount#forms::wordcount), as these data sets did not resolve the precise 
cleavage site. However, regions of consecutive cytosine or guanidine residues were found to 
be enriched within the sequences using the aforementioned online tool. When this technique 
reaches maturity, code will be generated allowing for unbiased peak detection, as well as a 
more complex and thorough analysis of sequence preference. 
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Chapter 3 
Characterisation of M. mazei Topo VI using Ensemble 
Biochemistry  
 
3.1 Introduction  
The ensemble characterisation of DNA topoisomerase (topo) activity in vitro can take multiple 
forms, with perhaps the most prevalent technique being agarose-gel electrophoresis. Due to 
varying plasmid topologies that alter the rate at which the plasmid migrates within the gel, the 
topology manipulation performed by topos can be assayed in a substantial amount of detail.  
For the characterisation of MmT6, this technique was indispensable.  
As seen in Figure 3.1, supercoiled (SC) plasmid DNA migrates the fastest through the 
gel due its more compact structure. Under these conditions, nicked DNA, also known as open 
circular (OC), travels the slowest as the nick prevents any twist or writhe from being stored in 
the plasmid, which therefore means it has the most open structure. If the plasmid is linearised 
(L) it will run true to size, should a DNA size marker be run simultaneously. In the case of 
pBR322*, the plasmid used here, the linearised form runs between the open circular and 
supercoiled species. If the DNA is partially relaxed, generally this means that the plasmid will 
run as a set of bands known as topoisomers, running progressively faster than the open 
circular. This is due to varying degrees of supercoiling still being present in the DNA, with 
increasing writhe leading to further migration through the gel. When DNA is relaxed by topos, 
rather than yielding a single fully-relaxed product, they reach an equilibrium in which different 
degrees of supercoiling remain. For type IA topos and type IIB topos, this equilibrium is 
thermodynamically expected, whereas type IIA topos are able to further relax the DNA, 
producing even narrower topoisomer distributions that are beyond the thermodynamic 
equilibrium [229-231]. This is known as topology simplification, and while the cause of this 
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phenomenon has been debated for some time, it remains unresolved. As MmT6 is a type IIB 
topo, it has been shown not to perform topology simplification, despite utilising ATP, which 
demonstrated that the free energy from ATP hydrolysis was not the determinant of topology 
simplification by type IIA topos [231]. Using atomic force microscopy (AFM), it has also been 
suggested that MmT6 bends the G-segment to a similar degree as type IIA [61], hence 
eliminating G-segment bending as the lone contributing factor of topology simplification [229]. 
The subject will not be addressed further in this work, however it is worth noting that MmT6 has 
proven to be a highly useful probe for exploring the possible mechanisms of topology 
simplification. A potential explanation explored in [231] was that geometric selection of the DNA 
crossing bound may be contributing. This remains a plausible hypothesis as Chapter 4 will 
detail that the MmT6 DNA crossing angle preference is ~88°, which is extremely close to 90°, 
like yeast topo II [120], which incidentally also doesn’t significantly simplify topology despite 
being a type IIA topo [229]. The issue is confounded, however, as E. coli topo IV, known to 
simplify topology to a high degree [61, 229], has a DNA crossing angle preference of ~85.5° 
[120]. 
 
Figure 3.1: The effects of DNA topology on the rate of migration through an agarose gel in 
absence of DNA intercalators. This illustrates how supercoiled (SC), open circular/nicked (OC), 
relaxed (rel), and linear (L) pBR322* migrate through a 1% (w/v) native agarose gel, run for 10 hr 
at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. For 
further details on the assay from which the gel was taken see Figure 3.6. 
 
Although gel electrophoresis was not the only technique to be utilised in this chapter, it 
comprised a major component of  this work and is often a key technique used in ensemble topo 
characterisation. Other techniques employed here in Chapter 3 were the PK/LDH (Section 
3.2.7.1) and radioactive ATP (Section 3.2.7.2) assays exploring MmT6 ATP hydrolysis activity, 
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as well as a membrane capture technique used to explore MmT6-dependent DNA binding 
(Section 3.2.6), all of which are described in full within the respective sections.  
 
3.2 Results and Discussion 
3.2.1 MmT6 expression and purification  
This project has centred around the in-depth characterisation of DNA topoisomerase VI from 
M. mazei (MmT6), using sensitive techniques of both an ensemble and single molecule nature. 
It has therefore been imperative that the enzyme be produced in considerable quantities and 
to a high degree of purity. The presence of contamination from other DNA-cleavage enzymes 
or ATPases were unacceptable, hence the optimisation and technical skill acquisition of MmT6 
protein production was paramount when this research began. Fortunately, James Berger and 
colleagues (Johns Hopkins University, Baltimore, MD, USA) had previously isolated and cloned 
MmT6, developing a robust purification protocol designed to produce protein of crystallographic 
standard [62, 195], as well as facilitating the work done here by gifting the MmT6 expression 
plasmid. 
 When topo VI was first discovered and characterised in 1994, it was done so by 
purification from the hyperthermophillic archaeon, Sulfolobus shibatae [167]. This seminal work 
revealed a heterotetrameric protein, formed of two Top6A and two Top6B subunits, of 47 and 
60 kDa, respectively, with ATP/Mg2+-dependent DNA relaxation and decatenation activities. 
Subsequently, evidence of over-expression and purification from E. coli was attained, 
demonstrating that active S. shibatae topo VI (SsT6) could be reconstituted from separately 
expressed/purified Top6A and Top6B subunits [193]. The Top6B subunit could be robustly 
expressed and purified, remaining soluble throughout, however Top6A required purification 
from inclusion bodies after denaturation and renaturation. This significantly affected the amount 
of active protein attained and led researchers to conclude that both subunits required dual 
expression from the same plasmid. Following work detailed the use of a pET3b-based 
expression plasmid, which allowed both subunits to be expressed simultaneously, thus allowing 
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the expression and purification of considerable amounts of active SsT6 in E. coli [194]. This 
approach has continued, with MmT6 being expressed from another dual expression vector 
derived from pST39 [232], which also expressed both Top6A and Top6B together. It is 
hypothesised that Top6A, in particular, requires the presence of Top6B in order to maintain 
structure and stability. It was recognised early on that Top6A is highly homologous to the 
eukaryotic meiotic factor Spo11 [171], the in vitro expression of which has also plagued Spo11 
research for some time. Very recently, the Saccharomyces cerevisiae Spo11 complex has 
finally been purified from insect cells, after decades of trial and error, achieved only through 
the identification and dual expression of Top6B-like homologues, Rec102 and Rec104 [210].  
 As previously mentioned, the MmT6 expression plasmid used in this research, was 
gifted by James Berger (Johns Hopkins University, Baltimore, MD, USA), with the expression 
and purification protocols implemented largely unchanged from previously published work [62, 
195]. This begins with the chemical transformation of the MmT6 plasmid into competent 
Rosetta™ 2 (Merck) E. coli expression cells, followed by expression in auto induction growth 
media (AIM) at 37°C for 24 hr. When samples of the expression culture were analysed using 
denaturing polyacrylamide gel electrophoresis (PAGE), MmT6 expression was confirmed with 
Top6B (69-kDa) and Topo6A (42-kDa) clearly visible (Figure 3.2). 
 
Figure 3.2: MmT6 expression. Rosetta 2 E. coli expression cells were transformed with the 
polycistronic dual expression vector carrying both the Top6A (45 kDa) and Top6B (65 kDa) 
subunit genes, and incubated at 37°C for 24 hrs. A 15 μL aliquot of the culture was run on a 
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precast 10% (w/v) polyacrylamide gel (Sigma) under denaturing conditions and stained with 
InstantBlue™ (Sigma). Blue arrows indicate the position of the Top6A and Top6B proteins.  
 
 
Figure 3.3: MmT6 purification. A: Nickel column number 1. As MmT6 was his-tagged, a nickel 
column (HisTrap™ FF Ni2+ column, GE Life Sciences) was used, with the MmT6 eluted using an 
imidazole gradient into 5 mL fractions. B: The fractions from A were pooled and passed over an 
SP Sepharose column (HiTrap™ SP Sepharose HP column, GE Life Sciences) followed directly 
by a Q Sepharose column (HiTrap™ Q Sepharose HP column, GE Life Sciences). Proteolysed 
Top6B remained bound to the SP sepharose, while folded Top6A and Top6B were bound to the 
Q Sepharose. The SP Sepharose column was removed and the Top6A and Top6B were eluted 
from the Q Sepharose using an NaCl gradient into 5 mL fractions. C: Post his-tag removal (via 
tobacco etch virus (TEV) protease incubation), the MmT6 was run down a second nickel column 
(HisTrap™ FF Ni2+ column, GE Life Sciences) to remove the his-tagged TEV and cleaved MmT6 
his-tag. MmT6 was eluted from the column in 5 mL fractions and concentrated down to 0.5 mL. 
D: The concentrated MmT6 was put down a Superose 6 10/300 (GE Life Sciences) gel filtration 
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column and eluted in 1 mL fractions. Fractions from each column were run on 10% (w/v) 
denaturing polyacrylamide gels (Sigma) and stained using InstantBlue™ (Sigma). Pooled 
fractions for all figure panels, which went on to subsequent purification steps, are highlighted in 
red (in D, the highlighted fraction represents the final product used for activity testing). 
 
Following expression, MmT6 expression cultures were lysed, and the soluble MmT6 
was subject to purification. The Top6B protein was his-tagged, which allowed Top6B/Top6A 
dimers to be purified using a nickel column (Figure 3.3A). This proved effective in separating 
the MmT6 protein from the bulk cellular extract. The MmT6 was eluted from the nickel column 
using an imidazole gradient, with fractions containing MmT6 being subject to further purification 
using both SP and Q Sepharose columns (Figure 3.3B). The purpose of this stage of the 
protocol was to remove any mis-folded or proteolysed Top6B. The Q Sepharose column was 
attached directly after the SP Sepharose, with proteolysed Top6B remaining bound to the SP, 
whilst fully folded Topo6A/Top6B dimers were bound to the Q Sepharose. By removing the SP 
Sepharose column, and then applying an NaCl gradient, the Topo6A/Top6B dimers were eluted 
(Figure 3.3B). Fractions containing MmT6 were then pooled and treated with tobacco etch virus 
(TEV) protease to remove the his-tag, prior to purification using a second nickel column. 
However, this time MmT6 without the his-tag was immediately eluted from the column whilst 
the cleaved his-tags and the his-tagged TEV protease remained bound (Figure 3.3C). To 
achieve increased purity, the MmT6 flow-through fractions were concentrated before being 
applied to a gel filtration column (Figure3.3D). Using size exclusion chromatography allowed 
the separation of the MmT6 from smaller contaminating proteins (see lane 4 versus lane 5 in 
Figure 3.3D).  
 Post gel filtration, the MmT6 was concentrated once more before relaxation activity was 
assessed (Figure 3.4), to determine whether active MmT6 protein had been purified in the 
absence of contaminating DNA cleavage enzymes. Without the gel filtration column, often 
activity testing would reveal topo-independent DNA linearisation, suggesting nuclease 
contamination, which, for numerous aspects of this research, was unacceptable. In general, 
MmT6 achieved optimal relaxation of 2 nM negatively supercoiled pBR322* between 10-40 nM 
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MmT6, in the presence of 10 mM MgCl2 and 1 mM ATP, incubated for 30 min at 37°C. Once a 
robust protocol for the expression of MmT6 was established, the work detailed over the 
remainder of this thesis was facilitated.  
 
Figure 3.4: MmT6 activity testing. Post gel filtration, MmT6 was used in a DNA relaxation assay 
to assess protein activity. MmT6 (0.4-114 nM) was incubated with 2 nM negatively supercoiled 
pBR322* with or without 1 mM ATP, at 37°C for 30 min, and then run on a 1% (w/v) native agarose 
gel for 15 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV 
illumination. 
 
3.2.2 SEC-MALS and iSCAT 
This section details preliminary assays exploring the overall complex formation of MmT6 as a 
heterotetramer formed of two Top6A and two Top6B subunits, ~220 kDa in size, using Size 
Exclusion Chromatography coupled to Multi-Angle Light Scattering (SEC-MALS) and 
Interferometric Scattering Technology (iSCAT). Both techniques allow the size of molecules to 
be determined using light scattering [233, 234]. Here, they were employed to determine 
whether MmT6 was composed of Top6A or Top6B monomers, Top6A/Top6B dimers or 
heterotetramers formed of two Top6A/Top6B dimers. SsT6, when first discovered, was 
demonstrated to be a heterotetramer in solution [167], with its crystal structure also 
demonstrating this [196]. MmT6, whilst the crystal structure was of the Top6A/Top6B dimer 
[195], also appeared to a heterotetramer in solution, with the major molecule size determined 
using SEC-MALS shown to be ~200 kDa, regardless of whether 2.27 or 0.45 μM MmT6 was 
used (Figure 3.5A). As SEC-MALS required relatively large amounts of protein, iSCAT was 
also employed which allowed molecular size determination at 20 nM MmT6. This similarly 
revealed that the majority of MmT6 molecules in solution were ~210 kDa (see peak 3, Figure 
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3.5B), and therefore heterotetramers. The iSCAT technique revealed further detail showing 
molecules that were either ∼60-70 kDa, determined to be Top6B monomers (see peak 1, 
Figure 3.5B) or ~100-110 kDa, determined to be Top6B/Top6A heterodimers (see peak 2, 
Figure 3.5B). These are likely present in very small quantities due to low-level complex 
degradation, rather than representing a single data point for the equilibrium between the dimer 
and heterotetramer. However, iSCAT measurements at different MmT6 concentrations would 
be necessary to determine whether MmT6 begins to dissociate into dimers as concentration 
decreases. It is highly likely that the Top6B detected is only present due to having not formed 
a dimer with Top6A during expression, rather than dissociating from Top6A in solution as no 
Top6A was detected. However, size limitations associated with iSCAT may prevent 
visualisation of free Top6A, therefore future work is required to fully understand MmT6 complex 
formation.  
 
Figure 3.5: MmT6 complex size determination using Size Exclusion Chromatography coupled to 
Multi-Angle Light Scattering (SEC-MALS) and Interferometric Scattering Technology (iSCAT). A: 
SEC-MALS data from 0.45 μM (green line) and 2.27 μM (red line) MmT6. Only one major peak was 
confidently measured to have a size of ~200 kDa. B: iSCAT data from 20 nM MmT6. Peak 1 
represents molecules sized ∼60-70 kDa, determined to be Top6B monomers. Peak 2 represent 
molecules sized ~100-110 kDa, determined to be Top6B/Top6A heterodimers. Peak 3 represent 
molecules sized ~200-220 kDa, determined to be Top6B2Top6A2 heterotetramers.  
	
3.2.3 MmT6 supercoil relaxation 
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The following section will detail experimental work conducted to explore the DNA relaxation 
activity of MmT6 using ensemble agarose gel-based methods. As described above, the 
relaxation activity of MmT6 can be probed in this way due to the topological status of a plasmid 
altering the way it migrates through a gel in response to an electrical field. Supercoiled plasmid 
DNA is more compact and will travel faster than the more openly-structured relaxed DNA, with 
the linearised plasmid running true to size, its gel position dependent on the size of the plasmid 
used. In this work the plasmid pBR322* (4325 bp) was heavily utilised, which is of E. coli origin 
and derived from one of the first widely-used cloning vectors, pBR322 (4361bp) [235]. The 
pBR322* plasmid has minor sequence changes, namely a single G to T transversion making 
pBR322* a high copy number plasmid [236], and a deletion which disrupted the tetracycline 
resistance gene.  
 Negatively supercoiled pBR322*, was used in preliminary assays exploring MmT6 
relaxation activity conditions and established a starting point, based on previous work [62, 167, 
171, 193-195], for the optimisation and characterisation thereof. The first topo VI to be 
characterised, S. shibatae topo VI (SsT6), revealed an enzyme capable of DNA relaxation and 
decatenation activity in the presence of ATP and Mg2+ [167], also shown later to be true for 
MmT6 [62, 195]. At the onset of this project, it was appropriate to confirm these findings with 
the MmT6 purified above, which indeed demonstrated the strict necessity for the both ATP and 
Mg2+ during DNA relaxation (Figure 3.6). As will be seen later, DNA cleavage activity by MmT6 
was promoted by the use the use of ADPNP, a non-hydrolysable analogue of ATP, which 
stabilised the MmT6-dependent DNA cleavage complex and generated linearised pBR322* 
(Figure 3.6) (see section 3.2.5 for detail on MmT6-dependent DNA cleavage). With basic 
conditions for activity established and in agreement with prior work, the activity of MmT6 was 
systematically explored, beginning with DNA relaxation and followed by decatenation (Section 
3.2.4), DNA cleavage (Section 3.2.5), DNA binding (Section 3.2.6) and ATPase activity 
(Section 3.2.7).  




Figure 3.6: MmT6 activity conditions. MmT6 (20 nM) was incubated with 2 nM negatively 
supercoiled pBR322* at 37°C for 30 min. The conditions varied were the presence or absence (+ 
or - respectively) of 1 mM ATP, 1 mM ADPNP or 10 mM MgCl2. The DNA only sample is incubated 
in the absence of MmT6. Samples containing ADPNP were treated with SDS and proteinase K, 
prior to electrophoresis. Samples were run on a 1% (w/v) native agarose gel for 10 hr at ~2 Vcm-
1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. OC: open circular 
or nicked, Rel: relaxed, SC: supercoiled, and L: linear.  
 
3.2.3.1 DNA topology 
There are numerous variables affecting in vitro MmT6 activity, which can be modified to further 
explore its enzymatic properties and mechanism. The first described here is DNA topology. 
Depending on the direction of helical rotation, constrained DNA can become either positively- 
(left-handed) or negatively- (right-handed) supercoiled, known as overwound and underwound, 
respectively [6]. Many topos display a preference for DNA supercoil chirality, for instance E. 
coli topo IV and human topo IIα preferentially relax positively-supercoiled DNA [119, 120, 156], 
whilst E. coli topo I prefers negatively-supercoiled [12, 20]. Some topos, like yeast topo II and 
human topo IIβ display no preference, relaxing both chiralities at highly comparable rates [120, 
145, 237]. To ascertain whether MmT6 displayed a chiral preference for relaxation, it was 
titrated into an assay containing 2 nM of either positively- or negatively-supercoiled pBR322*, 
1 mM ATP, 10 mM MgCl2, and incubated at 21 or 37°C for 30 min. Both temperatures were 
explored owing to the fact that both the ATPase (section 3.2.7) and single-molecule magnetic 
tweezers (Chapter 4) assays had to be conducted at 21°C. M. mazei itself, is a mesophilic 
archaeon that lives in freshwater and marine environments, with an optimal temperature of 30-
40°C [238, 239]. And so, whilst 21°C is below the optimum, it is not unlikely, based on its 
habitat, that M. mazei would experience, and persist in, reduced temperatures. This means 
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that exploring activity at a lower temperature does not render the finding insignificant to in vivo 
extrapolations, and also offers a solution to slowing the reaction so that more subtle effects can 
be explored. The chirality-dependence on MmT6 relaxation rate is a prime example, as at 21°C 
a more significant difference in rate can be seen, an effect which is reduced considerably at 
37°C (Figure 3.7). Based on the results in Figure 3.7, at 21°C, in the presence of negative 
supercoils, ~2-fold more enzyme is required to achieve a similar level of relaxation as positive 
supercoils, indicating a mild preference for the relaxation of positive writhe. In Chapter 4, the 
magnetic tweezers data corroborates this result, however, the in vivo significance of this 2 to 
3-fold rate enhancement on positive writhe isn’t clear, particularly as at 37°C, the effect is barely 
noticeable. E. coli topo IV and human topo IIα display ~25-fold and 10-fold rate enhancements, 
respectively, in the presence of positive writhe over negative at optimal temperatures [119, 120, 
156], implying this chirality-dependent behaviour is more likely to effect in vivo roles. 
Nevertheless, both the data discussed here and in Chapter 4, suggest MmT6 has an intrinsic 
mild preference for the relaxation of positive DNA writhe. When SsT6, the first topo VI 
characterised, was tested in the presence of both positive and negative supercoils, no 
appreciable difference could be seen between the two when incubated with SsT6 at optimal 
temperature [167]. This is in agreement with data here, which shows that at 37°, MmT6 
relaxation activity on either chiralities is very similar, as determined from the gels.  
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Figure 3.7: MmT6 titration, exploring relaxation activity of negatively or positively-supercoiled 
pBR322* at 21°C and 37°C. MmT6 concentration was varied from 0.5 to 40 nM, and was incubated 
with 2 nM pBR322*, 1 mM ATP, 10 mM MgCl2, for 30 min, at either 21°C or 37°C. OC: open circular 
or nicked pBR322*, Rel: relaxed topoisomers of pBR322*, and SC: supercoiled pBR322*. The 
DNA-only sample was incubated in the absence of MmT6. Samples were run on a 1% (w/v) native 
agarose gel for 12 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV 
illumination. 
 
 This result is further supported by exploring the ensemble relaxation behaviour of MmT6 
over time (Figure 3.8). Once again, the difference in rate can be seen more clearly when 
assayed at 21°C, showing the relaxation of positively-supercoiled pBR322* to reach completion 
2-3-fold faster than negatively-supercoiled, in the presence of 20 nM MmT6. Interestingly, 
increasing the temperature from 21 to 37°C had a more significant effect on rate for the 
relaxation of negative supercoils, increasing rate ~2.5-fold (full relaxation achieved by 6 min for 
37°C, and by 15 min for 21°C), compared to the ~0.5-fold increase for positive (full relaxation 
achieved by 4 min at 37°C, and by 6 min at 21°C). As explored thoroughly in Chapter 4, the 
DNA crossing geometry preference for MmT6 is slightly below 90°, an angle more common in 
positive supercoils than negative. Therefore, the angle fluctuation frequency, which would 
increase as a function of temperature, would likely have a more profound effect on negative 
supercoil relaxation, with negative supercoils sampling the MmT6 preferential angle more 
frequently. As discussed above, and in Chapter 4, it is not clear whether this subtle difference 
in relaxation rates has in vivo implications for MmT6 activity, however as M. mazei encodes a 
DNA gyrase, having MmT6 preferentially relax positive writhe over negative may reduce any 
interference with the DNA gyrase activity. It may also allow MmT6 to assist in the relaxation of 
positive writhe generated as a result of DNA replication and transcription. However, as will be 
shown, MmT6 is likely a preferential DNA decatenase, therefore differential effects in relaxation 
activity may be a by-product of its decatenation mechanism.  
 Time courses, such as those in Figure 3.8 can also inform on the processivity of the 
enzyme in question. In previous work, MmT6 was determined to be highly distributive, using a 
plasmid-chase assay [62]. Visual inspection of the gel in Figure 3.8, indicated that MmT6 under 
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the conditions used here, appeared to function via a mixture of processive and distributive 
behaviours, with negative supercoil relaxation appearing more processive, while the activity on 
positive was more distributive. The argument for processivity originates from the fact that 
relaxed topoisomers can be seen at very early time points (1-2 mins) for both chiralities, but 
more significantly in the case of negative supercoil relaxation. This form of analysis, however, 
is not definitive and further exploration would be extremely useful. In Chapter 4, the processivity 
of MmT6 will be explored again but it is important to note that magnetic tweezers DNA 
substrates are not identical to those found within cells, which means in vitro ensemble 
characterisation using supercoiled plasmid DNA may be more informative when it comes to 
addressing MmT6 processivity in vivo.  
 
Figure 3.8: Time course of MmT6-dependent relaxation of negatively- or positively-supercoiled 
pBR322* at 21°C and 37°C. Assay was conducted using 20 nM MmT6, 1 mM ATP, 10 mM MgCl2 
and 2 nM pBR322*. The DNA-only sample was incubated in the absence of MmT6. Samples were 
run on a 1% (w/v) native agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium 
bromide and imaged under UV illumination. 
 
3.2.3.2 Temperature 
As discussed in Section 3.2.3.1, varying the temperature at which the relaxation reaction was 
incubated, assisted in revealing subtle enzymatic effects. Here, the temperature was varied 
more dramatically and with the purpose of exploring the thermostability of MmT6, through 
relaxation activity. As the optimum growth temperature of M. mazei is 30-40°C [119, 120, 156], 
with MmT6 activity determined optimal at 37ºC [62, 195], the results shown in Figure 3.9 
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substantiate this, finding that the MmT6 purified in this work also relaxed negatively supercoiled 
pBR322* optimally at 40°C. Relaxation activity, whilst diminished, was detected at 20-30°, with 
a far steeper decrease in activity as the temperature exceeded 40-50°C. This suggested MmT6 
activity is not particularly stable at high temperatures which may be a function of the enzyme 
itself becoming structurally disrupted, or instead may be due to the interaction with the DNA 
becoming less efficient. Previous work [62], as well as work done in this chapter and in Chapter 
4, indicated that MmT6 preferentially binds DNA crossings, rather than binding the G-segment 
before subsequently capturing a T-segment. The movement of the DNA would increase with 
temperature, which may mean DNA crossings are less stable in position through time and may 
affect the MmT6 relaxation rate through prevention of DNA binding. However, SsT6, despite 
being from a hyperthermophile and determined optimally active at 80°C, was reduced to being 
only 40% active in DNA relaxation after a 40 min preincubation at 80°C, even though this 
temperature was determined optimal in the absence of preincubation [167]. This suggested 
SsT6 was not particularly thermostable, which may be true for all topo VI enzymes. A likely 
cause of this instability is the overall holoenzyme structure. Topo VI enzymes are 
heterotetramers with all four subunits held together via non-covalent interactions, and as 
described in Section 3.2.1, the stable expression and purification of topo VI relies on dual 
expression of both the Top6A and Top6B subunits. This is hypothesised to be due to one or 
both subunits relying on the other for stability. In addition to this, as described in section 3.2.2, 
the enzyme appears to be a heterotetramer in solution, meaning the Top6A/Top6B dimer must 
find and interact with another dimer, to form stable and active enzymes prior to interaction with 
DNA. It may be, therefore, that with both these structural implications, an increase in 
temperature rapidly disrupts the heterotetramer arrangement, first separating the two 
Top6A/Top6B dimers, before disrupting the interaction between the Top6A and TopB subunits 
within each dimer. Future work using biophysical techniques would be necessary to further 
explore the effects of temperature on MmT6 structure and activity, for example, preincubation 
of MmT6 at various temperatures followed by SEC-MALS.  
Chapter 3: Ensemble Results 
 95 
 
Figure 3.9: Effect of temperature on MmT6-dependent relaxation activity. MmT6 (37 nM) was 
incubated with 2 nM negatively supercoiled pBR322*, 1 mM ATP and 10 mM MgCl2, for 30 min at 
20 to 90°C. The DNA only sample was incubated in the absence of MmT6 and at 90°C. Samples 
were run on a 1% (w/v) native agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium 
bromide and imaged under UV illumination. 
 
3.2.3.3 Divalent metal cation identity and concentration 
All type II and type IA enzymes require Mg2+ during topology modulation, as it is integral to topo 
binding and cleavage activity, likely due to a coordination or stabilisation effect between the 
active-site tyrosine and the scissile phosphate, or their transition states [59]. In addition, type 
IB activity is stimulated in the presence of Mg2+, however it does not directly interact with the 
protein [240, 241]. The TOPRIM domain of type II and type IA topos harbours a DxD motif 
which coordinates Mg2+ [58]. This motif can, however, bind other divalent metal cofactors that 
may or may not permit topo activity. A common example is the use of Ca2+ in DNA-cleavage 
stimulation by type II topos such as DNA gyrase [242, 243] and Drosophila melanogaster topo 
II [244]. Although the main drive behind exploring divalent metal ion identity related effects on 
MmT6 activity began with the goal to generate more substantial DNA cleavage (Section 
3.2.5.2), its effects on relaxation activity were also systematically explored.  
 The divalent metal ions used, all derived from the chloride salt, were magnesium (Mg2+), 
manganese (Mn2+), zinc (Zn2+), calcium (Ca2+), cobalt (Co2+) and nickel (Ni2+), titrated into a 
MmT6 relaxation assay at 0.5 to 100 mM (Figure 3.10). Zinc, calcium and nickel did not support 
any relaxation, however calcium has been shown to support human topo II [245] and 
Mycobacterium tuberculosis DNA gyrase [246] relaxation, as well as cleavage by SsT6 [194]. 
Mg2+, as expected, was the optimal divalent metal ion cofactor during relaxation at a 
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concentration of 5-25 mM. However, at higher concentrations of Mg2+ (50 mM and above), 
relaxation activity was abolished. Possible explanations for this involve disruption of DNA 
binding through effects of increased ionic strength, however with reference to Figure 3.17 
exploring DNA cleavage as a function of metal ion cofactor identity, 50 mM Mg2+ supported 
robust levels of DNA cleavage. Therefore, the lack of relaxation activity at 50 mM cannot be 
due to interference with G-segment binding. Rather, it suggested that 50 mM Mg2+ disrupts 
relaxation activity through prevention of T-segment capture, rather than G-segment binding 
and cleavage. At 100 mM MgCl2, both relaxation and cleavage were inhibited, which may 
indicate that this concentration abolished DNA binding altogether.  
 
Figure 3.10: Exploring the effects of varying divalent metal ion identity and concentration on the 
relaxation activity of MmT6. MmT6 (20 nM) was incubated with 1 mM ATP, at 37°C for 30 min in 
Chapter 3: Ensemble Results 
 97 
the presence of different divalent metal ions. Divalent metal ions explored were magnesium 
chloride (MgCl2 or Mg2+), manganese chloride (MnCl2 or Mn2+), zinc chloride (ZnCl2 or Zn2+), 
calcium chloride (CaCl2 or Ca2+), cobalt chloride (CoCl2 or Co2+), and nickel chloride (NiCl2 or Ni2+), 
with each varied in concentration from 0.5 to 100 mM. The DNA-only sample was incubated in the 
absence of MmT6 and in the presence of 100 mM of the respective metal cation salt. All samples 
were run on a 1% (w/v) native agarose gel for 15 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium 
bromide and imaged under UV illumination. 
 
Mn2+ supported a modest amount of relaxation at 2 mM, in line with results found for 
human topo II [245, 247] M. tuberculosis DNA gyrase [246] and Vaccinia topo I [248], but not 
for Drosophila melanogaster topo II [249]. Interestingly, Co2+ supported the most relaxation 
after Mg2+, with 2 mM being optimal. This was also found to be the case for human topo IIα 
[250] and Vaccinia topo I [251], but not Yeast type I topo [136]. This is surprising considering 
the in vivo genotoxic effects of Co2+, hypothesised to be caused by either interference with DNA 
repair proteins [252], oxidative damage [253] or indeed poisoning of topo II activity promoting 
formation of DNA cleavage complexes [250]. The cleavage promoting effect of Co2+ can also 
be seen for MmT6 in Figure 3.10, as increasing Co2+ concentration results in the progressive 
appearance of a linear band between 5-25 mM. As no DNA linearisation is seen above 25 mM, 
this suggested the DNA damage is dependent on MmT6 activity, rather than protein-
independent oxidative damage.  
 
3.2.3.4 Potassium glutamate versus potassium acetate 
M. mazei is an acetate-metabolising archaeon, found to convert acetate to methane as a 
source of energy once the extracellular concentration surpassed 0.4 mM [254, 255]. In assays 
conducted here, potassium glutamate was selected as the monovalent salt at 100 mM, based 
on previous work [62, 195]. However, as MmT6 is from an organism that preferentially 
metabolises acetate, the effect of using potassium acetate, rather than glutamate, on relaxation 
activity was explored (Figure 3.11). At the concentration commonly employed in MmT6 
reactions (100 mM) both glutamate and acetate supported robust relaxation of 2 nM negatively 
supercoiled pBR322* by 37 nM MmT6 (Figure 3.11). Glutamate is known to have an effect on 
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the quality of gel electrophoresis resolution which can be seen here with topoisomer bands in 
the presence of acetate being far more defined. This indicated that replacing glutamate with 
acetate (at 100 mM) could provide a technical solution to producing gels with more distinct 
topoisomer distributions. However, increasing acetate concentration had a more severe 
inhibitory effect on relaxation activity, fully inhibiting MmT6 by 300 mM, whilst glutamate 
permitted some level of relaxation until 500 mM. As both were the potassium salt, this difference 
in activity was likely due to differential effects of the acetate and glutamate ions.  Any future 




Figure 3.11: Exploring the effects of potassium glutamate and potassium acetate on MmT6-
dependent relaxation activity. MmT6 (37 nM) was incubated with 2 nM negatively supercoiled 
pBR322*, 1 mM ATP and 10 mM MgCl2, for 30 min at 37°C. The buffer conditions were varied, 
using 100-800 mM potassium glutamate or potassium acetate. DNA only samples were incubated 
in the absence of MmT6. All samples were run on a 1% (w/v) native agarose gel for 10 hr at ~2 
Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination 
 
3.2.4 MmT6 decatenation activity 
Topo VI enzymes are hypothesised to be preferential DNA decatenases, based on the 
organisms in which these enzymes are found and the processes in which topo VI is integral, 
such as in Arabidopsis, where topo VI was shown to be vital during endoreduplication [169], as 
well as preliminary in vitro characterisation of archaeal SsT6 [167]. This section details the 
results of using two different DNA substrates in the characterisation of MmT6 decatenase 
activity, namely kDNA (Section 3.2.4.1) and singly-catenated plasmids (Section 3.2.4.2).  
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3.2.4.1 Decatenation using kDNA 
The use of kinetoplast DNA (kDNA) in exploring the in vitro decatenation activity of topos, has 
provided a means to attaining a qualitative assessment of decatenation activity. This substrate 
originates from the mitochondria of trypanosomes and is formed of an extended network of 
interlinked DNA plasmids of two sizes, called maxicircles (20-40 kb) and minicircles (0.5-1kb) 
[256]. Its use can be a qualitative measure of decatenation activity, with plasmids released from 
the network as a result of topo-dependent activity, which can then be visualised using gel 
electrophoresis. When SsT6 was first characterised, the use of kDNA revealed that 3-fold less 
SsT6 was required to fully decatenate kDNA, than was required for the relaxation of the same 
amount of negatively supercoiled plasmid [167], resulting in the hypothesis that SsT6 was a 
preferential DNA decatenase. However, with the inability to quantify or control how many 
plasmids are interlinked and by how much, comparing topo-dependent decatenation activity to 
supercoil relaxation using a gel-based approach is limited. Regardless of this, MmT6 
decatenation activity was explored using kDNA at both 37 and 21°C (Figure 3.12). If Figure 
3.12 is compared to Figure 3.7, which explored the effect of MmT6 concentration on supercoil 
relaxation, low-level decatenation activity can be seen at both temperatures using 0.5 nM 
MmT6, whilst supercoil relaxation isn’t detected until 2.5 nM MmT6 is used. This suggested 
that ~5-fold less MmT6 is required for decatenation and is in agreement with previous work 
done on SsT6[167]. The caveat, as previously alluded to, is that quantifying how many strand 
passage events are required to release plasmids from the kDNA network, compared to how 
many are required to begin resolving more relaxed topoisomers of supercoiled DNA, was not 
possible. It may be that 5-times fewer stand-passage events are required to fully decatenate 
kDNA than fully relax supercoiled DNA. Nevertheless, this result suggested that MmT6, like 
SsT6, is a preferential decatenase.  




Figure 3.12: MmT6 decatenation activity using kDNA. MmT6 (0.5-40 nM) was incubated with 250 
ng of kDNA in the presence of 1 mM ATP and 10 mM MgCl2, at 37°C or 21°C for 30 min. As 
plasmids are released from the network by MmT6, they can migrate into the gel, allowing the 
decatenation reaction to be visualised. All samples were run on a 1% (w/v) native agarose gel for 
15 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. 
 
3.2.4.2 Decatenation using singly-catenated plasmid DNA 
As just discussed, the use of kDNA in the quantitative analysis of topo-dependent decatenation 
activity is not possible due to the inability to quantify the number of strand-passage events 
required to fully decatenate the substrate. This, therefore, left the topo field with no reliable way 
to explore the ensemble in vitro decatenation activity in a calculable sense. The use of single-
molecule DNA braids, implemented in Chapter 4, has been used as a proxy for exploring 
decatenation activity [257], however, as DNA braids and catenated plasmids are not identical 
in nature, this approach is also limited in characterising bona fide decatenation activity. 
Recently, Nidda Waraich (JIC, Norwich, UK; Waraich et al. BioTechniques, in press, 2020) 
established a protocol, which generated a catenated substrate of two different-sized plasmids, 
catenated by a single link. This substrate allowed the quantitative analysis of MmT6 
decatenation activity, and moreover, as the plasmids are also negatively supercoiled, both the 
decatenation and relaxation activity can be monitored within the same reaction (Figure 3.13). 
As seen in Figure 3.13, decatenation activity was detected at MmT6 concentrations as low as 
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100 pM, with the substrate fully decatenated using 500pM MmT6, even though the relaxation 
of the plasmids wasn’t detected until 5 nM MmT6. This result indicates that MmT6 could be as 
much as ~10-fold more active during decatenation than relaxation. However, it must be 
considered that only a single strand-passage event was required to fully separate the two 
plasmids, whilst full relaxation required considerably more. This being said, the fact that MmT6 
displayed low-level decatenation activity at a concentration 50-fold lower than the first sign of 
relaxation (0.1 versus 5 nM), suggested that there is a preference for decatenation by MmT6. 
If this was purely a function of how many strand-passage events are required, you would expect 
to see a mixture of decatenation and relaxation occurring simultaneously at lower MmT6 
concentrations. As relaxation is entirely absent below 5 nM MmT6, this suggested that a unique 
feature of catenanes accelerated MmT6 activity. As explored thoroughly in Chapter 4, this is 
likely to be due to a preferential DNA crossing geometry close to 90° for MmT6, which appears 
far more often in catenanes than supercoils [119].  
As the protocol for the generation of this substrate has only recently been refined, 
significant quantities were not available. However, once more of the substrate is produced, 
exploring MmT6 cleavage, binding and ATPase activity in its presence would be invaluable to 
further consolidating the hypothesis of MmT6 and other topo VI enzymes as preferential DNA 
decatenases.   
 
Figure 3.13: MmT6 decatenation activity using singly-catenated, negatively supercoiled plasmid 
DNA. A singly catenated, negatively-supercoiled plasmid (2 nM) was decatenated by 0.1-20 nM 
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MmT6 in the presence of 1 mM ATP and 10 mM MgCl2, incubated at 37°C for 30 min. The catenated 
plasmids vary in size and when decatenated, can be seen as two bands that migrate further than 
the catenated substrate (labelled with the orange and green rings, left-hand side). As they are 
also negatively supercoiled; the relaxation of the plasmids can be seen at MmT6 concentrations 
~10 fold higher than when full decatenation is seen. OC: open circular, Rel: relaxed and Sc: 
supercoiled. All samples were run on a 1% (w/v) native agarose gel for 15 hr at ~2 Vcm-1, stained 
with 0.5 μg/mL ethidium bromide and imaged under UV illumination. 
 
3.2.5 MmT6 DNA cleavage 
Exploring DNA cleavage activity of topos using gel-based methods can inform on the specifics 
of this stage of the reaction, in the absence of canonical activity. Topo-dependent cleavage can 
be explored for a number of purposes, such as characterising inhibitory compounds [258-260], 
determining cleavage kinetics [241, 261] and studying DNA cleavage sequence preferences 
[54]. Here, MmT6 DNA cleavage activity was explored with the purpose of both gaining deeper 
mechanistic insight into the MmT6 reaction, as well as optimising DNA cleavage in order to 
facilitate work presented in Chapter 5, exploring MmT6 DNA sequence preferences.  
 As DNA cleavage is a highly transient stage of the topo reaction mechanism, exploring 
it requires disruption of the canonical topo reaction. In many cases, this is achieved through 
the use of cleavage-complex stabilising compounds, which prevent re-ligation by binding at the 
sites of topo-dependent DNA breakage [259]. Other methods include the substitution of Mg2+ 
for Ca2+, which promotes formation of the DNA cleavage complexes in E. coli DNA gyrase [242] 
and D. melanogaster topo II [244], or the use of ADPNP, which enhanced cleavage stabilisation 
by SsT6 [194]. For MmT6, with reference to Figure 3.6, the starting conditions for stimulating 
DNA cleavage were incubation of ~10-fold more MmT6 than used in relaxation assays, with 3-
4 nM negatively supercoiled pBR322*, in the presence of 10 mM MgCl2 and 1 mM ADPNP, at 
37°C for 30 min.  
In addition to the aforementioned modifications to in vitro protocols, resolution of topo-
cleaved DNA on a gel required further processing as a result of the formation of the covalent 
topo-DNA complex. Type II and type IA topos form 5ʹ phosphotyrosyl linkages with the DNA 
back bone, which are reversible during the canonical mechanism, but become stabilised during 
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DNA cleavage assays. If the topo is not removed the DNA will fail to migrate correctly through 
the gel and make resolution of the DNA species challenging. Therefore, all assays detailed in 
this section, post initial incubation, were followed by treatment with sodium dodecylsulphate 
(SDS) and proteinase K (PK), which successfully removed the MmT6 and allowed 
electrophoretic separation of the linear, nicked and supercoiled DNA species (see Chapter 2 
for DNA cleavage assay methods).  
 
3.2.5.1 DNA topology 
As with the optimisation of DNA relaxation, MmT6-dependent DNA cleavage was explored as 
function of DNA topology. MmT6 (120 nM) was incubated with either 4 nM negatively-
supercoiled, relaxed or linearised pBR322*, in the presence of 10 mM MgCl2 and 1 mM 
ADPNP, at 37°C for 30 min. As expected, using negatively supercoiled pBR322* stimulated 
the most cleavage, followed by relaxed (Figure 3.14). The amount of cleavage on linear is 
harder to assess, however, very little change in the DNA substrate occurs when incubated with 
MmT6 (Figure 3.14). This preliminary foray into cleavage activity also highlighted another 
aspect of MmT6 cleavage activity, in that a significant proportion of the DNA was nicked post 
MmT6 incubation. This could have been due to contamination with a nickase, however as will 
be discussed in section 3.2.5.6, treatment with ethylenediaminetetraacetic acid (EDTA) caused 
nick reversal, which is a hallmark of topo-dependent cleavage activity (nickase and nuclease 
activity is not reversible).  
 
 
Figure 3.14: Effect of DNA topology on DNA cleavage activity of MmT6, using negatively-
supercoiled, relaxed or linear pBR322*. MmT6 (120 nM) was incubated with 4 nM of either 
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negatively supercoiled (SC), relaxed (Rel) or linear (L) pBR322*, and 1 mM ADPNP and 10 mM 
MgCl2, for 30 min at 37°C. Samples were run on a 1% (w/v) native agarose gel for 10 hr at ~2 Vcm-
1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination.  
 
 Having established that supercoiled DNA stimulated more MmT6-dependent cleavage, 
further assays were conducted to explore if chirality also had an effect on cleavage, particularly 
with reference to section 3.2.3.1 which demonstrated the ~2-fold relaxation rate enhancement 
in the presence of positively supercoiled pBR322*. A simple explanation for why positive 
supercoils were relaxed more quickly would have been that MmT6 either bound or cleaved 
positive writhe more readily, however Figures 3.15-3.17 demonstrated this was not the case. 
To begin, an MmT6 titration was performed with either negatively- or positively-supercoiled 
pBR322*, which indicated that the more MmT6 used, the more DNA cleavage is attained 
(Figure 3.15). This assay also showed that negatively-supercoiled DNA was both nicked and 
linearised more than positively-supercoiled DNA, meaning the relaxation rate enhancement in 
the presence of positive writhe was not likely to be due to higher levels of DNA binding or 
cleavage. Just to note, the reason the outer lanes on the agarose gel in Figure 3.15 are less 
intense was due to uneven UV-transillumination, rather than sample loading errors. 
 
Figure 3.15: MmT6 titration to explore DNA cleavage activity using negatively and positively 
supercoiled pBR322*. MmT6 concentration was varied from 5 to 160 nM and incubated with 4 
nM pBR322*, 1 mM ADPNP, 10 mM MgCl2, at 37°C for 30 min. All samples were run on a 1% 
(w/v) native agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and 
imaged under UV illumination. 
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 To explore the chirality-dependent cleavage reaction further a time course was 
performed, using 160 nM MmT6, 4 nM pBR322*, 10 mM MgCl2 and 1 mM ADPNP, incubated 
at 37°C with samples taken at time points specified in Figure 3.16. Using ImageJ, the data 
attained using electrophoresis was quantified, with the percentage of DNA either remaining 
supercoiled, or becoming nicked or linearized, plotted as a function of incubation time. One 
interpretation of the MmT6 nicking behaviour would be that the single-stranded DNA break is 
an intermediate on the way to full DNA linearisation. This was found to be the case for E. coli 
DNA gyrase cleavage in the presence of either Ca2+ or inhibitors, in which DNA nicking 
increased at early time points only to decrease as DNA linearization increased, indicating the 
nicks were an intermediate [262]. As seen in Figure 3.16, this was not the case for MmT6 
cleavage on either negatively- or positively-supercoiled pBR322*, with both the nicking and 
double-stranded DNA cleavage activity occurring simultaneously, peaking early on and then 
remaining constant. This implied that DNA nicking was an intrinsic feature of in vitro MmT6 
DNA cleavage activity when incubated in the presence of ADPNP, and may suggest that for 
MmT6, nicking one DNA strand is not particularly well coupled to the cleavage of the second, 
unlike what has been found for D. melanogaster topo II [263] human topo IIα [264] and E. coli 
gyrase [262]. For both DNA supercoil chiralities, the amount of nicked DNA was ~50% and 
represented the most abundant DNA species produced by MmT6. However, the amount of 
linear DNA was ~40% for negative writhe and only ~28% for positive writhe, which further 
demonstrated that higher levels of cleavage were supported by MmT6 in the presence of 
negatively-supercoiled DNA. One aspect to consider, is that detection of DNA cleavage only 
confirms the presence of a G-segment, whilst relaxation activity requires both a G- and T-
segment. Therefore, as MmT6 DNA cleavage activity was found to be enhanced in the 
presence of negative writhe but relaxation occurred more rapidly in the presence of positive 
writhe, this suggested that G-segment only binding/cleavage may be elevated when the DNA 
is underwound, whilst overwound DNA promotes G- and T-segment binding or T-segment 
strand-passage.  




Figure 3.16: Time course of MmT6-dependent DNA cleavage activity on negatively (A) or 
positively-supercoiled (B)  pBR322*. Assays were conducted using 160 nM MmT6, 1 mM ADPNP, 
10 mM MgCl2 and 4 nM pBR322*, incubated at 37°C for 30 min. The DNA-only samples were 
incubated in the absence of MmT6. Samples were run on a 1% (w/v) native agarose gel for 10 hr 
at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. Data 
used in construction of the graphs was extracted from the gels using ImageJ and analysed in 
Excel. OC: open circular or nicked (blue), L: linear (red), and SC: supercoiled (green).  
 
3.2.5.2 Divalent metal cation identity and concentration 
As was conducted for relaxation (Figure 3.10), the effect of divalent cation identity and 
concentration was explored for MmT6-dependent DNA cleavage, using 0.5 to 100 mM of Mg2+, 
Mn2+, Zn2+, Ca2+, Co2+ and Ni2+, all in the form of the chloride salt. As with all cleavage reactions 
reported here for MmT6, 1 mM ADPNP was used in place of 1 mM ATP. SsT6, from the 
hyperthermophile S. shibatae, was shown to cleave DNA in the presence of 1 mM ADPNP and 
10 mM of either Mg2+ or Ca2+ [194]. Interestingly, in the presence of ADPNP and Mg2+, a large 
amount of DNA nicking was found, similar to that found here for MmT6 (Figures 3.15-3.17). 
However when the divalent cation was Ca2+, slightly more linearisation was detected and 
significantly less nicked DNA [194]. This was not the case for MmT6 (Figure 3.17) as Ca2+ 
stimulated significantly less DNA cleavage than Mg2+, and was also surpassed in efficacy by 
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Mn2+ and Co2+ (Figure 3.17 and 3.18). The most MmT6-depenedent DNA cleavage was 
detected in the presence of 25 mM MgCl2, indicating that a 5-fold increase in Mg2+concentration 
above what was determined optimal for relaxation (5 mM, see Figure 3.10), maximised the 
amount of DNA linearisation achieved. As mentioned in section 3.2.3.3, DNA relaxation was 
inhibited by 50 mM Mg2+, whereas DNA cleavage was still robust up until 100 mM. Both these  
 
Figure 3.17: Exploring the effects of varying divalent metal ion identity and concentration on the 
DNA cleavage activity of MmT6. MmT6 (160 nM) was incubated with 1 mM ADPNP and 4 nM 
negatively-supercoiled pBR322*, at 37°C for 30 min in the presence of different divalent metal 
ions. Divalent metal ions explored were magnesium chloride (MgCl2 or Mg2+), manganese 
chloride (MnCl2 or Mn2+), zinc chloride (ZnCl2 or Zn2+), calcium chloride (CaCl2 or Ca2+), cobalt 
chloride (CoCl2 or Co2+), and nickel chloride (NiCl2 or Ni2+), with each varied in concentration from 
0.5 to 100 mM. The DNA-only sample was incubated in the absence of MmT6 and in the presence 
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of 100 mM of the respective metal cation salt. The sample without ADPNP was run in the presence 
of MmT6 and 100 mM metal ion. All samples were run on a 1% (w/v) native agarose gel for 15 hr 
at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. OC: 
open circular or nicked, L: linear, and SC: supercoiled. 
 
findings indicated that a reaction stage post DNA cleavage was more sensitive to Mg2+ and 
was rate limiting, potentially T-segment capture or strand-passage. Mn2+ also stimulated an 
appreciable level of DNA linearisation by MmT6, and while the maximum (15 ± 3%) was ~10% 
less that that stimulated by 25 mM Mg2+ (26 ± 4%), Mn2+-stimulated cleavage remained at a 
constant maximum level between 25 and 100 mM, rather than being inhibited at 100 mM, which 
occurred in the presence of Mg2+ (Figure 3.17). The cause of this inhibition at 100 mM Mg2+ 
could be due the disruption of DNA binding by MmT6, or potentially prevention of ADPNP 
binding to Top6B, as Mg2+ is important for nucleotide binding to the GHKL domain [59], whilst 
Mn2+ (as well as Co2+, Ca2+, Zn2+ and Ni2+) is not.  
No cleavage was detected in the presence of Zn2+, and only a very small amount in the 
presence of Ni2+, which is unlikely to be MmT6-dependent as it is also present in the DNA-only 
sample and in the absence of ADPNP (Figure 3.17 and 3.18). Neither of these metal cofactors 
were able to stimulate relaxation either (Figure 3.10), indicating that either DNA cleavage is 
inhibited, or DNA binding altogether. Ni2+ is also a well-known cause of oxidative DNA damage, 
along with Fe2+ (iron) and Cu2+ (copper) [265],  both of which weren’t explored here for this 
reason. As the work here was mainly concerned with exploring conditions in order to maximise 
the levels of MmT6-dependent cleavage for research reported in Chapter 5, further exploration 
into how these various metal ions affected MmT6 activity was not a priority. However, future 
work could encompass exploring DNA binding in the presence of each cation to ascertain 
further detail on which reaction stage is being inhibited.  
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Figure 3.18: MmT6-depednent pBR322* linearization in the presence of different divalent metal 
ions. Using Image J and Excel, data was extracted from 3 separate assays, examples of these are 
seen in Figure 3.17, and the percentage of linearised DNA ± standard error (SE) was plot as a 
function of divalent metal ion concentration. The divalent metal ions explored were Mg2+ (pink), 
Mn2+ (purple), Zn2+ (yellow), Ca2+ (green), an Co2+ (blue).  
 
3.2.5.3 Buffer pH  
The next variable explored, for both DNA relaxation and cleavage by MmT6 was buffer pH, 
using Bis-Tris propane at pH 6-9 (Figure 3.19). Being able to assay such a wide range of pHs 
using a single buffer is facilitated in this case by the fact that Bis-Tris propane has two pKa 
values, 6.8 and 9.0.  The relaxation portion of this assay has been presented alongside the 
cleavage assay, rather than being discussed above in section 3.2.3, as pH appeared to affect 
relaxation and cleavage in different ways, and side by side comparison facilitated discussion 
more easily. MmT6-dependent DNA relaxation and cleavage is optimal at ~pH 7, however 
lower pH (pH 6) inhibited relaxation more significantly than higher pH (pH 8-9), whilst DNA 
cleavage remained robust at pH 6 (Figure 3.19). This suggested that a reaction stage post DNA 
cleavage was sensitive to acidic pH and was rate-limiting during the relaxation reaction, such 
as T-segment capture or strand-passage. DNA cleavage is inhibited progressively more 
between pH 8-9, which is true for relaxation, hence inhibition of DNA binding or cleavage likely 
Chapter 3: Ensemble Results 
 
 110
explains the relaxation inhibition under these conditions. D. melanogaster topo II demonstrated 
enhanced DNA cleavage (mainly nicking) at pH 5 [263], and human topo II was found to be a 
potent DNA damaging agent in vivo and in vitro under acidic conditions [266], corroborating the 
data found here, which also found DNA cleavage by MmT6 to remain robust at lower pH. Future 
work should explore the effect of even lower pH on MmT6 as the range used here was narrow.  
 
Figure 3.19: Exploring the effect of buffer pH on MmT6-dependent relaxation and DNA cleavage 
activity. For relaxation, MmT6 (12 nM) was incubated with 2 nM negatively supercoiled pBR322*, 
1 mM ATP and10 mM MgCl2, for 30 min at 37°C. For cleavage, MmT6 (120 nM) was incubated with 
3 nM negatively supercoiled pBR322*, 1 mM ADPNP and10 mM MgCl2, for 30 min at 37°C. For 
both relaxation and cleavage, the pH of the buffer (Bis-Tris propane) was varied from 6 to 9. The 
DNA-only sample was incubated in the absence of MmT6 and at pH 7. Samples were run on a 1% 
(w/v) native agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and 
imaged under UV illumination 
 
3.2.5.4 Temperature 
Similar to data presented in Figure 3.9, exploring the effect of temperature on MmT6-dependent 
relaxation, the effect of temperature on DNA cleavage was determined, albeit across a 
narrower range. Over 30-50°C, MmT6 DNA cleavage activity did not change (Figure 3.20), 
even though relaxation was severely compromised at 50°C (Figure 3.9), which again suggested 
that a stage post DNA cleavage is sensitive to elevated temperature, the likely cause being 
disruption of T-segment capture or strand-passage (as was found for Mg2+ concentration and 
acidic pH). T-segment capture is an attractive candidate to explain the differences between 
relaxation and DNA cleavage activity at 50°C, as it has been mentioned in this chapter and will 
be explored further in both sections below and in Chapter 4, as well as in published work [62], 
MmT6 preferentially acts on preformed DNA crossings in which the T- and G-segments are 
bound simultaneously. At higher temperatures, DNA will move more rapidly and to a greater 
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degree, so may be impeding T-segment binding, whilst maintaining similar levels of G-segment 
engagement, therefore affecting DNA relaxation but not necessarily DNA cleavage. Future 
work should take advantage of the effects that temperature, Mg2+ and pH have on MmT6 
relaxation and cleavage activity to further parse out the specifics of the reaction.  
 
Figure 3.20: Effect of temperature on MmT6-dependent DNA cleavage activity. MmT6 (80 nM) was 
incubated with 4 nM negatively supercoiled pBR322*, 1 mM ADPNP and 10 mM MgCl2, for 30 min 
at 30 to 50°C.  The DNA only sample was incubated in the absence of MmT6 and at 50°C. Samples 
were run on a 1% (w/v) native agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium 
bromide and imaged under UV illumination.  
 
3.2.5.5 Potassium glutamate versus potassium acetate  
As already discussed in Section 3.2.3.4, M. mazei is an acetate-metabolising archaeon, found 
to convert acetate to methane as a source of energy once the extracellular concentration 
surpassed 0.4 mM [254, 255]. So, along with exploring the effect of replacing glutamate with 
acetate in DNA relaxation, the effect on DNA cleavage was also explored (Figure 3.21). The 
results are underwhelming, showing that cleavage activity in the presence of both acetate and 
glutamate reduced with increasing concentration, the presence of either salt causing the DNA 
to migrate less efficiently which reduced resolution of the DNA species at higher 
concentrations. These results also suggested that the loss of relaxation activity was a function 
of disrupted DNA binding or cleavage. 




Figure 3.21: Exploring the effects of potassium glutamate and potassium acetate on MmT6-
dependent DNA cleavage activity. MmT6 (120 nM) was incubated with 3 nM negatively 
supercoiled pBR322*, 1 mM ADPNP and 10 mM MgCl2, for 30 min at 37°C. The buffer conditions 
were varied, using 100-800 mM potassium glutamate or potassium acetate. DNA only samples 
were incubated in the absence of MmT6 and using 800 mM potassium glutamate or potassium 
acetate. All samples were run on a 1% (w/v) native agarose gel for 10 hr at ~2 Vcm-1, stained with 
0.5 μg/mL ethidium bromide and imaged under UV illumination 
 
3.2.5.6 EDTA-reversal of DNA cleavage complexes 
Topos, of course, are not the only enzymes which utilise DNA breakage during their reaction 
mechanism. There are numerous others such as endonucleases; including those important for 
apoptosis [267] and restriction endonucleases which protect bacteria and archaea from 
invading viral DNA [268], exonucleases; including those critical for proof-reading and 
polymerase error correction during DNA replication [269], DNA nickases; such as those 
involved in the CRISPR/Cas9 genome editing system [270], and the meiotic Spo11 protein; 
which generates double-stranded DNA breaks during meiotic recombination [203]. However, 
even though all of these generate DNA cleavage sites on DNA, Spo11 in particular using a 
similar mechanism to topos [204], the cleavage is not reversible. Endonucleases, exonucleases 
and nickases do not form covalent DNA/protein intermediates and once the DNA is cleaved, 
they dissociate. Even though Spo11 does form a covalent intermediate, it requires 
endonucleolytic excision [203], as the DNA break cannot be reversed by the enzyme. Topos, 
on the other hand, can efficiently re-ligate the DNA backbone post strand-passage, and it is 
this behaviour which distinguishes topo-dependent DNA cleavage from other forms.  
 As previously described, ADPNP was utilised here as its addition in place of ATP 
promoted the formation of MmT6/DNA cleavage complexes. In other words, ADPNP, as it is 
nonhydrolyzable, caused MmT6 to freeze during the reaction cycle, post DNA cleavage, 
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remaining covalently bound to the 5ʹ scissile phosphate. This allowed the usually extremely 
transient DNA cleavage reaction by MmT6 to be explored, along with indicating that ATP 
hydrolysis is not required for DNA cleavage or those events preceding it, but is necessary for 
those which follow. However, these MmT6/DNA-cleavage complexes are still reversible, which 
was found to occur in the presence of ethylenediaminetetraacetic acid (EDTA) (Figure 3.22). 
These assays were conducted as a means to determine whether the elevated levels of DNA 
nicking in the presence of MmT6 was the consequence of a contamination, and began with the 
addition 40 mM EDTA to an MmT6 cleavage reaction, which was then incubated for 5 min at 
room temperature, before the addition of SDS and PK. As seen in Figure 3.22A, the sample 
treated with EDTA had far less DNA cleavage, with all of the double-stranded and most of the 
single-stranded cleavage absent as compared to a sample in which EDTA was omitted. This 
strongly suggested that, not only the DNA linearisation, but also the nicking activity was caused 
by MmT6 activity. It is thought that EDTA reverses the cleavage complex and promotes DNA 
re-ligation through its ability to chelate Mg2+, removing it from the topo active site, and this 
indicated that the presence of the metal cofactor is an important determinant in cleavage state 
maintenance [262]. This reaction was explored further, finding that 8-16 mM EDTA was optimal 
for cleavage reversal, with increasing EDTA concentration having less of a reversal effect 
(Figure 3.22B). A potential explanation for this is that higher concentrations of EDTA strip the 
metal from the MmT6 active site too quickly for resealing to occur, suggesting the reaction is 
multistep and not as straightforward as just removing the Mg2+ from the active site. Another 
potential explanation involves the binding of ADPNP. This is coordinated by a Mg2+ ion and the 
binding of nucleotide to Top6B is thought to cause Top6B subunit dimerisation, forming the 
second protein interface and thus preventing the stabilisation of double-stranded breaks once 
the DNA gate is opened to allow strand-passage [64]. At high EDTA concentrations, it is 
possible that the Mg2+ is stripped from the GHKL domain, causing ADPNP to dissociate and 
the Top6B subunits to separate. This could potentially lead to DNA gate separation with MmT6 
heterotetramers becoming dimers and thus preventing any re-ligation from occurring.  




Figure 3.22: EDTA-dependent reversal of MmT6 cleavage complexes. A: Preliminary assay in 
which 136 nM MmT6 was incubated with 4 nM negatively supercoiled pBR322*, 1 mM ADPNP and 
30 mM MgCl2, for 30 min at 37°C. For the ‘SDS’ sample, 3 μL of 2% SDS were added to the reaction 
mixture, whilst for the ‘EDTA’ sample, 40 mM EDTA was added and incubated at room 
temperature for 5 min before the addition of the SDS. This was followed by the addition of 
proteinase K (see Chapter 2 for method details). The DNA-only sample was incubated in the 
absence of MmT6. B: Effect of EDTA concentration on MmT6 cleavage complex reversal. A 
cleavage assay was performed in which 80 nM MmT6 was incubated with 4 nM negatively 
supercoiled pBR322*, 10 mM MgCl2 and 1 mM ADPNP, were incubated for 30 min at 37°C. This 
was followed by the addition of EDTA (8-100 mM) and a 5-min incubation at room temperature. 
C: The effect of incubation time in the presence of EDTA on MmT6 cleavage complex reversal. 
MmT6 (80 nM) was incubated with 4 nM negatively supercoiled pBR322*, 1 mM ADPNP and 10 
mM MgCl2, for 30 min at 37°C. This was followed by the addition of 30 mM EDTA, and further 
incubation at room temperature (0-30 min). For all samples presented in this figure, 3 μL 2% SDS 
and 3 μL proteinase K (New England Biolabs) were added post EDTA incubation (see Chapter 2 
for cleavage assay protocol). All samples were run on a 1% (w/v) native agarose gel for 8-12 hr 
at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. Data 
used in construction of the graphs was extracted from the gels using ImageJ and analysed in 
Excel. OC: open circular or nicked (bue), L: linear (red), and SC: supercoiled (green). 
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As well as being sensitive to EDTA concentration, the extent of MmT6 DNA cleavage 
reversal was also dependent on the incubation time, with the most reversal occurring after a 
30-min incubation in the presence of 30 mM EDTA (Figure 3.22C). In general, both the nicks 
and double-stranded breaks are resealed simultaneously, however, early on there appeared to 
be a low-level increase in the amount of nicked DNA, which may indicate that the double-
stranded DNA breaks are sealed using a nicked intermediate. This was also found for the 
reversal of DNA gyrase cleavage complexes, formed in the presence of different cleavage state 
stabilising drugs [262]. However, in the case of MmT6, more work on this topic is required to 
gain a deeper understanding of cleavage reversal (re-ligation) kinetics.  
 
3.2.6 MmT6 DNA binding 
Exploring the DNA binding behaviour of topos in the absence of catalytic activity, can inform 
on the optimal DNA substrate for binding, which can reveal further information on the 
mechanism and role of topos. For MmT6, work had been published prior to the research 
reported here, using fluorescently labelled DNA duplexes [62]. This work demonstrated that 
MmT6 had a preference for binding DNA duplexes longer than 40 bp, indicating a more 
extensive G-segment interaction than originally thought, and that the binding of supercoiled 
DNA had a ~60-fold preference over sheared salmon sperm DNA, indicating a preference for 
binding to DNA crossings and/or bends [62]. Along with other supporting data, these results 
led to the hypothesis that MmT6 preferentially binds and distributively relaxes single DNA 
crossings. The work reported here began prior to publication of the aforementioned study [62], 
however it supports and elaborates upon the DNA binding behaviour of MmT6 as a true DNA 
crossing sensor, using alternative and complementary methods.  
 All assays employed here involved the use of a filter-binding assay that captured 
MmT6/DNA complexes using nitrocellulose membranes, an established technique that has 
been utilised in various ways to research DNA binding and cleavage complex formation by 
various topos [156, 225, 258, 271-277]. For type II topos, catalytic activity in most cases (aside 
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from DNA gyrase) is dependent on the presence of ATP, whilst DNA binding only requires 
Mg2+, therefore allowing these two activities to be assayed separately using the presence or 
absence of ATP, respectively. By way of controls, nitrocellulose, in the form of 0.45 μm 
nitrocellulose Centrex MF filters (Whatman), was found to bind MmT6-bound DNA complexes 
whilst unbound DNA was eluted from the column, allowing the enrichment of MmT6/DNA 
complexes for further analysis. An initial assay involved incubating 16 nM MmT6 with different 
10 nM pBR322* topologies simultaneously and electrophoretically comparing the MmT6-bound 
DNA to that which was unbound (Figure 3.23). The pBR322* mixture contained negatively-
supercoiled, relaxed and linear plasmid, with MmT6 visually displaying a binding preference  
for supercoiled and nicked DNA, with linear pBR322* and the most relaxed topoisomers being 
bound less strongly. This is in agreement with the previous study which found MmT6 bound 
supercoiled DNA more strongly than linear [62], and tentatively indicated that MmT6 DNA 
binding increased with increasing superhelical density of topoisomers, a concept that will be 
elaborated upon below. Through the course of this work, particularly while exploring DNA 
cleavage by MmT6, a tendency to induce nicking in the presence of 1 mM ADPNP was found 
(Section 3.2.5). The result in Figure 3.23 indicated that MmT6 also displayed a preference for 
binding nicked DNA, as well as inducing it, the significance of which is unclear. Topo IV and 
topo II have been shown to bind and stabilise 4-base overhangs [56, 229], demonstrating a 
preference for binding to a transition-state species, a behaviour MmT6 may also share. It is 
perhaps not surprising that a type II topo would tightly bind to exposed DNA overhangs or nicks 
as their canonical activity relies on the transient cleavage and re-ligation of the duplex, 
mitigating the risk of releasing the DNA break as much as possible.  
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Figure 3.23: MmT6 DNA-binding activity using a mixture of linear, relaxed and negatively 
supercoiled pBR322*. The insert shows the gel analysed (using ImageJ) to form the main figure. 
MmT6 (16 nM) was incubated with a 10 nM mixture of pBR322* (linear, relaxed and negatively 
supercoiled DNA) and 10 mM MgCl2 for 30 min at 37°C. The unbound DNA (UB, blue) was 
separated from the MmT6-bound DNA (B, red) using 0.45μm nitrocellulose Centrex MF filters 
(Whatman) (see Chapter 2 for DNA binding assay methods). DNA samples were run on a 1% (w/v) 
native agarose gel for 12 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged 
under UV illumination. Data used in construction of the graph was extracted from the gels using 
ImageJ and analysed in Excel. OC: open circular or nicked, L: linear, Rel: relaxed and SC: 
supercoiled (green).  
 
 In order to attain a clearer picture of the binding affinity of MmT6 to different pBR322* 
topologies, another nitrocellulose-capture technique was employed in which 16 nM MmT6 was 
incubated with 10 nM negatively-supercoiled, positively-supercoiled, relaxed and linear 
pBR322* separately. The MmT6-bound DNA was captured, proteolyzed and purified prior to 
concentration determination. In Figure 3.24, the percentage of the total DNA in solution which 
was bound by MmT6 is shown. As expected, linear pBR322* was bound the least, with 
negatively-supercoiled pBR322* being bound preferentially. However, unexpectedly positively-
supercoiled and relaxed pBR322* were bound with equal affinity, despite MmT6 displaying a 
faster rate of relaxation on positively-supercoiled DNA over negatively-supercoiled (Section 
3.2.3, Figure 3.8). A simple explanation for the increased rate during positive supercoil 
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relaxation would have been an increased MmT6 binding affinity for positive writhe, however 
this does not seem to be the case. The binding result was supported by exploring DNA 
cleavage by MmT6 on both positive and negative writhe, with MmT6 inducing more DSBs on 
negatively-supercoiled DNA than positively-supercoiled (Section 3.2.5, Figure 3.16), a 
behaviour which can be described by differences in binding affinity. However, a conundrum 
arose, as why would MmT6 display a higher rate of relaxation on positive writhe, whilst 
supporting more binding and cleavage on negative writhe? Relaxation assays, by nature, 
indicate that during MmT6’s interaction with the DNA substrate, both the G-segment and T-
segment were present. For binding and cleavage activity, the presence of the T-segment is 
necessarily not compulsory and it may be that MmT6 binds and cleaves a G-segment alone 
more frequently when the DNA is underwound. This behaviour would initially suggest activity 
should be higher on negatively supercoiled DNA, but does not necessitate this outcome as for 
relaxation to occur both the G- and T-segments must be present. This suggested, instead, that 
the acceleration of a reaction stage post DNA binding and cleavage, was responsible for the 
increased rate during positive supercoil relaxation, and as explored in Chapter 4, was probably 
a consequence of the DNA crossing geometry facilitating strand passage. A similar behaviour 
has been documented for human topo IIα, demonstrating that whilst topo IIα relaxed positive 
writhe 10-fold more rapidly than negative, it maintained higher levels of binding and cleavage 
on negatively-supercoiled DNA [156]. The preference for positive supercoils seemed to rely on 
the elements within the topo IIα C-terminal domains, however CTD removal did not change 
cleavage behaviour, indicating that the CTDs promote activity on positive writhe through DNA 
geometry preference for strand passage, rather than increasing cleavage [157]. Human topo 
IIβ also maintains lower levels of cleavage on positively-supercoiled DNA whilst relaxing 
positive and negative writhe at comparable rates [157, 237], furthering suggesting that 
cleavage rates, as well as DNA binding, are not enough to inform on overall topo activity when 
considered alone.  
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Figure 3.24: DNA binding activity of MmT6 on negatively supercoiled, positively supercoiled, 
relaxed or linear pBR322*. MmT6 (16nM) was incubated with a 10 nM mixture of pBR322* (linear, 
relaxed and negatively supercoiled DNA) and 10 mM MgCl2 for 30 min at 37°C. The unbound DNA 
was separated from the MmT6-bound DNA using 0.45μm nitrocellulose Centrex MF filters 
(Whatman).  The MmT6-bound DNA concentration was measured using the Nanodrop™, enabling 
calculation of the percentage of pBR322* that was bound to MmT6, ± SE (see Chapter 2 for DNA 
binding assay methods). For each DNA substrate the assay was repeated three times.  
 
Whilst measuring the percentage of DNA bound to MmT6 for the different pBR322* 
topologies indicated a preference for binding more tightly to supercoiled DNA, this form of 
analysis can be taken deeper, employing a topoisomer-binding assay first described in [225]. 
This assay allowed the calculation of the relative dissociation constant (Kd) for MmT6 on 
different topoisomers of pBR322*. The Kd is used to describe how readily a molecular complex 
will reversibly separate into its constituents, and is therefore a measure of binding affinity. The 
Kd is calculated using equation 3.1, where E is the concentration of unbound MmT6, Dx is the 
concentration of unbound ‘x’ topoisomer and EDx is the concentration of the ‘x’ topoisomer 





Equation 3.1: Calculating the Kd for topoisomer ‘x’. E is the free enzyme concentration, D is the 
concentration of unbound DNA and ED is the concentration of MmT6-bound DNA. 
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 It is then possible to determine the ratio of Kd values for two different topoisomers 
equilibrated in solution, and therefore provide a measure of the relative affinity of MmT6 to one 










Equation 3.2: Calculating the Kd for topoisomer ‘x’ relative to topoisomer ‘y’. E is the free enzyme 
concentration, D is the concentration of unbound DNA and ED is the concentration of MmT6-
bound DNA. 
 
 At equilibrium, the relative concentration of free enzyme is equal, regardless of the 








Equation 3.3: Simplified version of equation 3.2, calculating the Kd for topoisomer ‘x’ relative to 
topoisomer ‘y’. D is the concentration of unbound DNA and ED is the concentration of MmT6-
bound DNA. 
 
This demonstrates that the relative Kd value for each topoisomer can be measured 
using the ratio of concentrations of unbound DNA topoisomers ([Dx]/[Dy]) and MmT6-bound 
DNA topoisomers ([EDy]/[EDx]), producing a value that described the affinity of MmT6 for 
topoisomers of varying superhelical density. The lower the relative Kd, the higher the affinity of 
MmT6 for that particular topoisomer. The relative concentrations of each topoisomer in the 
unbound and MmT6-bound fractions was determined using densitometric analysis of agarose 
gel images. 
Commercially available pBR322* (obtained from Inspiralis) can be purchased as 
relaxed, negatively supercoiled and positively supercoiled, however none of these options 
provided extended distributions of different topoisomers on which to measure MmT6 binding 
affinity. Therefore, Archeoglobus fugidus reverse gyrase was employed to convert highly 
negatively supercoiled pBR322* into extended distributions of both positive and negative 
topoisomers (Figure 3.25). Using a time course it was determined that incubating 11 nM 
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negatively supercoiled pBR322* with 100 nM reverse gyrase at 95°C generated an extend 
distribution of negatively and positively supercoiled topoisomers after 10 s and 20 s, 
respectively (Figure 3.25A). This was then coupled to a DNA purification protocol (see Chapter 
2), which generated pure DNA samples of the desired topology and purity (Figure 3.25B). To 
confirm the DNA topology, the samples were run in the presence of 1.5 μg/mL chloroquine 
(CQ). The DNA intercalation of CQ has the effect of making negative topoisomers run more 
relaxed and positive topoisomers to become more positive, which can be seen in Figure 3.25C, 
confirming the expected DNA topology of both topoisomer distributions.  
 
Figure 3.25: Utilising Archeoglobus fugidus reverse gyrase to generate extended positive and 
negative topoisomer distributions of pBR322*. A: Time course of A. fulgidus reverse gyrase 
activity on negatively supercoiled pBR322*. Reverse gyrase (100 nM) was incubated with 11 nM 
negatively supercoiled pBR322* and 1 mM ATP, at 95°C, to determine the appropriate incubation 
time for the generation of negative and positive topoisomer distributions (10 and 20 s, 
respectively). B: Time course of A. fulgidus reverse gyrase activity on negatively-supercoiled 
pBR322*, as in A, but followed by DNA purification prior to gel electrophoresis. C: The topology 
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of purified pBR322* from B was confirmed using agarose gel electrophoresis in the presence of 
1.5 μg/mL chloroquine. All samples were run on a 1% (w/v) agarose gel for 13 hr at ~2 Vcm-1, 
stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. The gel containing 
chloroquine (see Figure 3.25C) was soaked in 1x TAE for ~1 hr, prior to ethidium bromide 
staining. Pos: positively supercoiled pBR322*, and Neg: negatively-supercoiled pBR322*. 
 
A limitation of producing DNA topology distributions in this manner was that there was no 
control over the amount of each topoisomer produced. For instance, in the negatively 
supercoiled sample there may be more of the topoisomers with lower superhelical density than 
high, with the reverse being true for the positively supercoiled sample. This may hinder direct 
comparison between MmT6 binding on positive and negative writhe, however, it does not affect 
drawing conclusions within the data sets for each chirality.  
 Once pBR322* samples of the desired topology were attained, 5 nM pBR322* was 
incubated with 8 nM MmT6 and 10 mM MgCl2 before separation of the MmT6-bound DNA from 
the unbound DNA using nitrocellulose membrane capture. It is worth noting here, that for all 
topo-binding assays of this nature, it is advisable to keep the molar concentration of topo below 
that of the DNA in order to prevent multiple topo molecules binding to a single plasmid, a 
situation that the membrane-capture technique cannot distinguish. In all cases presented here, 
the MmT6 concentration is moderately above the DNA, and this is due to MmT6 DNA binding 
being too weak to bind sufficient amounts of DNA for accurate quantification post membrane 
capture, particularly for binding to linear DNA. Data presented in Figure 3.24, in which the 
MmT6:DNA ratio was 1.6:1 demonstrated that whilst MmT6 was in excess only ~17% of the 
negatively supercoiled DNA was bound, with less than 5% linear being bound. This suggested 
that, while some plasmids may be bound by more than one MmT6 molecule, it likely wasn’t 
happening frequently enough to dramatically affect the results, particularly as no evidence of 
cooperativity in MmT6 binding activity has been documented.  
 Once the MmT6-bound and -unbound DNA samples were purified they were run 
simultaneously on a 1% native agarose gel for 13 hr at ~2 Vcm-1 and stained with 0.5 μg/mL 
ethidium bromide. As previously described, the binding affinity of MmT6 to particular 
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topoisomers was calculated by measuring the band intensity on images of agarose gels (see 
Figure 3.26A for an example of a gel). The ratio of unbound DNA to MmT6-bound DNA 
concentrations allowed determination of the relative Kd and provided a measure of MmT6 
affinity for each topoisomer. As seen in Figure 3.26B, the Kd decreased for increasing 
superhelical density, with more supercoiled topoisomers of both positive and negative chirality 
being bound more tightly by MmT6. This further indicated that MmT6 recognised and bound 
DNA crossings preferentially, as highly supercoiled topoisomers have more opportunities for 
MmT6 binding, than less supercoiled ones, and will therefore be bound more frequently. An 
interesting comparison is topo IV DNA binding behaviour assayed using the same technique 
[225]. Whilst this work didn’t incorporate the use of positively-supercoiled DNA as was done 
here, topo IV was shown to exhibit increased binding with increased negative supercoiling, also 
demonstrating that topo IV had a preference for supercoiled DNA. However, this was 
hypothesised to be due to its recognition or induction of DNA bending, which occurs far more 
frequently in DNA as the superhelical density is increased. Indeed, using the single-molecule 
magnetic tweezers, topo IV exhibited only a single binding position on a plectoneme of multiple 
DNA crossings, which generated the hypothesis that it was bound to the distal end of the 
plectoneme [120], while MmT6 activity indicated multiple plectoneme binding sites (see 
Chapter 4 for MmT6-related magnetic tweezers assays). This difference between MmT6 and 
topo IV may be evident in the relationship between the binding affinity and superhelical density. 
For topo IV this relationship was linear whilst for MmT6 binding, the data is not well described 
using a linear equation. However, even though the data is not presented with fits, negative 
topoisomer binding data (Figure 3.26B, blue circles) can be well described using an inverse 
relationship, similar to that found using the magnetic tweezers (Chapter 4), exploring the 
relaxation rate as a function of superhelical density. This provided further evidence that MmT6 
preferentially binds DNA crossings. The data for positive supercoil binding has demonstrated 
once again that MmT6 binding to positive supercoils is not equivalent in nature to negative 
supercoil binding. However, in both the positive and negative data sets, a large portion of the 
topoisomers could not be resolved leading to a loss of information about binding to more highly 
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supercoiled molecules. This precluded the ability to accurately fit the data, an issue which was 
more acute for positive topoisomer binding. However, the data indicated that MmT6 binding to 
negative topoisomers with lower superhelical density is tighter than binding the equivalent 
positive topoisomers. Although, as previously described, the inability to control the 
concentration of each topoisomer between the different chiralities may prevent accurate 
comparison between the data sets. Nevertheless, this result was supported by the data 
presented in Figure 3.24, in which MmT6 demonstrated more robust binding to negatively 
supercoiled DNA. In future work, optimisation of the use of chloroquine and netropsin in 
resolving more negative and positive topoisomers, respectively, could inform further on the 
MmT6 DNA binding behaviour as a function of superhelical density and chirality. This would 
also help circumvent issues associated with assigning linking numbers to topoisomers that are 
very highly supercoiled. Here the most highly-supercoiled band was described as having 25 
supercoils (based on a specific linking difference of ~0.06 [225]), however in reality it was a 
collection of different topoisomers which couldn’t be resolved by conventional agarose-gel 
electrophoresis equipment. An alternative would be to employ capillary gel electrophoreisis, 
which has been demonstrated to accurately resolve highly supercoiled topoisomers [278]. 
Another possibility would be to explore binding in the presence of single topoisomers.  
 
Figure 3.26: MmT6 DNA binding affinity as a function of the number of supercoils in pBR322*. A: 
MmT6 (8nM) was incubated with 5 nM pBR322*, either positively (pos) or negatively (neg) 
supercoiled, and 10 mM MgCl2, for 30 min at 37°C. The MmT6-bound DNA (B) was separated from 
the unbound DNA (UB) using 0.45μm nitrocellulose Centrex MF filters (Whatman). The bound and 
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unbound DNA samples were run on a 1% (w/v) agarose gel for 13 hr at ~2 Vcm-1, stained with 0.5 
μg/mL ethidium bromide and imaged under UV illumination. B: Calculation of the dissociation 
constant ratio (KdUB/KdB) for MmT6-dependent binding to positively (pink) and negatively (blue) 
supercoiled topoisomers, plot as a function of the number of supercoils within each topoisomer. 
Data was extracted from the gel in Figure 3.25A using ImageJ and analysed in IgorPro7 
(Wavemetrics). Method was first described in [225]. Data is derived from the average of three 
separate assays. 
 
3.2.7 MmT6 ATPase activity 
All type II topos hydrolyse ATP during DNA topology manipulation, with the only exception 
being the ATP-independent relaxation of negative supercoils by DNA gyrase [11]. It has 
therefore been of great interest to characterise how these enzymes hydrolyse ATP, under 
which circumstances it is stimulated, and, whilst it remains a critical point of discussion, why 
ATP is necessary in those cases where the reaction is thermodynamically favourable [279, 
280]. For instance, MmT6 relaxes DNA to thermodynamic equilibrium just like the ATP-
independent activity of topo IA [231], yet ATP is strictly required for MmT6 activity. A number 
of structural and biochemical studies have been performed using topo VI enzymes (including 
MmT6) in which the aim was to dissect ATP turnover and explore the DNA-dependence on 
ATPase activity of both wild type and mutant topo VI enzymes [62, 64, 67, 195]. 
 The first crystal structures of the Top6B subunit were achieved using a truncated form 
of S. shibatae topo VI (SsT6), both with and without ADPNP [64]. These structures revealed 
that in the presence of nucleotide, the Top6B subunits dimerised, much like that which has 
been demonstrated for type IIA topos and MutL, all of which harbour the ATP-binding GHKL 
domain [91, 281-284]. Along with the fact that ADPNP is sufficient to cause DNA cleavage, 
these data indicate that ATP hydrolysis is not important for DNA binding, N-gate dimerisation 
or G-segment cleavage in topo VI. Another study delved further still by determining the 
structure of truncated SsT6 Top6B in complex with various ATP analogues, representing 
various stages of the Top6B ATP-turnover cycle [67]. This work demonstrated that the major 
structural changes that occur within Top6B happen upon ATP biding and Pi release. Nucleotide 
binding alone drove Top6B subunit dimerisation, which appeared to be tightly coupled to DNA 
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cleavage and suggested a major role of ATP for topo VI was in formation of a stable Top6B 
subunit interface, which caused conformational changes in Top6A and led to DNA cleavage. 
Tightly coupling DNA cleavage to the dimerisation of the Top6B subunits would protect against 
the formation of permanent double strand breaks [68], and as topo VI enzymes have only two 
gates, rather than three like type IIA, this coupling may be even more important. The ATP-
bound conformation, known as the restrained state (achieved using ADPNP and ADP･AIF4-), 
sequesters the bound nucleotide from solvent and positions critical amino acids for ATP 
hydrolysis [67]. Top6B in complex with ADP and Pi retained the restrained conformation, 
indicating hydrolysis does not directly cause structural changes within the enzyme [67]. Other 
experiments had already found that ADP/Pi release was rate limiting for topo II and tightly 
coupled to strand passage, suggesting that a conformational change was required for said 
release [285]. The Top6B structural work corroborated this by demonstrating that Top6B only 
returned to a relaxed state in the absence of the scissile Pi. This study then speculated that the 
T-segment itself, is responsible for causing conformational changes which lead to its passage, 
as well as facilitating Pi release by re-exposing the ATP binding site to solvent. Indeed, it was 
recently demonstrated that MmT6 ATP hydrolysis was dependent on regions of the Top6B 
subunit which are extremely likely to interact with the T-segment [62]. 
 With this previous data in mind, the work reported in the remainder of this section details 
further exploration of the ATP-hydrolysis activity of MmT6 as a function of DNA topology, using 
two alternative methods: the pyruvate kinase/lactate dehydrogenase-coupled (PK/LDH) assay 
(section 3.2.7.1) and the [γ-32]-ATP assay (3.2.7.2). 
 
3.2.7.1 PK/LDH ATPase assay 
The PK/LDH assay is a spectroscopic technique which couples the hydrolysis of ATP to the 
oxidation of reduced nicotinamide adenine dinucleotide (NADH), the concentration of which 
can be tracked as a function of absorbance at 340 nm (A340) (NADH absorbs strongly at 340nm, 
whilst NAD+ does not). This is achieved by conducting the topo-dependent ATPase reaction in 
the presence of pyruvate kinase (PK), lactate dehydrogenase (LDH) and their respective 
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substrates; phosphoenolpyruvate (PEP) and NADH. As seen in Figure 3.27, ATP hydrolysis, 
such as by a type II topo, generates ADP which is a substrate for PK. PK uses the ADP to 
convert PEP into pyruvate while also resynthesising the ATP. The pyruvate generated by PK 
is the substrate for LDH, which converts it to lactate by oxidising NADH, therefore the ATP 
hydrolysis by the enzyme in question is coupled to the oxidation of NADH and a reduction in 
A340 (Figure 3.27). The Beer-Lambert law (Equation 3.4) can then be used to convert the 
change in A340 to a concentration value with the loss of NADH equimolar to the hydrolysis of 
ATP, where A is the absorbance, 𝜺	 is the molar extinction coefficient, c is the molar 
concentration and ℓ is the path length. 
𝐴 = 𝜀𝑐ℓ 
Equation 3.4: The Beer-Lambert law. A is the absorbance, 𝜺	is the molar extinction coefficient, c 
is the molar concentration and 𝓵 is the path length. 
 
This technique has been widely utilised in the investigation of topo ATPase activity [63, 
286-294], including for MmT6 [62], in both the mechanistic characterisation of topo ATPase 
activity and the exploration of drug-based topo inhibition. Benefits of using this approach 
include the continuous nature of the measurement and the ATP re-synthesis, meaning that 
changes to the ATP:ADP ratio needn’t affect enzyme activity as ADP is continually re-
phosphorylated. However, for the work reported in this section, the PK/LDH assay did not prove 
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Figure 3.27: Biochemistry of the PK/LDH ATPase assay. ATPase activity (here from the activity 
of MmT6) converted ATP to ADP + Pi. The ADP created was used a substrate for pyruvate kinase 
(PK), which converted phosphoenolpyruvate (PEP) to pyruvate and regenerated the ATP. 
Pyruvate was then converted to lactate by lactate dehydrogenase (LDH), which involves the 
conversion of NADH to NAD+. Therefore, the ATP hydrolysis reaction by the ATPase was linked 
to the loss of NADH in solution, followed by measuring the decrease in absorbance at 340 nm 
(A340).   
 
 To begin, a control was conducted using 200 nM E. coli DNA gyrase in the presence of 
21 nM relaxed pBR322* (Figure 3.28). For negative supercoiling, the specific activity of gyrase 
ATP hydrolysis is known to be ~1 s-1 [295, 296]. Knowing this meant that the PK/LDH system 
could be tested using an enzyme for which a large body of data already existed. With reference 
to Figure 3.28, four samples were prepared; without NADH (green line) to attain a measure of 
the back ground A340; with ADP added after 10 min (blue line) to make sure the PK and LDH 
enzymes functioned as expected; gyrase and relaxed pBR322* with ATP added after 10 min 
(yellow line); and the last contained gyrase and relaxed pBR322* with ATP added after 10 min 
and novobiocin (novo) added after 45 min (red line). Novo is a potent ATPase inhibitor of 
gyrase, which functions via competitively binding the GHKL domain, therefore preventing ATP 
binding [100, 297]. The addition of 2 mM ADP in the control sample (Figure 3.28, blue line) 
demonstrated the system functioned correctly as the A340 dropped dramatically to background 
levels, congruent with the loss of NADH, which is used at 400 μM. The samples containing 
gyrase and relaxed pBR322* (red and yellow lines) were allowed to equilibrate for 10 min prior 
to the addition of 2 mM ATP. Once ATP was added the A340 declined linearly as ATP hydrolysis 
by gyrase caused NADH oxidation. To confirm that this loss of NADH was dependent on gyrase 
ATP hydrolysis activity, 10 μM novo was added to one sample (red line) at 45 min, and caused 
the A340 decline to cease. This confirmed that the change in the A340 was indeed caused by 
gyrase ATP hydrolysis activity (Figure 3.28). The gradient of the slope from the gyrase, 
pBR322* and ATP containing sample (yellow line) allowed the calculation of gyrase ATPase 
specific activity, which for this assay was 0.2 s-1. Even though this was a fifth of what was 
expected (~1 s-1), there are a number of explanations for this. The gyrase concentration was 
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difficult to accurately assess and as this value was used in the calculation of the specific activity, 
this may be a source of significant error. The activity of gyrase also changes between 
purification batches and it is possible the preparation used here was not as active as those 
used in previous research. However, as seen in Figure 3.28B, DNA gyrase behaved as 
expected, with samples from both the gyrase-containing samples being run a 1% (w/v) agarose 
gel to assess topology. The sample which contained gyrase and ATP successfully supercoiled 
the relaxed pBR322*, whereas the sample containing novo is more relaxed, consistent with the 
ATP-independent relaxation of negative supercoils by gyrase. In the latter sample, the DNA 
began relaxed and prior to novo addition, gyrase would have significantly supercoiled it. 
However, during the remaining 65 min, novo would have prevented ATP binding, so gyrase 
instead switched to relaxation, which does not require ATP [11]. 
 
Figure 3.28: Using the PK/LDH ATPase assay to explore ATP hydrolysis activity of E. coli DNA 
gyrase. A: A340, in the presence of 200 nM gyrase, 2 mM ATP and 21 nM relaxed pBR322*, 
decreased over time due to the ATP hydrolysis activity of gyrase, leading to a reduction in NADH 
concentration. An aliquot of 2 mM ATP was added after 10 min to allow the system to equilibrate. 
At 45 min 10 μM novobiocin (novo) was added to one of the two samples containing 200 nM 
gyrase, 2 mM ATP and 21 nM relaxed pBR322* (red line), and not to the other (yellow line). As 
controls, a sample without NADH (green line), to show the baseline absorbance, and a sample in 
which 2 mM ADP, instead of 2 mM ATP, was added at 10 min to establish the PK and LDH enzymes 
were functioning as expected (blue line). The gradient of the yellow line was used to calculate 
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the specific activity of gyrase. B: The samples containing 200 nM gyrase, 2 mM ATP and 21 nM 
relaxed pBR322*, with and without 2 μM novo (red and yellow, respectively), were ran on a 1% 
(w/v) agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged 
under UV illumination. 
 
 Once the gyrase control confirmed that the PK/LDH system functioned as expected, 
attention was turned to using MmT6 and negatively supercoiled pBR322* in order to explore 
MmT6 ATP hydrolysis activity. Initial assays, using similar concentrations of enzyme (200 nM) 
and DNA substrate (21 nM), as used for the gyrase, failed to yield any results with no decrease 
in A340 detected. A low-level ATPase signal for MmT6 was finally achieved using 750 nM MmT6 
in the presence of 93 nM negatively supercoiled pBR322*, a DNA:enzyme ratio of 1:8 (Figure 
3.29A). The slope of the line is shallow and also short lived, indicating that MmT6 not only 
hydrolyses ATP more slowly than type IIA topos, but also appeared to either be tightly coupled 
to the presence of DNA writhe or the enzyme did not remain active in solution for a considerable 
length of time. The former explanation is supported by data which will be presented in the 
following section (Section 3.2.7.2). Whilst it was unclear whether the slope was caused by 
MmT6 activity, an ATP hydrolysis rate was calculated regardless and found to be 0.029 s-1 or 
1.7 min-1. Recently-published data exploring MmT6 ATPase activity utilised the PK/LDH assay, 
used a DNA:Enzyme ratio of 1:4 (500 nM MmT6 and 136 nM supercoiled plasmid), reporting 
the specific activity of MmT6 ATP hydrolysis to be ~2.3 min-1 [62]. This added some validity to 
the specific activity value calculated from the data in Figure 3.29A. A more robust MmT6 
ATPase signal was also measured here using this same ratio, incubating 181 nM negatively 
supercoiled pBR322* with 750 nM MmT6 (Figure 3.29B). This produced a more significant 
decrease in A340, which also demonstrated a relatively shallow gradient and only proceeded for 
30 min before the A340 remained relatively constant (only showing the background level of 
reduction in A340 caused by the oxidation of NADH in solution over time). The specific activity 
calculated using this data was 0.032 s-1 or 1.92 min-1, which is not only highly similar to the 
value calculated from the data in Figure 3.29A, but also to the value reported in the previously- 
published work [62]. Together, this suggested the activity was indeed MmT6-dependent, and 
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by taking a sample every 5 min post the addition of ATP, the change in DNA topology could be 
tracked during the course of the reaction (Figure 3.29C). This preliminary gel-based data further 
indicated that MmT6 ATP hydrolysis activity is highly coupled to the presence of it substrate, 
and potentially indicated that once the DNA was fully relaxed, background MmT6-dependent 
ATP hydrolysis did not occur. This is in line with data previously reported, in which the basal 
MmT6 ATP hydrolysis activity in the absence of DNA was ~0 s-1. This is not generally the case 
with type IIA topos, which have a far more appreciable background ATP hydrolysis activity 
when the optimal DNA substrate has been converted to product or is not present at all. Gyrase 
is a good example, maintaining around 5% ATPase activity in the absence of DNA, and even 
though linear DNA is neither the optimal substrate nor able to store topological alterations 
attempted by gyrase activity, it can fully stimulate the DNA-dependent gyrase ATPase activity 
[295]. During supercoiling, it is thought that as gyrase can wrap DNA and present the T-
segment by doing so, linear DNA facilitates this behaviour, regardless of whether topology 
changes can be stored or not. MmT6 ATP hydrolysis activity was around 30-fold lower than 
that published for gyrase, and raised important questions relating to the in vivo roles of MmT6. 
Previous MmT6 work highlighted this, suggesting there may be an unknown cofactor or 
condition that could accelerate MmT6 activity in vivo, as the current value for ATPase activity 
would render MmT6 a highly inefficient DNA relaxase that would be unable to support DNA 
replication [62]. An alternative explanation will be provided in Chapter 4, as data suggested 
MmT6 was highly adapted to the preferential removal of catenanes, which in turn disfavoured 
supercoil relaxation. As neither the singly catenated DNA substrate used in Section 3.2.4.2, or 
positively supercoiled pBR322*, were available at the time of performing these ATPase assays, 
their affects have not been explored, so future work should encompass this.  




Figure 3.29: Using the PK/LDH ATPase assay to explore ATP hydrolysis activity of MmT6. A: The 
A340, in the presence of 750 nM mMT6, 2 mM ATP and 93 nM negatively supercoiled pBR322*, 
decreased over time due to the ATP hydrolysis activity of MmT6, leading to a reduction in NADH 
concentration. The 2 mM ATP was added to one sample containing 750 nM MmT6 and 93 nM 
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negatively supercoiled pBR322* after 10 min to allow to system to equilibrate (yellow line), but 
not to the other (red). As controls, a sample without NADH (green line), to show the baseline 
absorbance, and a sample in which 2 mM ADP, instead of 2 mM ATP, was added at 10 min to 
establish the PK and LDH enzymes were functioning as expected (blue line). The gradient of the 
portion of yellow line within the grey box was used to calculate the specific activity of MmT6. The 
inset shows the DNA after 80 min for the samples containing MmT6 and DNA (with and without 
ATP), which were run on a 1% (w/v) agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL 
ethidium bromide and imaged under UV illumination. B: Same as in A, however, 750 nM MmT6 
was incubated with 181 nM of negatively supercoiled pBR322*. C: DNA samples from Figure 
3.29B, were taken during the course of the reaction (every 5-6 min) once the ATP had been added 
to the sample containing 750 nM MmT6 and 181 nM negatively supercoiled pBR322*, as well as 
after 120 min for both the MmT6 samples, with and without ATP. These samples were run on a 
1% (w/v) native agarose gel for 10 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and 
imaged under UV illumination. 
 
 Using the PK/LDH assay to explore MmT6 ATP hydrolysis was technically challenging 
owing to tight coupling of activity to substrate concentration. This meant that in order to see an 
appreciable decrease in A340, excessive amounts of supercoiled pBR322* were necessary in 
order to achieve the desired concentration in a 100 μL sample volume, which is quite typical 
when using 96-well plates for this form of assay. It was, of course, not impossible as both the 
two data sets reported here and the previously published MmT6 characterisation data were in 
agreement as to the final value for the specific activity of MmT6 ATPase activity, but also the 
DNA:enzyme ratio necessary to reliably detect the activity. However, an alternative approach 
was employed, described in the following section, which allowed more efficient substrate usage 
and higher sensitivity.  
 
3.2.7.2 Radioactive ATPase assay 
Due to the technical drawbacks just described (Section 3.2.7.1) for using the PK/LDH assay in 
the exploration of MmT6 ATP hydrolysis activity, a radioactive ATPase assay was employed. 
This assay involved the use of [γ-32]-ATP and measuring the amount of [γ-32]-Pi released as a 
result of MmT6-dependent activity by analysing the samples with thin-layer chromatography 
(TLC). In effect, this assay was akin to a relaxation assay, with the difference being the final 
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product analysed, which here was the unhydrolysed [γ-32]-ATP and released [γ-32]-Pi, achieved 
using TLC plates and a phosphorscreen, rather than looking at DNA topology using an agarose 
gel. Using radioactivity meant that a smaller reaction volume could be utilised, and ATPase 
activity could be detected with higher sensitivity; both of these factors facilitating a more 
comprehensive exploration of how DNA topology modulated MmT6 ATPase activity. 
 When exploring ATPase activity of topos it is incredibly useful to have a competitive 
inhibitor that specifically binds the protein of interest and prevents further ATP hydrolysis, such 
as the use of novo with E. coli gyrase (Figure 3.28). Using novo allowed confirmation that the 
ATPase activity being measured was of gyrase origin. Highly effective inhibitors of MmT6 
ATPase activity are lacking, which is a further limitation currently effecting topo VI research. 
However, there is one compound named radicicol which was shown to inhibit S. shibatae topo 
VI (SsT6) via a competitive mechanism similar to that of GyrB and novo [196, 215, 298]. For 
SsT6, full inhibition of activity was achieved with 200 μM radicicol, but when tested against 
MmT6, 600 μM and above was needed (Figure 3.30). This demonstrated that radicicol does 
not inhibit MmT6 to the same degree as SsT6, with neither cases coming close to the potency 
of novo on DNA gyrase. Nevertheless, 2 mM radicicol was employed here with the aim of trying 
to establish basal MmT6 activity, as contaminating ATPases, even in minute quantities, could 
affect the results due to the techniques sensitivity.  
 
Figure 3.30: The effect of radicicol on MmT6 relaxation activity. MmT6 (40 nM) was incubated with 
2 nM negatively supercoiled pBR322*, 1 mM ATP, 10 mM MgCl2, and radicicol (1 to 600 μM), for 
30 min at 37°C. The samples were run on a 1% (w/v) native agarose gel for 10 hr at ~2 Vcm-1, 
stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. 
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 These assays explored MmT6 ATP hydrolysis activity when 1 μM MmT6 was incubated 
with 430 nM of either negatively supercoiled, relaxed or linear pBR322*, or in the absence of 
DNA (with or without 2 mM radicicol). Samples were taken at time points 1, 2, 4, 6, 8, 10, 15, 
20 and 30 min and quenched using 5 µl of 2% SDS and 100 mM EDTA, for samples containing 
DNA. For those samples incubated in the absence of DNA, the time points were 10, 20, 30, 40, 
50 and 60 min and 2 μM MmT6 was used. A 1 µL aliquot of each time point was then spotted 
onto a TLC plate and placed in a solution of 0.5 M lithium chloride and 1 M glacial acetic acid. 
The TLC plate was then fully dried and exposed to a phosphorscreen for 1 hr prior to 
visualisation using the Typhoon FLA 7000 plate reader. Results for the TLC plates can be seen 
in Figure 3.31, in which the [γ-32]-ATP and released [γ-32]-Pi can be seen as a lower and upper 
signal, respectively. Much like gel electrophoresis, the released [γ-32]-Pi can be separated from 
the [γ-32]-ATP as it is smaller and will therefore travel at a faster rate up the TLC plate. The 
ATP-alone control demonstrated that there was no background released [γ-32]-Pi in the ATP 
preparation. A very small amount of released [γ-32]-Pi was detected when MmT6 was incubated 
in the absence of DNA, which was mostly absent when 2 mM radicicol was added. Progressive 
accumulation of released [γ-32]-Pi can be seen when MmT6 is in the presence of all DNA 
substrates, however the spots are clearly more intense for the sample containing supercoiled 
pBR322* (Figure 3.31).  
 The data visualised by the TLC plates was converted to change in ATP concentration 
over time by analysing the TLC plate images using GelAnalyzer. The image was converted to 
a plot of pixel intensity and the area of the two peaks were calculated. The ratio in peak area 
allowed the calculation of how much ATP had been hydrolysed in each sample (Figure 3.32), 
which was then plotted against time to establish the rate of MmT6-dependent ATP hydrolysis.  
 




Figure 3.31: Examples of thin layer chromatography (TLC) plates showing MmT6-dependent Pi 
release. The substrates common amongst all 6 TLC plates are 450 μM radioactive ATP ([γ-32]-
ATP) and 10 mM MgCl2. TLC plate 1 was [γ-32]-ATP only, plate 2 was 1 μM MmT6 and 450 μM [γ-
32]-ATP, plate 3 was 1 μM MmT6, 450 μM [γ-32]-ATP and 2 mM radicicol, plate 4 was 1 μM MmT6, 
450 μM [γ-32]-ATP and 430 nM negatively supercoiled pBR322*, plate 5 was 1 μM MmT6, 450 μM 
[γ-32]-ATP and 430 nM relaxed pBR322*, and plate 6 was 1 μM MmT6, 450 μM [γ-32]-ATP and 430 
nM linear pBR322*. All TLC plates imaged using the Typhoon FLA 7000 plate reader. 
 
 
Figure 3.32: Illustration of how the raw data obtained from TLC plates was analysed for ATP 
hydrolysis rate of MmT6. The TLC plate shows 2 dark spots per sample, the lower being 
unhydrolysed [γ-32]-ATP and the upper being released [γ-32]-phosphate. Using GeneAnalyzer 
software, the pixel intensity is measured for each sample, which produced peaks and the volume 
of these were calculated. Using the equation shown in the illustration, the concentration of [γ-32]-
phosphate released by MmT6-dependent activity was calculated from these peak volumes (V1 
and V2) and used to determine the rate of ATP hydrolysis.  
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 All data derived from these assays can be seen in Figure 3.33. MmT6 ATPase activity 
was maximised in the presence of supercoiled pBR322* as compared to relaxed or linear, with 
the specific activities calculated to be 0.093 ± 0.01 s-1, 0.002 ± 0.001 s-1 and 0.002 ± 0.002 s-1, 
respectively (Figure 3.33A and D). This meant that the presence of DNA writhe enhanced 
MmT6 DNA-dependent ATPase activity by 4.7-fold. Previously published work on MmT6 also 
documented a ~5-fold increase in MmT6 ATPase activity when in the presence of supercoiled 
plasmid as opposed to sheared salmon sperm DNA [62], further validating the work described 
here. An intriguing aspect of the results found in the presence of supercoiled pBR322* was that 
after 15 min, the ATP hydrolysis rate declined to a rate similar to that achieved for linear and 
relaxed pBR322* (Figure 3.33A). To explore this, a DNA relaxation time course was performed 
in tandem using the identical DNA:enzyme ratio which was utilised in the radioactive ATPase 
assay (Figure 3.33B). This demonstrated that at 15 min all of the negatively supercoiled 
pBR322* had been fully converted to a relaxed product, providing further evidence that the 
ATPase activity of MmT6 was tightly coupled to the presence of a supercoiled substrate. In 
addition to this control over ATPase activity in the presence of DNA, the data obtained with 
MmT6 alone demonstrated that the basal MmT6 ATPase activity was incredibly low, at 0.008 
± 0.001 s-1, which is 0.5 min-1 (Figure 3.33C and D). This is also in line with the previous work, 
which found the basal rate ≈ 0 s-1, with the heightened sensitive of the radioactivity assay over 
the PK/LDH assay potentially allowing a more detailed assessment. This may also be why the 
values calculated for MmT6 specific ATPase activity were ~3-fold higher when measured using 
the radioactive ATPase assay, as opposed to the PK/LDH assay. In any case, all values 
calculated here and in prior published work using MmT6 [62] are relatively similar to each other 
and display highly equivalent behaviours, both in the DNA:enzyme ratio necessary to reliably 
collect data and the activity maximisation of MmT6 in the presence of DNA writhe. This adds a 
great deal of confidence that the work performed here is reflective of the true MmT6 behaviour 
and also established the use of either the radioactive ATP or PK/LDH assays as a means of 
exploring this.  
 




Figure 3.33: The effect of DNA topology on the ATP hydrolysis activity of MmT6. A: The 
radioactive ATPase assay was employed to measure the rate of ATP hydrolysis of MmT6 (1 μM) 
± SE in the presence of 430 nM pBR322*, either negatively supercoiled (red), relaxed (blue) or 
linear (green), 450 μM [γ-32]-ATP and 10 mM MgCl2, at 21°C. The data was fit well by a linear 
equation, in which the gradient was used to determine rates of ATP hydrolysis, and therefore the 
specific activity of MmT6 (sec-1) in the presence of different pBR322* topologies. For the sample 
containing negatively-supercoiled DNA, the linear fit included data points from 1 to 15 min, whilst 
for relaxed and linear all data points were used in the fit. Data is the average across three separate 
assays. B: Agarose gel based MmT6-dependent relaxation time course performed to accompany 
the supercoiled data in Figure 3.33. The same protein:DNA ratio was employed (2:1), in which 39 
nM MmT6 was incubated with 17 nM negatively supercoiled pBR322*, 450 μM ATP and 10 mM 
MgCl2, at 21°C, with samples taken at the same time points as Figure 3.33 (1, 2, 4, 6, 8, 10, 15, 20 
and 30 min). The samples were run on a 1% (w/v) native agarose gel for 15 hr at ~2 Vcm-1, stained 
with 0.5 μg/mL ethidium bromide and imaged under UV illumination. OC: open circular or nicked, 
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Rel: relaxed, and Sc: supercoiled. C: Basal rate of MmT6 hydrolysis ± SE, in the absence of DNA, 
was measured using the radioactive ATPase assay, by incubating 2 μM MmT6 with 450 μM [γ-
32]-ATP at 21°C, taking a sample at 10, 20, 30, 40, 50 and 60 min (yellow). The data were fit to a 
linear equation, which was used to determine the rate of ATP hydrolysis and therefore the 
specific activity of MmT6 (sec-1) in the absence of DNA. D: The specific activity of MmT6 ATP 
hydrolysis ± SE, in the presence of different DNA topologies, supercoiled (red), relaxed (blue), or 
linear (green) or no DNA (yellow).  
 
3.3 Conclusions 
Throughout this chapter, the utilisation of various biochemical techniques in the 
characterisation of MmT6 activity has led to gaining a deeper insight into how MmT6 functions 
and under which conditions, providing the ideal backdrop for single-molecule characterisation, 
detailed in Chapter 4. The data described here reveal a topo that has a mild rate enhancement 
for the relaxation of positive writhe, increased activity in the presence of catenated DNA 
molecules, and a significant preference for the binding and relaxation of DNA writhe. Taken 
together, the data reveals a picture of MmT6 as a DNA crossing sensor, binding and resolving 
crossings in an ATP-dependent fashion, with loss of writhe leading to loss of ATP hydrolysis 
activity. DNA topology has a striking effect on activity, with ATPase and DNA binding enhanced 
5-fold and 4-fold, respectively, in the presence of negatively supercoiled pBR322* as opposed 
to linearised pBR322*. This data suggested that topological features of supercoiled DNA were 
recognised and acted upon by MmT6, likely the intramolecular DNA crossings formed due to 
the increased superhelical density, and that these crossings stimulate MmT6 activity, which is 
minimal in their absence. MmT6 ATPase activity is tightly coupled to presence of DNA writhe, 
with MmT6 basal activity in the absence of DNA practically non-existent. The explanation for 
this behaviour may be due to the enzyme only operating with two protein interfaces which must 
alternately open and close to both allow the passage of the T-segment, as well as protect from 
forming stabilised double-stranded DNA breaks once the G-segment has been cleaved. Type 
IIA enzymes do not appear to have quite such tightly coupled ATPase activity to the presence 
of both the G- and T-segment within the enzyme cavity, potentially due to the presence of the 
third protein interface, known as the C-gate. This may afford a higher level of protection against 
generating double-stranded DNA breaks.  
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 MmT6 ensemble characterisation using biochemical approaches has allowed deeper 
insight into the in vitro behaviour of topo VI enzymes as well as facilitate further considerations 
as to its in vivo roles. With a preference for in vitro decatenation, and an intrinsic inefficiency 
during supercoil relaxation, it is likely that MmT6 is a preferential DNA decatenase in vivo that 
functions via the direct detection of DNA crossings. This is likely modulated by a preference for 
a particular DNA crossing geometry which is found more frequently in DNA catenanes than 
DNA supercoils. This hypothesis will be expanded upon in the chapters to come (particularly 
Chapter 4), with a complete picture presented in Chapter 6.  
 
3.4 Future Work 
During the discussion of the data presented in this chapter, numerous areas which require 
further study have been highlighted. This section will bring these suggestions together, as well 
as speculate on further biochemical characterisation of MmT6 which is currently outstanding. 
With regards to ATPase characterisation, exploring how catenated DNA and positively 
supercoiled DNA modulate this activity would inform further on the preferential activity of 
MmT6, which was not completed during the work reported here. If MmT6 preferential relaxes 
positive writhe over negative, and preferentially decatenates rather than relaxes, an even 
greater stimulation of ATPase activity should be present than was seen in the presence of 
negative writhe. Measurements of MmT6 binding on catenated DNA may also be illuminating. 
On particularly intriguing and unresolved element of in vitro MmT6 activity explored here 
is that DNA cleavage and binding are higher for negative writhe, despite a ~2-fold preference 
for the relaxation of positive writhe. Further exploration into why this occurs may advance 
understanding on the true DNA binding and cleavage behaviour of MmT6. The explanation 
offered here is that during binding and cleavage, only the G-segment needs to be present, 
however for relaxation to occur, both the G- and the T-segment are necessary. The techniques 
used to explore binding and cleavage do not provide a way of distinguishing whether one or 
both DNA segments were present and therefore it may be that binding and cleavage are 
facilitated to a higher degree on negative writhe through an enhancement of MmT6 G-segment 
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only interactions. Perhaps the underwound DNA interacts with elements of Top6A more readily, 
and/or can be bent more easily, G-segment bending being a behaviour already known for 
MmT6 [61]. It may also more closely resemble a transition-state.  
 Another facet of MmT6 activity touched upon here is that increasing magnesium 
concentration alters relaxation and cleavage activity in different ways. Relaxation is inhibited at 
50 mM Mg2+ whereas cleavage at this concentration remains robust. A potential explanation for 
this is reminiscent of the data discussed in the previous paragraph. For cleavage only the G-
segment need be present and so perhaps 50 mM Mg2+ does not prevent MmT6 binding to the 
G-segment, but does prevent the binding and passage of the T-segment, possibly through 
electrostatic effects mediated by the Mg2+ or interference with nucleotide binding and Top6B 
dimerisation. The way in which Mg2+ concentration effects MmT6 activity is worthy of further 
analysis, with deeper characterisation of how Top6A coordinates and utilises Mg2+ ions via the 
TOPRIM domain not only informing on topo VI enzymes, but potentially also type IIA topos and 













Characterisation of M. mazei Topo VI Using Single-
Molecule Magnetic Tweezers 
4.1 Introduction 
The utilisation of magnetism in biological research began in 1950 with in vivo experiments 
exploring physical qualities of the cytoplasm, in which cells phagocytosed magnetic particles 
that were then manipulated using external magnetic fields [299]. Later, single DNA duplexes 
were tethered to a slide at one extreme end, and to a magnetic bead at the other, in which DNA 
elasticity [300] and supercoiling [301] were explored by manipulating the DNA molecule using 
external permanent magnets. This formed the initial groundwork for the development of the 
magnetic tweezers (MT) as a broadly applicable technique in the single-molecule study of 
biological polymers. Whilst the work reported here relies on manipulation of DNA, single-
molecule MT have also been used in research on microtubules [302], collagen [303], and 
protein folding/unfolding [304, 305] (see [306] for a comprehensive review). However, DNA 
remains the most commonly explored biopolymer using MT, not only allowing the 
characterisation of physical DNA properties [300, 301, 307-309] but also the activity of proteins 
that interact with DNA such as helicases [227, 310, 311], polymerases [312, 313] and 
topoisomerases (topos) [119, 120, 158, 222, 224, 314]. As the magnetic tweezers are able to 
achieve forces of 10-3-102 piconewtons (pN), have a temporal resolution of 10-1-10-2 and, most 
importantly, can apply torque [315], they have been particularly effective in topo research (see 
Chapter 1, section 1.5 for more information) as DNA topology can be precisely controlled and 
manipulated, with the activity of topos being tracked at high temporal-spatial resolution [222].  
There are variations on the magnetic tweezers set up (see [222, 315]), with the basic 
configuration employed in the research reported here (Figure 4.1). A sample cell, housing the 
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experimental substrates, is mounted above an inverted oil immersion microscope objective, 
atop motorised stages. Above the sample cell, two permanent magnets are fixed 1 mm apart 
 
Figure 4.1: Magnetic tweezers (MT) instrument set up. A: Simplified schematic highlighting the 
major components of the MT instrument. B: Photograph of the MT instrument used in the 
research reported here. 
 
which generate the magnetic field used to manipulate the magnetic beads within the sample 
cell. An LED light source is focused on the sample cell and relays an image to a CCD camera. 
See Figure 4.1A for a schematic and 4.1B for a photograph of the actual instrument used. 
Within the sample cell and via non-covalent interactions, DNA is tethered at one end to the 
slide surface via the interaction between digoxigenin and antidigoxigenin, and at the other end 
to a micron-sized, streptavidin-coated paramagnetic bead via interactions with DNA-
incorporated biotin. Either a single torsionally-constrained duplex, or two unconstrained 
duplexes can be attached to the bead, depending on whether DNA supercoiling or braiding is 
being explored, respectively (Figure 4.2). The height of the bead from the surface of the sample 
cell is obtained using the diffraction rings, which are produced as a consequence of light 
scattered by the bead interfering at the camera. The appearance of these concentric rings 
around the bead being tracked change depending on the position of the bead from the sample 
cell surface. Rotation of the magnets above the sample cell causes the entrained magnetic 
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bead within to rotate, thereby also rotating the attached DNA and changing its linking number. 
For a single, intact, torsionally-constrained duplex, this rotation causes twist to accumulate 
before the DNA buckles to generate writhe, forming a supercoiled structure known as a 
plectoneme (Figure 4.2A). The formation of the plectoneme is accompanied by a reduction in 
DNA extension, bringing the bead closer to the surface of the sample cell. Therefore, the activity 
of topos, which generally relax supercoils, can be tracked as a function of DNA extension. With 
each topo-dependent removal of a supercoil, the DNA extension increases and this can be 
measured in real time and with high resolution, affording the ability to see single strand-
passage events (Figure 4.2A). For DNA braiding, the situation is similar, however as the DNA 
is unconstrained (e.g. via a DNA nick, or a single interaction with the sample cell surface), twist 
cannot be stored in the duplexes as the magnets are rotated. Instead, the DNA molecules wrap 
each other, generating writhe without changing the twist. The generation of a DNA braid, also 
results in reduction of DNA extension, and topo-dependent unlinking of the braid causes the 
DNA extension to increase, allowing the activity to be tracked in the same manner as supercoil 
relaxation (Figure 4.2B).  
 
Figure 4.2: Illustration of DNA topology manipulation from within the sample cell. A: DNA 
supercoiling. Rotation of the fixed magnets above the sample cell causes the bead-bound DNA 
duplex within to rotate, producing a supercoiled structure called a plectoneme, which decreases 
the DNA extension. DNA topoisomerases (topos) can relax the plectoneme, removing supercoils 
and increasing the DNA extension. B: DNA braiding. Rotation of the fixed magnets above the 
sample cell, causes the two bead-bound DNA duplexes within to wrap each other, producing a 
DNA braid, which decreases the DNA extension. Topos can unlink the braid, increasing the DNA 
extension. 
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Here, using topo VI from M. mazei as a model (MmT6), the single-molecule magnetic 
tweezers assay has been employed, in combination with ensemble biochemistry (described in 
Chapter 3), to gain a deeper insight into the topo VI mechanism, particularly how the topology 
of the DNA substrate modulates activity. Previous research, whilst instructive, has left us with 
the conundrum that the activity of topo VI seems far below that which is necessary to support 
the cell in terms of transcription- and replication-induced supercoil relaxation [62]. The data 
presented here forms a compelling case for the preferential decatenation activity of MmT6 as 
an intrinsic quality of the enzyme, arising from a strict DNA crossing angle preference of 88°, 
which in turn significantly disfavours the removal of supercoils. MmT6 also behaves as a true 
DNA crossing sensor, with a dramatic increase in the rate of strand passage with increasing 
DNA writhe. Moreover, these data extend to providing an explanation for why topo VI remains 
a vital component of some eukaryotic systems, such as during endoreduplication in plants [169, 
178], despite the presence of other highly-efficient type IIA topos. Topo VI may be a dedicated 
decatenase, the activity of which will not be dominated by the necessity to relax transcription- 
and replication-induced supercoils (discussed in Chapter 6). 
 
4.2 Results and Discussion 
4.2.1 Magnetic force calibration 
The MT assay is a technique that facilitates the manipulation of DNA topology under precise 
force, allowing for in-depth characterisation of how DNA tension and topology affects the 
catalytic activity of MmT6. As described above, in the set up used here, a DNA duplex was 
tethered to a sample slide at one extreme end, and to a 1 μm magnetic bead at the other. Two 
permanent magnets were fixed parallel to the sample cell, above the tethered DNA, and 
exerted an upwards magnetic force on the bead. The magnitude of this force is controlled by 
the distance between the sample cell (housing the DNA tethered magnetic beads) and the 
permanent magnets. As the magnets moved further from the slide, the force on the DNA duplex 
decreased. To calibrate the force applied to the DNA as a function of magnet position, the DNA 
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extension and the variance of the bead position in the x coordinate were experimentally 




Equation 4.1: Calculating the magnetic force on the DNA-tethered bead. 
Where Fz is the force applied to the bead by the magnets, kB is the Boltzmann constant, T is 
the temperature in Kelvin, z is the DNA extension and x is the displacement of the bead in the 
x coordinate. To derive this equation, some physical concepts require consideration.  
To begin, the tethered bead is considered as an inverted simple pendulum. For a simple 
pendulum the downward force acting on the suspended object is gravity. For the DNA tethered 
bead, the equivalent force is upwards and supplied by the magnetic field. In an ideal system, a 
simple pendulum when displaced from equilibrium, oscillates back and forth infinitely in a 
sinusoidal manner. In reality, friction and air resistance will cause a pendulum to eventually 
stop swinging and return to its equilibrium position. For the magnetic tweezers system, the 
bead is in water and at the microscopic scale this could be compared to a macroscopic 
pendulum submerged in treacle. If you were to displace this treacle-submerged pendulum it 
would move back to equilibrium but no longer oscillate around it, and this is described as a 
critically damped system. Whilst the bead is, in reality, being constantly displaced from 
equilibrium due to the Brownian motion of water particles, the force from the magnetic field 
constantly, and without oscillation, brings the bead back to equilibrium. Another assumption for 
a simple pendulum is that the tether is mass-less in relation to the suspended mass and can 
therefore be disregarded. The magnetic tweezers set up achieves better than this as mass is 
not a considered variable in the calculations. A third simple pendulum assumption is that the 
tether cannot bend nor stretch and whilst DNA can undergo these deformations, in these 
assays, the position of the bead is averaged over such a long period of time so that an accurate 
measurement can be obtained. The final assumption addressed here is that a simple pendulum 
swings in a perfect plane. Again, whilst the magnetic bead does move in the x, y and z 
coordinates, the calculations focus only on its movements in the x direction and this is recorded 
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over a considerable period such that an accurate average can be determined. It’s important to 
note here that even for a simple pendulum in a perfect system, approximations and simple 
assumptions are made during calculations.  
 
Figure 4.3: Effect of magnet proximity on bead displacement. A: Illustration of coordinate 
annotation, from the perspective of the tethered DNA duplex. The x and y coordinates are parallel 
to the sample cell surface, while z is perpendicular. B-D: The displacement of the bead (left y 
axis, grey line) over time (x axis) as a function of magnet position from the sample cell (right y 
axis, black line), for the x, y and z coordinates, labelled B, C and D, respectively. 
 
The displacement of the bead from equilibrium arises from constant bombardment by 
water molecules in all directions, i.e. Brownian motion, and this displacement in the x 
coordinate is related to the force in z. Shown in Figure 4.3 and 4.4, as the magnets were moved 
further from the sample cell, the magnetic force acting on the bead decreased, which allowed 
the bead displacement due to Brownian motion to increase, as the magnets exerted less 
upward force to counteract this. This demonstrated how the beads displacement is related to 
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the magnetic force. In the z coordinate, not only does the bead move more drastically from 
equilibrium, the DNA extension also decreases, as the upward force on the bead diminishes 
(Figure 4.3D). In the x coordinate the bead is entrained by the magnetic field lines and so 
maintains alignment. Whilst it is possible to use the variance of the bead position in the y 
coordinate to calculate the force in z, being perpendicular to the magnetic field lines results in 
the bead being able to freely rotate, and hence the radius of the bead must be considered. For 
the purposes of this research, using the bead displacement in the x coordinate is sufficient. 
However, in systems using very short pieces of DNA, using the bead displacement in y can 
increase accuracy of measurements as the need to include the radius of the bead increases 
the extension value. Here, a 12 kb DNA duplex was utilised to experimentally determine the 
magnetic force. This is because the longer the DNA is, the less stiff it becomes and therefore 
the speed of the oscillation is reduced. This is important as the DNA mustn’t oscillate near the 
frame rate of the camera if accurate measurements are to be gathered.  
 
 
Figure 4.4: The distribution of the beads position in x as a function of magnet position from the 
sample cell. When the magnets are close to the sample cell, they exert a high magnetic force on 
the bead, reducing the extent of its displacement from equilibrium. As the magnets are moved 
further from the sample cell, the magnetic force deceases and the bead displacement increases. 
 
To begin deriving an equation to calculate the magnetic force on the bead, the physics 
of the simple pendulum is used. With reference to figure 4.5, some terms need defining: Fx is 
the restoring force which occurs in the opposite direction to the displacement force, Fz is the 
upwards force on the magnetic bead from the magnetic field gradient, T is a tensile force  
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Figure 4.5: The simple pendulum and the DNA-tethered magnetic bead. The simple pendulum is 
acted upon by the downwards force of gravity multiplied by the mass of the tethered object. The 
DNA tethered bead displaced from equilibrium is acted upon by the upward magnetic force (Fz). 
Fx is the restoring force which occurs in the opposite direction to the displacement from 
equilibrium, Δx is the distance of displacement from equilibrium in the x direction, T is a tensile 
force provided by the DNA tether, z is the DNA contour length and θ is the angle of displacement 
from the equilibrium.  
 
provided by the DNA tether, Δx is the distance of displacement from equilibrium in the x 
direction, z is the DNA contour length and θ is the angle of displacement from equilibrium. 





Equation 4.2: Trigonometry relates the tensile force (T) to the magnetic force in z (Fz) and the 
angle of displacement (cosθ). 
 
𝐹B = 𝑇 sin 𝜃 
Equation 4.3: Trigonometry relates the restoring force (Fx) to the tensile force (T) and the angle 
of displacement (sinθ). 
 
Or in terms of distance,  
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∆𝑥 = 𝑧	 sin 𝜃 
Equation 4.4: Trigonometry relates the distance of displacement (Δx) to the DNA contour length 
(z) and the angle of displacement (sinθ). Equation 4.3 written in terms of distance, rather than 
force. 
 
The small angle approximation is then used which states that if the angle of displacement is 





Equation 4.5: The restoring force (Fx), is roughly equal to the magnetic force in z (Fz), divided by 
the DNA contour length (z) and multiplied by the beads displacement in x (Δx). 
 
Equation 4.5 highly resembles Hooke’s law, which describes the force needed to displace a 
resting spring (Fx) in terms of its stiffness, otherwise known as the spring constant k (measured 
in N/m), multiplied by the distance of displacement (Δx), 
𝐹B =	−𝑘	∆𝑥 
Equation 4.6: Hooke’s law. 
So, now the movement of the bead in the x coordinate follows the physics of a spring, another 
equation can be considered which describes the potential energy (PE) stored in a spring when 





Equation 4.7: Elastic potential energy equation. 
Where k is the spring constant and Δx is the distance of displacement. This equation can then 
be combined with the equipartition theorem equation. The equipartition theorem states that 
within a closed system the thermal energy is on average distributed equally amongst each 
component, or degree of freedom, and this is equal to M
#
kBT, where kB is the Boltzmann constant 
and T is the temperature in kelvin. The movement of the bead in x (Δx) can be considered a 
single degree of freedom, which means the equipartition equation can be set to equal equation 
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Equation 4.8: Equipartition theorem combined with the elastic potential energy equation.  
If equation 4.8 is combined with equation 4.5 which finds k (Fx/Δx) equal to Fz divided by the 





Equation 4.1: Calculating the magnetic force on the DNA-tethered bead. 
As is well established, the Boltzmann constant multiplied by room temperature expressed in 
kelvin is 4.06 pN nm. The average displacement of the bead in x (Δx), along with the DNA 
contour length (z) were experimentally determined and used to calculate the force on the bead 
as a function of magnet position.  
 
Figure 4.6: Magnetic force on the bead as a function of magnet position from the sample cell. All 
15 data sets are rainbow coloured with the average force at each magnet position plotted ± SE in 
black (black circles and black line). The insert shows the double exponential line of fit in red, with 
the equation F = +3.4674 exp(-0.64175Zmag)+2.6918exp(-6.3144Zmag). 
 
Data was experimentally obtained and analysed in IgoPro7 (wavemetrics) using a 
procedure coded by Dr Keir Neuman (NHLBI, NIH, Bethesda, US). For all 15 data sets, the 
extension of the DNA at each magnet position and the variance of the bead position in the x 
Chapter 4: Single-Molecule Results 
 
 152
coordinate were extracted and used to calculate the force at each position (Figure 4.6). The 
data sets were then averaged and fit to a double exponential with the equation, 
 
F = +3.47 exp(-0.64Zmag) + 2.69exp(-6.31Zmag) 
 
Equation 4.9: Double exponential equation fit to magnetic tweezers force calibration data. F is 
the force on the magnetic bead and Zmag is the position of the magnets above the sample cell. 
 
This equation was then inputted into the software that runs the MT instrument so that the 
experimentalist can either get an accurate idea of the force on the DNA at a given magnet 
position, or input a particular force and have the magnets move to the appropriate position 
automatically. This became an invaluable tool in subsequent data collection. 
 
4.2.2 MmT6 supercoil relaxation 
To begin exploring the single-molecule behaviour of MmT6, the MT supercoiling assay was 
employed, described in detail elsewhere [221, 222]. As opposed to agarose gel analysis of 
DNA topology, the magnetic tweezers imparts not only control over the precise level and 
chirality of DNA supercoiling, but also allows the real-time detection of supercoil relaxation by 
MmT6 with the ability to capture single strand-passage events. Rotating the magnetic bead 
anticlockwise, leads to the formation of positive writhe (left-handed crossings), whilst negative 
writhe (right-handed crossings) is generated by rotating the bead clockwise (Figure 4.7). 
Generally, data collection began with the calibration of the DNA tether. The DNA extension is 
plotted as a function of DNA turns, forming a plot known as a hat curve, owing to its shape 
(Figure 4.7). At low force (0.2 pN), as the magnets were rotated either clockwise or 
anticlockwise, the DNA extension decreased symmetrically as writhe was generated (Figure 
4.7, light grey). However, at high force the hat curve becomes asymmetric, as the clockwise 
rotation promoted DNA melting over the formation of negative writhe. Generally, this didn’t 
affect MmT6-dependent assays, as a lower force (0.4 pN) was found to be optimal. It is a 
consideration, however, in section 4.2.3, exploring the effect of force on MmT6 activity. 
Calibration of the chosen DNA tether is important as it established whether the bead was 
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indeed tethered by a single, coilable DNA molecule. Sometimes the bead was found to be 
tethered to two or more duplexes, generating an uncharacteristic hat curve, or the DNA was 
nicked, meaning twist and writhe cannot be stored in the molecule and so DNA extension was 




Figure 4.7: Coilable 5-kb DNA tether hat curve. DNA extension is plotted as a function of magnet 
turns at three forces, 0.2 pN (low force, light grey), 0.5 pN (low-moderate force, medium grey) and 
1.0 pN (high force, dark grey). At high force the DNA extension is insensitive to clockwise magnet 
rotation, as DNA is melted rather than negatively supercoiled. At low-to-moderate force, DNA 
extension decreased as the magnets were rotated clockwise/anticlockwise, due to the formation 
of DNA writhe.  
 
As previously described, rotation of the DNA leads to a reduction in its extension due 
to plectoneme formation, which can be tracked using the diffraction pattern of the attached 
magnetic bead. Upon addition of MmT6 and ATP, the DNA extension increased over time as 
supercoils were removed by MmT6, hence the relaxation reaction was tracked via DNA 
extension change over time (Figure 4.8). Based on the calibration (Figure 4.7), the removal of 
a supercoil at 0.4 pN equated to an extension change of ~110 nm, with MmT6-dependent 
relaxation occurring as an abrupt increase in of ~110 nm. This is equal to a change in Lk of 2, 
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and was expected of MmT6 as it is a type II topo. Figure 4.8 demonstrates three examples of 
MmT6-dependent plectoneme relaxation, in which 16 positive turns were added to the DNA 
molecule before being relaxed in steps of ~110 nm (ΔLk=2). Once the DNA extension exceeds 
the threshold set, the magnets automatically recoil the DNA.  
 
Figure 4.8: MmT6-dependent relaxation of a plectoneme. A, B and C: All three traces are examples 
of MmT6-dependent plectoneme relaxation of positive writhe using 500 pM MmT6, 1 mM ATP, 
under 0.4 pN at 21°C. The single-headed arrows indicate the point at which the magnets are 
rotated, adding 16 positive turns to the DNA. The double headed arrows indicate the period of 
time in which MmT6 relaxed the positive writhe. This is evident as abrupt DNA extension 
increases of ~110 nm, which are highlighted using a dashed red line, and represent single strand-
passage events by MmT6. The light grey points are the raw data (frame rate = 200 Hz) with the 
black representing the smoothed data, achieved using the Savitzky–Golay filter in Igor Pro 7 
(smoothing window = 199 data points). 
 
Once established that MmT6 was amenable to exploration using the MT set up, the 
chirality-dependent relaxation activity of MmT6 was measured as a function of MmT6 
concentration (250-2000 pM) (Figure 4.9). The observed DNA extension changes revealed that 
MmT6 relaxed negative supercoils 2-3 times slower than positive supercoils. The measured 
average relaxation rates for supercoils of either chirality increase as a function of MmT6 
concentration with the data fit to a Michaelis-Menten-like rate equation, resulting in an apparent 
Kd (Kd,app) 3-fold lower for the relaxation of positive DNA writhe.  
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Figure 4.9: Magnetic tweezers supercoil relaxation data. A: Example trace of MmT6-dependent 
supercoil relaxation. Data collected under 0.4 pN, at 21°C, using 500 pM MmT6 and 1 mM ATP. 
Each strand passage event is evident as an abrupt DNA extension increase of ~110 nm, 
corresponding to a ΔLk of 2. The light grey points are the raw data with the black representing 
the smoothed data, achieved using the Savitzky–Golay filter in Igor Pro 7. Relaxation of negative 
writhe is highlighted in blue, and positive in red. Positive writhe is relaxed faster, resulting in 
shorter events (<1 min) being compressed when plotted on the same axis as negative supercoil 
relaxation. B: Average relaxation rate of MmT6 (± SEM) on positive and negative supercoils as a 
function of MmT6 concentration, collected under 0.4 pN, at 21°C, and with 1 mM ATP. Data were 
fitted (dashed lines) to a rate function ( 𝑽𝟎 =
𝑽𝒎𝒂𝒙[𝑬]
𝑲𝒅,𝒂𝒑𝒑/[𝑬]
	). Raw data was analysed in Igor Pro 7 using 
a T-test-based method, first described in [227]. 
 
In line with the single-molecule relaxation assay results, the preferential relaxation of 
positive supercoils by MmT6 was also supported by an agarose gel based approach (Figure 
4.10), showing the relaxation of supercoiled pBR322* to occur at 4 min for positively 
supercoiled and 8 min for negatively supercoiled. An aspect of topo VI activity, previously 
described in [62] and built upon here, is that the rate of reaction, whilst reliable, is far slower 
than type IIA topos in supercoil relaxation. Even at high concentrations above those considered 
standard in single-molecule measurements (e.g. 2 nM MmT6), the maximum rate measured 
for positive and negative supercoil relaxation was only 6.4 ± 0.6 and ∼4 ± 0.5 strand passage 
events min-1, respectively. Wendorff and Berger found the maximal rate of ATP hydrolysis by 
MmT6, using the PK/LDH system, to be ∼3 ATP min-1 during relaxation of negatively 
supercoiled plasmid [62]. Here the ATPase rate was determined to be ∼5 ± 0.9 ATP min-1, 
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using a radioactive ATPase assay (see Chapter 3). If it is assumed that a single strand-passage 
event requires the hydrolysis of two ATP molecules, both values for the MmT6 ATPase rate 
correspond well with a rate of ∼1.5 - 3.5 strand passage events min-1 on negative supercoils, 
between 0.25- 2 nM MmT6. As discussed [62], this rate is not only a fraction of the relaxation 
rate of type IIA topos, but it also seems unlikely that MmT6 could support cellular DNA 
metabolism as a DNA relaxase in M. mazei (replication rate for M. mazei calculalted in Wendorff 
et al., 2020 [62]).  
 
Figure 4.10: Agarose gel-based supercoil relaxation time course. Negatively or positively 
supercoiled pBR322* was incubated at 21°C, with 20 nM topo VI, the reaction was halted at 
consecutive time points using 50 mM EDTA. Samples were run on a 1% (w/v) native agarose gel 
for 15 hr at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination.  
 
The processivity of type II topo activity, i.e. the number of T-segments passed during a 
single G-segment binding event, can vary depending on the enzyme being assayed and the 
DNA substrate present. For MmT6, each strand-passage event is evident in the trace, as an 
abrupt DNA extension change of ∼110 nm (at 0.4 pN), which is expected for the resolution of 
a single DNA crossing (Figures 4.8 and 4.9A). This provides preliminary evidence of 
distributivity, as many seconds to minutes elapsed between strand passage events, indicating 
that MmT6 binds and resolves a single crossing, before disengaging the G-segment and 
rebinding the next crossing. With the magnetic tweezers affording this level of detail, this 
analysis can be taken further, extracting each dwell time between strand-passage events and 
plotting them as a function of the number of DNA crossings within the plectoneme (Figure 4.11). 
In the average relaxation rate analysis, the automatic recoiling of the DNA was initiated 2-3 
DNA crossings from full relaxation as it was evident early on that MmT6 struggled to fully relax 
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plectonemes. Using 750 pM MmT6, a concentration determined to be effective for both positive 
and negative plectoneme relaxation, MmT6 was left to fully relax the DNA (Figure 4.11A and 
B). This produced a characteristic trace shape with the dwell time duration dramatically 
increasing as the DNA approached a fully relaxed state. Plotting these dwell times as a function 
of the level of DNA supercoiling clearly demonstrated that the rate of reaction decreased with 
decreasing DNA crossing number, which fit well to an inverse relationship, where the time taken 
to relax the crossing was inversely proportional to the number of crossings present (Figure 
4.11C).  
  
Figure 4.11: Topo VI relaxation rate is dependent on the level of DNA supercoiling. A: An example 
trace of 750 pM topo VI fully relaxing 20 negative supercoils in a 5 kb DNA duplex under 0.4 pN 
at 21°C. DNA extension is plotted against time, with the dramatic extension decrease 
corresponding to manual rotation of the magnets causing rapid DNA supercoiling. The slower 
DNA extension increase corresponds to topo VI-dependent relaxation activity. B: Same as in A, 
aside from the DNA being positively supercoiled. C: Dwell time (± SEM) between topo VI-
dependent strand-passage events, plotted against the level of DNA supercoiling. Data were fitted 
to an inverse function, where the time taken for topo VI to perform a strand-passage reaction is 
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inversely proportional to the number of DNA crossings present in the substrate. Inset illustrates 
MmT6 binding behaviour, based on the data, as a highly distributive crossing sensor, with each 
DNA crossing within the plectoneme constituting a binding position for topo VI. Data analysed 
in Igor Pro 7, using a T-test based method, first described in [227]. 
 
This further supports MmT6’s distributive nature in supercoil relaxation, but also cements the 
idea, described earlier [62], that this enzyme recognises and binds DNA crossings as a primary 
substrate, making each crossing along the plectoneme a potential site of activity. This is the 
converse of topo IV plectoneme binding behaviour, which was found to bind at a single site, 
likely at the end loop [120]. This DNA crossing binding behaviour of MmT6 is further supported 
by the MmT6 ATPase and DNA binding assays described in Chapter 3. The ATPase rate was 
not only dramatically stimulated in the presence of DNA writhe but also ATPase activity was 
tightly coupled to the presence of DNA writhe, with ATP hydrolysis decreasing once the DNA 
reached a relaxed state. The DNA binding of MmT6 in the absence of ATP, assayed using a 
nitrocellulose membrane capture technique, also indicateed that with increasing levels of 
supercoiling there is increased MmT6 binding.  
 
4.2.3 Effect of Force on MmT6 Supercoil Relaxation 
Alongside shedding light on the behaviour of MmT6, the enzyme titration also provided a useful 
guide for determining the most appropriate enzyme concentration to use in further supercoil 
relaxation assays. Based on both the plectoneme relaxation time and the unambiguity of the 
trace (i.e. being able to clearly distinguish each strand-passage event), the MmT6 
concentration of 750 pM was chosen to assay the effect of force on the supercoil relaxation 
activity. Whilst a constant magnetic force on the DNA could cause tensile-related effects on 
topo activity, being able to control this variable is an important asset of the MT. It can facilitate 
the deceleration of reaction steps, and allow the elucidation of previously uncapturable events. 
This proved invaluable in the study of E. coli topo I and III kinetics, in which the gate opening 
dynamics could be measured for the first time [224].  
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Figure 4.12: DNA extension as a function of magnet turns for different forces acting on a DNA 
plectoneme. A: Positive supercoiling at 0.2 (magenta), 0.5 (pink), 1.0 (purple), 1.5 (dark blue) and 
2.0 pN (light blue). The first black circle is the buckling point in which writhe is formed and the 
second is 10 magnet rotations later, producing 10 supercoils. The black line is a linear fit 
(y=bx+a), the gradient of which is the DNA extension change per magnet turn, plotted in C. B: 
Negative supercoiling at 0.2 (magenta), 0.4 (pink), 0.6 (purple), and 0.8 pN (dark blue). The black 
circles denote the same as in A, with the DNA extension change per magnet turn being plotted 
in D. C: DNA extension change ± SE per magnet rotation as a function of force, for positively 
supercoiled DNA. The data was heuristically fitted to a power trendline (y=axb) (red dashed line). 
D: DNA extension change ± SE per magnet rotation as a function of force, for negatively 
supercoiled DNA. The data was heuristically fit to a linear trendline (y=bx+a) (red dashed line).  
 
 At low force the DNA extension as a function of magnet turns is symmetrical whether 
positive or negative turns are added. However, as described above, high force promotes DNA 
melting rather than negative writhe formation for negative supercoiling (Figure 4.7) [316]. This 
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means that force-dependent effects on MmT6 positive supercoil relaxation can be assayed to 
a higher degree of force compared to negative. As force is increased, there are two important 
aspects which change and therefore require consideration when conducting assays and 
comparing data. These are the magnet turns at which the DNA buckles, converting twist to 
writhe, and the extension change per magnet turn. This information was determined by 
collecting data on the DNA extension as a function of magnet turns for each force used (Figure 
4.12). The force regime for positive supercoils was 0.2, 0.5, 1, 1.5 and 2 pN (Figure 4.12A and 
C), whilst for negative supercoils it was 0.2, 0.4, 0.6 and 0.8 pN (Figure 4.12 B and D). For 
each force the number of turns at which the DNA buckled to form a plectoneme, and the DNA 
extension change per turn, was different. For example, clockwise magnet rotation at 0.2 pN 
caused the DNA to buckle at turn 3 and each subsequent turn corresponded to a change in 
DNA extension of ~79 nm (Figure 4.12A and C). However, at 1.5 pN, the DNA buckled at ~13 
turns, and the DNA extension change per turn was only ~43 nm (Figure 4.12A and C). This is 
information is vital to both conducting the experiments and analysing the data. Regardless of 
force, the same number of DNA crossings in the plectoneme (i.e. writhe) must be input, so 
knowledge of the buckling point facilitated this. Data analysis required knowledge of the 
extension change per linking number expected as the DNA is relaxed.  
Once all the necessary calibration data was obtained (Figure 4.12), the average MmT6 
relaxation rate in the presence of a plectoneme with a writhe of 10 at each force was analysed. 
The outcome can be seen in Figure 4.13. The average relaxation rate on positive supercoils 
exhibited a biphasic character, with the rate increasing from very low (0.2 pN) to moderate force 
(0.5-1 pN), and then decreasing once more as the force increased further (Figure 4.13A). This 
is partially reflected in the negative supercoil data, however as the force cannot be varied to 
the same extent without causing DNA melting, the data extracted is limited (Figure 4.13B). 
Nevertheless, this behaviour suggested that either a single rate-limiting step was being 
changed in two ways, or that increasing the force changed two different steps. The true 
meaning of this data is still unclear however a possible model is that at low force the rate is 
decreased due to increased supercoil movement, which may hinder MmT6 binding efficiency. 
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As the force increased, supercoil diffusion decreased and this may allow more efficient MmT6 
binding. Indeed, it has been previously demonstrated that increasing the force reduced the 
diffusion rate of the plectoneme [317]. The subsequent rate decrease at high force may be a 
function of increasing twist. As force is increased, more twist is required before the DNA buckles 
to form writhe. For supercoiled circular DNA, twist and writhe are partitioned into ~25% twist 
and ~75% writhe [6]. For the MT setup, the DNA tension provided by the magnetic force results 
in twist remaining constant once the DNA buckles to form writhe, with each rotation post-
buckling entirely accommodated by increasing writhe [158, 223]. As the force increases, more 
twist is required before buckling occurs which results in plectoneme formation with a higher 
twist density. Increased twist could hinder a variety of stages during the MmT6 reaction such 
as DNA binding and cleavage, therefore reducing the rate. When the force-dependent supercoil 
relaxation activities of E. coli DNA gyrase (gyrase) were assayed, a similar biphasic result was 
reported for the relaxation of positive writhe, in which gyrase activity increased when force was 
increased from 0.2 to 1 pN [318]. This was predicted to be due to torque-dependent 
acceleration of the DNA-wrapping, which is subsequently inhibited as torque increased further. 
As MmT6 cannot wrap DNA, this can’t explain the data reported here.  
 
Figure 4.13: The effect of force on MmT6 supercoil relaxation activity. A: The average rate of 
positive supercoil relaxation ± SE by 750 pM MmT6 as a function of force, using 1 mM ATP at 
21°C. B: The average rate of negative supercoil relaxation ± SE by 750 pM MmT6 as a function of 
force, using 1 mM ATP at 21 °C.  
 




4.2.4 MmT6 Unlinking Activity Using DNA Braids 
As demonstrated in section 4.2.2, the distributive nature of MmT6 relaxation activity, as 
assayed using MT, was evident independently of the supercoil chirality, however positive 
crossings were still relaxed 2-3-fold faster than negative. Interestingly, a few type IIA 
topoisomerases including E. coli topo IV and human topo IIα also demonstrated preferential 
relaxation of positive writhe [120, 158]. The detailed basis for chiral preference likely varies 
amongst type II topos, however one commonality was that the enzymes preferred a particular 
DNA crossing geometry for either binding or T-segment capture. In order to explore how the 
geometry of the DNA crossings and the presence of twist, play a role in chirality sensing by 
MmT6, the MT-based DNA braiding assay was utilised. In this assay, rather than tethering a 
single torsionally constrained duplex, two unconstrained DNA duplexes were attached to a 
single magnetic bead, which, upon rotation of the magnets, wrapped the duplexes around one 
another (see Figure 4.2B), creating writhe without changing the twist [257]. In contrast to the 
supercoiled substrate, DNA writhe is created directly in the braiding system (rather than via the 
conversion of twist to writhe), therefore the magnets are rotated clockwise for positive crossings 
and anticlockwise for negative. This braided DNA substrate is far more akin to a catenated 
substrate than supercoiled, and allows the exploration of how writhe affects enzymatic 
behaviour in the absence of changing twist. It is worth noting, that 20 magnet rotations (at low 
force) generate a plectoneme which requires 10 relaxation events to become fully relaxed; 
whilst for braiding 10 magnet rotations produces a braid which is fully unlinked via 10 strand-
passage events. This arises as a consequence of supercoiled DNA being intramolecular writhe 
and braided DNA being intermolecular writhe. 
 As with supercoiled DNA, the braided substrate required calibration in terms of DNA 
extension as a function of magnet turns (hat curve), before the addition of  MmT6. The hat 
curve of a bead tethered by two DNA duplexes has a highly characteristic shape, and must be 
confirmed prior to data collection (Figure 4.14). A braid hat curve should be triphasic, beginning 
with a dramatic decrease in DNA extension as the first turn is executed, which is followed by a 
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shallower extension decrease as the braid is formed. At ~20 turns (for 0.5 pN), the braid 
buckled and wrapped around itself forming a four-duplex supercoiled braid structure with each 
magnet turn producing a larger DNA extension decrease than for braiding. In general, assays 
are performed using the single crossing and braid substrates only, as activity on the supercoiled 
braid structure is not quantifiable, due to difficulty in characterisation as a result of its topological 
complexity.  
 
Figure 4.14: Braided DNA tether hat curve. DNA extension was plotted as a function of magnet 
turns. The braid curve is symmetrical, with the first full positive or negative turn resulting in a 
dramatic extension decrease (see i, in dashed box). Subsequent turns cause the DNA extension 
to decrease with a shallower gradient as the DNA braid is formed (see ii). Eventually the braid 
buckles upon itself and produces a supercoiled braid structure (see iii), with each magnet turn 
resulting in a larger DNA extension decrease than for braiding. Data collected under 0.5pN, at 
21°C, using 5 kb DNA tethers. 
 
  In the case of MmT6, the braided DNA substrate had a surprising effect on MmT6 
activity. In Figure 4.15A, an example trace of 50 pM MmT6 activity (0.5 pN), shows how a 
positive braid is relaxed in two rapid bursts which corresponded to 5 strand-passage events at 
rates of 0.6 to 1.25 strand-passage events sec-1. In Figure 4.15B, using 100 pM MmT6 on a 
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negative braid, the situation was similar with rapid bursts of 2 or more consecutive strand-
passage events also occurring. It was evident that the average rate of braid unlinking had 
increased ~5-fold above that of supercoil relaxation (e.g. 500 pM MmT6 gave an average rate 
of 3.5 ± 0.8 strand-passage events/min on positively supercoiled DNA, and 18.9 ± 2.3 strand-
passage events/min on positive braids) (Figure 4.16A). Moreover, MmT6 was capable of 
sustaining robust activity at concentrations ∼5-fold lower than was achievable in supercoil 
relaxation, with a mild processive behaviour (e.g. passing a consecutive T-segment whilst 
remaining bound to the initial G-segment). Rates for MmT6 processive activity (dwell times between 
events not included in the average) (Figure 4.16B) are comparable to the rates of other type IIA 
topos, for instance E. coli DNA gyrase, measured using a rotor bead tracking technique, showed 1 
strand passage event sec-1 [319], and E. coli topo IV has been documented to have a rate as high 
as 2.5 strand passage events sec-1 using a positively supercoiled magnetic tweezers assay [119].  
The average unlinking rates by topo VI at concentrations ranging from 50 to 900 pM, were 
well described by a Michaelis-Menten-like function, providing Vmax values of 21.4 ± 0.5 and 10.9 ± 
1.3 strand passage events min-1, and Kd,app to be 66.5 ± 7.3 and 164.2 ± 72.4 pM, for the unlinking 
of positive and negative braids respectively (Figure 4.16A). The chiral preference remains, with the 
Vmax being 2-fold higher, and the Kd,app being 2.5-fold higher, for positive braid-unlinking over 
negative. This further suggests the chiral selection originates from a DNA-crossing geometry 
preference for MmT6 which occurs at a stage between binding and strand-passage. Based on DNA 
binding experiments (Chapter 3, Section 3.2.6), the chiral selection may be occurring after initial G-
segment binding as MmT6 exhibits tighter binding to negative writhe than it does positive, 
suggesting that perhaps the cleavage of the G-segment and/or passage of the T-segment through 
the break, is sensitive to the crossing angle. However, as this magnetic tweezers data doesn’t 
delineate between binding, cleavage and strand passage, exactly when the chiral selection takes 
place isn’t clear. Moreover, the binding assays don’t discriminate between DNA crossing binding or 
G-segment alone, so it is plausible that MmT6 binds non-productively to negative writhe more than 
it does on positive.   
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Figure 4.15: MmT6-dependent braid unlinking examples. A: Positive braid writhe unlinked by 50 
pM MmT6, with 1 mM ATP, under 0.5 pN at 21°C. The black arrow indicates where 10 clockwise 
(+) magnet rotations were initiated. The light grey points are the raw data with the black 
representing the smoothed data, achieved using the Savitzky–Golay filter in Igor Pro 7. The red 
dashed line indicates periods of inactivity (horizontal portions) and processive bursts of multiple 
strand passage events (diagonal portions). The solid red line is a scale bar, highlighting how the 
unlinking activity is occurring in steps larger than a ΔLk of 2.  B: Negative braid writhe unlinked 
by 100 pM MmT6, with 1 mM ATP, under 0.5 pN at 21°C. All annotations are the same as in A, 
aside from the black arrow which denotes the addition of 10 anticlockwise (-) rotations. Kinetic 
parameters measured can be seen described in Figure 2.5. 
   
 The MmT6 Vmax for unlinking was around 3-fold higher than for supercoil relaxation and 
largely due to bursts of two or more unlinking events in rapid succession. This rapid unlinking 
could be due to either simultaneous binding and unlinking by multiple enzymes or a processive 
unlinking by a single enzyme, with these scenarios distinguishable based on the enzyme 
concentration dependence. Extracting the rates of the processive bursts in the absence of the 
dwell times, as well as the size of these bursts (termed step size and measured in number of 
strand-passage events), the values remain fairly constant across large changes in MmT6 
concentration suggesting that this burst activity is likely due to processive unlinking by a single 
enzyme (Figure 4.16B and C). On the other hand, the duration of the dwell times between 
events decreases with increasing MmT6 concentration, further indicating that a single enzyme 
drives a burst of multiple unlinking events (Figure 4.16D). This striking outcome strongly 
suggests that a unique geometrical property manifested in DNA braids, but absent/rare in 
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Figure 4.16: MmT6-dependent braid unlinking. A: The average rate of topo VI braid unlinking 
activity (± SEM), both positive and negative chirality, measured as the number of strand-passage 
events/min and plotted as a function of topo VI concentration. Data were fit (dashed lines) to a 
Michaelis-Menten-like function ( 𝑽𝟎 =
𝑽𝒎𝒂𝒙[𝑬]
𝑲𝒅,𝒂𝒑𝒑/[𝑬]
	). B: The processive burst rate of topo VI (± SEM), 
measured as the number of strand-passage events/min within each burst, and plotted as a 
function of topo VI concentration. A burst is defined as rapid topo VI activity corresponding to 
the passage of two or more consecutive T-segments, in which individual strand-passage events 
cannot be discerned. C: The processive burst size of topo VI (± SEM), measured as the number 
of strand-passage events/burst, and plotted as a function of topo VI concentration. D: The dwell 
times between processive bursts of topo VI activity, plotted as a function of topo VI 
concentration. A dwell time is defined as a period of time in which the DNA extension remains 
constant, reflecting lack of topo VI-dependent braid unlinking activity. In Figures 4A-D, data was 
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collected under 0.5 pN force, at 21°C, using 1 mM ATP, with topo VI activity on positive DNA 
braids being highlighted in red, and in blue for negative DNA braids. 
 
The DNA crossing angle of the G- and T-segment is considered an important factor in 
the DNA substrate preference of type II topos. Recent work from the Neuman lab (NHLBI, NIH, 
Bethesda, USA) (data not shown) suggested all angles within a braid are wider than those 
found in supercoils, dependent on DNA tension, spacing and temperature, something that was 
also documented in Charvin et al. [223]. More work is required to fully understand DNA braid 
geometry, however it is likely that this change in DNA-crossing angle stimulated MmT6 activity 
as MmT6 transitioned from being perfectly distributive on supercoils to mildly processive on 
braids. A potential explanation is that this is a function of DNA-crossing angle, with the diffusion 
of the T-segment into the MmT6 cavity at the appropriate juxtaposition to the G-segment, 
occurring rapidly for braids, and rarely for supercoils. MmT6 behaviour may also be affected 
by twist, since braided DNA is unable to store any perturbations in twist, only writhe. In 
supercoiled molecules the twist is changed dramatically from the relaxed state, depending on 
the force. Therefore, MmT6 processivity on braided DNA could be due to more stable binding, 
or faster cleavage/re-ligation, in the absence of changing twist. In Section 4.2.6, the effect of 
DNA geometry on MmT6 activity will assayed directly.  
 
 
Figure 4.17: Agarose gel based assay of DNA decatenation and relaxation by MmT6. On the left, 
a singly catenated, negatively supercoiled plasmid substrate is decatenated by 0.1-20 nM MmT6. 
The catenated plasmids vary in size and when decatenated, can be seen as two bands that 
migrate further than the catenated substrate. As they are also negatively supercoiled, the 
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relaxation of the plasmids can be seen at MmT6 concentrations ~10 fold higher than when full 
decatenation is seen. This is further corroborated by a relaxation assay performed using 
negatively supercoiled pBR322* (right-hand gel), where relaxation activity is not detected until 
~10 fold the MmT6 concentration necessary for decatenation. OC: open circular, Rel: relaxed and 
Sc: supercoiled.  Both reactions were incubated for 30 min at 37°C. 
 
As mentioned above, the braided DNA substrate is often likened to a catenated 
substrate and topo-dependent unlinking activity is considered a proxy for exploring 
decatenation activity. This parallel between braided and catenated DNA arises due to the braid 
also forming intermolecular writhe with DNA crossing geometries more similar to catenanes 
than supercoils [223]. Therefore, the data presented here may indicate that MmT6 is more 
efficient at decatenation than supercoil relaxation, in vivo, in line with its predicted role. 
However, decatenation has been a more challenging activity to quantify using traditional gel-
based topology assays, due to the reliance on kinetoplast DNA (kDNA). This substrate 
originates from the mitochondria of trypanosomes and is formed of an extended network of 
interlinked DNA plasmids of two sizes called maxicircles (20-40 kb) and minicircles (0.5-1kb) 
[256]. As discussed in Chapter 3, its use can be a qualitative measure of decatenation activity, 
with plasmids released from the network as a result of topo-dependent activity, which can be 
visualised using gel electrophoresis. However, with the inability to quantify or control how many 
plasmids are interlinked and to what degree, comparing a topo-dependent decatenation activity 
to supercoil relaxation using a gel-based approach is limited. Recently, a DNA substrate was 
developed by Nidda Waraich (JIC, Norwich, UK; Waraich et al. BioTechniques, in press, 2020. 
See Section 3.2.4.2), in which two plasmids of different sizes are singly-linked. This facilitated 
a far more quantitative approach to studying decatenation activity and allowed the comparison 
of MmT6-dpendent decatenation activity to supercoil relaxation. As seen in Figure 4.17, MmT6 
activity during decatenation was detectable at MmT6 concentrations 10-fold lower than for 
supercoil relaxation (0.1-0.5 and 5 nM MmT6, respectively). This further supports the MT-based 
data, which also demonstrated robust activity in braid unlinking at concentration 5-10-fold lower 
than plectoneme relaxation (25-50 and 250-500 pM, respectively). Again, this strongly 
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suggested that there was a unique feature of both braids and catenated DNA molecules that 
enhanced MmT6 activity.  
 
4.2.5 Effect of Force on MmT6 Unlinking Activity  
As was achieved for supercoil relaxation activity (section 4.2.3), varying the tensile force on the 
braid was conducted to illuminate further nuances of MmT6 behaviour. In the case of 
plectonemes, the force is perpendicular to the plectoneme axis, which makes parsing the 
effects of force on the supercoils and MmT6 activity more theoretically challenging as it’s 
unclear whether the plectoneme itself experiences any of this force directly, or if the effects of 
force arise from the accompanying changes in twist. In the case of a DNA braid, the magnetic 
force runs parallel to the DNA, meaning force has a direct effect on the DNA crossings, and 
likely the activity of MmT6. The calibration for this form of analysis was simpler for DNA braids, 
than it was for supercoils. Due to the absence of changing the twist, DNA braids remain chirally 
symmetrical at high force, unlike the DNA melting which occurs during negative supercoil 
formation. This results in the ability to assay the effect of force on MmT6-dependent negative 
braid unlinking to the same degree as positive, in theory. In reality, as explored below, MmT6 
was more sensitive to force during negative braid unlinking and did not display activity to the 
same force maximum as for positive braid unlinking.  In supercoils, knowledge of both the 
buckling point (where twist is converted to writhe), and the DNA extension change per magnet 
rotation, as a function of force, were necessary for accurate assay execution and data analysis. 
However, for braids, only the latter piece of information is relevant as writhe is input immediately 
upon magnet rotation, independent of the force.  




Figure 4.18: DNA extension change per magnet rotation, for different forces acting on a DNA 
braid. A: The DNA extension change per magnet rotation for a positive DNA braid under 0.5, 1 ,2, 
3 and 4 pN of force ± SE. Data points black circles, joined by a red dashed line. B: The DNA 
extension change per magnet rotation for a negative DNA braid under 0.5, 1 ,2 and 3 pN of force 
± SE. Data points black circles, joined by a red dashed line.  Please note that for most data points 
in A and B, the error bars are too small to be visualised.   
 
The force regime for positive braid unlinking was 0.5, 1, 2, 3 and 4 pN, and for negative braid 
unlinking it was 0.5, 1, 2 and 3 pN. Calibration data for the DNA extension change per magnet 
rotation can be seen in figure 4.17. The values for positive (4.18A) and negative (4.18B) braids 
are similar, but as mentioned above, should be symmetrical. The reason this is not the case 
for this data is entirely due to different braids being utilised for positive verses negative braid 
unlinking. Depending on the duplex spacing of the DNA braid, the extension change per 
magnet rotation can be subtly different. Whilst this shouldn’t affect the results dramatically it is 
worth noting as DNA spacing modulates the angle distributions of the DNA crossings, and as 
explored in future sections, MmT6 is sensitive to DNA crossing angles.  
Varying the force in the magnetic tweezers braiding system (Figure 4.19) revealed a 
similar effect on MmT6 activity to that of supercoil relaxation. For positive-braid writhe, 
increasing the force from 0.5 to 1 pN resulted in a moderate rate increase, whereas for 
negative-braid writhe the rate at these two forces was the same (4.19A). This is reminiscent of 
the initial rate increase in supercoil relaxation when force was increased from 0.2 to 0.5 pN 
(Figure 4.13), with the potential explanation for this being the same, e.g. a low-level increase 
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in force reduces the diffusion rate of DNA crossings, enhancing MmT6 DNA-crossing binding 
efficiency. This is then followed by a significant drop in unlinking rate for both positive and 
negative braids as force is increased further. Negative-braid unlinking was more sensitive to 
force increases, with no activity detected at 4 pN. MmT6 was still able to unlink positive braids 
at 4 pN, however activity was severely compromised. This decrease in activity was determined 
to be largely a consequence of an increase in dwell times between unlinking events as force 
increased (Figure 4.19B). Both processivity and step size were largely unaffected, however 
there was a mild decrease in both for the unlinking of positive braids with high force reducing 
both to the level measured for negative braid unlinking (Figures 4.19 C and D). This force-
dependent rate reduction could be the result of two different factors. It may be due to a force-
dependent step in the catalytic cycle that becomes rate limiting, for example, transferring a 
DNA strand against DNA tension.  
 
Figure 4.19: The effect of force on MmT6 unlinking activity. A: The average rate of positive (red) 
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B: The average dwell times (s) between unlinking events for positive (red) and negative (blue) 
braids (± SEM), plotted against force. C: The average processivity rate (strand-passage 
events/min/burst) for positive (red) and negative (blue) braid unlinking (± SEM), plotted against 
force. D: The average step size for positive (red) and negative (blue) braid unlinking bursts (± 
SEM), plotted against force. Assays in Figures A-D conducted using 500 pM topo VI and 1 mM 
ATP, at 21°C. 
 
However, it is more likely to be due to the increased force causing a change in the DNA crossing 
angle distribution disfavouring MmT6 activity, possibly affecting both binding time and strand-
passage efficiency. A similar form of analysis was completed for E. coli DNA gyrase (gyrase), 
in which unlinking of positive and negative writhe was measured for different forces. Like 
MmT6, gyrase had a distinct preference for unlinking positive braid writhe, however, unlike 
MmT6, it was able to efficiently unlink positive braids at high force (5 pN), and unable to unlink 
negative braids under all force conditions assayed (0.2 – 5pN). These distinctions between 
MmT6 and gyrase are likely due to the way in which the enzymes engage with DNA, as 
wrapping of the DNA around the gyrase GyrA C-terminal domains, heavily favours interaction 
with positive DNA crossings, disfavouring negative. Whilst MmT6 demonstrates a mild chiral 
preference for positive crossings, it does not wrap DNA and therefore does not disfavour 
negative braid unlinking as strongly. 
 
4.2.6 MmT6 DNA Crossing Geometry Preference 
Based on the data reported here, for both supercoil relaxation and braid unlinking, MmT6 
displayed a 2 to 3-fold rate enhancement during positive DNA crossing resolution, compared 
to negative. In combination with exploration into how force affects MmT6 activity, these results 
suggest that MmT6 may have a preference for a particular DNA crossing angle, that is; the 
angle in which the G and T-segment juxtapose, which is more common in positive crossing 
than negative. Due to the rate increase in the presence of positive writhe, this indicated that 
the angle preference was below 90° as acute angles are more common in positive DNA 
crossings [119, 120]. In order to explore MmT6’s preferential DNA geometry in more detail, 
unlinking rates of a single crossing by MmT6 were measured, in which the crossing geometry 
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can be well-defined and therefore its effect on activity determined. A single crossing, in this 
context , describes one full 360° rotation of the magnetic bead, which creates an intertwined 
DNA substrate that is fully relaxed by type II topos in a single strand-passage event. This 
method was first described in [120] and applied to E. coli topo IV. Shown in Figure 4.14, when 
the braid goes from fully relaxed to a single crossing, achieved by one 360° magnet rotation, 
there is a distinct drop in DNA extension. This allowed straightforward measurement of the 
unlinking rate of a single crossing of either chirality. These measurements were conducted at 
high MmT6 concentration as they were complete in a single catalytic event, and this ensured 
T-segment binding, rather than G-segment binding, was rate limiting. This, when combined 
with Monte-Carlo simulation-derived crossing angle distributions, allows determination of the 
MmT6 crossing angle preference. This is facilitated due to single positive and negative 
crossings being identical in every respect, aside from the crossing angle distributions. An 
enzyme with a preference for a crossing angle below 90° will have increased activity on positive 
crossings, as is true for MmT6 and topo IV [119, 120], whereas if the enzyme binds 
preferentially to perfectly symmetric crossing angles (90°), there would be no difference 
between the rate of relaxation on positive and negative crossings, as seen for yeast topo II 
[120].  
 
Figure 4.20: Braid tether calibration and geometric fit. A: The DNA extension of a 3 kb double 
tether, plot as a function of magnet rotations and fit to a geometric function [120]: 𝑳 =
	-𝑳𝟎𝟐 − 𝟒𝒆𝟐𝒔𝒊𝒏𝟐(𝒏𝝅)	– 𝐫 +	√𝒓𝟐 − 𝒆𝟐, |𝒏| < 𝟎. 𝟓,  where L is the measured DNA extension (dependent 
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on the force applied), L0 is the maximum DNA extension (dependent on the force), e is half the 
separation distance between the DNA molecules, n is the number of magnet rotations, and r is 
the radius of the magnetic bead to which the tethers are bound. The first term in the expression 
describes the extension of a twisted swing, whilst  the second two terms are a correction for the 
spherical bead, see [120] for a full description. The output from the fit in terms of DNA spacing 
are found in Table I, Appendix II. B: Geometric parameters of the DNA tethers, attained through 
the calibration and subsequent geometric fit (seen in Figure 7A), namely the length of the DNA 
tethers (L) and the separation distance between them (x, or 𝟐𝒆). Along with the force and number 
of turns, this information is used in Monte Carlo (MC) and Brownian Dynamics (DB) simulations. 
 
 To begin, the braid being assayed requires precise calibration of the first crossing, 
meaning DNA extension is measured for every 10th of a magnet rotation. This data was then 
fitted to a geometric function, which allows the calculation of both the length and spacing of the 
DNA attached to the bead (see Figure 4.20). This information, along with the magnetic force 
applied to the bead, as DNA tension affects the DNA crossing angle distribution, is integral to 
executing DNA crossing angle simulations as a means of obtaining the angle distributions of 
the DNA crossing geometry being assayed. Once calibration is complete, data collection in the 
presence of MmT6 was undertaken, adding one full turn in one direction, allowing MmT6 to 
unlink the DNA crossing, before adding a full turn in the opposite direction and so on (Figure 
4.21A and B). The times taken to relax either positive or negative crossings were plotted as 
histograms and fit with single exponentials to attain the characteristic unlinking times for the 
crossing geometry being assayed (Figure 4.21C). In agreement with results from DNA braids 
and supercoils, the characteristic unlinking time from the fitting on positive crossings (τL) for the 
braid assayed in Figure 5 was 8.4 ± 1.4 s, which was 4.7-fold faster than that of negative 
crossings (τR) (43.8 ± 6.9 s), suggesting that a positive crossing geometry facilitates topo VI 
activity through the higher probability of forming the preferred crossing angle (Figure 4.21C). 
For all data collected and analysed in this section see Appendix II Figures 1-3 and Table 1. To 
relate this experimentally derived data to a more precise value for the DNA crossing angle 
preference of MmT6, both Monte Carlo (MC) (Figure 4.22A) and Brownian Dynamics (BD) 
simulations were performed to determine the distribution of crossing angles formed for a given  
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Figure 4.21: Experimental data collection and analysis of MmT6 single-crossing unlinking 
activity. A: Single crossing assay schematic with DNA crossing geometry for positive (left-
handed, red) and negative (right-handed, blue) DNA writhe. One 360° clockwise magnet rotation 
imparts a positive crossing, which is unlinked by MmT6, followed by the generation and 
subsequent MmT6-dependent unlinking of a negative DNA crossing, formed by a 360° 
anticlockwise magnet rotation. The crossing angle is defined as the clockwise angle between the 
top and bottom DNA strands, and for positive crossings this is an acute angle (α), and obtuse for 
negative crossings (π-α). For MmT6, achieving the preferred angle (α0<90) requires a smaller 
thermal fluctuation of positive crossings, therefore there is a higher probability of α0 being 
achieved than for negative crossings. B: Single crossing unlinking data, collected for a braid 
formed from 3-kb DNA tethers, spaced 624 nm apart, at a force of 1 pN, using 900 pM MmT6 and 
1 mM ATP. Positive crossings (red) were relaxed more rapidly than negative crossings (blue). C: 
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Distributions of the MmT6-dependent unlinking times for negative (blue bars) and positive (red 
bars) crossings, of the data shown in B. The data (N=100) were fitted with single exponentials, 
P(t) = Aexp(-t/τ), giving characteristic unlinking times of τR= 43.8 ± 6.9 for negative crossings, and 
τL= 8.4 ± 1.4 for positive crossings, with a ratio of τL/ τR = 0.19 ± 0.04.  
 
DNA geometry and force. The BD simulations were executed by Parth Desai (NHLBI, NIH, 
Bethesda, USA). The crossing angle distribution were obtained by simulating the thermal 
fluctuations of two DNA molecules, the movements of which were dependent on DNA length, 
the tension applied to the DNA, temperature, and the spacing between the DNA duplexes. So, 
whilst the average crossing angle was not necessarily the preferred crossing angle (α0), this 
fluctuation resulted in α0 being formed at a certain frequency, which was related to the 
measured unlinking rate of a single crossing (assuming that achieving α0 is rate limiting). The 
MC and BD simulations can predict how probable α0 is under the given DNA crossing geometry 
for positive and negative crossings. If the assumptions that the time taken to unlink the crossing 
is dependent on a single rate limiting step, which is likely as the unlinking times are 
exponentially distributed, and that this step is dependent on the DNA crossing angle, then τL/ 
τR  is equal to the ratio of negative and positive crossing angle probabilities (Figure 4.22B). In 
other words, for the crossing geometry in Figures 4.21 and 4.22, the positive crossing is relaxed 
4.7 times faster than the negative, and so using this ratio, the angle that appears 4.7 times 
more often in positive crossings than negative can be determined. This was repeated for 
fourteen different crossing geometries, with all resulting in extremely similar values for crossing 
angle preference, independent of the average or most probable crossing angle for that 
particular braid geometry (Figure 4.22C) or the force under which the data was collected 
(Figure 4.22D0. 
 Together these data indicated that the preferred crossing angle for MmT6 was 87.8° ± 
0.4°, when using MC simulations, and 87.4° ± 0.4°, when using BD simulations. Supported by 
MC simulations done in Stone et al. [119], this angle preference can account for the consistent 
∼2-fold difference in rate between the positive and negative supercoil relaxation and braid 
unlinking assays, with 87.4-87.8° appearing in positive crossings ∼2-fold more frequently. This 
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value is not dissimilar to that found for topo IV, attained using the same assay, of 85.5° [120]. 
However, one distinct difference is that topo VI was far more strict about the crossing angles 
on which it would act. If the imposed crossing angle (αL) is defined as the most common angle 
 
 Figure 4.22: Preferred DNA crossing angle measurements for topo VI. A: Crossing angle 
probability distributions for single positive (PL(α), red) and negative (PR(α), blue) crossings, from 
Monte Carlo (MC) simulations [223] for the tether geometry and force seen in Figure 5. The 
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positive angle probability distributions were attained directly, whereas the negative distributions 
were derived from the relationship PR(α) = PL(180°-α). For Brownian dynamics (BD) simulations, 
the negative crossing angle distributions, like the positive, were measured directly. The imposed 
crossing angle (αL, black-dotted line) is the most probable angle for the positive crossing angle 
distribution, in this case ≈79°. B: Ratio of negative to positive probability from Figure 4.22A 
plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle 
(α0) can be determined, illustrated by the black arrow. For this tether geometry and force, τL/τR = 
0.19 ± 0.04, which gave α0 of 87.9° ± 4.4° when using MC simulations, and 83.5° ± 4.2° when using 
BD simulations. The error associated with α0, as is the same for Figures 6C and D, is the 
combination of the statistical and systematic error. C: Preferred crossing angles (α0) from 
fourteen different DNA tether geometries, plotted against the most probable positive crossing 
angles (αL), or imposed crossing angles, as measured by MC simulations (filled circles, left-hand 
plot) and BD simulations (open circles, right-hand plot). D: Preferred crossing angles (α0) from 
fourteen different DNA tether geometries, as measured by MC simulations (filled circles, left-hand 
plot) and BD simulations (open circles, right-hand plot), plotted against the force on the DNA 
tether. The combined average preferred crossing angle for topo VI, ascertained using MC 
simulations, was 87.8° ± 0.4° (± SEM), and using BD simulations, was 87.4° ± 0.4° (± SEM), both 
values represented by the dotted line and error shading in plots C and D.  
 
to appear in the positive distribution (see Figure 4.22A), then the most acute αL that MmT6 
could unlink was 77°, anything lower than this and no activity was detected. However, topo IV 
seemed far more versatile and was able to unlink crossings with αL as low as 50° [18]. This 
may suggests that MmT6 either cannot remain bound to a disfavoured crossing for long enough 
to achieve the preferred angle, or that it cannot exert any control over the crossing angle, whilst 
topo IV may be able to. MmT6 is the most structurally simple type II topo and so it is possible 
that the lack of large CTDs and/or a third protein interface, renders it a far more passive 
crossing sensor. Taken together, the data obtained from the single crossing assays not only 
provides an explanation for the chiral selectivity of MmT6, but also strengthens the idea that 
topo VI is a preferential decatenase. Using MC simulations, it has been shown that angle 
distributions within catenanes are distributed around 90°, whilst supercoils are more acute at 
60° [19]. A strict crossing angle preference of 88°, would indeed predispose topo VI to being 
far more active in decatenation than supercoil relaxation. Moreover, simulating the crossing 
angle distributions using two distinct simulation techniques and attaining strikingly similar 
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values for MmT6 α0, not only adds confidence to the accuracy of this value but also supports 
the use of either simulation technique in DNA crossing angle distributions. 
 
4.3 Conclusions 
In this study, it has been demonstrated that not only is MmT6 a perfectly distributive and 
extremely slow supercoil relaxase, confirming work done in [62], but that in the presence of 
braided and catenated DNA substrates, its rate increased 5 to 10-fold, matching rates 
determined for other type IIA topos on their respective optimal substrates [19, 35]. Along with 
the observation that MmT6 has an extremely strict preference for DNA crossing geometries 
close to 90°, which appear far more frequently in catenanes than they do in supercoils [119], 
these data strongly indicates that MmT6 is a preferential decatenase, which in turn intrinsically 
disfavours supercoil relaxation (Figure 4.23). This leads to providing a potential explanation for 
the presence of topo VI in higher eukaryotes, during situations in which the genome is rapidly 
replicated, such as endoreduplication in plants, explored in depth in Chapter 6.  
 The chiral selectivity for positive writhe, explained by the crossing angle preference of 
87.4-87.8°, was an unforeseen result. Whilst being consistently significant, on both plectonemic 
and braided DNA substrates, the 2 to 3-fold increase in rate on positive writhe is not particularly 
stark, unlike the difference seen for topo IV, which relaxed positive writhe 21-fold faster than 
negative [120]. So whether this rate difference for MmT6 has in vivo implications isn’t clear, 
however as M. mazei encodes a DNA gyrase which maintains the genome in a negatively-
supercoiled state, perhaps the slight angle preference for positive DNA crossings, prevents 
MmT6 from interfering with the activity of DNA gyrase. It may also indicate, as supercoils ahead 
of replication forks are positive, that MmT6 can help support the relief of replication and 
transcription induced torsional strain in combination with other topos.  
 Another surprising outcome of this work was the switch from being highly distributive in 
the presence of supercoils, to mild processivity on braids. There are two main differences 
between the magnetic tweezers supercoiling and braiding substrates: (1) braids do not 
accumulate twist upon magnet rotation, whilst supercoils do, and (2) the DNA-crossing angle 
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geometries within a braid are wider than those within the plectoneme. So it is likely that one of, 
or a combination of the two, is promoting processivity by MmT6. The more likely candidate is 
the DNA-crossing angle, promoting binding and strand passage on braids, as opposed to twist-
related effects. This is due to results obtained by varying the upwards force on the DNA by the 
magnets (Figures 4.13 and 4.19). For braids, the main effect on the MmT6 reaction caused by 
increasing force, is an increase in dwell time between relaxation events (Figure 4.19B), 
suggesting that the time it takes for MmT6 to bind increased as angle distributions narrowed. 
There was also a moderate decrease in processivity rate and step size on positive braids, which 
again could be a function of the preferred angle becoming less probable as force increased 
(Figure 4.19C and D). Therefore, MmT6 may have struggled to remain bound to the G-segment 
long enough to capture and pass a consecutive T-segment at the correct juxtaposition. 
However, this does not rule out the possibility that twist played a role, as using high force during 
positive supercoil relaxation (Figure 4.13A), also caused a dramatic decrease in rate. The main 
change in a supercoil with increasing force is the amount of twist required to buckle the DNA 
and produce writhe, hence increased twist may also be inhibitory during supercoil relaxation. 
The data trend obtained from the force titration experiments on both positive and negative 
supercoil relaxation (Figure 4.13A and B) also indicated that increased force affected either 
one rate limiting step in two ways, or two different steps. This is clearer for positive supercoil 
relaxation, as high force promotes melting of negatively supercoiled DNA, thereby precluding 
measurements at high forces (Figure 4.13). From low to medium force (0.2-1 pN) the rate 
increases modestly before rapidly declining at high force (>1 pN). The initial rate increase may 
be a function of slowing the diffusion of the crossings within the plectoneme so that they are 
more easily captured by topo VI, as indeed it has been demonstrated that increasing the force 
can have a dramatic effect on the diffusion of the plectoneme itself [317]. The rate decrease at 
high force may be a function of increasing twist perturbations away from the relaxed state, that 
could affect a variety of stages during the MmT6 reaction such as DNA binding and cleavage.
 Taken together, the data presented in this chapter provides both supporting evidence 
for the previously documented inefficiency in supercoil relaxation [62], but also extends to 
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providing an explanation for this as a function of a strict crossing angle preference close to 90°. 
It was demonstrated that MmT6 was more active and processive during braid unlinking, and 
together with ensemble measurements of decatenation activity, it seems likely that MmT6 is 
preferential decatenase, which intrinsically disfavours the removal of supercoils.  
 
 
Figure 4.23: Summary model for chirality-dependent MmT6 activity. MmT6 DNA binding and 
strand passage has a chiral selectivity, which results in the passage of the T-segment occurring 
more rapidly when the DNA crossing angle ≈ 90°. This angle geometry is far more probable in 
braided and catenated DNA substrates than in supercoils, hence MmT6 preferentially 
decatenates whilst disfavouring the relaxation of supercoils. Larger thermal fluctuations must 
take place for supercoils to reach the preferred MmT6 crossing angle, and are therefore less 
efficiently relaxed. Chiral selection of positive supercoils over negative supercoils can also be 
explained by an angle preference of slightly below 90°, as this angle appears more often in 
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positive supercoils than negative. MmT6 and DNA structures modelled in PyMol, using PDB: 
2Q2E (MmT6)[195] and PDB: 1ZEW (B-form DNA) [320]. 
 
4.4 Future work   
The MT approach has gained popularity in the characterisation of topo activity at the single-
molecule level, due to its exquisite sensitivity, highly quantifiable measurements and full control 
over DNA topology. The work reported here not only expands on this, but represents the first 
foray into the single-molecule behaviour of topo VI, using MmT6 as a model enzyme. A lot of 
insight has been gained from this work and the groundwork has been laid for future mechanistic 
studies on this curious enzyme. This could include exploration into the effects of salt 
concentration, the effect of twist density on activity, or mutational studies in which MmT6 is 
systematically explored for protein regions important for various aspects of activity (similar to 
that done using ensemble techniques [62]). The MT set up was used to explore DNA binding 
by topo IV, finding it both bends and over twists DNA upon binding in the absence of ATP [321], 
and this is another example of an assay which could be applied to topo VI. As mentioned in 
Chapter 1 and section 4.2.3, the MT set up facilitated the first measurement of gate opening 
dynamics for E. coli topo I and III [224]. This has not been achieved for a type II topo, and 
MmT6 would make a marvellous candidate for the exploring gate-opening, due to it having only 
two protein interfaces (N-gate and DNA-gate), rather than the three present in type IIA topos 
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Chapter 5 
Utilising Next Generation Sequencing to Explore Type 
II DNA Topoisomerase Sequence preference in vitro 
Using Plasmid DNA 
 
5.1 Introduction 
The work included in this section (Section 5.1) has been adapted from previously published 
work by McKie et al., 2020 [54] and appears with full permission.  
As they are vital to cellular survival and constitute effective antibiotic and anti-cancer 
targets, understanding the DNA binding and cleavage profiles of DNA topoisomerases (topos) 
is of great interest to the field. Whereas the fundamental biochemistry of the topo reactions has 
been established, how their activity is regulated across the genome and through time in vivo 
has only recently begun to be addressed in a systematic manner with the utilisation of next-
generation sequencing (NGS) technologies. NGS platforms have been adapted to generate 
genome-wide maps and sequence context of binding and cleavage of topos. Continuous 
refinements of these techniques have resulted in the acquisition of data with unprecedented 
depth and resolution, which has shed new light on in vivo topo behaviour. The binding and 
activity of topos over the genome in vivo was difficult to study until the advent of NGS. Over 
and above traditional chromatin immunoprecipitation (ChIP)-seq approaches that probe protein 
binding, the unique formation of covalent protein–DNA linkages associated with DNA cleavage 
by topos affords the ability to probe cleavage and, by extension, activity over the genome. NGS 
platforms have facilitated genome-wide studies mapping the behaviour of topos in vivo, how 
the behaviour varies among species and how inhibitors affect cleavage. Many NGS 
approaches achieve nucleotide resolution of topo binding and cleavage sites, imparting an 
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extent of information not previously attainable. Discussed below are the current examples in 
which NGS has been utilised to perform in vivo topo binding and cleavage activity.  
 
5.1.1 Next-generation sequencing  
The first widely used sequencing technique was developed in 1977 by Frederick Sanger and 
colleagues, which employed the use of chain terminating dideoxynucleotides [322]. It was later 
automated by Applied Biosystems with the development of the AB370 in 1987, which 
accelerated sequencing time and increased accuracy by using capillary electrophoresis [323]. 
Whilst this was a revolutionary technique for the time, and facilitated the completion of the first 
human genome in 2004 [324], this ‘first generation’ sequencing method had its limitations. 
Sanger sequencing is relatively low-throughput, time-intensive, and expensive. Efforts to 
ameliorate sequencing resulted in the development of affordable, high-throughput 
technologies. This led to a number of innovations in the DNA sequencing field and the birth of 
next-generation sequencing (NGS) platforms [325], which allow cell-free library preparation 
and are able to perform millions of parallel sequencing reactions, detecting the output directly 
without electrophoresis. This meant that genomes could be fully sequenced in an 
extraordinarily short timeframe. The main drawback, particularly for the first NGS platforms, 
was the relatively short read length. However, this was circumvented through the development 
of new algorithmic tools for aligning short reads.  
In 2005 the first NGS platform was released by Roche, the 454 genome sequencer 
[326]. The detection method used, called pyrosequencing, relied on the activity of 
pyrophosphate, which would emit light when a base was incorporated, and allowed the 
sequencing of ~200,000 reads, ~110 bp long per run, generating 20 Mb of data. More recent 
advances made reads of 700 bp possible, generating 0.7 GB of data in less than 24 h with the 
454 GS FLX Titanium system. In 2006, Sequencing by Oligo Ligation Detection (SOLiD) by 
Agencourt, was bought by Applied Biosystems [323]. This NGS platform uses octamer oligos, 
each with a unique fluorescent label, that interrogate the first two bases in the sequence 
adjacent to the sequencing primer. Once the label colour is detected, it is released by cleavage 
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between bases 5 and 6 of the octamer, and another probe will hybridize to the next two free 
bases and so on. The process is then repeated using a sequencing primer one nucleotide 
shorter than the first. In this manner, the first-round sequences bases in positions 4, 5, 9, 10, 
14, 15, etc., whilst the second round sequences 3, 4, 8, 9, 13, 14, etc., until sequencing primer 
position 0 is reached [327]. Due to each base being interrogated twice, early SOLiD systems 
benefitted from high accuracy, with more recent versions able to sequence 85 bp fragments 
with 99.99% accuracy [323]. Also, in 2006, the Illumina platform was released, which facilitates 
detection using fluorescently-labelled reversible-terminator nucleotides. Each nucleotide is 
uniquely coloured allowing its incorporation to be detected, before the subsequent removal of 
the 3ʹ terminator group along with the fluorescent probe. Numerous Illumina platforms have 
since been manufactured, employing this technique, such as MiSeq, HiSeq and NextSeq, with 
the main difference between these systems being the depth of parallel sequencing power and 
data output. The most recently released Illumina technology, Novaseq, can perform up to 40 
billion sequencing reactions in parallel, of up to 250 bp in length with an output maximum of 
6000 Gb. This sequencing scale has opened the door to a wide range of innovative approaches 
that leverage these platforms to develop unique methodologies to probe field-specific 
questions. The research cited here relies on using one of the three aforementioned platforms. 
In most instances, the choice of platform is somewhat arbitrary, largely dictated by the best 
available sequencing depth and length. A comprehensive overview of sequencing platforms is 
provided in [323].  
 
5.1.2 Non-specific DSB mapping 
Genome metabolism is highly coordinated, dynamic and staggeringly complex, with numerous 
proteins interacting with both the duplex and other proteins, to maintain DNA integrity while 
facilitating DNA processing. DNA within each cell is subject to an assault from both endogenous 
and exogenous factors, resulting in various forms of damage that require either repair or 
tolerance [328]. Arguably one of the more toxic forms of damage is the induction of DNA breaks, 
particularly DSBs, which can lead to carcinogenic translocations or cell death [329]. One early 
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use of NGS was to explore the DSB landscape of the genome, to better understand when and 
where the majority of DSBs occur. One such study developed a generalized technique called 
BLESS (direct in situ Breaks Labelling, Enrichment on Streptavidin and next-generation 
Sequencing) [330]. By labelling DSBs in situ, the level of false positives caused by genome 
shearing during extraction was minimized, allowing the resolution of the “breakome” in both 
human and mouse cells. The cells were fixed and lysed to attain purified nuclei, which were 
then subject to biotinylated adapter ligation. The genomic DNA could then be fragmented and 
enriched for endogenously labelled DSBs using streptavidin. Exposing cells to aphidicolin, an 
inhibitor of DNA polymerase, it was found that replication stress is a major driver of DSB 
generation, particularly within genes and satellite regions. BLESS was also able to accurately 
identify telomere ends as well as Sce-1 endonuclease sites.  
A subsequent study developed an alternative technique, designed to overcome noise 
and background complications associated with BLESS, as well as to gain information on DSB 
end structure [331]. Termed END-seq, this protocol involves embedding mouse thymocytes or 
lymphocytes within agarose before soaking the agarose in proteinase K solution, followed by 
an RNase solution. The agarose embedded cells are then end repaired and adapter ligated, 
using a specifically indexed and biotinylated adapter. The DNA is then extracted, sheared, and 
immunoprecipitated using streptavidin, before ligation of the second adapter. The DNA library 
was single-end sequenced using Illumina Hiseq2500 or Nextseq500. This technique proved to 
be highly-sensitive, with nucleotide resolution at break sites, and led to a number of new 
insights in the field of T- and B-cell research. It also has potential as a tissue specific CRISPR-
Cas9 off target cleavage detection protocol. A limitation, however, is evident in the end repair 
stage in which 3ʹ-overhangs are resected and 5ʹ-overhangs are filled-in to blunt the DNA for 
adapter ligation. This means that any information concerning the length of the overhang is lost.  
 
5.1.3 Spo11 DSB mapping 
One of the first studies to implement the use of NGS in topoisomerase-specific genome-wide 
DSB mapping, explored the generation of meiosis specific DNA cleavage by the 
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topoisomerase-related protein, Spo11, in Saccharomyces cerevisiae [205]. Spo11 acts as a 
homodimer and is highly homologous to the topoisomerase VIA subunit [203]. It is responsible 
for DSB generation during meiosis, which ultimately leads to chromosomal recombination, 
making Spo11 an important factor in driving evolution through the generation of genome 
diversity. Spo11 homodimers form covalent 5ʹ phosphotyrosine linkages on both strands of a 
DNA duplex, generating a DSB with a 2-base overhang, a process highly reminiscent of the 
type II topoisomerases. The main difference being that Spo11 DSBs are irreversible and are 
followed by endonucleolytic cleavage adjacent to the bound Spo11. This releases the Spo11 
monomer covalently attached to an oligonucleotide (oligo) and generates 3ʹ overhangs, which 
facilitate strand invasion and recombination. The released Spo11-bound oligos are separated 
into two distinct subpopulations of equal quantity, longer (21–37 nt) and shorter (<12 nt). Pan 
and colleagues used these oligos to develop an NGS-based approach, termed Spo11-oligo-
seq, designed to overcome limitations encountered by previous studies employing DNA 
microarray analysis, to attain a comprehensive genome-wide Spo11-mediated DSB map with 
nucleotide resolution at the cleavage sites [205]. 
Nuclear extracts were obtained from synchronous meiotic yeast cells and the Spo11-
bound oligos captured via immunoprecipitation and then released by proteolytic digestion 
(Figure 5.1A). The oligos were then 3′-GTP tailed using terminal deoxynucleotidyl transferase 
(TdT) and ligated to a double-stranded DNA adapter using T4 DNA ligase before the 
complementary strand was synthesized using Klenow polymerase. The DNA was purified using 
denaturing polyacrylamide gel electrophoresis (PAGE), before a second round of 3′-GTP end 
tailing, adapter ligation and strand synthesis. The original oligo cannot be further modified as 
the 3′ adapter has an inverted dT and the 5′ DNA end is blocked by the phosphotyrosine 
residue. Sequencing adapters were then added via PCR before the oligos were sequenced 
using the 454 platform (Roche). The fragments could then be aligned and bioinformatically 
processed, generating an in-depth representation of Spo11-DSB activity genome wide. This 
revealed a complex picture in which the DSB landscape in S. cerevisiae is influenced by 
numerous factors in a hierarchical manner, and that the concept of DSB ‘hotspots’ [332] is 
Chapter 5: NGS Results 
 
 188
misleading. Spo11 demonstrates an opportunistic cutting activity where most sites can 
constitute a cleavage site but with variable probability that is modulated by numerous other 
factors. 
 
5.1.4 DNA topoisomerase II DSB mapping 
In 2014, human topoisomerase II (topo II), both the α- and β-isoforms collectively, became the 
first true topoisomerases explored at the genome-wide scale [333]. Human colon cancer cells 
(HCT116) were treated with etoposide (a topo II cleavage-complex stabilizing agent) and the 
genomic DNA extracted. Here, two different methods were implemented to capture both SSBs 
and DSBs, named SSB-seq and DSB-seq, respectively. In order to label SSBs, nick-translation 
was used, a technique first described in 1977, which enables labelling of DNA at a nick site 
[334]. In this case, digoxigenin-labelled dUTP was used so that the nicked DNA fragments, 
once sonicated, could be immunoprecipitated using anti-digoxigenin. For DSB-seq, the DNA 
was 3ʹ-end tailed using TdT in the presence of biotinylated dNTPs so that after sonication, the 
DNA could be enriched using streptavidin-coated beads. S1-nuclease was used to cleave the 
3ʹ-end tailing and then both the SSB- and DSB-seq DNA populations were adapter ligated and 
sequenced using Illumina. 
This study highlighted the tendency of low-dose etoposide to produce SSBs, as 
opposed to DSBs, indicating that etoposide predominantly acts on a single monomer of topo 
II, suggesting in turn that only one cleavage site is poisoned, leaving the other to be freely re-
ligated. This is in agreement with a previous study that found only 3% of etoposide-stabilized 
cleavages are DSBs [335]. It is worth noting, that whilst topo I (type IB) can form single-stranded 
nicks, these nicks do not have the free 3ʹ-OH group, so are not substrates for nick-translation 
and won’t be labelled, making SSB-seq topo II-specific. Whole-genome analysis revealed that 
topo II SSBs and DSBs were enriched at transcription start sites and more prevalent in highly 
expressed genes, further demonstrating the cellular necessity of topo II in regulating topology 
during transcription. 
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In 2016, came a comprehensive study looking specifically at murine liver topo IIβ 
activity, using ChIP-seq, ChIP-exo and Hi-C [163]. For an in-depth ChIP-seq protocol see [336], 
however, in short, DNA protein interactions were stabilized using a crosslinking agent and topo 
IIβ-bound DNA was enriched using anti-topo IIβ antibody. The crosslinking was reversed, and 
the DNA underwent library preparation in which the ends were repaired, A-tailed, and adapters 
were ligated before sequencing using the Illumina HiSeq2500 platform. 
Topo IIβ and topo IIα, whilst being structurally and catalytically alike, are functionally 
distinct, performing different cellular functions. Topo IIβ knockouts are lethal owing to disruption 
of neuronal differentiation [26]. Conditional knockouts implicated topo IIβ activity in retinal 
development [159] and ovulation [160], and the use of poisons showed it played a role in 
spermatogenesis [161] and lymphocyte activation [162]. This has led to a picture of topo IIβ 
being an important factor in tissue-specific development and cellular differentiation, a concept 
elaborated upon by Uusküla-Reimand and colleagues with the help of ChIP-seq [163]. They 
found topo IIβ interacts with the transcriptional regulator CTCF and the cohesin complex and 
acts on DNA located at the borders of chromosomal domains as well as conserved transcription 
factor binding sites. 
Topo IIα activity genome-wide was also explored in depth in 2018 [155], using human 
leukaemia K562 cells treated with etoposide, mitoxantrone, genistein or p-benzoquinone, all of 
which are known topo II inhibitors. DNA was extracted and sonicated before bead-based 
immunocapture using rabbit anti-topo IIα polyclonal antibody. The DNA was released from the 
topo IIα using calf alkaline phosphatase (CIP), an enzyme capable of phosphodiesterase 
activity at 3% of its canonical monophosphatase activity. CIP is therefore able to partially 
remove the phosphotyrosine residue, allowing for end repair and adapter ligation. The 
generated libraries were then sequenced using the illumina HiSeq2500 platform. In agreement 
with past studies, they found that the majority of topo IIα cleavage sites were SSBs rather than 
DSBs, the latter only making up 1.3–3.4% of cleavage events. Reads clustered in regions of 
compact genome, reminiscent of the cleavage profile of yeast Spo11, and with a preference 
for regions with high transcriptional activity. They also identified chromosomes that consistently 
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contained more topo IIα cleavage sites than others. In particular chromosome 11 that includes 
the KMT2A gene, which houses a drug-induced leukemia translocation break point. The 
KMT2A gene, along with others, forms the KMT2A recombinome, and a proportion of these 
genes demonstrated significantly higher levels of topo IIα cleavage. They also concluded that 
topo IIα cleavage sites were enriched in genes necessary for DNA metabolism and 
transcriptional regulation. 
As protocols are refined, an increasingly more precise DSB landscape for topo II is 
emerging. In 2019, DSB maps were generated with cleavage-site nucleotide resolution for 
human and yeast topo II [337]. The protocol, termed cleavage complex (CC)-seq (Figure 5.1B), 
begins with genomic DNA extraction from human or yeast cells treated with etoposide, followed 
by a phenol-chloroform extraction to remove bulk proteins, leaving protein-bound DNA in the 
aqueous fraction. The DNA is then sonicated and enriched using a silica membrane, which will 
only bind DNA that is protein bound. The library preparation then occurs in two phases, with 
the P7 adapter being ligated to the protein-free DNA end. The topo II is then cleaved using 
TDP2, an enzyme evolved to rescue stalled topo II cleavage complexes in vivo [338], before 
the P5 adapter is ligated and the library is sequenced. In this study the NGS platforms used 
were the Illumina MiSeq and NextSeq 500. 
As this study was conducted on both human and yeast cell lines, species-specific 
conclusions about topo II activity could be made. For both human and yeast, topo II activity 
was increased in gene dense regions of the genome. However, only a correlation with 
transcription rate and gene length was observed in human cells. For yeast, topo II activity was 
concentrated in intergenic regions, which are numerous and evenly spaced. For human cells, 
topo II activity was found in the gene bodies just downstream of the transcription start site and 
was maximized for genes that are longer and more actively transcribed. This strengthens the 
hypothesis that topo II in human cells plays an integral role in topology maintenance during 
transcription. This gene-local activity pattern may not be necessary in yeast as the genome is 
both far smaller and less complex. There is also the potential alternative that in yeast cells topo 
I may be more active in relieving transcriptional stress on the duplex than topo II, whilst in 
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human cells this role is more evenly shared. It is worth noting that for topo IIα specifically [155], 
activity in the absence of cleavage-complex stabilizing drugs was found to be located at the 
distal ends of genes, with the addition of drugs causing a proximal shift.  
 
Figure 5.1: NGS protocols to map topo cleavage sites genome wide. (A) Spo11-oligo-seq began 
with DNA extraction from meiotic S. cerevisiae cells. HA-tagged Spo11-bound DNA oligos are 
enriched with the HA-antibody, before the protein is removed using proteinase K. The 3ʹ end is 
extended using TdT and an adapter is ligated which contains an inverted dT residue. The 
complementary strand is synthesized, followed by separation using denaturing PAGE, 3ʹ end 
tailing and adapter ligation on the newly synthesized strand, which can then be sequenced using 
the Roche 454 platform [205]. (B) CC-seq, used to map topo II cleavage, began with DNA 
extraction from etoposide treated human cells. The bulk protein is removed using phenol-
chloroform extraction, whilst the protein bound to DNA remains in the aqueous phase. The DNA 
can then be sonicated and enriched using a silica membrane. The first ligation attached adapters 
to the sonicated end, which was then followed by TDP2-dependent removal of the topo II, before 
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a second adapter ligation followed by sequencing using the Illumina NextSeq and Miseq 
platforms, [337]. (C) Topo-seq, used to map gyrase cleavage, began with DNA extraction from E. 
coli cells treated with ciprofloxacin (cfx), oxolinic acid (oxo) or microcin B-17 (MccB17), followed 
by sonication. Gyrase cleavage complexes were then enriched using the SPA-antibody before 
proteinase K treatment and use in the Accel NGS 1S kit to generate fragments that can be 
sequenced using the Illumina Nextseq platform [339]. 
 
An analysis of etoposide-induced topo II cleavage complexes (topoIIcc) in mouse and 
human cell lines used the aforementioned END-seq protocol, which was adapted to explore 
both processed and unprocessed topoIIcc [340]. Mouse embryonic fibroblasts (MEFs) depleted 
of the cohesin subunit, SMC3, exhibited a dramatic decrease in topoIIcc, whereas Smc3+/+ 
control cells exhibited topoIIcc enrichment at cohesin sites. Not only was this decrease in 
topoIIcc proportional to coehsin levels in MEFs, similar results were obtained with a HCT-116 
human cell line depleted of RAD21, another member of the cohesin complex. Moreover, 
depleting MEFs for the WAPL protein, responsible for cohesin removal from DNA, also 
increased the levels of etoposide-induced DNA damage. Interestingly, whilst topo II activity as 
well as binding (also measured here using ChIP-seq) was dependent on cohesin occupancy; 
the converse relationship was not apparent, with RAD21 and CTCF levels remaining 
unchanged in topoIIβ−/− B cells. 
Whilst the activity and binding of topo II was found to be dependent on cohesin, the 
processing of these sites was sensitive to transcriptional activity. Etoposide-induced topoIIcc 
occurring within transcription start sites (TSS) or gene bodies were more likely to produce 
chromosomal translocations than those occurring in intergenic regions, with higher levels of 
translocations in regions of high transcription and decreased levels of translocations on addition 
of the transcriptional inhibitor 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB). In 
eukaryotic cells, the conversion of a topoIIcc to a protein-free DSB is mediated by TDP2. The 
processing of topoIIcc in the presence of DRB was decreased, with more lesions remaining 
protein-bound, whilst transcriptional activation by INFβ increased levels of protein-free DSBs. 
Hence, the processing and repair of topoIIcc is stimulated by transcriptional activity, and this in 
turn leads to an increase in translocation rate. This effect seemed to be dependent on 
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proteasome activity, rather than TDP2, with proteasome inhibition by epoxomicin increasing 
the number of topoIIcc that are reversible (protein-bound) and decreasing the amount of 
protein-free DSBs 5.5-fold. 
 
5.1.5 DNA topoisomerase IV DSB mapping 
In 2018, NGS was used to explore DNA topoisomerase IV (topo IV) binding and cleavage sites 
genome wide in E. coli [125, 341]. To explore binding in the absence of cleavage, a traditional 
ChIP-seq method was employed in which topo IV was allowed to bind DNA and then 
crosslinked, followed by antibody-based fragment capture. To explore topo IV cleavage 
complexes, a novel approach was developed, called NorflIP, relying on norfloxacin, a quinolone 
that traps cleavage complexes produced by prokaryotic type II topoisomerases. 
Four highly enriched topo IV binding sites were found, one of which corresponded to 
the dif site, a previously confirmed hotspot of topo IV cleavage. The dif (deletion induced 
filamentation) site is located at the replication terminus and is important for chromosome dimer 
resolution [342]. To identify additional binding sites, the raw sequencing data were filtered for 
sites showing the highest Pearson correlation with the sequencing pattern at the dif site. This 
approach led to the identification of 19 additional topo IV binding sites throughout the 
chromosome. These sites were found frequently within intergenic regions and spanned 200 bp 
with no significant consensus sequence. Topo IV binding enrichment was also detected in GC-
rich regions. By combining this binding data with specific topo IV cleavage sites, enhanced with 
norfloxacin, it was found that only certain binding sites correspond to topo IV cleavage sites, 
indicating that not all DNA binding results in topo IV cleavage of the DNA. The dif site remained 
strong for both binding and cleavage by topo IV, as well as a site at 2.56 Mb. However, the 
other strong binding sites were not present in the norfloxacin-dependent cleavage data. A 
characteristic topo IV-dependent peak profile was found in which two 170 bp peaks were 
present, separated by a 130 bp reduction in sequencing coverage. This was hypothesized to 
be due to the presence of topo IV residues remaining covalently bound to the 5′ ends of the cut 
site and preventing adapter ligation and sequencing. This characteristic signal was used to 
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algorithmically detect genome-wide topo IV cleavage sites. Using this approach 88 sites, 
common across three different experiments, were identified. As expected, topo IV cleavage at 
the dif site was the most enriched. Interestingly, most NorflIP sites were not observed in the 
ChIP-seq binding experiments, indicating that not only does binding not strongly correlate with 
cleavage, but that cleavage does not strongly correlate with binding. No strong consensus 
sequence preference for topo IV cleavage was detected, beyond a slight bias for GC 
dinucleotides and an increased spacing between GATC motifs around the cleavage sites. 
 
5.1.6 DNA gyrase DSB mapping 
In 2018, an NGS approach was developed that allowed the precise identification of gyrase 
cleavage sites genome-wide in E. coli, facilitating in depth analysis of drug driven cleavage in 
vivo [339]. The method, named Topo-seq (Figure 5.1C), involved trapping gyrase cleavage 
complexes using either oxolinic acid (OXO), ciprofloxacin (CFX), or microcin B 17 (MccB17) 
and immunoprecipitating the resulting fragments. They then underwent a single-strand library 
preparation protocol that only ligates adapters to the 3′ free strand from the cut site. This 
method was developed to avoid issues caused by the 5′ covalent linkage to the active site 
tyrosine of gyrase. Proteinase K treatment leaves the phosphotyrosyl residue at the 5′ cut site, 
which drastically reduces ligation efficiency of the sequencing adapters. In previous studies, 
the use of CIP or TDP2 offered an enzymatic solution. However, the efficiency of these 
enzymes is not always optimal, leading to the introduction of potential artefacts. In topo-seq, 
this effect is mitigated entirely by solely focusing on the unbound 3ʹ single strand. By 
sequencing only these strands from either side of the cut site, the expected characteristic signal 
of gyrase cleavage involves a bimodal peak with a sharp 4-base sequence loss in the centre, 
indicative of gyrase cleavage. This unique signal allowed gyrase cleavage sites to be 
accurately called and subsequently analysed. 
Using this approach, Sutormin and colleagues identified 4635 gyrase cleavage sites 
(GCSs) when cells were treated with CFX, 5478 when treated with OXO and 732 when treated 
with MccB17. An in-depth comparison among these inhibitors and their cleavage sites revealed 
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not only inhibitor-specific cleavage patterns, but also inhibitor concentration-dependent effects. 
Having identified a wealth of cleavage sites, robust analysis of the gyrase sequence preference 
was facilitated, finding the gyrase binding motif to be both extensive and degenerate. This motif 
is ∼130 bp in length, symmetrical on either side of the cleavage site and present in all cleavage 
sites, regardless of the inhibitor used. It exhibits a periodic GC content fluctuation, reminiscent 
of the binding pattern seen for eukaryotic nucleosomes. The only inhibitor-specific differences 
identified were associated with the precise cleavage site. The tendency for CFX and OXO to 
intercalate and drive cleavage at guanine nucleotides was confirmed. However, the sequence 
preference for MccB17 exhibited a variable pattern and was unlike oxo and cfx. This likely 
reflects the fact that OXO and CFX have a different mode of action to MccB17. 
Gyrase showed a strong cleavage preference for highly transcribed loci, producing the 
most distinct enrichment of GCSs around the rRNA operons, known to have high rates of 
transcription. Furthermore, the use of rifampicin, a transcriptional inhibitor, not only decreased 
the number of cfx-dependent cleavage sites by half, but also produced significant relocation of 
GCSs away from rRNA operons and decreased gyrase avoidance of poorly transcribed 
regions. Together, these data implicate E. coli gyrase directly in topology manipulation during 
transcription. 
 
5.1.7 DNA topoisomerase IA DSB mapping 
The first type IA topoisomerase to be explored using NGS was done in concert with gyrase and 
RNA polymerase (RNAP) from Mycobacterium tuberculosis [113]. Whilst M. tuberculosis is a 
well-known and devastating human pathogen, with resistant strains beginning to dominate in 
some areas of the world [343], it is also a curious bacterial species in regard to topoisomerase 
encoding. Whilst the majority of bacterial species encode 4 topoisomerases: two type IA 
topoisomerases (topo I and topo III) and two type IIA topoisomerases (DNA gyrase and topo 
IV), M. tuberculosis has only one type IA (topo I) and one type IIA (DNA gyrase) [344]. The 
rationale behind this study was to obtain direct evidence of topo I and DNA gyrase interacting 
at sites of transcription, to further support the twin-supercoiled domain model of transcription 
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and the role that topoisomerases play in removing accumulated torsional stress in the DNA 
caused by the transcriptional machinery. Hypothesized by Liu and Wang in 1987, the twin-
supercoiled domain model describes how the separation of the DNA strands during 
transcription and replication would lead to positive supercoiling ahead of the protein machinery 
and negative supercoiling behind [111]. Indeed, numerous in vitro studies support this 
hypothesis, demonstrating that transcription alters DNA topology [345]; inhibition of DNA 
gyrase leads to positive supercoil accumulation [105] and mutation of topo I causes negative 
supercoil accumulation [346]. However, direct evidence of the association of bacterial 
topoisomerases and the transcriptional machinery was not obtained until a ChIP-seq-based 
protocol was implemented genome wide using M. tuberculosis [113]. ChIP-seq involves the 
crosslinking of protein to DNA, the DNA of which is enriched for fragments bound to a protein 
of interest, usually using a protein-specific antibody. So, the data set produced by the 
subsequent sequencing of this DNA library generates a binding profile for the protein, rather 
than a direct read out of cleavage activity. 
In this study, the binding of M. tuberculosis gyrase and topo I were compared to the 
binding of RNAP. In agreement with the twin-supercoiled domain model, both topo I and gyrase 
were found to be specifically enriched in regions of transcriptional activity, with a high 
correlation with RNAP binding. As expected, RNAP was enriched at promoter sequences with 
topo I enrichment proximally-located and gyrase enrichment both overlapping with RNAP and 
downstream. In addition, both gyrase and topo I were highly enriched at the origin of replication, 
directly implicating them in replication, whilst only gyrase displayed a binding peak at the 
termination site. This is likely due to M. tuberculosis gyrase having a dual activity of both 
negative supercoiling and efficient decatenation [347], the latter being a role usually fulfilled by 
topo IV in other bacteria. 
In 2019, another study from the same group, explored topo IA activity in more depth, 
contrasting binding and cleavage in Mycobacterium smegmatis, a close relative of M. 
tuberculosis [348]. In this study, four libraries were produced, three to probe topo IA cleavage, 
and another for topo IA binding. The first of the topo IA cleavage protocols involved the use of 
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a poisonous topo IA mutant, with a substitution in the topoisomerase-primase (TOPRIM) 
domain (D108A), previously shown to cause accumulation of cleavage complexes [349]. Once 
transformed into competent M. smegmatis cells, an increase in cleavage complexes and 
stimulation of the SOS response were detected, demonstrating that the mutant protein was 
being expressed and interacting with the genome. The second technique designed to probe 
topo IA cleavage implemented the use of a newly discovered topo IA inhibitor, imipramine [350]. 
Imipramine is a tricyclic antidepressant that has been shown to act specifically on topo IA from 
mycobacteria and prevent re-ligation, thereby increasing DNA cleavage complexes. The third 
technique, designed to probe binding, followed a traditional ChIP-seq type method. They also 
managed to capture wild-type topo IA cleavage sites, in the absence of inhibitors. In all four 
cases, topo IA-specific DNA fragments were immunoprecipitated and sequenced using the 
Illumina Genome Analyzer IIx. 
Being able to contrast binding and cleavage, as with topo IV [125, 341], revealed a 
similar disconnect between binding and catalytic activity. Whilst binding was shown genome-
wide and somewhat evenly distributed, for topo IA, the cleavage profiles were far more region-
specific. Multiple regions displayed topo IA binding enrichment where cleavage was completely 
absent. In vitro assays demonstrated that the enriched sequence was cleavable. However, 
topo IA inhibition by Nucleoid Associated Proteins (NAPs) measured in vitro suggests that the 
inhibition of topo IA cleavage in vivo could arise from the presence of NAPs. A unique feature 
amongst type IA topoisomerases is the mycobacterial topo IA sequence preference for both 
binding and cleavage, which was identified in previous in vitro studies [351-353]. Analysis of 
the genome-wide cleavage sites of M. smegmatis topo IA revealed a similar consensus 
sequence as previously established for topo IA in vitro, indicating that topo IA binds and cleaves 
DNA in a sequence-dependent manner in vivo. 
As with the previous study looking at topo IA and gyrase co-localization in M. 
tuberculosis, topo IA in M. smegmatis exhibited increased occupancy and cleavage associated 
with RNAP and highly transcribed genes. However, in M. smegmatis both cleavage and binding 
were detected at the termination site, a result not previously seen, implicating topo IA in 
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chromosome segregation and suggesting that, like mycobacterial gyrase, topo IA also has dual 
activities in both relaxation and decatenation. In most bacterial species the dedicated type IA 
topo involved in decatenation is topo III, an enzyme absent in mycobacterial species. In vitro 
assays performed in this study did indeed show that M. smegmatis topo IA had significant 
catenation and decatenation activity, and therefore may also be involved in chromosome 
segregation along with gyrase, in vivo. 
 
5.1.8 DNA topisomerase IB DSB mapping 
Currently only one study has mapped genome-wide activity of human topo IB, a type IB 
topoisomerase [354]. Using HCT116 human colon cancer cells, topo IB binding was assayed 
using a ChIP-seq method, and cleavage by a method termed Top1-seq. Top1-seq involved the 
use of camptothecin, a topo IB inhibitor, to generate covalent cleavage complexes, which were 
enriched using immunoprecipitation and then sequenced. 
Topo IB binding enrichment was highly correlated with transcription, with 67% of DNA-
bound topo IB interacting with transcribed genes both upstream of the TSS and downstream 
of the transcription termination site. By quantifying the transcription level of genes using RNA-
seq, a method developed to allow sequencing of the transcriptome [54], increased topo IB 
occupancy was shown to correlate with increased levels of transcription, providing further 
evidence for its role in transcriptional topology regulation in eukaryotic cells, much like topo IA 
in prokaryotes. Comparison of the binding landscape of topo IB to RNAPII revealed their 
localization was highly correlated, in a manner that suggested a direct protein-protein 
interaction, rather than topo IB being solely bound to regions of torsional stress within the 
genome. To explore this, cellular extracts were subjected to a pull-down assay, which 
confirmed the direct interaction between topo IB and RNAPII in the absence of DNA, indicating 
that topo IB is in integral member of the transcriptional machinery and is recruited to sites of 
RNAPII engagement. 
As mentioned, this study used a technique called Top1-seq, which was designed to 
capture catalytically-engaged topo IB, using a brief camptothecin treatment. Whilst binding of 
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topo IB was high at promoters, particularly in concert with RNAPII, catalytically engaged topo 
IB was diminished at TSS but enriched within gene bodies, again with a positive correlation 
with transcription level. Cleavage was also biased towards the template strand, indicating that 
topo IB activity is coupled to the movement of the transcriptional machinery. Using 
complementary in vitro assays, RNAPII was found to enhance topo IB relaxation activity and 
increase processivity under physiological ionic conditions, whilst none of the other general 
transcription factors seemed to have an effect on topo IB relaxation activity. The interaction 
between RNAPII and topo IB was mapped to the CTD of RNAPII and the NTD of topo IB. An 
interaction that increased the time topo IB spends in the cleaved state, enhancing the 
processive removal of supercoils. 
 
5.1.9 Remarks on the current literature 
Since the advent of NGS technologies in 2005, numerous techniques have been developed to 
explore genome-wide DNA binding and cleavage landscapes, which has both answered and 
posed new questions concerning in vivo topo behaviour. Encouraging evidence in support of 
the widely accepted twin-domain model, has established a greater understanding of 
topoisomerase activity during transcription and to a lesser extent replication. Topo II and topo 
I in eukaryotes exhibit higher levels of activity in the vicinity of highly transcribed genes [333, 
354], as has also been shown for mycobacterial topo I and gyrase [348]. Topo IV, on the other 
hand, demonstrates a clear preference for the dif site in E. coli [125, 341], supporting the idea 
that decatenation is its primary cellular function [122]. 
Using NGS as a means to explore topo cleavage across the genome, encouraged 
innovation in protocol development to circumvent issues which arise as a result of the covalent 
linkage between the protein and the DNA backbone. Proteinase K will remove the majority of 
the protein but will not cleave the phosphotyrosyl bond, leaving the adduct to interfere with 
sequencing adapter ligation. Two enzymatic solutions have been used to remove the adduct, 
namely CIP and TDP2, the first of which is very inefficient and the second far less commercially 
accessible. Using a single-strand DNA library preparation kit, as Sutormin and colleagues did 
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when exploring DNA gyrase activity [339], offers another elegant solution by only sequencing 
the free 3' DNA strand. 
One particularly intriguing result has come from contrasting topoisomerase binding with 
cleavage activity. For some proteins, e.g., topo IV and topo IA, the correlation between them is 
so low that most binding sites do not constitute cleavage sites and vice versa. The nature of 
the techniques used to explore binding verses cleavage (such as using cleavage complex 
stabilizing agents which bias cleavage preference) and the platforms used to sequence the 
fragments, may contribute to this discrepancy. However, in vitro biochemical data also suggest 
that the relationship between cleavage and binding is not so clear. For example, topo IIα whilst 
being more catalytically active on positively supercoiled DNA, maintains higher levels of 
cleavage on negatively supercoiled DNA [156]. This raises questions as to the determinants of 
topo binding and cleavage sites; how do the factors known to influence binding and activity 
including DNA topology and sequence play off against protein-mediated recruitment or 
inhibition in trans, and what other factors may influence topo binding and cleavage in vivo. It is 
clear the answer is not straightforward, with topo IB being directly recruited as part of the 
transcriptional machinery [354] and mycobacterial topo IA [348] and prokaryotic DNA gyrase 
[339] exhibiting more substantial DNA sequence preferences. As with all cellular processes, 
the mechanisms governing DNA topology maintenance are often not only protein-specific but 
also species-specific. A difficulty with collecting such vast amounts of data is the interpretation 
thereof, which has been challenging in some cases due to the complexity of the cellular 
environment. One possible approach would be the use of in vitro NGS techniques to map topo 
binding and cleavage in which DNA topology and sequence can be systematically controlled 
in addition to the use of specific proteins and precise buffer conditions, including inhibitor 
addition. Such an approach would complement genome-wide studies and could provide 
insights that could aid in the interpretation of genome-wide results. NGS is undoubtedly a very 
powerful technique, both in isolation and as part of an experimental repertoire, which will 
hopefully be further implemented in the field of DNA topoisomerases. 
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The work presented in the remainder of this chapter demonstrates a novel in vitro 
technique, which can be used to further explore topo cleavage activity, imparting a far higher 
level of control over the assay conditions. This technique, named SHAN-seq (Simplified High 
Accuracy eNd-sequencing) could potentially allow the systematic evaluation of how different 
topos bind and cleave DNA, how inhibitors and other proteins affect this behaviour, and reveal 
any DNA topology-dependent effects. The latter, in particular, is a factor of which one has very 
little to no control over in vivo. Data such as this would be highly complementary to in vivo 
studies and could help inform future conclusions drawn from the vast quantities of data often 
produced by NGS techniques. SHAN-seq is accessible, relatively simple, and fast, allowing the 
in-depth characterisation of DNA cleavage activity in vitro and under specifically controlled 
conditions.  
 
5.2 SHAN-seq protocol and optimisation 
SHAN-seq is a novel in vitro technique that employs the use of accessible equipment and 
materials, paired with NGS, to thoroughly explore type II topo-dependent cleavage activity. The 
initial motivation behind the development of this technique was to find an innovative way to 
explore potential M. mazei topo VI (MmT6) sequence preferences and elucidate the base-
stagger generated during cleavage. For topo VI, this has only be explored once before using 
radioactivity, for S. shibatae topo VI (SsT6) [194]. This work found that SsT6 generated ATP-
dependent DSBs in which the overhang formed was 2 bases. This was a new finding for a type 
II topo, as all type IIA topos explored thus far generate 4-base staggers [355]. This 
strengthened the division between the type IIA and B topos, and the 2-base stagger was also 
confirmed to be produced during Spo11-dependent cleavage [205, 356], reinforcing the 
relationship between Spo11 and the Top6A subunit. However, this has not since been shown 
for any other topo VI enzyme, and therefore attaining evidence of this using MmT6 would 
solidify the conclusion that this is a hallmark of topo VI activity. For SsT6, little sequence 
preference could be determined, however cleavage hotspots were clearly visible when SsT6 
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cleaved pBR322 and a preference for an adenine (A) or thymine (T) within the overhang was 
detected. This work clearly demonstrated that, whilst robust sequence preference could not be 
determined, there was some unknown factor predisposing SsT6 to higher levels of activity in 
precise regions. The hope for SHAN-seq was that it could reveal far more detail on the cleavage 
activity of MmT6, potentially finding sequence preference and confirming the base stagger. In 
reality the scope of this work increased to include preliminary exploration into the cleavage 
activity of E. coli DNA topoisomerase IV (EcT4) and E. coli DNA gyrase (EcGyrase) as well as 
MmT6, and also demonstrated its efficacy in exploring DNA cleavage by other enzymes such 
as restriction enzymes.  
 SHAN-seq, as previously stated, involves the use of accessible materials and 
equipment and follows a relatively simple protocol. The assay begins with a typical topo 
cleavage assay, in which the enzyme of choice is allowed to cleave the DNA, usually under 
conditions that favour cleavage-complex stabilisation. For example, the conditions used here 
for MmT6 were 2 mM ADPNP and 10 mM MgCl2, for EcT4 were 2 mM ADPNP and 20 mM 
CaCl2, and for EcGyrase were 20 mM CaCl2 in the absence of nucleotide, all of which are a 
deviation from optimal activity conditions and increase the number of cleavage-complexes 
produced. Therefore, all data reported here involves cleavage in the absence of inhibitors 
known to stabilise the cleavage complex, and therefore may represent more ‘natural’ cleavage 
behaviour. Of course, if drug-dependent cleavage effects were of interest, these conditions 
could be easily amended to satisfy the research question at hand. This is also true for the DNA 
substrate used, in which the experimenter has the freedom to control the topology of the DNA 
used as well as full rein over the DNA sequence. For instance, a suspected cleavage site from 
other experiments such as in vivo NGS assays, could be engineered into the DNA substrate 
used during SHAN-seq. Here pBR322* was used, to explore the effect of DNA topology on 
topo-dependent cleavage.  
 Once the cleavage reaction is complete, the DNA, with the topo still covalently attached, 
must be sheared to produce 100-500 bp DNA fragments, a prerequisite for most NGS 
platforms. DNA fragments any longer than 500 bp will begin to impact both the adherence of 
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DNA to the sequencing chip and the in situ PCR reaction. The method of DNA shearing used 
here was sonication. Optimisation of sonication conditions are necessary to ensure the DNA is 
fully fragmented, but not over-processed so as to disrupt the covalent DNA-protein interaction. 
Here, sonication conditions were established which resulted in the vast majority of the DNA 
substrate being sheared to the appropriate length (Figure 5.2A).   
 
 
Figure 5.2: Sonication and alkaline phosphatase optimisation. A: Two samples of sonicated 10 
nM negatively supercoiled pBR322* and run on a 1% (w/v) agarose gel alongside a 1 kb plus DNA 
ladder, at 80V for 2 hr. B: Topo VI titration of cleavage activity (MmT6 incubated in the presence 
of 1 mM ADPNP and 10 mM MgCl2 for 30 min at 37°C) treated with either proteinase K and SDS or 
Antarctic alkaline phosphatase, and run on a 1% (w/v) agarose gel at 80V for 2 hr.  
 
 After sonication, the sample is applied to a commercially available nitrocellulose column 
(0.45μm nitrocellulose Centrex MF filter, Whatman). As nitrocellulose is negatively charged, 
DNA is unable to bind, whilst proteins generally bind readily. Therefore, any DNA that is protein-
bound will remain embedded within the nitrocellulose membrane, whilst unbound DNA is 
eluted. This provides an enrichment technique independent of the need for specific protein 
antibodies, and allows the enrichment within the sample for protein-bound DNA, thereby 
decreasing the level of noise associated with the sequencing. This technique is potentially 
cruder than antibody-based enrichment, with an increased likelihood that some nonspecific 
DNA-protein interactions and DNA associated with contaminating proteins, will also be 
captured. This is mitigated however by the use of nitrocellulose wash steps and highly pure 
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protein, respectively, and in general, the results within this chapter indicate that this enrichment 
technique is effective in capturing topo-cleaved DNA fragments. The protein-bound DNA was 
eluted using 0.8% sodium dodecyl sulphate (SDS) solution and purified, with the resultant DNA 
product remaining covalently attached to protein.  
 The purified DNA was then subjected to the first round of sequencing adapter ligation, 
which was performed by the NHLBI sequencing core at the National Institutes of Health 
(Bethesda, USA). This stage is crucial to attaining nucleotide resolution of the topo cleavage 
site. As some DNA ends in the sample were covalently bound to topo, they were protected 
from being processed during adapter ligation. The sequencing adapters are important as they 
are a means to adhering the fragments to the sequencing chip surface, allowing primer binding 
for both PCR amplification of the library and sequencing, as well as uniquely identifying the 
DNA samples using DNA indexes. Usually indexing is used to discriminate between two or 
more assay samples which have been pooled together and sequenced in parallel. In this case, 
the indexed adapters are being used to discriminate between sonication-dependent and topo-
dependent DNA cleavage sites. This is achieved through performing the adapter ligation phase 
in two stages. The first stage, as the DNA remains covalently bound to protein, results in only 
protein-free DNA ends being repaired and ligated. The adapters used in Illumina DNA library 
preparation are called Y-shaped, owing to the fact that each primer contains sequence which 
allows it to form a duplex with its complementary partner, but also sequence which uniquely 
maps back to that specific primer. This results in the ability to also discriminate between the 
top and bottom DNA strands, with the 5ʹ end ligated to a different index to the 3ʹ side. Once the 
DNA is sequenced, this will produce a data set which can be separated into four parts, each 
specific to a particular strand of a particular end of the fragment being sequenced. However, 
before the DNA is ligated to the adapters, it must be blunted using an end repair protocol. The 
DNA is treated with an enzyme cocktail (T4 DNA polymerase, E. coli DNA Polymerase I Klenow 
fragment and T4 polynucleotide kinase), which resects 3ʹ overhangs and fills in 5ʹ overhangs. 
This is crucial to resolving the size of the base stagger as a DNA duplex cleaved by topo will 
produce a cut site in which both sides have a 5ʹ overhang. This means the DNA within the 
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overhang will be filled in on both sides of the cut site, doubling its presence within fragments, 
relative to the adjacent nucleotides. It is this sequence enrichment which leads to precise 
identification of topo cleavage sites, with the number of bases enriched against the background 
informing on the size of the overhang (Figure 5.3). However, during this first end repair stage, 
the topo bound DNA ends are not processed, only the ends produced by sonication. Following 
end repair, blunt ends are phosphorylated, followed by adenylation, which then allows the 
subsequent ligation of the adapters. 
 Once the sonicated DNA ends were adapter-ligated, the DNA library was treated with 
proteinase K and SDS to remove the majority of the protein. Whilst most of the protein is 
removed in this way, proteinase K cannot hydrolyse the phospho-tyrosyl linkage formed 
between the 5ʹ phosphate of the DNA and the active site tyrosine of the topo. This adduct still 
requires removal however, as its presence dramatically reduces adapter ligation efficiency. As 
mentioned in the introduction, the two enzymatic solutions available for the removal of the 
phospho-tyrosyl are TDP2 and alkaline phosphatase (specifically calf-intestinal alkaline 
phosphatase, CIP). TDP2 has evolved to process topo-dependent cleavage complexes in vivo 
and can do so efficiently [338], whilst CIP is primarily a monophosphatase but reportedly retains 
diphosphatase activity at 3% of its monophosphatase activity [155]. Both these solutions have 
drawbacks, with TDP2 being far less commercially available and CIP being very inefficient. 
Regardless of this, CIP was used in an extended protocol (e.g. overnight incubation) to remove 
the adduct. Initially, Antarctic alkaline phosphatase was used, and during optimisation was 
found to be ineffective at removing the protein from the DNA in the absence of a preliminary 
proteinase K/SDS treatment (Figure 5.2B). CIP was then procured for use instead due to its 
higher activity. Once incubation with CIP was complete, the DNA was returned to the NHLBI 
sequencing core for the second round of end repair and adapter ligation. 
 




Figure 5.3: Expectation of sequencing data output. Sequencing data is represented as a 
histogram of how many times a particular nucleotide was sequenced within the DNA library. Due 
to the 5ʹ overhang type II topos generate on both sides of the cleavage site, this sequence will be 
enriched (black bars) relative to the nucleotides on either side (grey bars).  
 
Once the DNA ends were no longer protected by topo, they were end repaired and 
ligated to unique adapters forming the complete DNA library. As described in section 5.1.1, the 
Illumina platform uses fluorescently-labelled reversible-terminator nucleotides during 
sequencing. DNA fragments are adhered to the flow cell surface at one extreme end and 
undergo bridge PCR in which a cluster of each fragment is generated, in order to increase the 
intensity of the fluorescent signal. Each nucleotide is uniquely coloured allowing its 
incorporation to be detected and recorded, before the 3ʹ-terminator group and the fluorescent 
probe are removed and another nucleotide is introduced. Potentially, this allows millions of 
fragments to be sequenced in parallel. See figure 5.4 for an illustration of the SHAN-seq 
protocol.  
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Figure 5.4: SHAN-seq protocol. 1. Topo cleaves the plasmid DNA. 2. DNA with covalently-bound 
topo is sonicated to shear the plasmid into 100-500 bp fragments. 3. The sample is enriched for 
topo-bound DNA using a nitrocellulose column. The topo-DNA complexes are eluted from the 
column using SDS. 4. DNA undergoes the first round of adapter ligation on the exposed DNA 
ends. This begins with end repair to blunt the DNA, followed by phosphorylation. 5. The DNA is 
then adenylated (not shown) so that the Y-shaped sequencing adapters can be ligated. The 5ʹ and 
3ʹ ends are uniquely barcoded using index 1 (yellow) and 2 (green), respectively. 6. The topo is 
then removed from the DNA using proteinase K and SDS. This leaves a phospho-tyrosyl adduct 
attached to the 5ʹ strand. 7. The adduct is removed using calf intestinal alkaline phosphatase 
(CIP). 8. The DNA is then subject to a second round of end repair and phosphorylation. 9. 
Following a second adenylation step (not shown) a different Y-shaped adapter is ligated in which 
the 5ʹ and 3ʹ ends are barcoded with index 3 (red) and 4 (blue) respectively. 10. The DNA library 
is then produced via PCR to generate 2 pools of fragments, those barcoded with index 1 and 4, 
and those with index 2 and 3. 11. The DNA is then paired-end sequenced using the Illumina Miseq 
platform.  
 
5.3 Results and Discussion 
5.3.1 Agarose gel-based cleavage patterns 
If topos cleave DNA in a preferential manner, this should be observable using in vitro ensemble 
methods, as a reproducible DNA fragmentation pattern, as visualised via electrophoresis. This 
has been documented in the past for S. shibatae topo VI [194], E. coli gyrase [89, 357-360], 
bacteriophage T4 topo II [361], Drosophila melanogaster topo II [362, 363], and mammalian 
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topo II [364], to name a few. Often no strong consensus sequence is found among the 
preferential cleavage sites, however there is clearly one or more determinants driving the 
increased cleavage at certain sites for most topoisomerases. This is also strongly influenced 
by intercalating drugs, such as oxolinic acid, amsacrine and doxorubicin, which bias cleavage 
to certain DNA sequences, as seen for gyrase and topo II [339, 365, 366]. In the data presented 
here, topos are stimulated to form cleavage complexes in the absence of specific drugs, with 
the goal to attain a representation of the enzymes more ‘natural’ cleavage activity. This was 
achieved by using ADPNP, the non-hydrolysable ATP analogue, for M. mazei topo VI (MmT6) 
and E. coli topo IV (EcT4), and replacing MgCl2 with 20 mM CaCl2 for EcT4 and E. coli DNA 
gyrase (EcGyrase). Each topo was incubated with pBR322*, which was either linear, negatively 
supercoiled, positively supercoiled or relaxed. This was performed at relatively high topo 
concentrations to capture as many cleavage complexes as possible (MmT6 - 500 nM, EcT4 - 
150 nM and EcGyrase - 64 nM). The pBR322* was then linearised using an EcoRI digestion, 
with the linear pBR322* being the exception due to previous EcoRI-digestion prior to the topo-
dependent cleavage assay. As there is only a single EcoRI site in pBR322*, EcoRI will linearise 
any uncleaved pBR322* and produce two or more fragments on those which have been 
cleaved by topo. The DNA samples were run on a 1% (w/v) agarose gel, loading 200-400 ng 
of DNA in order to maximise the likelihood of clearly resolving the cleavage pattern (Figure 
5.5). All three topos fragmented the DNA in a reproducible pattern, unique to each topo and in 
some cases preliminary evidence of topology-dependent cleavage effects can be seen.  
 DNA cleavage by MmT6 clearly demonstrates its preference for particular DNA sites 
with bright DNA fragment bands appearing in all three samples of the same size, regardless of 
the DNA topology (Figure 5.5A). Interestingly however, there is a visual difference dependent 
on the DNA topology. For negatively and positively supercoiled DNA the appearance of the 
DNA fragments is far more ‘smeared’ than it is for the linear sample. This could indicate that 
sequence preference is more important for stimulating cleavage when the DNA is linear. As 
discussed in chapters 3 and 4, MmT6 is preferentially attracted to DNA crossings, cleaving 
writhed DNA with a far higher activity than linear, an effect also documented elsewhere [62]. 
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Therefore the ‘smeared’ appearance of the supercoiled DNA samples could indicate that as 
writhe increases, the necessity for cleavage at specific sites decreases. It may also indicate, 
more simply, that the level of cleavage is increased in general with increasing writhe, however 
the preferential sites do not visually appear brighter than in the linear sample.   
 
Figure 5.5: Agarose gel-based cleavage patterns produced by type II topos. A: Cleavage activity 
of 500 nM M. mazei topo VI in the presence of 11 nM of linear, negatively supercoiled and 
positively supercoiled pBR322*. B: Cleavage activity of 150 nM E. coli topo IV in the presence of 
11 nM of linear, negatively supercoiled and positively supercoiled pBR322*. C: Cleavage activity 
of 64 nM E. coli gyrase in the presence of 11 nM of linear, negatively supercoiled, positively 
supercoiled and relaxed pBR322*. All assays run on a 1% (w/v) agarose gel.  
 
 DNA cleavage by EcT4, also forms a reproducible DNA fragmentation pattern, which is 
insensitive to DNA topology (Figure 5.5B). Out of the three topos characterised in this work, 
EcT4 demonstrates the most cleavage and generates the most complex cleavage pattern. This 
activity also appears to be independent of DNA topology with each lane being visually identical. 
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One particularly strong site stands out at ∼3000 bp, with another at ∼1500 bp, the latter 
presumably being the partner fragment to the former (full length pBR322* is ~4.4 kb). 
 DNA cleavage by EcGyrase demonstrated an unexpected result, with one cleavage site 
being significantly more represented in the sample which contained negatively supercoiled 
pBR322*. This indicates there is a topology-sensitive EcGyrase cleavage site that is cleaved 
more efficiently when the DNA is underwound. This is intriguing as it indicates that gyrase 
cleaves its product (negatively supercoiled) more readily than its substrate (positively 
supercoiled or relaxed). In addition, the previously recorded ‘strong gyrase site’ (SGS) in 
pBR322, at position 990, is apparently absent in the data presented here. Much of the work 
done previously using EcGyrase, focused on cleavage site preferences using quinolone-
derived inhibitors [275, 360]. These inhibitors function by intercalating between the topo-
dependent DNA breaks and preventing re-ligation, thereby increasing the number of stalled 
cleavage complexes and killing cells through a disruption in DNA replication and transcription 
[367, 368]. Multiple avenues of evidence suggest that using drugs to explore DNA cleavage by 
topos strongly biases the cleavage specificity [339, 360, 369, 370]. For instance, quinolone-
derived drugs (oxolinic acid and ciprofloxacin) demonstrate a clear preference for cleavage at 
G residues, while Microcin B-17, another gyrase inhibitor, promotes DNA cleavage with an 
alternative and far more degenerate sequence preference [339]. This may explain why the SGS 
of pBR322* has not been cleaved in this work, as no quinolone inhibitor was used. This 
provides further evidence of how dramatically certain drugs can bias cleavage, with their use 
producing data which may poorly represent the ‘natural’ cleavage by the enzyme. As most NGS 
studies require the use of inhibitors to stimulate topo-specific cleavage in vivo (discussed in the 
5.1), this calls into question how much this data can truly inform on the normal activity of topos, 
with the inhibitors used potentially disrupting this behaviour.  
 Whilst it is not possible to determine the precise cleavage sites using this method alone, 
this data provided both encouragement that the three topos tested cleave pBR322* 
preferentially and that this should be evident in the sequencing, but also provided an excellent 
reference point for comparing to the NGS data.  
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5.3.2 NGS controls 
To test whether SHAN-seq was capable of determining cleavage sites and overhangs using 
plasmid DNA in vitro, a restriction enzyme control was conducted. Like topos, restriction 
enzymes also generate DSBs, and in some cases form 5ʹ overhangs. Restriction enzymes are 
distinct however, in that cleavage is irreversible, the protein does not form a covalent interaction 
with the DNA back bone, and in many cases the sequence specificity is extremely strict. The 
enzyme chosen here was MluCI, which cleaves pBR322* seven times at the sequence AATT, 
generating 4-base 5ʹ overhangs. Linear pBR322* was incubated with MluCI and then sonicated. 
As the enzyme does not remain covalently bound to the DNA, the sample cannot be enriched 
using the nitrocellulose columns, nor can the two extreme ends of the DNA be uniquely 
indexed, meaning the sample is end-repaired and adapter ligated in one stage prior to 
sequencing. Along with the MluCI positive control, a DNA-only negative control was also 
performed in which 10 nM linear pBR322* was sonicated and sequenced. This was important 
as it is necessary to know how the plasmid fragments due to sonication in the absence of 
protein (Figure 5.6A). Generally speaking, sonication will fragment the DNA randomly but AT-
rich areas are known to be more sensitive to shearing [371].  
The NGS results clearly demonstrated all seven of the MluCI restriction sites (Figure 
5.6B), appearing precisely where they were predicted to. At three positions, the overhang is 
not present due to the fragment size being below the lower sequencing size limit. For instance, 
the site at bp 59 would generate a 59 bp fragment, and the two sites at bp 1320 and 1334 
(Figure 5.6C) would produce a 10 bp fragment between them, both of which are below 100-
500 bp size recommendation and unlikely to be sequenced. However, this small caveat (e.g. 
the overhang enrichment may not be resolvable if cleavage sites are too numerous or close 
together) also demonstrated that despite this, the peaks were found precisely where expected. 
In addition, four of the seven sites did demonstrate a 4-base enrichment at the AATT sequence 
(Figure 5.6D), validating that this method can determine both sequence preference and 
overhang size. It can also inform on the type of overhang generated, 5ʹ or 3ʹ. This is due to the 
Chapter 5: NGS Results 
 
 212
end-repair stage of adapter ligation. As previously mentioned, the enzyme mixture used to blunt 
the DNA resects 3ʹ overhangs and fills in 5ʹ overhangs. Whilst this has the effect of doubling 
the sequence within 5ʹ overhangs, this sequence is removed from 3ʹ overhangs and would be 
discernible in the NGS data as a loss of sequence corresponding to the size of the overhang, 
rather than the enrichment seen here (Figure 5.6D).  
 In addition to validating that SHAN-seq performs as intended, this control also 
demonstrated that it has value in the characterisation of other types of DSB-inducing enzymes, 
such as restriction enzymes, making it a broadly applicable and versatile technique in the field 
of DNA-protein interactions.  
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Figure 5.6: SHAN-seq NGS controls. For all plots, data is displayed as nucleotide (bp) read count 
at each position along the pBR322* sequence. A: Negatively supercoiled pBR322* sonicated and 
sequenced using Illumina Miseq PE-75. B: Linear pBR322* cleaved by MluCI, sonicated and 
sequenced using Illumina Miseq PE-75. The red bars and numbers indicate the predicted MluCI 
restriction sites. C: Close up view of the peaks between 1,316 and 1,341 bp. D: Close up view of 
the peak at 3,530-3553 bp. The sequence in red in parts C and D is the MluCI cleavage specificity 
(AATT). 
 
5.3.3 DNA Topoisomerase VI NGS Results 
DNA topo VI from M. mazei (MmT6), was both the focus of this research and the incentive 
behind the development of this technique. As previously remarked, exploration into the 
sequence preference and cleavage overhang size for topo VI has only been conducted once 
before, using the S. shibatae enzyme [194]. It was found that topo VI produced DSBs in the 
presence of ATP, generating 2-base overhangs with no strong sequence preference beyond 
an increased probability of an A or T being present in the overhang. Expanding on this 
preliminary foray into topo VI cleavage behaviour was an important aspect of the work reported 
here.  
 MmT6 (500 nM) was incubated with 10 nM negatively supercoiled pBR322* in the 
presence of ADPNP and 10 mM MgCl2, conditions which were established as optimal for 
cleavage in Chapter 3. As described in Section 5.2, sequencing adapter ligation of DNA 
cleaved by MmT6 occurred in two phases with the intention being the unique indexation of the 
topo cleavage sites, allowing the data to be separated from DNA breaks produced by 
sonication. This proved highly effective, as not only was the resolution of MmT6-dependent 
cleavage sites facilitated, but this also highlighted some current drawbacks, discussed below, 
associated with the DNA preparation phase that will be improved upon in future work (see 
section 5.5).  
 The NGS data for MmT6 cleavage showed clear peaks across pBR322* (Figure 5.7), 
in comparison to the DNA-only control (Figure 5.6A). As seen in figure 5.7A, there were two 
peaks in the same position for all DNA strands sequenced, at positions ~2.3 and ~3.4 kb. This 
was not predicted as the 5ʹ and 3ʹ sonicated strands (yellow and green respectively, see Figure 
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5.7) should have a very different appearance to the 5ʹ and 3ʹ MmT6-cleaved strands (red and 
blue respectively). There are, however, a number of explanations to account for this result. 
  
Figure 5.7: NGS data for M. mazei topo VI (MmT6) cleavage activity. All data are plotted as 
nucleotide read count (read depth) for each position along pBR322*. A: NGS data for MmT6 
cleavage, plotted in regard to the strand sequenced, 5ʹ sonicated end (yellow), the 3ʹ sonicated 
strand (green), the 5ʹ MmT6 cleaved (red) end and the 3ʹ MmT6 cleaved end (blue). On the blue 
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plot, the peaks enlarged in parts B-G are labelled with their respective letter. B-G: Close up 
images of the MmT6 peaks, as labelled in A, showing the characteristic peak shape indicative of 
MmT6 cleavage activity, which appears insensitive to read depth.  
 
If it is assumed that peaks associated with MmT6-cleaved ends are true MmT6 cleavage sites, 
the peaks in the same positions in the sonicated-end data may have been adapter-ligated 
during the first round, despite originating from MmT6 cleavage. Reasons for the DNA end no 
longer being protected by covalently bound MmT6 include MmT6-induced G-segment bending 
causing structural vulnerabilities within the DNA, therefore sensitising it to sonication near the 
cleavage site. Another possibility is the conversion of MmT6-induced nicks into double-
stranded breaks (DSBs) during sonication. As discussed in Chapter 3, ADPNP stimulates 
MmT6 to cause significant levels of nicks, along with DSBs, and it has been observed that DNA 
is more likely to shear within a 10 bp radius of pre-existing nicks [372].  
 Despite the presence of two peaks (positions ~2.3 and ~3.4 kb) in all data sets, the data 
associated with the MmT6-cleaved strands has revealed both new information on MmT6 
cleavage activity, but also highlighted a potential weakness in the SHAN-seq protocol. The 5ʹ 
and 3ʹ MmT6-cleaved NGS data are quite distinct form one another, despite sharing the same 
origin. Firstly, the depth of sequencing is 56-fold higher for the 3ʹ strand than the 5ʹ strand 
(Figure 5.7A, blue and red plots, respectively). The most likely cause for this lies in the use of 
CIP to remove the phospho-tyrosyl adduct. Whilst reportedly CIP has diphosphatase activity at 
3% of the canonical monophosphatase activity [155], it appears likely that the adduct is not 
being removed efficiently and is therefore interfering with adapter ligation/indexing the 5ʹ strand 
of the MmT6 cleavage sites.  
Sequencing the 3ʹ strand from the MmT6 cut site, which is unmodified during cleavage, 
revealed visually obvious peaks with a highly characteristic shape (Figure 5.7A, blue plot). For 
close-ups of these peaks see Figure 5.7B-G. Across the pBR322* sequence, 15 ‘strong’ and 
14 ‘weak’ MmT6 cleavage sites were identified using visual inspection based on a peak shape 
and sequencing depth. The peaks were 26 nucleotides in width with nucleotides 13 and 14 
enriched relative to the twelve on either side. The read depth of nucleotides 13 and 14 was 
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roughly the sum of the read depth of the left twelve nucleotides and of those on the right. This 
originates from each sequence being cropped to 14 bp in length prior to alignment to the 
reference genome. As expected from MmT6 cleavage, the sequence in the overhang will be 
enriched relative to the sequence directly surrounding it, and this will inform on the size of the 
overhang, as discussed in Sections 5.2 and 5.3.2. In the case of MmT6 the width of this 
enrichment is two nucleotides, therefore indicating that MmT6 generates DSB with 2-base 
overhangs. This is exactly in line with expectations for MmT6, as both S. shibatae topo VI and 
Spo11 have also been confirmed to produce DSBs with 2 bp overhangs [194, 205]. This result 
helps to cement the conclusion that, in general, topo VI enzymes cleave DNA, generating 2-
base overhangs, and this forms a critical distinction from the type IIA topos.  
 To attain further confidence that the peaks seen within the NGS data are indeed MmT6 
cleavage sites, the NGS data set was compared to the gel-based data from section 5.3.1. The 
size of the fragments seen on the gel were compared to the ‘theoretical’ fragment sizes which 
would be produced if MmT6 were to cleave linear pBR322* at the site of each peak. For 
instance, in the NGS data there was a peak at nucleotide 3394, that if cleaved would form two 
fragments, 3394 and 931 bp in size. In Figure 5.8, The NGS data is plotted alongside the gel-
based data. Stronger cleavage sites, identified on the NGS data as ‘a’ and ‘b’, are coloured 
dark grey for the NGS and gel-based data plot. The NGS strong sites were determined visually, 
with the two sites (positions ~2.3 and ~3.4 kb) chosen based on a read depth of 10,000 or 
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Figure 5.8: NGS data versus gel-based data for MmT6-dependent fragmentation of pBR322*. The 
NGS data is on top in blue. The strong cleavage sites are labelled as ‘a’ and ‘b’. Below, the 
fragment sizes predicted by the sequencing were compared to those extracted from the gel-
based assay. Strong cleavage sites (large peaks in NGS data/bright cleavage bands in gel-based 
data) are dark grey, while other weaker cleavage sites are light grey. For the NGS fragment sizes, 
the strong sites are labelled with 1 or 2 to demonstrate they are partners with both being formed 
should MmT6 cleave linearised pBR322* at the position indicated on the NGS data.  
 
above. As cleavage at these sites would produce two fragments, the data points are labelled 
as 1 or 2, to demonstrate they are partners. All sites derived from the NGS data are plotted as 
partner fragments. This is not possible for the gel-based data, and instead the fragments which 
are clearly resolvable are plotted, with brighter bands being categorised as ‘strong’ cleavage 
sites. By comparing these two data sets, further confidence in the validity of the NGS data is 
obtained as many strong cleavage sites within the NGS data match well to the fragment sizes 
extracted from analysis of the gel in section 5.3.1. In some cases, strong cleavage sites seen 
in the NGS data correspond well with brighter bands seen on the gel (see peaks ‘a’ and ‘b’ in 
Figure 5.8). Also, a bright band on the gel corresponds to a fragment ~2.8 kb in size, with the 
sequencing indicating that was due to the combined effect of cleavage at two weaker sites 
which both form a 2.8-kb fragment.  
 
Figure 5.9: Illustration of which pBR322* sequences were extracted from each peak on the MmT6 
NGS data to use in sequence preference analysis. The nucleotide numbering is used in Figure 
5.10 which analyses sequence identity of positions 1-35. The black arrows indicate the scissile 
phosphate, immediately upstream of nucleotide 1. 
 
Chapter 5: NGS Results 
 
 218
With further confidence that the NGS data of the 3ʹ MmT6-cleavaed strand was 
reflective of true MmT6 cleavage activity, analysis of the sequence at each of these sites was 
permitted. To see a full list of the sequences used in the analysis, see Table II in the Appendix 
III. As the 2-base enrichment is present, it is possible to extract the sequence at the precise 
site of cleavage and this was done for the 5ʹ sequence immediately downstream of the cleavage 
site on the top and bottom strands (see Figure 5.9). Using the browser-based software 
WebLogo [228], the sequence present at the strong and weak cleavage sites were analysed 
for nucleotide indentity similarities at each position, both separately and together. No strict 
consensus was found, but there was a clear preference for a C in position 4 and for a G/C in 
position 3 (which corresponded to a increased preference for a C/G in position -1 and for G in 
position -2 on the opposite strand, see Figure 5.9). This is particularly clear for the strong sites 
(Figure 5.10A), with this preference present but less significant for the weak sites (Figure 
5.10B), and therefore also diltued when strong and weak sites are analysed toegther (Figure 
5.10C). This may explain why sites analysed in Figure 5.10B are cleaved less frequently than 
those in Figure 5.10A. Another difference is that an A/T identity is common in position 8 for 
strong sites, however this is not the case for the weak sites and could be another factor causing 
less cleavage at these sites. Overall, the sequence preference is weak, yet the cleavage sites 
seem precise. This indicates that there may be a yet unknown feature that unites these sites 
which has yet to be analysed. For instance, there is evidence that type II topos, including topo 
VI, can bend the G-segment [61], and so it is plausible that MmT6 cleavage site sequences 
may represent DNA that is more easily bent. As MmT6 has been shown to bind the G- and T-
segment as a DNA crossing and that the T-segment interacts with Top6B [62], this form of 
analysis overlooks the possibilty of T-segment binding preference. Future work could include 
simulations of supercoiled pBR322* to gain perspective on probable T segment DNA regions 
that interact with a given G-segment. 
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Figure 5.10: Sequence preference analysis of MmT6 cleavage sites using WebLogo. A: Sequence 
preference analysis for strong MmT6 cleavage sites. B: Sequence preference analysis for weak 
MmT6 cleavage sites. C: Sequence preference analysis for strong and weak MmT6 cleavage sites. 
The cleavage occurs just upstream of nucleotide 1, see Figure 5.9. 
 
When DNA cleavage characterisation was conducted using S. shibatae topo VI (SsT6), 
the enzyme was found to generate a 2-base stagger, like MmT6, but no sequence preference 
was found aside from an increased probability of A or T nucleotides present in the overhang 
[194]. Using MmT6 data, this result was somewhat supported by the finding that 66% of 
nucleotides, positioned 5ʹ of the cut site, were an A or a T. This work also found SsT6 had a 
strong cleavage site around the SspI restriction site (position 4168 on EcoRI-linerised 
pBR322*). Even though this does not correspond to either of the strong cleavage sites identified 
here, cleavage activity is detected in this region for MmT6, both upstream and downstream of 
the SspI restriction site. However, it is not strong cleavage as measured using the NGS and 
gel-based data. There are a number of explanations for why the MmT6 data generated in this 
current work, does not match up well with work done on the SsT6. MmT6 and SsT6 are different 
enzymes encoded for by different archaeal organisms, which live in extremely different 
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conditions. M. mazei is a mesophilic archaeon, living in freshwater and marine environments, 
with an optimal temperature and pH of 30-40°C and 6.8-7.2, respectively [238, 239]. S. shibatae 
is a hyperthermophillic organism isolated from acidic high temperature environments with an 
optimal temperature and pH of 70-75°C and 2-3, respectively [373]. These wildly different 
environments will no doubt have had consequences for the adaptation of the intracellular 
proteins in each of these organisms. This is also evident biochemically, as SsT6 was found to 
perform robust DNA cleavage in the presence of CaCl2, whilst MmT6 activity in the same 
conditions is barely detectable (see Chapter 3). Another explanation for the differences 
between MmT6 and SsT6 DNA cleavage activity could be due to the different DNA topology 
they likely interact with. M. mazei encodes a DNA gyrase and the genome is negatively 
supercoiled, whilst S. shibatae encodes a reverse gyrase and likely has a relaxed or positively 
supercoiled genome [374]. This data warns against taking information attained from the 
characterisation of a single species and applying it more broadly.   
 Sequence preference analysis for S. cerevisiae Spo11 found cleavage is promoted 3ʹ 
of C nucleotides and disfavoured 3ʹ of G [205, 375] with the dinucleotides cleaved most often 
being CT, CA, TA and CC. A similar form of analysis was conducted for the MmT6 cleavage 
sites (Figures 5.11 and 5.12). The nucleotides immediately upstream and downstream of the 
cut site were labelled -1 and 1, respectively. As evident in the previous analysis (Figure 5,10), 
the nucleotide in position -2 was found to exhibit nucleotide identity preference and so was also 
analysed (Figure 5.11A). The most common nucleotide in position -2 for MmT6 cleavage was 
G (66%) followed by C (17%), T (8%), and A (3%) (Figure 5.11B). In position -1 the most 
frequently observed nucleotide was C (59%), followed by G (31%), T (7%), and A (3%) (Figure 
5.11C). This means that cleavage is also promoted 3ʹ of C nucleotides, as had been found for 
Spo11 [205]. The difference however, is that MmT6 cleavage is not disfavoured 3ʹ of G 
nucleotides, with G being the second most frequently observed in position -1, unlike Spo11 
which disfavours G [205, 375]. The identity of the dinucleotides at position -2 and -1 can be 
seen in Figure 5.12A with the 3 most common sites being GC, GG and CC. Interestingly, for 
MmT6, G nucleotides are completely absent from position 1, a cleavage behaviour also seen 
Chapter 5: NGS Results 
 221 
for Spo11 [205] (Figure 5.11D). And in addition, the identity of the dinucleotides which were 
cleaved is very similar to Spo11, with those more likely cleaved by MmT6 being CC, CA, CT  
 
Figure 5.11: Sequence analysis of the precise MmT6 cleavage site. A: Position numbering of the 
nucleotides 2 bp upstream and 1 bp downstream of the cleavage site. The scissile bound is 
denoted as the two black triangles. B: Nucleotide identity as a percentage (%) for position -2. C: 
Nucleotide identity as a percentage (%) for position -1. D: Nucleotide identity as a percentage (%) 
for position 1. In all charts G is yellow, C is green, T is orange and A is blue.  
 
and GA (Spo11 cleavage sites: CT, CA, TA and CC [205]) (Figure 5.12B). The sequence 
preference derived for S. cerevisiae Spo11 was 5ʹ-C^[A/C/T] (the ‘^’ symbol denoting the 
scissile phosphate). For MmT6 the sequence preference was found to be 5ʹ-GC^[A/C/T], or 
perhaps more reflectively denoted as 5ʹ-[G/C][G/C]^[A/C/T]. The similarities between these 
preference sequences could indicate DNA binding is similar between Top6A and Spo11. 
However, the difference regarding G-nucleotide occupancy speaks to their evolutionary 
distance, being two distinct enzymes performing different cellular activities. Recent molecular 
characterisation of the S. cerevisiae Spo11 complex, also explored the change in Spo11 
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cleavage behaviour in vivo as a consequence of the F260A point mutation [210], an amino acid 
predicted to be within the DNA binding channel [376]. This mutation disrupted the wildtype 
dinucleotide preference for cleavage, reducing the frequency of C in position -1, whilst also 
reducing the suppression of G in this position. This preliminary result offers intriguing insight 
into the potential amino acids which modulate DNA sequence preferences for both Spo11 and 
Topo VI. 
 
Figure 5.12: MmT6 cleavage site dinucleotide identity preference. A: Dinucleotide identity as a 
percentage (%) for positions -2 and -1. B: Dinucleotide identity as a percentage (%) for positions 
-1 and 1. Nucleotide position numbering as seen in Figure 5.11A. All data points have been 
corrected for the average dinucleotide enrichment of pBR322*. 
 
5.3.4 DNA Topoisomerase IV NGS Results 
Topo IV from E. coli (EcT4) was the second topo to be explored using SHAN-seq. It is a type 
IIA topo, which produces DSBs with 4-base overhangs. As evident from the gel in section 5.3.1, 
in the presence of 2 mM ADPNP and 20 mM CaCl2 (instead of the optimal ATP and MgCl2), 
many EcT4-dependent cleavage complexes are formed on pBR322* in a manner seemingly 
insensitive to DNA topology. In order to gain insight into the sequence preference of topo IV at 
these sites, SHAN-seq was used.  
In total, 4 strong sites (read depth ≥ 700 bp count) and 11 weak sites (read depth < 700 
bp count) were identified visually based on a characteristic peak shape seen in the EcT4 data 
and absent in the DNA only control (Figure 5.13). All peaks were present in each sample, 
insensitive to the DNA topology (Figure 5.13A), which is in agreement with the gel-based data 
(see Figure 5.5). The characteristic peak shape for EcT4 data was formed from sequence 
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enrichment spanning ~60-70 bp, with a bimodal peak separated by a central reduction in read 
depth, spanning ~15-20 bp (Figure 5.13B-D). Whilst this allowed the identification of EcT4 
activity, the shape formed precluded the ability to precisely map the cleavage site and therefore 
the nucleotide composition at the scissile phosphate or the size of the overhang. One 
explanation for this outcome was the use of sonication breaking the DNA around EcT4 binding 
sites, potentially due to DNA deformation upon binding producing structural vulnerabilities. This 
would therefore lead to enrichment around the cleavage site, but sequence loss at the precise 
location. Another explanation is CIP not efficiently removing the phospho-tyrosyl adduct, which 
goes on to disrupt adapter ligation of sequences from the cleavage site. Interestingly, a similar 
peak shape indicative of EcT4 cleavage activity was found using an in vivo NGS-technique 
called NorFliP [125, 341]. In this study, EcT4 activity was studied genome-wide using the 
cleavage-complex stabiliser norfloxacin, forming two peaks ~170 bp wide with a central 
sequencing loss of 130 bp. This was attributed to the 5‘ adduct interfering with adapter ligation 
as in this study only proteinase K was used, with no solution offered in the paper for the adducts’ 
removal. Regardless, EcT4 was shown to generate hundreds of cleavage sites across the 
genome, consistent with data presented here indicating that of the three topos assayed, T4 
maintains the highest levels of cleavage.  
To gain further confidence that the peaks seen within the NGS data correspond to bona 
fide EcT4 cleavage sites, the NGS data was compared to the gel-based data. As described for 
MmT6 analysis (section 5.3.3), pBR322* fragment sizes for cleavage at each peak on the NGS 
data were compared to the fragments seen on the gel with stronger sites labelled on the NGS 
data and represented as dark grey circles on the graph (Figure 5.14). For the NGS data, strong 
sites were identified based on a read depth count of ≥700, whilst for the gel they were identified 
based on the band brightness. As for MmT6, the correlation between the two data sets is very 
good, with strongly enriched peaks corresponding to bright bands seen on the gel, and an 
overall agreement between all data points. So, despite not having resolved the cleavage site 
or seen the predicted 4-base stagger enrichment, the peaks within the NGS data are likely valid 
EcT4 cleavage sites.  




Figure 5.13: NGS data for E. coli topo IV (EcT4) cleavage activity. All data are plotted as nucleotide 
read count (read depth) for each position along pBR322*. A: NGS data for EcT4 cleavage, plot in 
regard to the topology of the DNA substrate used, negatively supercoiled (blue), positively 
supercoiled (red) and relaxed (yellow). On the negatively supercoiled (blue) plot, the peaks 
enlarged in parts B-D are labelled with their respective letter. B-D: Close up images of the EcT4 
peaks, as labelled in A, showing the characteristic peak shape indicative of EcT4 cleavage 
activity, which appears insensitive to read depth.  
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Figure 5.14: NGS data versus gel-based data for EcT4-dependent fragmentation of pBR322*. The 
NGS data is on top in blue. The strong cleavage sites are labelled as ‘a’, ‘b’, ‘c’ and ‘d’. Below, 
the fragment sizes predicted by the sequencing were compared to those extracted from the gel-
based assay. Strong cleavage sites (large peaks in NGS data/bright cleavage bands in gel-based 
data) are dark grey, while other weaker cleavage sites are light grey. For the NGS fragment sizes, 
the strong sites are labelled with 1 or 2 to demonstrate they are partners with both being formed 
should EcT4 cleave linearised pBR322* at the position indicated on the NGS data.  
 
 The type of sequence preference analysis performed on the MmT6 data was facilitated 
due to the resolution of the precise cleavage site. For EcT4, the cleavage site position can be 
roughly predicted (e.g. centrally located between the two peaks) but not precisely. This led to 
sequence composition analysis of the DNA within each peak, as compared to the whole 
pBR322* sequence. To do this, a 56 bp sequence, spanning the entire EcT4 cleavage site was 
extracted and analysed for the presence of certain dinucleotides (Figure 5.15). See Table III in 
Appendix III for information on each sequence extracted. A clear preference for C/G rich 
regions was found with the dinucleotides CG, GG, GC, CC and GT all shown to be enriched in 
the EcT4 cleavage sites relative to the background. This is in agreement with the EcT4 in vivo 
NGS study, which also found GC dinucleotides enriched near the cleavage sites [125, 341]. 
This may reflect T4 DNA binding preference and as these GC rich regions lie in the vicinity of 
the cleavage site, they may be involved in G-segment bending or interactions with the C-
terminal domain (CTD) of the ParC subunit.  





Figure 5.15: Dinucleotide identity preference for EcT4 cleavage sites. The enrichment (%) is 
calculated from the frequency that a particular dinucleotide appears in the EcT4 cleavage site 
sequences minus its frequency across pBR322* as a whole.  
 
Using non-NGS techniques and promoting cleavage by EcT4 in the presence of 
quinolone-derived inhibitors found a preference for cleavage after a purine (G or A) with the 
following nucleotide most commonly being A or T, with a C in this position disfavoured. Whilst 
the data presented here cannot speak to this, they also found G-rich tracts to be common 
upstream of cleavage [275], a feature also observed here. Using Staphylococcus pneumoniae 
topo IV (SpT4), it was found that cleavage site-specificity in the presence of various quinolone 
drugs could be compressed into the consensus sequence, G(G/C)(A/T)A^GNNCT(T/A)N(C/A) 
[370]. Without cleavage site resolution, it is difficult to attain any agreement among this 
sequence and the EcT4 derived data presented here, however as seen for MmT6 and SsT6, 
there is often a fair amount of disparity between enzymes from different organisms. In addition, 
most, if not all, work published on the subject of topo-dependent cleavage has been achieved 
through the use of complex-stabilising drugs, which, as previously described, bias cleavage to 
certain sites which may not reflect strong cleavage sites in the absence of drugs.  
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5.3.5 DNA Gyrase NGS Results  
The third topo explored using SHAN-seq was E. coli DNA gyrase (EcGyrase). It has been the 
subject of a number of studies looking at DNA binding and cleavage activity in the context of 
the DNA sequence [339, 360, 377, 378]. The studies often use quinolone-derived inhibitors to 
stimulate cleavage by EcGyrase. Here, only CaCl2 was used to stimulate cleavage with the 
hope of attaining data on the more ‘natural’ cleavage site preference of EcGyrase.  
 
Figure 5.16: NGS data for E. coli DNA gyrase (EcGyrase) cleavage activity. All data are plotted as 
nucleotide read count (read depth) for each position along pBR322*. Data is displayed depending 
on the DNA topology of pBR322* used in the sample, negatively supercoiled (blue), positively 
supercoiled (red) and relaxed (yellow). EcGyrase dependent cleavage sites are labelled using 
asterisks.  
 
 Whilst the assay was limited by the availability of highly pure gyrase, a preliminary look 
into EcGyrase cleavage activity in vitro as a function of DNA topology was facilitated using 
SHAN-seq. Only three sites could be tentatively selected as EcGyrase-dependent, based on 
the read depth relative to the background (see Figure 5.16, peaks highlighted using asterisks). 
Interestingly, the second of the three sites was only enriched in the sample that contained 
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negatively-supercoiled pBR322*, suggesting this site was topology-sensitive. When this site, 
and the other two were compared to the agarose gel-based data from Section 5.3.1, the 
agreement was excellent, including the topology-sensitive site (Figure 5.17). In the gel (see 
Figure 5.5) there were two fragments (~1.5 and 3 kb) which were far more enriched in the 
sample using negatively-supercoiled DNA, which the NGS data suggested is due to topology-
sensitive cleavage around base 1500 of pBR322*. This preliminary data suggests that DNA 
topology can affect DNA cleavage through a modulation of EcGyrase sequence preference. 
 
 
Figure 5.17: NGS data versus gel-based data for EcGyrase-dependent fragmentation of 
negatively-supercoiled pBR322*. The NGS data is on top in blue. The strong cleavage sites are 
labelled as ‘a’, ‘b’ and ‘c’. Below, the fragment sizes predicted by the sequencing were compared 
to those extracted from the gel-based assay. Strong cleavage sites (large peaks in NGS 
data/bright cleavage bands in gel-based data) are dark grey, while other weaker cleavage sites 
are light grey. For the NGS fragment sizes, the strong sites are labelled with 1 or 2 to demonstrate 
they are partners with both being formed should EcGyrase cleave linearised pBR322* at the 
position indicated on the NGS data.  
 
 Unfortunately the data was unable to inform on the precise cleavage site at each of the 
three peaks, which prevents analysis of the cleavage site preference. However, sequences, 
140 bp in length, were extracted with 70 bp either side of the peak centre and analysed for 
dinucleotide identity (see Table IV, Appendix III for sequence information). This revealed an 
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enrichment of dinucleotides made up of G and C, or C and T (Figure 5.18). In a previous study, 
also using an NGS technique called topo-seq, EcGyrase cleavage activity was analysed in vivo 
in the presence of oxolinic acid, ciprofloxacin and microcin B17. This work showed that there 
was a GC-content fluctuation that occurred either side of the precise cleavage site, which was 
hypothesized the be involved in binding to the GyrA CTDs and appeared independent of the 
drug used. The data collected using SHAN-seq only covers three sequences, and without 
nucleotide resolution of the cleavage site, the sequences cannot be analysed confidently for 
fluctuations in GC content. However, there are numerous tracts of three of more G/C 
nucleotides in the sequences with the GC content being 66, 64.5 and 59.6%, all of which are 
higher than the overall GC content of pBR322* (53%). This may indicate a preference for 
wrapping DNA with periodic repeats of G or C nucleotides. The preference for EcGyrase to 
wrap DNA with fluctuations in GC content was also found using radioactivity assays and it was 
determined that the G and C nucleotides were exposed as the DNA wrapped the GyrA CTDs 
[377], a concept elaborated upon in [339].  
 
Figure 5.18: Dinucleotide identity preference for EcGyrase cleavage sites. The enrichment (%) is 
calculated from the frequency a particular dinucleotide appears in the EcGyrase cleavage site 
sequences minus its frequency across pBR322* as a whole.  
 
 The pBR322 plasmid has been used in topology assays for some time and in the past, 
a strong gyrase cleavage site was determined at position 990, when EcGyrase cleaved 
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pBR322 in the presence of oxolinic acid [358-360]. This site is not represented by the work 
reported here, either in the NGS or gel-based assay. This strongly suggests that some 
cleavage sites are inhibitor-specific, and whilst oxolinic acid induced a high level of cleavage 
by EcGyrase at this site, in its absence it wasn’t cleaved at all (see Figures 5.16 and 5.17). 
Therefore, any extrapolation, based on this observation, that the site at 990 may represent a 
cleavage site for gyrase under normal circumstances would be false. Indeed further work is 
required, particularly establishing gyrase cleavage site-specificity in the absence of cleavage-
complex stabilising drugs, which is a topic far more unexplored. SHAN-seq, when optimised, 
offers an elegant solution to studying the drug-dependent and -independent EcGyrase 
cleavage activities.  
  
5.4 Conclusions 
The use of SHAN-seq has provided new data on the cleavage activity of MmT6, EcT4 and 
EcGyrase, all in the absence of inhibitors and providing insights previously unseen. This 
technique gives the experimenter complete control over the reaction conditions, such as DNA 
topology, DNA sequence, inhibitors and other proteins, all of which can be systematically 
assayed. The use of nitrocellulose filters in the enrichment of topo-bound DNA also allows 
proteins without specific antibodies to be explored in a highly accessible manner. Despite 
stages of SHAN-seq requiring optimisation (explored in section 5.5 below), its ability to 
elucidate precise cleavage sites, inform on the size of the overhang and whether it’s on the 5ʹ 
or 3ʹ strand, has been confirmed through the use of restriction enzyme MluCI and MmT6.  
 MmT6 was shown to cleave pBR322* with the preference 5ʹ-[G/C][G/C]^[A/C/T], 
generating 2-base 5ʹ overhangs. EcT4 demonstrated a unique cleavage site peak shape which 
allowed the identification of 15 potential cleavage sites. Even though nucleotide resolution of 
the cleavage site was absent, the sequences demonstrated an elevated GC content. It also 
showed that EcT4 activity is independent of DNA topology. EcGyrase was shown to generate 
the least amount of cleavage, with one particular site (~1.5 kb) clearly demonstrating topology-
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sensitive activity, with its cleavage only occurring on negatively supercoiled pBR322* (not 
positively supercoiled or relaxed).  
Using code written and executed by Rachel Kim (NHLBI, NIH, Bethesda, USA), the 
NGS data was circularised, creating an informative figure for use in comparison between 
different samples (Figure 5.19). As seen in Figure 5.19A, the cleavage profiles of MmT6, EcT4 
and EcGyrase were compared. This revealed that the topology sensitive site for EcGyrase was 
also enriched in the EcT4 data, however for EcT4 this site was not sensitive to topology. The 
data can also be compared among different topologies (Figure 5.19B), highlighting topology-
sensitive sites. This method of data presentation could be extended to comparing cleavage 
profiles using different inhibitors, or any variable the experimenter decides to explore. In 
conclusion, SHAN-seq is an accessible technique, which has proven successful in the 
exploration of topo-dependent cleavage activity in vitro using plasmid DNA. 
 
Figure 5.19: Circular plots of NGS data. A: Comparison of NGS data generated from the cleavage 
of negatively supercoiled pBR322* by EcGyrase (green), EcT4 (blue) and MmT6 (red). B: 
Comparison of NGS data generated from the cleavage of relaxed (yellow), negatively supercoiled 
(blue) and positively supercoiled (red) pBR322* by EcGyrase. Code written and executed by 
Rachel Kim.  
 
5.5 Future Work 
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Whilst SHAN-seq shows great promise in the characterisation of topo-dependent cleavage 
activity, during the course of this chapter, certain pitfalls have been highlighted. One major 
issue, which has plagued all topo NGS studies, is the removal of the phospho-tyrosyl adduct. 
Without its removal, adapter ligation of the 5ʹ strand from topo cleavage sites will not occur and 
therefore won’t be sequenced. There have been a number of solutions to this, namely 
enzymatic digestion. CIP was the choice here, being readily accessible through commercial 
means and evidence that its diphosphatase activity is sufficient to remove the adduct [155]. 
However, evidently CIP did not function efficiently, exemplified in the MmT6 NGS data from the 
MmT6-dependent 5ʹ strand, which was barely sequenced whilst the 3ʹ MmT6-dependent strand 
was sequenced to a significant depth. The adapter ligation stage in which the 3ʹ and 5ʹ ends are 
uniquely indexed offers an alternative approach, by allowing the 3ʹ NGS data to be separated 
from the 5ʹ data. In the case of MmT6, this worked surprisingly well and despite the failure of 
the 5ʹ MmT6-clevaed end sequencing, the opposite strand revealed the information 
independently. This was similar to an NGS technique employed for gyrase cleavage site 
characterisation in which a single stranded DNA library generation kit was used, in which only 
the 3ʹ strand was sequenced [339]. This work was also able to reveal the nucleotide overhangs 
associated with gyrase cleavage activity, demonstrating further the expendable nature of the 5ʹ 
strand. In some cases, the enzyme TDP2 was employed, which is the protein responsible for 
rescuing stalled topo II in vivo by cleaving the phospho-tyrosyl [338]. However, caveats to the 
use of TDP2 include commercial inaccessibility and where it is available, the quantity and purity 
required arelacking. If large amounts of highly pure TDP2 were made, this could form a more 
robust approach to removing the adduct in vitro, and TDP2 itself has been used with success 
in in vivo topo NGS studies [337].  
 Another potential issue is the use of sonication. Based on the data presented here, 
particularly the EcT4 data, there is evidence that DNA is breaking in the vicinity of the cleavage 
site and this is being sequenced instead of the precise cleavage site. One potential explanation 
for this is that during sonication the DNA is sheering around the bound protein. However that 
would suggest the DNA becomes protein-free and therefore would be indexed in the first stage 
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of adapter ligation. This wasn’t the case as the data is derived from the EcT4-cleavaed DNA 
end. That then leads to possibility that the DNA is shearing away from the cut site but remaining 
bound to protein. Topos tend to have extended DNA binding surfaces involved in 
docking/bending of the G-segment or sensing the T-segment, therefore it is possible that DNA 
will remain bound to the topo, despite sonication-dependent cleavage. Whilst sonication is the 
gold-standard in generating random DNA fragments, it may too harsh on the cleavage 
complexes. Enzymatic fragmentation options exist, which will be explored as SHAN-seq is 
further optimised.  
 An alternative use for this method, which has not yet been discussed, is in the 
exploration of topo DNA-binding activity. Rather than allowing the enzyme to cleave the DNA, 
binding can be explored by omitting nucleotide, in the case of MmT6. The DNA could then be 
sonicated and then enzyme removed prior to sequencing. This would allow the comparison of 
DNA binding to DNA cleavage activity, which, as discussed in section 5.1, is often not well 
correlated, and has raised some important questions about topoisomerase activity in vivo. The 
caveat with exploring binding is that it would be difficult to obtain data on the exact binding 
position of the topo, however it can still inform on whether certain regions of the DNA substrate 
are bound more frequently than others. 
 The continuation of work done on SHAN-seq is currently the role of Rachel Kim (NHLBI, 
NIH, Bethesda, US), with the goal to establish an optimised SHAN-seq protocol, before 
exploring the activity of different topos on various DNA topologies and with inhibitors. This is in 












Discussion and Conclusions 
6.1 Introduction 
When this research project began, it was with the aim to further characterise Methanosarcina 
mazei DNA topoisomerase VI (MmT6) in vitro, to advance our understanding of type IIB topos 
and develop MmT6 as a tractable model system for expanding knowledge of other topo VI 
homologues. Both the presence of topo VI in eukaryotes [180] and the homology to Spo11 
[171], makes research on this little-known archaeal enzyme important in a broader context, 
findings of which will hopefully be translated into furthering eukaryotic research in the field of 
DNA metabolism.   
 The research conducted here was fortunate enough to be a transatlantic collaboration 
between the UK-based lab of Prof. Anthony Maxwell (JIC, Norwich, UK), and the US-based lab 
of Dr. Keir Neuman (NIH, Bethesda, USA). The former lab specialises in the utilisation of 
ensemble biochemical techniques, and the latter in the use of the biophysical single-molecule 
technique, the magnetic tweezers. This allowed MmT6 characterisation to benefit from the 
application of multiple, complementary techniques, which facilitated acquisition of novel results 
and revealed previously unseen enzymatic behaviours that have led to generating a well-
supported hypothesis of MmT6 activity. The remainder of this final chapter is concerned with 
bringing all these findings together and discussing implications of the data with an expanded 
perspective.  
 
6.2 Characterisation of M. mazei topo VI using ensemble and 
single-molecule methods 
The use of both ensemble and single molecule methods in the characterisation of MmT6 
produced highly-complementary data, and revealed that MmT6 had preference for binding DNA 
writhe with a crossing geometry of 87.4-87.7°, thus predisposing MmT6 to decatenation and 
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braid unlinking, rather than supercoil or plectoneme relaxation. An overview of the results 
amassed during this project can be seen in Figure 6.1, highlighting findings which correspond 
to each step of the hypothesised MmT6 reaction cycle.  
 
Figure 6.1: Results attained over the course of this research project and the MmT6 reaction cycle 
steps on which they inform. The MmT6 reaction cycles has been illustrated with reference to data 
attained in [62, 64, 67, 195]. An unbound MmT6 holoenzyme (1) interacts with a DNA crossing 
formed of the G- (blue) and T-segment (orange), with the Top6B subunits dimerising in response 
to ATP binding (2). The G-segment is cleaved (3), the T-segment is passed through the cleaved 
G-segment (4), before the G-segment is re-ligated (5). ATP hydrolysis occurs during strand 




passage and re-ligation (a), with the release of ADP/Pi causing the Top6B subunits to separate. 
The enzyme either remains bound to the G-segment, ready to capture a consecutive T-segment, 
or dissociates from the G-segment (6). The results discussed through this thesis are summarised 
beside each numbered stage of the MmT6 reaction cycle. Abbreviations are 
Ethylenediaminetetraacetic acid (EDTA), negatively supercoiled DNA ((-)SC), positively 
supercoiled DNA ((+)SC), relaxed (Rel) and linear (Lin), and magnesium ions (Mg2+).   
 
MmT6 was shown to be a heterotetramer in solution, meaning the holoenzyme does 
not assemble on the DNA from Top6A/Top6B dimers or Top6A and Top6B monomers. It also 
demonstrated that basal ATP hydrolysis activity was almost non-existent in the absence of a 
DNA substrate, indicating that DNA is a key activator of MmT6 ATPase activity. In the presence 
of DNA, MmT6 bound in a Mg2+-dependent fashion, with increased affinity for writhed DNA 
substrates. It was demonstrated, using a membrane capture technique, that the relative MmT6 
dissociation constant decreased as DNA superhelical density increased. This DNA writhe-
dependent MmT6 stimulation was also seen when exploring ATP hydrolysis activity using a 
radioactive ATPase assay, and strand passage measured using the magnetic tweezers. The 
MmT6 ATP hydrolysis rate was ~5-fold higher in the presence of negatively supercoiled 
pBR322*, compared with either linear or relaxed pBR322*, and was tightly coupled to the 
presence of a writhed DNA substrate. Utilisation of the magnetic tweezers plectonemic DNA 
substrate allowed analysis of MmT6 strand-passage rate as a function of the number of 
supercoils. This demonstrated that MmT6 rate decreased with lowering supercoil density, with 
the data fitted to an inverse relationship in which strand-passage rate was inversely 
proportional to the number of supercoils. These data, along with research published during the 
course of this project [62], indicate that MmT6 directly senses and resolves DNA crossings, 
preferentially binding both the G- and T-segment simultaneously. This is unlike the 
hypothesised behaviour of type IIA topos, which are believed to bind the G-segment before 
capturing the T-segment [11, 51].  
 Using either the magnetic tweezers plectoneme or supercoiled pBR322*, in single-
molecule and ensemble assays respectively, MmT6 was a largely-distributive and slow 
supercoil relaxase, demonstrating an ATP hydrolysis rate ~30-fold lower than type IIA topos. 
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As previously discussed [62], this would likely render MmT6 unable to keep up with the 
demands of DNA replication and transcription within M. mazei cells, and led to the reasoning 
that in vitro assays may be excluding a condition or molecule which enhances MmT6 rate in 
vivo. However, the use of the magnetic tweezers braided DNA substrate enhanced MmT6 
average rate of reaction ~5-6-fold as compared to plectoneme relaxation at the same MmT6 
concentration. In addition, MmT6 behaviour went from being highly distributive in the presence 
of supercoils to partially processive during braid unlinking. This suggested a factor more 
common in braids than plectonemes was responsible for enhancing MmT6 activity and allowing 
the enzyme to remain bound to the initial G-segment for long enough to capture and pass a 
consecutive T-segment. In addition, when the rate was extracted for the processive bursts only, 
the rate of MmT6 was no longer dramatically lower than that of other type IIA topos. Using a 
positive braid, the MmT6 average processive rate was measured to be 0.5-0.7 strand-passage 
events s-1, which is far more comparable to that found for E. coli DNA gyrase at 1 strand 
passage event s-1 [319], and E. coli topo IV at 2.5 strand passage events s-1 [119]. In addition, 
when the processive rate for braid unlinking is compared to the average rate of plectoneme 
relaxation, MmT6 activity was enhanced 7-23-fold, depending on the MmT6 concentration 
used. DNA braids have been used as a proxy for studying decatenation activity, despite 
structural differences [257], therefore it was necessary to analyse MmT6 activity through 
ensemble techniques using catenated plasmids. This data supported the DNA braid unlinking 
results, demonstrating 5-10-fold less MmT6 was required for efficient decatenation activity, 
than for supercoil relaxation, under identical conditions.  
 Using both agarose gel-based ensemble techniques and the single-molecule magnetic 
tweezers, at 21°C, MmT6 displayed a weak yet significant 2-3-fold rate enhancement in the 
presence of positive writhe over negative. This was demonstrated not to be a function of 
enhanced binding or cleavage on positive writhe, with both these measurements demonstrated 
to be higher for negative writhe. Along with the data discussed in the previous paragraph, this 
suggested MmT6 had a DNA crossing geometry preference. This was explored in depth using 
the magnetic tweezers single crossing assay, first described in [120]. A preference for positive 




writhe indicated that MmT6 had a preference for acting on juxtaposed G- and T-segments with 
angles lower than 90°, as these angles are more common in positive, with negative writhe 
angles more commonly obtuse. The preferred MmT6 DNA crossing angle was determined to 
be 87.4-87.7°, and even though this value is very close to 90°, it is enough to affect the chiral-
dependent rate of relaxation. Monte Carlo simulations of plectonemes with a single supercoil 
at 0.4 pN showed that the preferred MmT6 angle appears ~2.8-fold more often in a single 
positive supercoil, compared to a negative supercoil (Figure 6.2A). In addition, when catenane 
angles were simulated in previously published work [119], the angle distributions were far 
broader and centred at 90°. Therefore, not only did the crossing angle preference explain the 
difference in rate on positive and negative writhe, but extended to providing a mechanism for 
the preferential decatenation activity of MmT6. Furthermore, this preferred angle is far less 
common in more supercoiled substrates, distributions of which peak around 60° [119], 
presenting an explanation for the highly inefficient MmT6 DNA relaxase activity.  
 
Figure 6.2: Supercoil DNA crossing angle distributions measured using Monte Carlo (MC-) 
simulations. DNA crossing angle distributions for a single positive (pink circles) and a single 
negative (blue circles) supercoil, measured using an MC-simulation under 0.4 pN, using a 5-kb 
DNA duplex. Black dotted lines indicate the probability of the MmT6 preferred angle (~87.55°) for 
a positive or negative crossing.  
 
 In addition to the use of the ensemble and single-molecule techniques, mentioned 
above, a Next Generation Sequencing (NGS) technique was developed to explore MmT6 DNA 
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cleavage sequence preference and measure the base-overhang generated during double-
stranded cleavage in vitro. The technique, named SHAN-seq, was able to not only reveal both 
these pieces of information about MmT6, but also allowed a preliminary glance into the 
sequence preferences of other type II topos, E. coli DNA gyrase and topoisomerase IV. It is 
hoped, that once SHAN-seq is refined, that it will be a useful and accessible technique to the 
field of DNA topoisomerase research. For MmT6, it revealed that MmT6 cleaved the DNA 
generating 2-base overhangs with a preference for cleavage after G/C dinucleotides. Further 
work is necessary to understand this sequence preference, however, the work described in 
Chapter 5, demonstrated the validity of this technique as well as showcased its promise in the 
collection of in vitro topo-dependent cleavage data. 
 
6.3 M. mazei topo VI findings in a broader context  
6.3.1 Understanding the activity of topo VI from the archaeal perspective 
Archaea constitute the third domain of the tree of life, alongside the bacteria and eukarya. 
Archaea earnt their distinction from bacteria, previously having been grouped together, based 
on their unique ribosomal proteins and RNA [379]. In terms of topoisomerase encoding, 
archaea are quite diverse. Almost all contain topo VI, aside from the order Thermoplasmatales, 
which instead encodes a DNA gyrase, whilst some, such as the Methanosarcina order encode 
both gyrase and topo VI [72]. In addition to type II topos, all archaea, aside from the 
Thuamarchaea, encode one or two copies of a type IA topo, which, in terms of sequence 
similarity, resembles bacterial and eukaryotic topo III, as opposed to bacterial topo IA [380]. 
This has led to the belief that topo VI must be integral to the removal of positive supercoils 
during transcription and replication, particularly in archaea lacking a gyrase, as topo III is known 
to have preferential decatenation activity [381] and topo IA is known to relax negative writhe, 
not positive (unless a ss-DNA region is present). However, the work reported here solidifies 
the observation found in [62], that M. mazei topo VI is an extremely inefficient DNA relaxase, 
and provides evidence of its preferential decatenation activity. If this behaviour is true of all 
archaeal topo VI enzymes, then those organisms which lack DNA gyrase, would struggle to 




relieve torsional stress ahead of replication forks at a pace required by the cell. The current 
literature confounds the issue as the first archaeal type IA topo explored in vitro, from the 
hyperthermophile Desulfurococcus amylolyticus, also termed topo III, did exhibit robust 
relaxation activity of both positive and negative writhe at 95°C. However, it has also been 
established in Sulfolobus solfataricus, that of the three type IA topos it encodes, two are reverse 
gyrases [382] (another type IA topo important in positive supercoiling of hyperthermophillic 
genomes [383]), and the third is topo III, exhibiting preferential decatenation activity [384]. It 
may be that in archaea which lack DNA gyrase or a type I topo capable of positive supercoil 
relaxation, that topo VI has evolved more efficient DNA relaxation activity, in a similar sense to 
how Mycobacterium tuberculosis DNA gyrase has evolved to be efficient in both DNA 
supercoiling and decatenation in the absence of topo IV [347]. M. mazei encodes both topo VI 
and DNA gyrase, as well as two uncharacterised type IA topos, meaning that topo VI may not 
be required during positive supercoil relaxation and hence has evolved to preferentially 
decatenate. It is also important, as was done in Wendorff et al. [62], to consider the doubling 
time of the archaea in question, as the slow relaxation by topo VI may be adequate to support 
the growth of that particular organism. This did not seem to be the case for M. mazei and the 
involvement of unknown accessory factors that may enhance rate or processivity of topo VI 
has been postulated [62].   
 
6.3.2 Implications for eukaryotic systems that express topo VI homologues    
Whilst research on the eukaryotic topo VI and Spo11 proteins has the potential to create a 
large impact in eukaryotic cellular understanding, the proteins have been notoriously hard to 
express and purify for investigation in vitro. Therefore, utilising the far more accessible archaeal 
enzymes, has already shed light on the mechanism of the eukaryotic counterparts and will 
hopefully lead to advancements in their expression and in vitro characterisation, and, in 
addition, provide a means of screening compounds that can then be used against eukaryotic 
enzymes in herbicidal and anti-cancer treatments. For example, the Hsp90 inhibitor radicicol 
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was found to inhibit S. shibatae topo VI using in vitro techniques [215], which later led to the 
discovery that it also inhibited human type IIA topos and therefore had promise as an anti-
cancer treatment [385]. Furthermore, using a high-throughput screen, the compound 
hexylresorcinol was found to inhibit M. mazei topo VI in vitro, which was subsequently 
confirmed to also effect the growth of A. thaliana seedlings, potentially through the inhibition of 
plant topo VI [386]. So whilst archaea are not always considered fundamental to furthering our 
knowledge on eukaryotic systems, archaeal topo VI has given important insight into the field of 
eukaryotic DNA metabolism, with its in vitro characterisation also advancing understanding on 
the mechanism of Spo11 [171, 172]. The work reported here hopes to maintain this trend, 
providing not only intriguing results into archaeal DNA metabolism, but leading to a deeper 
understanding of eukaryotic biology, in particular the role of topo VI in plants.  
Genomic analysis of Arabidopsis thaliana revealed three distantly related homologs of 
the Topo6A/Spo11 subunit (AtSPO11-1, -2 and -3) and one of the Topo6B (AtTOP6B) subunit 
[175, 176, 178]. AtTOP6B and AtSPO11-3, the plant topo VI subunits, have high levels of 
expression and the proteins have also been demonstrated to interact [38]. A. thaliana mutants, 
homozygous for null mutations in either AtTOP6B or AtSPO11-3, display identical phenotypes, 
with severely growth-stunted plants failing to live much past 4-5 weeks [178]. Furthermore, 
double mutants displayed a phenotype identical to that of either single mutant, demonstrating 
the proteins likely function in the same process, or even the same protein complex. These 
studies suggested that the topo VI homologues play a key role in DNA replication and cell 
growth. A process called endoreduplication, in which the genome is replicated multiple times 
in the absence of cellular division, is critical for plant growth to enlarge cells of the hypocotyl 
and leaves [179]. Endoreduplication is deficient in the AtSPO11-3/AtTOP6B mutants and can 
explain the dwarf aspect of the phenotype [30, 31]. However, A. thaliana possesses four type 
I topoisomerases [180], along with both topoisomerase II and DNA gyrase, both of which are 
type IIA topos capable of the same reactions as topo VI, namely DNA decatenation, unknotting 
and relaxation. So why A. thaliana requires topo VI exclusively during endoreduplication is not 
clear. The research done here, whilst conducted on an archaeal topo VI, hopes to help provide 




an explanation for this, as topo VI has an intrinsic preference for decatenation, arising as a 
function of a strict DNA crossing angle preference. This means topo VI not only has a significant 
rate increase in the presence of catenanes and braids, but strongly disfavours the relaxation of 
supercoils. During the endocycle, the genome is replicated to variable degrees, however in 
wild-type A. thaliana trichomes this can be as high as 32C [179], with mutants in topo VI unable 
to replicate the genome past 8C [169, 178]. With increasing DNA replication, comes elevated 
levels of transcription, and therefore extensive pressure on the protein machinery involved in 
these processes. With both replication and transcription involving strand separation, significant 
levels of DNA supercoiling will occur which is efficiently dealt with by the type I and type IIA 
topos. It is possible, therefore, as these proteins are extremely efficient at relaxation, that those 
topos which are known to be able to decatenate in vitro, become subsumed by the necessity 
to relieve torsional stress generated ahead of replication and transcription forks in vivo. With 
this reaction so heavily disfavoured by topo VI, it can decatenate and unknot the genome 
unhindered, allowing the cell to continue through the endocycle. The research described here 
clearly does not rule out the possibility of protein-protein recruitment, temporal regulation, or 
other activity-modulating factors which lead to the indispensability of topo VI in 
endoreduplication, but does provide a rationale that is independent of the requirement of these 
yet unknown components. In A. thaliana, topo VI accessory proteins have been identified, 
known as RHL1 and BIN4, which are believed to interact with topo VI directly [181, 182], 
however the mechanism through which they interact is still not well understood. They are worth 
mentioning as it is still possible that they enhance or direct topo VI activity in some way, 
however there have been no archaeal homologues found of either RHL1 or BIN4.  
 
6.4 Conclusions  
Throughout the course of this research project, DNA topoisomerase VI from M. mazei, has 
been further characterised using both ensemble and single-molecule methods. This has led to 
the generation of the hypothesis that MmT6 is DNA crossing sensor with an angle preference 
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of ~87.4-87.7°, which predisposes it to decatenation whilst disfavouring the removal of 
supercoils. In the presence of a more geometrically-preferred substrate (DNA braid or 
catenated plasmids), activity is enhanced 5-23-fold (dependent on which metrics you compare), 
with the data collected here forming robust supporting evidence for the preferential 
decatenation activity of MmT6. However, further work is still required. Nonetheless, MmT6 has 
proven to be a highly tractable model system for archaeal type IIB characterisation, amenable 
to the use of both ensemble and single-molecule techniques; these findings hopefully aiding 























List of abbreviations 
A340: absorbance at 340 nm 
ADP: adenosine diphosphate 
ADPNP: 5′-adenylyl β,γ-imidodiphosphate 
AIM: autoinduction media 
ATP: adenosine triphosphate 
B: bound DNA 
BB: MmT6 binding buffer 
Bp: base pairs 
BSA: bovine serum albumin 
BWB: bead wash buffer 
CaCl2/Ca2+: calcium chloride/calcium ion  
CCD: charge coupled device 
CIP: calf intestinal alkaline phosphatase 
CTD: C-terminal domain 
CoCl2/Co2+: cobalt chloride/cobalt ion 
DB: MmT6 dilution buffer 
DSB: double-stranded DNA break 
DTT: dithiothreitol 
EcGyrase: E. coli DNA gyrase 
EcT4: E. coli DNA topoisomerase IV 
EDTA: ethylenediaminetetraacetic acid 
EtBr: ethidium bromide 
G-segment: gate segment 
Gyrase: DNA gyrase 
h or hr: hour(s) 
HCl: hydrochloric acid 
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iSCAT: inferometric scattering technology 
kDNA: kinetoplast DNA 
KOH: potassium hydroxide 
LED: light emitting diode 
Lk: linking number 
MB: MmT6 minimal buffer 
MgCl2/Mg2+: magnesium chloride/magnesium ion 
min: minute(s) 
MmT6: Methanosarcina mazei DNA topoisomerase VI 
MnCl2/Mn2+: manganese chloride/manganese ion 
MT: magnetic tweezers 
NaCl: sodium chloride 
NADH/NAD+: nicotinamide adenine dinucleotide reduced/oxidised 
Neg: negatively supercoiled 
NGS: next-generation sequencing 
NiCl2: nickel chloride/NiCl2 
NTD: N-terminal domain 
OC: open circular/nicked plasmid DNA 
PAGE: polyacrylamide gel electrophoresis  
PBS: phosphate buffer solution 
PCR: polymerase chain reaction 
PEP: phosphoenolpyruvic acid 
PK: proteinase K 
PK/LDH: pyruvate kinase/lactate dehydrogenase 
Pos: positively supercoiled 
RB: MmT6 relaxation buffer 





SC: supercoiled plasmid DNA  
SDS: sodium dodecylsulphate 
SEC-MALS: size exclusion chromatography coupled to multi-angle light scattering 
SHAN-seq: simplified high accuracy end sequencing 
SSB: single-stranded DNA break 
SsT6: Sulfolobus shibatae DNA topisomerase VI  
TDP2: tyrosyl-DNA phosphodiesterase 2 
TLC: thin layer chromatography 
Topos: DNA topoisomerases 
Topo IA: DNA topoisomerase IA 
Topo IB: DNA topoisomerase IB 
Topo II: DNA topoisomerase II 
Topo III: DNA topoisomerase III 
Topo IV: DNA topoisomerase IV 
Topo V: DNA topoisomerase V 
Topo VI: DNA topoisomerase VI 
Topo VIII: DNA topoisomerase VIII 
T-segment: transport segment 
UB: unbound 
WB: wash buffer 
w/v: weight/volume 
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Figure I: Supporting data for Figures 3.17-3.18, exploring the effects of varying divalent metal ion 




with 1 mM ADPNP, at 37°C for 30 min in the presence of different divalent metal ions. Divalent 
metal ions explored were magnesium chloride (MgCl2 or Mg2+), manganese chloride (MnCl2 or 
Mn2+), zinc chloride (ZnCl2 or Zn2+), calcium chloride (CaCl2 or Ca2+), cobalt chloride (CoCl2 or 
Co2+), and nickel chloride (NiCl2 or Ni2+), with each varied in concentration from 0.5 to 100 mM. 
The DNA-only sample was incubated in the absence of MmT6 and in the presence of 100 mM of 
the respective metal cation salt. All samples were run on a 1% (w/v) native agarose gel for 15 hr 
at ~2 Vcm-1, stained with 0.5 μg/mL ethidium bromide and imaged under UV illumination. OC: 
open circular or nicked, L: linear, and SC: supercoiled. 
 
 
Figure II: Supporting data for Figure 3.26, MmT6 DNA binding affinity as a function of the number 
of supercoils in pBR322*. MmT6 (8nM) was incubated with 5 nM pBR322*, either positively (pos) 
and negatively (neg) supercoiled, and 10 mM MgCl2, for 30 min at 37°C. The MmT6-bound DNA 
(B) was separated from the unbound DNA (UB) using 0.45μm nitrocellulose Centrex MF filters 
(Whatman). The bound and unbound DNA samples were run on a 1% (w/v) agarose gel for 13 hr 
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Figure III: Single crossing data analysis for braid 2 (see table I, appendix II). A: Calibration curve 
of DNA extension as a function of magnet rotations (black circles), fit the geometric function, 𝑳 =
	-𝑳𝟎𝟐 − 𝟒𝒆𝟐𝒔𝒊𝒏𝟐(𝒏𝝅)	– 𝐫 +	√𝒓𝟐 − 𝒆𝟐, |𝒏| < 𝟎. 𝟓 (red line), calculating the DNA spacing on the bead to 
660 nm. B: Example trace of positive (pink) and negative (blue) single crossings being input 
mechanically (DNA extension decrease), and removed by 900 nM MmT6 (DNA extension 
increase), under 0.5 pN, at 21°C. C: Unlinking times for negative crossings under 0.5 pN, plot as 
a histogram and fit to a single exponential resulting in a characteristic unlinking time (τR) 21.06 ± 
3.5 s. D: Unlinking times for positive crossings under 0.5 pN, plot as a histogram and fit to a 
single exponential resulting in a characteristic unlinking time (τL) 10.2 ± 1.4 s. E: Crossing angle 




Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 0.5 pN. The positive 
angle probability distributions were attained directly, with the negative distributions derived from 
the relationship PR(α) = PL(180°-α). F: Ratio of negative to positive probability from Figure 1E 
plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle 
(α0) can be attained, illustrated by the black arrow. For this tether geometry and force (0.5 pN), 
τL/τR = 0.48 ± 0.09, which gave α0 of 88.11° ± 4.4° when using MC simulations, and 85° ± 4.3° when 
using BD simulations (BD plots not shown). G: Unlinking times for negative crossings under 1 
pN, plot as a histogram and fit to a single exponential resulting in a characteristic unlinking time 
(τR) 18.49 ± 2.8 s. H: Unlinking times for positive crossings under 1 pN, plot as a histogram and 
fit to a single exponential resulting in a characteristic unlinking time (τL) 9.6 ± 1.1 s. I: Crossing 
angle probability distributions for single positive (PL(α), pink) and negative (PR(α), blue) 
crossings, from Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 1 
pN. The positive angle probability distributions were attained directly, with the negative 
distributions derived from the relationship PR(α) = PL(180°-α). J: Ratio of negative to positive 
probability from Figure 1I plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ 
PL(α0), the preferred angle (α0) can be attained, illustrated by the black arrow. For this tether 
geometry and force (1 pN), τL/τR = 0.52 ± 0.08, which gave α0 of 88.82° ± 4.4° when using MC 
simulations, and 87.75° ± 4.4° when using BD simulations (BD plots not shown). K: Unlinking 
times for negative crossings under 1.5 pN, plot as a histogram and fit to a single exponential 
resulting in a characteristic unlinking time (τR) 18.32 ± 2.2 s. L: Unlinking times for positive 
crossings under 1.5 pN, plot as a histogram and fit to a single exponential resulting in a 
characteristic unlinking time (τL) 10.6 ± 0.6 s. M: Crossing angle probability distributions for 
single positive (PL(α), pink) and negative (PR(α), blue) crossings, from Monte Carlo (MC) 
simulations [223] for the tether geometry seen in A, under 1.5 pN. The positive angle probability 
distributions were attained directly, with the negative distributions derived from the relationship 
PR(α) = PL(180°-α). N: Ratio of negative to positive probability from Figure 1M plotted on a 
semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle (α0) can be 
attained, illustrated by the black arrow. For this tether geometry and force (1.5 pN), τL/τR = 0.58 ± 
0.08, which gave α0 of 89.04° ± 4.5° when using MC simulations, and 88.5° ± 4.4° when using BD 
simulations (BD plots not shown). The error associated with α0 is the combination of the 
statistical and systematic error. 
 







Figure IV: Single crossing data analysis for braid 3 (see table I, appendix II). A: Calibration curve 
of DNA extension as a function of magnet rotations (black circles), fit the geometric function, 𝑳 =
	-𝑳𝟎𝟐 − 𝟒𝒆𝟐𝒔𝒊𝒏𝟐(𝒏𝝅)	– 𝐫 +	√𝒓𝟐 − 𝒆𝟐, |𝒏| < 𝟎. 𝟓 (red line), calculating the DNA spacing on the bead to 
660 nm. B: Example trace of positive (pink) and negative (blue) single crossings being input 
mechanically (DNA extension decrease), and removed by 900 nM MmT6 (DNA extension 
increase), under 0.7 pN, at 21°C. C: Unlinking times for negative crossings under 0.7 pN, plot as 
a histogram and fit to a single exponential resulting in a characteristic unlinking time (τR) 8.18 ± 
1.9 s. D: Unlinking times for positive crossings under 0.7 pN, plot as a histogram and fit to a 
single exponential resulting in a characteristic unlinking time (τL) 5.4 ± 0.8 s. E: Crossing angle 
probability distributions for single positive (PL(α), pink) and negative (PR(α), blue) crossings, from 
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Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 0.7 pN. The positive 
angle probability distributions were attained directly, with the negative distributions derived from 
the relationship PR(α) = PL(180°-α). F: Ratio of negative to positive probability from Figure 1E 
plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle 
(α0) can be attained, illustrated by the black arrow. For this tether geometry and force (0.7 pN), 
τL/τR = 0.65 ± 0.17, which gave α0 of 88.81° ± 4.4° when using MC simulations, and 85.75° ± 4.3° 
when using BD simulations (BD plots not shown). G: Unlinking times for negative crossings 
under 1 pN, plot as a histogram and fit to a single exponential resulting in a characteristic 
unlinking time (τR) 7.2 ± 1.1 s. H: Unlinking times for positive crossings under 1 pN, plot as a 
histogram and fit to a single exponential resulting in a characteristic unlinking time (τL) 6.6 ± 1.3 
s. I: Crossing angle probability distributions for single positive (PL(α), pink) and negative (PR(α), 
blue) crossings, from Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 
1 pN. The positive angle probability distributions were attained directly, with the negative 
distributions derived from the relationship PR(α) = PL(180°-α). J: Ratio of negative to positive 
probability from Figure 1I plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ 
PL(α0), the preferred angle (α0) can be attained, illustrated by the black arrow. For this tether 
geometry and force (1 pN), τL/τR = 0.9 ± 0.19, which gave α0 of 89.28° ± 4.5° when using MC 
simulations, and 86.25° ± 4.3° when using BD simulations (BD plots not shown). K: Unlinking 
times for negative crossings under 1.5 pN, plot as a histogram and fit to a single exponential 
resulting in a characteristic unlinking time (τR) 10.5 ± 1.7 s. L: Unlinking times for positive 
crossings under 1.5 pN, plot as a histogram and fit to a single exponential resulting in a 
characteristic unlinking time (τL) 7.4 ± 1.1 s. M: Crossing angle probability distributions for single 
positive (PL(α), pink) and negative (PR(α), blue) crossings, from Monte Carlo (MC) simulations 
[223] for the tether geometry seen in A, under 1.5 pN. The positive angle probability distributions 
were attained directly, with the negative distributions derived from the relationship PR(α) = 
PL(180°-α). N: Ratio of negative to positive probability from Figure 1M plotted on a 
semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle (α0) can be 
attained, illustrated by the black arrow. For this tether geometry and force (1.5 pN), τL/τR = 0.7 ± 
0.15, which gave α0 of 89.12° ± 4.5° when using MC simulations, and 87.55° ± 4.4° when using BD 
simulations (BD plots not shown). The error associated with α0 is the combination of the 
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Figure V: Single crossing data analysis for braid 4 (see table I, appendix II). A: Calibration curve 
of DNA extension as a function of magnet rotations (black circles), fit the geometric function, 𝑳 =
	-𝑳𝟎𝟐 − 𝟒𝒆𝟐𝒔𝒊𝒏𝟐(𝒏𝝅)	– 𝐫 +	√𝒓𝟐 − 𝒆𝟐, |𝒏| < 𝟎. 𝟓 (red line), calculating the DNA spacing on the bead to 
660 nm. B: Example trace of positive (pink) and negative (blue) single crossings being input 
mechanically (DNA extension decrease), and removed by 900 nM MmT6 (DNA extension 
increase), under 0.5 pN, at 21°C. C: Unlinking times for negative crossings under 0.5 pN, plot as 
a histogram and fit to a single exponential resulting in a characteristic unlinking time (τR) 11.42 ± 
1.64 s. D: Unlinking times for positive crossings under 0.5 pN, plot as a histogram and fit to a 
single exponential resulting in a characteristic unlinking time (τL) 6.6 ± 1.2 s. E: Crossing angle 




Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 0.5 pN. The positive 
angle probability distributions were attained directly, with the negative distributions derived from 
the relationship PR(α) = PL(180°-α). F: Ratio of negative to positive probability from Figure 1E 
plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle 
(α0) can be attained, illustrated by the black arrow. For this tether geometry and force (0.5 pN), 
τL/τR = 0.57 ± 0.12, which gave α0 of 84.04° ± 4.2° when using MC simulations, and 88.25° ± 4.4° 
when using BD simulations (BD plots not shown). G: Unlinking times for negative crossings 
under 0.7 pN, plot as a histogram and fit to a single exponential resulting in a characteristic 
unlinking time (τR) 9.2 ± 1.5 s. H: Unlinking times for positive crossings under 0.7 pN, plot as a 
histogram and fit to a single exponential resulting in a characteristic unlinking time (τL) 6.1 ± 0.9 
s. I: Crossing angle probability distributions for single positive (PL(α), pink) and negative (PR(α), 
blue) crossings, from Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 
0.7 pN. The positive angle probability distributions were attained directly, with the negative 
distributions derived from the relationship PR(α) = PL(180°-α). J: Ratio of negative to positive 
probability from Figure 1I plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ 
PL(α0), the preferred angle (α0) can be attained, illustrated by the black arrow. For this tether 
geometry and force (0.7 pN), τL/τR = 0.7 ± 0.13, which gave α0 of 85.57° ± 4.3° when using MC 
simulations, and 88.25° ± 4.4° when using BD simulations (BD plots not shown). K: Unlinking 
times for negative crossings under 1 pN, plot as a histogram and fit to a single exponential 
resulting in a characteristic unlinking time (τR) 12.3 ± 1.7 s. L: Unlinking times for positive 
crossings under 1 pN, plot as a histogram and fit to a single exponential resulting in a 
characteristic unlinking time (τL) 6.6 ± 1 s. M: Crossing angle probability distributions for single 
positive (PL(α), pink) and negative (PR(α), blue) crossings, from Monte Carlo (MC) simulations 
[223] for the tether geometry seen in A, under 1 pN. The positive angle probability distributions 
were attained directly, with the negative distributions derived from the relationship PR(α) = 
PL(180°-α). N: Ratio of negative to positive probability from Figure 1M plotted on a 
semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle (α0) can be 
attained, illustrated by the black arrow. For this tether geometry and force (1 pN), τL/τR = 0.54 ± 0.1, 
which gave α0 of 87.45° ± 4.4° when using MC simulations, and 88.25° ± 4.4° when using BD 
simulations (BD plots not shown). The error associated with α0 is the combination of the 
statistical and systematic error. O: Unlinking times for negative crossings under 1.5 pN, plot as 
a histogram and fit to a single exponential resulting in a characteristic unlinking time (τR) 10.6 ± 
1.8 s. P: Unlinking times for positive crossings under 1.5 pN, plot as a histogram and fit to a 
single exponential resulting in a characteristic unlinking time (τL) 5.2 ± 0.8 s. Q: Crossing angle 
probability distributions for single positive (PL(α), pink) and negative (PR(α), blue) crossings, from 
Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 1.5 pN. The positive 
angle probability distributions were attained directly, with the negative distributions derived from 
the relationship PR(α) = PL(180°-α). R: Ratio of negative to positive probability from Figure 1Q 
plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle 
(α0) can be attained, illustrated by the black arrow. For this tether geometry and force (1.5 pN), 
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τL/τR = 0.49 ± 0.11, which gave α0 of 87.88° ± 4.4° when using MC simulations, and 87.75° ± 4.4° 
when using BD simulations (BD plots not shown). S: Unlinking times for negative crossings 
under 1.7 pN, plot as a histogram and fit to a single exponential resulting in a characteristic 
unlinking time (τR) 9.5 ± 1.8 s. T: Unlinking times for positive crossings under 1.7 pN, plot as a 
histogram and fit to a single exponential resulting in a characteristic unlinking time (τL) 4.7 ± 0.7 
s. U: Crossing angle probability distributions for single positive (PL(α), pink) and negative (PR(α), 
blue) crossings, from Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 
1.7 pN. The positive angle probability distributions were attained directly, with the negative 
distributions derived from the relationship PR(α) = PL(180°-α). V: Ratio of negative to positive 
probability from Figure 1I plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ 
PL(α0), the preferred angle (α0) can be attained, illustrated by the black arrow. For this tether 
geometry and force (1.7 pN), τL/τR = 0.49 ± 0.12, which gave α0 of 88.07° ± 4.4° when using MC 
simulations, and 88.25° ± 4.4° when using BD simulations (BD plots not shown). W: Unlinking 
times for negative crossings under 2 pN, plot as a histogram and fit to a single exponential 
resulting in a characteristic unlinking time (τR) 11.6 ± 2.3 s. X: Unlinking times for positive 
crossings under 2 pN, plot as a histogram and fit to a single exponential resulting in a 
characteristic unlinking time (τL) 5.08 ±  0.9 s. Y: Crossing angle probability distributions for 
single positive (PL(α), pink) and negative (PR(α), blue) crossings, from Monte Carlo (MC) 
simulations [223] for the tether geometry seen in A, under 2 pN. The positive angle probability 
distributions were attained directly, with the negative distributions derived from the relationship 
PR(α) = PL(180°-α). Z: Ratio of negative to positive probability from Figure 1Y plotted on a 
semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle (α0) can be 
attained, illustrated by the black arrow. For this tether geometry and force (2 pN), τL/τR = 0.44 ± 
0.11, which gave α0 of 88.07° ± 4.5° when using MC simulations, and 89.75° ± 4.5° when using BD 
simulations (BD plots not shown). Ai: Unlinking times for negative crossings under 2.2 pN, plot 
as a histogram and fit to a single exponential resulting in a characteristic unlinking time (τR) 14.6 
± 2.3 s. Bi: Unlinking times for positive crossings under 2.2 pN, plot as a histogram and fit to a 
single exponential resulting in a characteristic unlinking time (τL) 5.8 ± 1 s. Ci: Crossing angle 
probability distributions for single positive (PL(α), pink) and negative (PR(α), blue) crossings, from 
Monte Carlo (MC) simulations [223] for the tether geometry seen in A, under 2.2 pN. The positive 
angle probability distributions were attained directly, with the negative distributions derived from 
the relationship PR(α) = PL(180°-α). Di: Ratio of negative to positive probability from Figure 1M 
plotted on a semilogarithmic axis. Using the relationship τL/τR = PR(α0)/ PL(α0), the preferred angle 
(α0) can be attained, illustrated by the black arrow. For this tether geometry and force (2.2 pN), 
τL/τR = 0.4 ± 0.1, which gave α0 of 87.74° ± 4.3° when using MC simulations, and 88.75° ± 4.4° when 
using BD simulations (BD plots not shown). The error associated with α0 is the combination of 
















on Positive (τL)  
Unlinking Time 











1 1 624 8.43 43.85 0.19 87.87 83.5 
2 0.5 660 10.17 21.06 0.48 88.11 85 
 1  9.64 18.49 0.52 88.82 87.75 
 1.5  10.59 18.32 0.58 89.04 88.5 
3 0.7 679 5.38 8.18 0.66 88.81 85.75 
 1  6.56 7.27 0.90 89.28 86.25 
 1.5  7.39 10.50 0.70 89.12 87.75 
4 0.5 677 6.57 11.42 0.57 84.04 88.25 
 0.7  6.05 9.19 0.66 85.57 88.25 
 1  6.61 12.34 0.54 87.45 88.25 
 1.5  5.15 10.61 0.49 87.88 87.75 
 1.7  4.65 9.51 0.49 88.07 88.25 
 2  5.08 11.61 0.44 88.07 89.75 
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Appendix III 
Table II: Sequence information of MmT6 cleavage sites on pBR322*, detected using the Illumina 




(bp) Top Strand sequence 
Position 
(bp) Bottom Strand sequence 
























































































































































Table III: Sequence information of EcT4 cleavage sites on pBR322*, detected using the Illumina 
NGS platform. The sequences have been characterised as strong and weak. 
 
No. Position (bp) Top strand sequence 
Strong topo IV cleavage sites 
1 1414-1470 ACGCGGCGCATCTCGGGCAGCGTTGGGTCCTGGCCACGGGTGCGCATGATCGTGCT 
2 1846-1902 AGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTA 
3 2809-2865 CCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC 
4 3890-3946 TTGCTCTTGCCCGGCGTCAACACGGGATAATACCGCGCCACATAGCAGAACTTTAA 
Weak topo IV cleavage sites 
1 379-434 CCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTG 
2 493-549 GAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGG 
3 861-916 ACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAG 
4 930-985 CCGGCATGGCGGCCGACGCGCTGGGCTACGTCTTGCTGGCGTTCGCGACGCGAGGC 
5 1169-1225 TCGGCGAGAAGCAGGCCATTATCGCCGGCATGGCGGCCGACGCGCTGGGCTACGTC 
6 1569-1625 AACGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAA 
7 2180-2236 CGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGAT 
8 2413-2469 CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGA 
9 2661-2717 GTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGT 
10 2980-3036 TATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGC 
11 3375-3431 TAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACC 
 
 
Table IV:  Sequence information of EcT4 cleavage sites on pBR322*, detected using the Illumina 
NGS platform. The last column is the GC content (%) of each fragment (pBR322* GC content is 
53%). Fragment number 2 was topology-sensitive and only cleaved when negatively 
supercoiled pBR322* was used.  
 







2 1353-1493 GAATGCGCAAACCAACCCTTGGCAGAACATATCCATCGCGTCCGCCATCTCCAGCAGCCGCACGCGGCGCATCTCGGGCA 64.5 
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GCGTTGGGTCCTGGCCACGGGTGCGCATGATCGTGCTCCT
GTCGTTGAGGACCCGGCTAGG 
3 2637-2777 
GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGC
TTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGT
GGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCG
GTGTAGGTCGTTCGCTCCAAG 
59.6 
 
